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Abstract  
 
Irritable Bowel Syndrome (IBS) is a chronic functional disorder of the 
gastrointestinal system with prevalence in adults of 10-20%.  IBS is 
characterised by a number of troublesome symptoms including 
abdominal bloating, pain and excess gas, and has substantial impact on 
quality of life in addition to wider economic implications.  Conventional 
medical treatment can be problematic however, due to the lack of 
established aetiology and the number of symptoms reported.  
Concurrently, use of complementary and alternative medicine (CAM) to 
relieve IBS symptoms is reported to be as high as 50%, although the 
benefits and impact of such treatments are not fully substantiated by 
primary research data.  However, evidence has shown that people 
affected may benefit from psychological intervention in terms of reduced 
use of health care services and reported symptoms.     
 
This thesis has examined psychological factors that influence use of 
CAM and quality of life in individuals affected by IBS.  These factors were 
explored within the theoretical framework of an extended common-sense 
model of illness representations (CSM), which incorporated treatment 
beliefs.  The main aim of the thesis was twofold: to examine the illness 
perceptions and treatment beliefs that influenced CAM use and to 
explore pathways from illness and treatment representation to quality of 
life in CAM-users and those not using CAM (non-users).   
 
A web-based cross-sectional study and minimum six month time-period 
follow-up study were conducted.  Participants were primarily recruited 
from an IBS self-help network in the UK and other online message 
boards.  The cross-sectional study (n=653) considered illness 
perceptions and treatment beliefs associated with CAM use and how 
these factors differed in influencing coping strategies and quality of life in 
CAM-users and non-users.  The follow-up study (n=197) focused on 
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exploration of the influence of illness perceptions and treatment beliefs at 
study time one, on coping strategies and quality of life at study time two.   
 
The findings demonstrated that components of illness perceptions 
influenced CAM use, coping strategies and quality of life.  Treatment 
beliefs were more strongly implicated in influencing the use of CAM.  At 
the cross-sectional stage, stronger perceptions of illness consequences 
and emotional representations were major influences on reduced 
reported quality of life measures and poorer emotional outcomes in both 
survey groups, where similar strength effects were observed.  There 
were many observed instances of partial mediation of maladaptive and 
dysfunctional coping strategies such as self blame and behavioural 
disengagement.  In addition, follow up data demonstrated a reduction of 
the influence of illness perceptions (time one) on quality of life (time two) 
compared to the cross-sectional data.  Moreover, evidence of mediation 
effects was only detected in CAM-users in the follow-up study.  
 
These results highlight the importance of psychological factors, in 
particular illness perceptions, and to an extent, treatment beliefs in 
influencing coping strategies, quality of life and emotional outcome in 
those affected by IBS.  Practical and theoretical implications of the 
findings are considered and future applications discussed.  This thesis 
concludes with the proposal of a novel conceptual model to utilise a 
multiconvergent approach to enhance the quality of life and emotional 
outcomes in those affected by IBS.   
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Overview of thesis 
 
Irritable Bowel Syndrome (IBS) is a functional, chronic disorder affecting 
the bowel and is characterised by a number of symptoms including bouts 
of abdominal pain and bloating.  Prevalence in the population is indicated 
to be between 10-20% of the population (Jones & Lydeard, 1992; Wilson, 
Roberts, Roalfe, Bridge, & Singh, 2004) with a well documented female 
predominance in terms of health care seekers (Hungin, Chang, Locke, 
Dennis, & Barghout, 2005) The impact of IBS on everyday life is 
substantial (Amouretti et al., 2006; Lea & Whorwell, 2001).  In wider 
economic terms, it has been documented those affected with IBS are 
frequent users of health care services (Talley, 2008) and contribute to a 
significant proportion of lost working hours (Hungin et al., 2005).   
  
Treatment can often be problematic and reported to be unsatisfactory for 
many with IBS (Hayee & Forgacs, 2007).  Such insufficient scope of 
conventional treatment is seemingly mirrored by estimates that as many 
as 50% of those with IBS will use CAM for their symptoms (Kong et al., 
2005).  Concerns exist with CAM treatments for IBS as many lack 
demonstrated efficacy (Wersch, Forshaw & Cartwright, 2009), there may 
be potential for conventional and CAM treatment interactions (e.g. 
Shane-McWhorter & Geil, 2002) in addition to significant financial impact 
to the individual.  Improved management of IBS is therefore a desirable 
objective from many angles. 
 
As IBS is a functional illness with no organic manifestation of disease, 
aetiological focus has repeatedly fallen on the examination of 
psychological factors.  Evidence from both IBS and other chronic illness 
populations has suggested that perceptions related to illness influence 
quality of life and outcomes, more so than the illness itself (Drossman et 
al., 1999; Hayee & Forgacs, 2007).  Exploration of CAM use has also 
indicated stronger perceptions of illness may be indicative of a worse 
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illness experience in those that opt to use CAM (Hilsden, Scott, & 
Verhoef, 1998).  Individuals may also have concerns with their treatment 
that leads them to try what they perceive as more natural treatments 
(e.g. Bishop, Lewith, & Yardley, 2006).  
 
Identification of psychological factors that are influential on health related 
quality of life may enhance understanding of the role of psychology in 
IBS and offer future opportunities for focus on improving management 
(Rutter & Rutter, 2002; 2007).  Furthermore, by exploring reasons for 
CAM use and how CAM-users’ beliefs and perceptions differ from those 
not using CAM.  It may also be determined those using CAM perceive a 
more intense illness experience that may influence CAM use and if use 
of CAM affects quality of life judgements.  This thesis reports research 
which systematically addresses illness perceptions in those affected with 
IBS and the relationship of such perceptions with CAM use and reported 
quality of life.  To date, no published research has amalgamated these 
factors in the context of a systematic and theoretical framework. 
 
The aim of the research presented in this thesis is to examine the illness 
perceptions and treatment beliefs of individuals affected by Irritable 
Bowel Syndrome (IBS), using the common-sense model (CSM) of illness 
representations (Leventhal, Leventhal, & Contrada, 1998).  Two specific 
areas of investigation are presented.  Firstly, an exploration of which 
illness perceptions and treatment beliefs are associated with use of 
complementary and alternative medicine (CAM) in IBS is presented.  
Secondly, the influence of illness perceptions and treatment beliefs on 
coping and quality of life is considered in both those using CAM and 
those opting not to use CAM to relieve IBS symptoms.  The research 
presented has implications both for greater understanding of illness 
perceptions and treatment beliefs in IBS.  There is also potential for 
findings to potentially assist in developing future self-management 
strategies and patient centred medical consultations for those people 
presenting with IBS.     
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The following chapter introduces these two branches of research and is 
split into two parts.  The first part of the chapter (section 1.1) presents 
research that has highlighted the importance of psychological factors in 
IBS, with particular focus on illness perceptions and their influence on 
health related quality of life and CAM use.  In the second part of the 
chapter (section 1.6), a systematic review is presented that considers 
factors associated with CAM use in IBS.  Further evidence also suggests 
a role for treatment beliefs in influencing CAM use in that individuals may 
be concerned by effects of conventional medication while also having 
more positive beliefs about CAM. 
 
Chapter two outlines the theoretical approach of the research, proposing 
an extended version of the common-sense model of illness 
representations (e.g. Leventhal, Diefenbach, & Leventhal, 1992) as the 
most appropriate theoretical framework for the research.  This model 
allows for a structured and systematic approach to examining which 
illness perceptions and treatment beliefs are influential in CAM use.  The 
model also allows examination of pathways from perceptions and beliefs 
to outcome and if these can be explained through coping strategies, a 
process referred to statistically as mediation.  Also considered are the 
benefits of a prospective study, to examine changes in CSM components 
over time.   
 
Chapter three outlines the methodology employed in the research.  It 
considers a suitable approach to incorporating a qualitative component 
into a survey based design.  The protocol for conducting both a cross-
sectional and a follow-up study are outlined.  As the research was 
conducted via the internet, issues relevant to web-based research are 
also considered.  This chapter also outlines the statistical methods that 
were employed in chapters four, five and six.   
 
Chapter four presents the first part of the research analysis from the 
cross-sectional study.  This chapter examines the role of illness 
perceptions and treatment beliefs in influencing CAM use in those 
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affected by IBS.  Illness perceptions and treatment beliefs between CAM-
users and non-users (those not using CAM for IBS) are considered and 
how these factors influence use of more than one type of CAM (in CAM-
users) and which factors predict CAM use. 
 
Chapter five provides an examination of the pathways within the CSM 
and this is examined for CAM-users and non-users.  Relationships 
between components of illness perceptions and treatment beliefs are 
considered in addition to consideration of differences in quality of life 
between the two groups.  The CSM pathways are tested for evidence of 
mediation in each group.  Illness perceptions and treatment beliefs are 
firstly correlated with outcome and then coping.  Significant relationships 
are then tested for a relationship between coping and outcome whilst 
controlling for perceptions and beliefs. 
 
Findings from the follow-up study are outlined in chapter six.  Changes in 
components of the CSM are examined across the two study time points.  
Similar to the analysis conducted in chapter five, mediation was tested by 
assessing the influence of perceptions and beliefs (at study time one) on 
outcome (time two) and on coping (time two).  Significant relationships 
are then assessed for an influence of coping on outcome (time two) 
when controlling for illness perceptions and beliefs at time one.  
 
Chapter seven offers reflection and discussion of the research findings, 
conclusions, implications and areas for future direction.  This chapter 
considers all the findings presented in the thesis and considers the 
strengths, limitations and the practical and theoretical implications of the 
research conducted.  This chapter argues that the research presented in 
the thesis makes a new and substantial contribution to the understanding 
of CAM use in those affected by IBS and how the pathways in the CSM 
may differ over time depending on whether or not individuals use CAM to 
relieve the symptoms of IBS.  Future directions for the research are also 
considered. 
 
 23 
 
Chapter 1  
 
Irritable Bowel Syndrome, illness perceptions and the use of 
complementary and alternative medicine: an introduction to the 
research 
 
This chapter reviews the role of psychological factors and illness 
perceptions in Irritable Bowel Syndrome (IBS) and thus outlines the 
broad psychological context within which the research is set.  
Specifically, the chapter addresses the relationship between IBS 
symptoms and depression, anxiety and stress, and the role of illness 
perceptions in quality of life and healthcare seeking including CAM use.  
A systematic review of the use of CAM in IBS is presented and informs 
the rationale for the research presented in this thesis. 
 
PART 1: 
 
1.1 The importance of psychological factors in Irritable Bowel 
Syndrome 
This section introduces a definition, prevalence figures and process of 
diagnosis for IBS.  Aetiology of IBS is also briefly considered in addition 
to highlighting the importance of psychological factors in IBS and in 
influencing CAM use and quality of life.  
 
1.1.1 Definition of IBS  
IBS is a chronic functional disorder of the bowel characterised by a 
varying number of recurrent symptoms.  It is one of the most commonly 
reported disorders of the group of Functional Gastrointestinal Disorders 
(FGID) (Drossman et al., 1999).  Functional illnesses are classified as 
such when no aetiological factor or biological marker is present.  The 
National Institute for Health and Clinical Excellence guidelines (NICE) 
refer to IBS as: 
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“a chronic, relapsing and often life-long disorder.  It is 
characterised by the presence of abdominal pain or 
discomfort, which may be associated with defecation and/or 
accompanied by a change in bowel habit.  Symptoms may 
include disordered defecation (constipation or diarrhoea or 
both) and abdominal distension, usually referred to as 
bloating.  Symptoms sometimes overlap with other 
gastrointestinal disorders such as non-ulcer dyspepsia or 
celiac disease.  People with IBS present to primary care with a 
wide range of symptoms, some of which they may be reluctant 
to disclose without sensitive questioning.”  (NICE, 2008, p.4). 
 
 
The NICE definition recognises the possibility for co-morbidity with other 
organic and functional conditions, a factor suggestive that IBS can be 
influenced by somatic sensations from other conditions.  The key 
symptoms in IBS are abdominal pain or discomfort accompanied by 
constipation, diarrhoea and abdominal bloating.  The presence of 
numerous symptoms, indicate the motivation behind the classification of 
IBS as a syndrome.   
 
1.1.2 Diagnosis and prevalence of IBS 
Prevalence of IBS is estimated to range from 10% to 20% in western 
populations (Jones & Lydeard, 1992; Thompson, Heaton, Smyth, & 
Smyth, 2000; Wilson et al., 2004).  Corresponding rates have been 
reported in non-western populations from China (Drossman, 1999) 
although reported rates from a Thai population were lower than those 
from British and American participants (Danivat, Tankeyoon & 
Sriratanaban, 1988).   Moreover, more recent data from a large scale 
web-based study in the US showed slightly lower prevalence of 7% 
(Andrews et al., 2005).  However, current prevalence estimates may 
under estimate actual prevalence as many that fit IBS diagnostic criteria 
have been found to not seek medical care (Jones & Lydeard, 1992; 
Saito, Schoenfeld, & Locke, 2002; Thompson et al., 2000).   
 
From both postal and web-based studies, IBS seems most prevalent in 
those in middle adulthood, approximately ages 30 to 50 (Hungin et al., 
2005; Wilson et al, 2004) and declines with age (Corazziari, 2004).  
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Those with IBS have also been shown to be more likely to have a lower 
income, lower levels of education and feel as though they have lived with 
symptoms over a number of years (Andrews et al., 2005).  Prognosis 
estimates indicate an average duration of 10 years or greater and many 
report no improvement in symptoms over time (Hungin et al., 2005). 
 
Evidence has suggested female predominance in healthcare seeking for 
IBS (Andrews et al., 2005; Hungin et al., 2005; Thompson et al., 2000; 
Wilson et al., 2004).  However, as many with IBS do not seek healthcare 
(Saito et al., 2002), the prospect that a proportion of non-seekers of 
healthcare are male is possible.  It is currently unclear whether the 
gender disparity in IBS care seeking represents biological or 
environmental distinctions related to gender or differences in reasons for 
healthcare seeking (Corazziari, 2004). 
 
Diagnosis of IBS in adults, until recently, involved elimination of possible 
organic causes often resulting in both unnecessary investigations and 
lengthy referrals to specialists (Foxx-Orenstein, 2006; NICE, 2008).  It is 
in this way that ‘functional’ illnesses are sometimes considered to be 
diagnoses of exclusion.   Increased understanding of IBS however, has 
resulted in a shift towards validated symptom-based diagnostic criteria 
(table 1.2) which has helped ‘legitimise’ IBS as a recognised medical 
complaint (Drossman, 1999; Lea & Whorwell, 2003).   This move has 
seen an emphasis on firstly the Manning criteria (Manning, Thompson, 
Heaton & Morris, 1978) and more recently successive versions of the 
Rome criteria (e.g. Drossman, 1999; Drossman & Dumitrascu, 2006).  As 
well as IBS, the Rome criteria list over 30 FGID complaints including 
functional heartburn and functional abdominal pain syndrome 
(Drossman, 1999).  Diagnosis of IBS relies on close examination of an 
individual’s symptoms.  The basis of the Rome II criteria for IBS is the 
presence of continuous symptoms for a minimum of 12 weeks during the 
preceding 12 months.  Within such diagnostic criteria, the early 
elimination of possible ‘red flag’ signals such as unexplained weight loss 
or rectal bleeding is vital as this may indicate possible serious organic 
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conditions needing immediate medical attention (NICE, 2008).  NICE 
guidelines currently recommend that abdominal pain or discomfort, 
bloating or a change in bowel habit (tables 1.1 & 1.2) that has been 
present for the previous six months is indicative of IBS (NICE, 2008).  
 
Symptom led criteria have been useful in determining IBS in research 
studies and in influencing how IBS is diagnosed in general practice (table 
1.2).  The recent move to the Rome III criteria has seen a relaxation on 
the idea that symptoms should be present during the previous 12 
months.  The Rome III criteria, proposes symptoms should be evident 
during the previous six months (Drossman & Dumitrascu, 2006) and 
consequently, prevalence has been shown to increase with this 
relaxation of symptom duration (Sperber, Shvartzman, Friger, & Fich, 
2007).  The influence of the Rome III criteria on current NICE guidelines 
is evident in terms of both the type and duration of problematic 
symptoms (table 1.1) and suggests greater applicability of the Rome 
criteria into clinical practice.  Although clearly beneficial, symptom led 
criteria have been criticised on the grounds that the lack of a ‘gold 
standard’ of IBS classification and constant revision of criteria (as well as 
the use of different criteria) results in problems with diagnosis and 
therefore estimates of prevalence become less reliable (Boyce, Koloski, 
& Talley, 2000; Corazziari, 2004).  
 
The Rome criteria also recognise sub-types of IBS, which have been 
used largely for research purposes.  There may be a diagnosis of either 
diarrhoea predominant IBS (IBS-D) if there are no constipation related 
symptoms present or constipation predominant IBS (IBS-C) with no 
indicators of diarrhoea.  If no one type of IBS can be identified then the 
person may be classed as ‘alternating’ (IBS-A) in that there is sufficient 
variation in symptoms that no overwhelming sub-type is recognized.  In 
addition to the subtypes of IBS, there also exists a classification of 
‘refractory IBS’ for particularly severe cases (NICE, 2008).  
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Table  1.1 Key IBS symptoms reported and pattern of diagnosis in 
adults (adapted from Agrawal & Whorwell, 2006; NICE, 2008)  
 
Abdominal pain or discomfort present for at least 6 months that is: 
 relieved by defecation 
Or: 
 associated with altered bowel habit or stool appearance   
And at least two of the following symptoms: 
 
 Abdominal bloating, distension, hardness or tension 
 Altered stool evacuation (straining, urgency or feelings of incomplete 
evacuation – may form diagnosis of either diarrhoea or constipation 
predominant IBS, IBS-D and IBS-C respectively) 
 
 Symptoms are made worse by eating 
 
 Passage of mucus 
The following symptoms may also be used to support diagnosis: 
 Low backache 
 Nausea 
 Lethargy 
 Leg pain 
 Urinary symptoms (increased frequency, urgency or urge incontinence) 
Possible ‘red flag’ symptoms to refer for further investigation: 
 Unexplained or unintentional loss of weight 
 Rectal bleeding 
 A family history of ovarian or bowel cancer 
 Looser and more frequent stool over 6 weeks in people over 60 
 Anaemia  
 Abdominal or rectal masses (e.g. lumps or obstructions) 
 Inflammatory markers indicative of inflammatory bowel disease  
 
Several studies have shown that diagnosing IBS for research purposes 
using the Manning criteria results in higher prevalence than when 
compared with Rome I or II (Corazziari, 2004; Hillilä & Färkkilä, 2004; 
Koloski, Talley, & Boyce, 2001; Yale et al., 2008).  Similarly, comparison 
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of the Rome I and II criteria suggests that rates of IBS decrease further 
when using the Rome II criteria (Boyce, Talley, Burke, & Koloski, 2006; 
Corazziari, 2004), however other studies have shown moderate 
agreement between Rome I and II criteria (Yale et al., 2008).  These 
inconsistencies in diagnostic criteria may cast some doubt on the 
reliability of prevalence statistics and also highlight the need for a gold 
standard of diagnostic criteria for IBS (Hillilä & Färkkilä, 2004).  The 
move towards symptom led diagnosis has however removed the need for 
time consuming, costly and invasive GI investigations. 
 
Table  1.2 Comparison of Manning, Rome I and Rome II symptom-
based criteria for IBS (adapted from Corazziari, 2004). 
 
Manning criteria  Rome I criteria  Rome II criteria 
Abdominal pain relieved by 
bowel movement 
 
Continuous/recurrent 
symptoms of: 
Abdominal pain relieved by 
bowel movement or associated 
with change in frequency or 
consistency of stool. 
Continuous/recurrent 
symptoms for at least 12 
weeks in preceding 12 months: 
Abdominal pain or discomfort 
accompanied by two out of 
three features: 
 
Pain associated with looser 
stools 
 
In addition to two or more of 
the following (at least a quarter 
of the time): 
Relief with defecation 
Associated with a change in 
onset frequency 
Or, change in consistency of 
stool 
 
Pain associated with more 
frequent bowel movements 
 
Altered stool frequency 
Altered stool form (hard or 
loose) 
 
Symptoms that cumulatively 
support IBS diagnosis: 
Over 3 bowel movements a 
day 
Less than 3 bowel movements 
a week 
 
Sensation of incomplete 
evacuation 
 
Altered stool passage 
(straining or urgency, feeling of 
incomplete evacuation) 
Altered stool frequency 
(solid/lumpy or watery/loose) 
Passage of mucus 
 
Passage of mucus Altered stool passage – 
straining, urgency or feeling of 
incomplete evacuation 
 
Distension of abdomen 
 
Bloating or feeling of 
abdominal distension 
Passage of mucus; bloating or 
feeling of abdominal distension 
 
 
 
Individuals with IBS may present with other functional GI symptoms such 
as functional dyspepsia (FD) and gastro-oesophageal reflux disease 
(GORD) (Quigley, 2006; Corazziari, 2004) and non-GI complaints such 
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as chronic fatigue syndrome/myalgic encephalomyelitis, joint pain and 
pelvic complaints (Whitehead, Palsson, & Jones, 2002).   The fact that 
many with IBS also report non-GI symptoms has led to some speculation 
that there may be a degree of hyper-vigilance in regard of being aware of 
symptoms (Talley, 2008).  There may also be ‘secondary’ complaints of 
tiredness, lethargy and urinary problems (table 1.2).  Recommendations 
now include these factors (e.g. NICE, 2008) although there is no directive 
to treat factors such as fatigue or urinary problems per se.  The implicit 
assumption appears to rest on these problems decreasing following 
successful treatment of the most troublesome symptoms (Quigley, 2006). 
 
1.1.3 Aetiology 
As IBS is a functional gastrointestinal (GI) illness, with an as yet 
unidentified aetiology, a number of hypotheses regarding the aetiology of 
IBS have been proposed.  Visceral hypersensitivity (Quigley, 2006), 
altered gut motility (Jones et al., 2000; Quigley, 2006) and environmental 
factors (Hayee & Forgacs, 2007) have all been suggested as aetiological 
factors.  Some cases develop as post-infectious IBS, although these are 
thought to reflect a minority of individuals (Foxx-Orenstein, 2006).  
Genetic influences on IBS have been suggested however parental 
response to the illness has been shown to have a greater influence on 
children of those parents with IBS than genetic influences (Levy et al., 
2001).   Localised actions in the intestine, such as disrupted handling of 
gas, have also been proposed as causal factors (Caldarella, Jordi Serra, 
Fernando Azpiroz, & Malagelada, 2002; Serra, Azpiroz, & Malagelada, 
2001).  Full consideration of these factors however, is beyond the aims of 
the research presented in this thesis.    
 
In the absence of established aetiological factors, IBS has been 
conceptualised as a biopsychosocial disorder where several factors may 
influence the onset and maintenance of IBS symptoms (Drossman, et al., 
1999; Hayee & Forgacs, 2007).  In this context, IBS is considered a 
result of disruption in the brain-gut neural axis, where a complex 
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interaction between biological and psychosocial factors occurs resulting 
in symptoms (Drossman, et al., 1999).   
 
Current aetiological explanations for IBS have focused on the brain-gut 
axis (Drossman et al., 1999; Hayee & Forgacs, 2007).  In the 
complicated array of neurotransmitters, nerves and muscles between 
brain and gut, disruption of the pathways results in the manifestation of 
IBS symptoms such as abdominal pain and excess gas in the bowel 
(Guthrie & Thompson, 2002).  The biopsychosocial framework allows for 
consideration of the contribution of psychological and environmental 
factors on symptoms and behaviour (Drossman, 1998; Engel, 1977).  In 
some cases, it is thought a genetic predisposition to IBS may be evident 
that may be triggered by social, psychological or environmental stimuli 
(Drossman, 1998).  Early life events, attitudes to illness and possible 
traumatic events may all influence the development of an individual in 
psychosocial terms.  In turn this may affect a disposition for stress, 
emotional state, coping skills or learning illness behaviour from a family 
member (Drossman et al., 1999).  Moreover, there is evidence to 
suggest the onset and maintenance of IBS symptoms may be related to 
psychological factors such as stress, anxiety or depression (figure 1.1; 
Drossman et al., 1999; Lea & Whorwell, 2003).   
 
Current understanding of the interaction between brain and gut 
implicates a bi-directional process of emotional or perceptive states 
affecting GI sensation, motility and other IBS symptoms (Mulak & Bonaz, 
2004; Posserud, Ersryd, & Simrén, 2006).  Conversely, visceral 
sensation may affect perception of (abdominal) pain and emotional 
states resulting in escalation of symptoms (Drossman, 1999).  IBS 
symptoms are said to occur when communication between the GI muscle 
structure, the central nervous system (CNS), the autonomic nervous 
system (ANS) and neurons in the enteric nervous system (ENS) is 
disrupted (Foxx-Orenstein, 2006).   
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1.1.3.1 The influence of personality, stress, mood and abuse on IBS 
symptoms 
Some people diagnosed with FGIDs (including IBS) report a history of 
sexual or physical abuse in their past (Drossman et al., 1999).  This may 
be categorised as unwanted touching or being exposed to unpleasant 
images (Talley, Boyce, & Jones, 1997).  One problem with many studies 
reporting abuse is their reliance on retrospective self-report data which 
may over or under-estimate this association (Koloski et al., 2001).  
Certain psychological correlates appear to have particular significance in 
relation to IBS.  Drossman et al. (1999) found that between 42 and 61% 
of patients seen in gastroenterology clinics for FGIDs fall into the 
categories of anxiety disorders, mood disorders (including depression) or 
somatoform disorders (including hypochondria and somatisation 
disorders, where individuals express psychological distress through 
bodily symptoms).  However,   population based studies by Talley, 
Boyce, and Jones (1998) and Talley et al. (1997) conducted in Australia, 
suggest no relationship between care seeking in IBS and anxiety, mood 
or somatoform disorders.   
 
Despite there being no personality ‘profile’ distinct to IBS (Drossman et 
al., 1999) those with IBS have shown higher levels of both trait anxiety 
and neuroticism (Drossman, Whitehead, & Camillieri, 1997).  Neuroticism 
in particular seems to give rise to an exaggerated response to 
physiological sensation or symptoms (Koloski et al., 2001).  Drossman et 
al. (1988) found that IBS patients scored higher on personality traits such 
as hypochondria, hysteria and depression than non-consulters whilst 
symptom severity was controlled.  The findings from this study suggest 
that such personality factors may be independent of IBS itself and 
attributable to the individual.  The small number of studies in this area 
suggests further research needs to be conducted before ruling out the 
role of personality traits as an aetiological factor (Koloski et al., 2001).    
 
The link between increased stress and IBS is long established 
(Wilhelmsen, 2000).  Stress has been found to be a predictor of 
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exacerbating symptoms and prompting healthcare seeking (Drossman et 
al., 1999).  Stress has also been strongly linked with severity of 
symptoms.  Over the course of 16 months in a sample of 117 outpatients 
with IBS, chronic life stress predicted 97% of the variance in symptom 
intensity (Bennett, Tennant, Piesse, Badcock, & Kellow, 1998).  
Participants who showed improvement were not subject to chronic stress 
in their everyday life.  A further study by the same authors with 188 
outpatients fulfilling various FGIDs found that chronic stress provoked 
intestinal symptoms to a greater degree in the IBS sub-group of 
participants (Bennett et al., 1998).  
 
Stress has also been investigated using exclusively female samples.  
Levy, Jarret, Cain, & Heltkemper (1997) found a positive correlation 
between stress and IBS symptoms over one menstrual cycle.  When 
controlling for the menstrual cycle, stress was still linked to GI symptoms 
but not attributed to increases in stress during certain phases during a 
menstrual cycle (Levy et al., 1997).  However, the sample in this study 
was small (n=26) and only 38% of women reported a relationship 
between stress and IBS symptoms.  In larger samples, the relationship 
between stress and IBS symptoms appears to be small over time.  Over 
the course of a year, 383 women were found to demonstrate a weak 
correlation between stress and IBS symptoms (Whitehead, Crowell, 
Robinson, Heller, & Schuster, 1992).  It is clear however, that stress is a 
contributory factor in the experience of IBS and may influence 
differences in individuals’ responses to symptoms. 
 
It is plausible in this context, that psychological factors can precipitate 
and maintain symptoms of IBS.  Initial mood or emotional disturbances 
may affect GI symptoms as well as GI sensations affecting mood and 
emotions.  The variation in psychological influence on bowel function 
may also explain the variation in quality of life reported in IBS, which may 
result from such factors as poor coping strategies (Drossman et al., 
1999).   
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Figure 1.1 A biopsychosocial conceptualisation of IBS illustrating 
the relationship between early life, physiology, psychological 
factors, symptom experience, illness related behaviour and 
outcome (adapted from Mulak & Bonaz, 2004 and Drossman et al., 
1999).  
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1.1.4 Treatment and management strategies 
The impact of IBS on the individual and in wider economic terms is often 
substantial.  Conventional medical treatment has a number of options 
that attempt to reduce this impact (summarised in table 1.3) albeit the 
emphasis is on management of symptoms rather than cure.   
 
1.1.4.1 Impact of IBS 
The preceding sections have highlighted those with IBS have the 
potential for an extensive symptom experience meaning there is often 
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considerable impact of IBS.  Effective treatment is therefore desirable 
from both an individual and wider economic perspective.  Those affected 
with IBS tend to use healthcare services more often (Talley, 2008) and 
may be referred for costly secondary consultations (Wilson et al., 2004).  
In wider economic terms, IBS also contributes to a significant proportion 
of lost working hours and productivity (Dean et al., 2005; Hungin et al., 
2005; Wilson et al., 2004).  Moreover, several studies have 
demonstrated that IBS has a detrimental effect on multiple facets of daily 
life such as sleep, diet, sexual function, travelling and absence from work 
(Amouretti et al., 2006; Chang, 2004; Dancey & Backhouse, 1993; 
Dancey, Hutton-Young, Moye, & Devins, 2002; Faresjo, Grodzinsky, 
Foldevi, Johansson, & Wallander 2006; Halder et al., 2004; Lea & 
Whorwell, 2001; Luscombe, 2000; Spiegel et al., 2004).     
 
Dancey and Backhouse (1993) examined the impact of IBS with data 
gathered from 148 users of a self-help network in the UK.  Open 
questionnaire responses showed many participants reported feelings of 
anxiety and depression, felt unable to talk to others about their IBS and 
believed others could often be unsympathetic.  Participants felt IBS 
affected their working life.  Personal and intimate relationships also 
suffered as intimacy or even meeting someone could be problematic due 
to pain.  Over two thirds of participants stated that travel and leisure were 
affected.  Many participants in addition, felt stressed and had tried to 
alter their lifestyle, work and diet in an effort to make their IBS more 
manageable.  GPs were perceived to show a lack of sympathy as well as 
not explaining symptoms or stating there was nothing wrong.  Similarly, 
Amouretti et al. (2006) in examining 253 participants diagnosed with IBS 
found having IBS had a significant impact on reported quality of life.  
Longer symptom duration and perceived severity were predictive of more 
impaired quality of life.  In comparing people with IBS to healthy controls, 
IBS negatively impacted on elements of daily living, leisure activities, 
work, travel and social relationships and for some individuals was 
perceived to have become more severe since the onset of their 
symptoms.  There has been further suggestion that reported quality of 
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life may differ in different sub-groups of participants.  A US study 
performed a comparison of 147 patients recruited from a GI clinic and 84 
patients with IBS via the internet.  Those recruited online reported 
significantly poorer quality of life scores when compared to the GI clinic 
group suggesting the online participants may represent a distinct group 
of people affected by IBS (Jones, Bratten, & Keefer, 2007).  Further 
study however, is needed to substantiate these findings. 
 
1.1.4.2 Management of IBS symptoms 
It is recommended (NICE, 2008) that GPs adopt a patient centred 
approach incorporating dietary advice, suggested fibre supplementation 
and prescription of anti-spasmodic or anti-diarrhoeal medication as first 
line treatments.  If symptoms persist anti-depressants may be 
recommended or, in some cases, psychological treatments may be 
suggested if symptoms continue for over 12 months (NICE, 2008).  
Some GPs may also recommend complementary and/or alternative 
medicine (CAM) to relieve symptoms, although some CAM treatments 
have been shown to offer no benefit to those affected with IBS (table 
1.3).   
 
One randomised controlled trial conducted on 116 patients with IBS 
examined the effect of standard Chinese herbal medicine, personalised 
Chinese herbal medicine and placebo, found a significant improvement 
in symptoms rated by both patients and gastroenterologists.  The 
personalised treatment group still showed benefits up to 14 weeks later 
(Bensoussan et al., 1998).  Similarly, Yadav, Jain, Tripathi, and Gupta 
(1989) found herbal preparations to be useful over 6 weeks of treatment 
in 169 patients with IBS when compared with placebo, although standard 
treatment was more effective.  Both treatments were no better than 
placebo at six month follow up.   
 
As both conventional medical care and CAM treatments have debatable 
application in IBS, psychological treatments may be of benefit.  A number 
of psychological treatments may be recommended for IBS including 
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Cognitive Behavioural Therapy (CBT), Biofeedback, relaxation training 
and hypnosis (NICE, 2008).  Despite some claims that psychological 
treatments fare better than standard conventional care (Hayee & 
Forgacs, 2007), evidence for psychological treatments appears to be 
mixed.  Snelling (2006) argues that trials are often with small samples or 
lack necessary control in terms of blinding or control groups.  One study 
that compared CBT, relaxation and standard care found no difference 
between the three treatments (Boyce, Talley, Balaam, Koloski, & 
Truman, 2003).  Although other studies have reported benefits, the 
studies often fall short of requirements for controlled trials (Snelling, 
2006). 
 
Gonsalkorale, Miller, Afzal, and Whorwell (2003) suggest that hypnosis 
may work well in reducing symptoms for up to five years as well as 
reducing consultation rates and conventional medication use following 
hypnosis.  In reviewing studies that used hypnotherapy to control IBS 
symptoms, hypnosis was found to be effective in over half of trials 
included in the review (10 out of 18 studies) (Wilson, Maddison, Roberts, 
Greenfield, & Singh, 2006).  Although the results for hypnosis appear 
promising, it is argued this should take place as part of a specialist care 
programme and is not suitable for everyone affected by IBS (Hayee & 
Forgacs, 2007; Whorwell, 2006).  Promising results also come from CBT 
studies. However as with hypnotherapy, this approach is also not suited 
to every individual (Hayee & Forgacs, 2007).  CBT attempts to adjust the 
impact of cognitions and behaviour that may result in increased stress 
and GI symptoms (Lackner et al., 2007).  A meta-analysis of controlled 
trials has shown success rates for psychological treatments to be 
promising (Lackner, Mesmer, Morley, Dowzer, & Hamilton, 2004).  
Despite this success, local availability of such treatments may be limited 
for many (Lea & Whorwell, 2004).  The success of psychological 
treatments does however provide further support for a psychological 
approach to managing IBS symptoms. 
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Other psychological techniques have also been incorporated into self-
management interventions for IBS.  These approaches have focused on 
attempting to control symptoms by facilitating a greater understanding of 
IBS.  Ringström, Störsrud, Lundqvist, Westman and Simrén (2009) 
reported a promising pilot study based on an intervention educating 
individuals about aspects of IBS, known as ‘IBS school.’  Although no 
control group was used with this small sample (n=12), participants 
reported satisfaction with the information provision and knowledge about 
IBS increased.  Quality of life also improved and GI symptoms were 
reduced.  Ringström et al. (2010) compared 71 IBS patients who 
received the ‘IBS school’ intervention to 72 patients who received written 
information about IBS.  The structured education sessions had significant 
benefits in reducing symptoms, illness related anxiety, and facets of 
quality of life improved when compared with the information only group 
(Ringström et al., 2010).  
 
Similarly, Robinson et al. (2006) used a self help guidebook for IBS, with 
a participant group of 420.  The guidebook contained information to help 
participants cope with their IBS including information about treatments, 
diet and lifestyle.  Participants received either the book alone, the book 
with attendance at a one-off self-help group (which provided the 
guidebook and a group session) or were assigned to a control group with 
no intervention (i.e. usual care for IBS).  The guidebook group over the 
course of a year reported a 60% reduction in healthcare consultations for 
their IBS and a reduction in symptoms compared to the control group.  
The self-help group seemed to offer no additional benefit and symptom 
scores (as oppose to perceived symptoms) did not change significantly in 
any group.  The fact that perception of IBS changed and the number of 
healthcare consultations declined, suggest that the provision of self-help 
information about IBS at the time of consultation was beneficial.  
Similarly, Jarrett et al. (2009) assigned 188 participants with IBS to either 
a ‘usual care’ group, a self management session (including information 
about diet, education, relaxation and cognitive-behavioural strategies) 
delivered in person, or a third group that had a mixture of in-person 
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contact and self-help sessions over the telephone.  Over the course of 12 
months, the self-help groups reported fewer GI symptoms and improved 
quality of life compared with the ‘usual care’ group. 
 
 
Table  1.3 Summary of treatment guidelines for adults with IBS; 
adapted from the NICE guidelines (NICE, 2008). 
 
Treatments for IBS Treatment details 
Dietary and lifestyle 
advice 
Self help information (exercise, time for relaxation and 
medication).   Dietary advice on eating regularly with enough 
liquids and fibre and cutting down on unhealthy food and 
drink (and specific ingredients found in some foods).  The 
use of pro-biotic cultures may be recommended for a period 
of 4 weeks.  
 
Pharmacologic 
treatments 
Antispasmodic medication, Loperamide (anti-diarrhoeal 
treatment) or laxatives are first line pharmacologic 
treatments.  Anti-depressants are second line treatments if 
first line medication has limited success.  Doses at all stages 
should be reviewed according to clinical effect and potential 
side effects. 
  
Psychological 
treatments 
Treatments such as Cognitive Behavioural Therapy, 
Biofeedback or Hypnosis should be considered if 
pharmacologic treatment is unsuccessful after 12 months. 
 
Complementary and 
alternative medicines 
There is limited evidence for relief of symptoms from some 
herbal compounds although more research is needed.  
There is no current evidence that Acupuncture or 
Reflexology will give symptom relief (NICE, 2008). 
 
 
 
The preceding studies offer interesting and valuable findings suggesting 
symptoms may be reduced by enhancing feelings of control and 
understanding of IBS.  The benefits of a ‘positive’ diagnosis of IBS 
(NICE, 2008) on presentation with symptoms has positive therapeutic 
benefits (Hayee & Forgacs, 2007).  In treating IBS, GP consultations are 
important aspects of the treatment process where certain therapeutic 
qualities of the consultation may be enhanced by addressing patient 
concerns about their symptoms (Ilnyckyj, Graff, Blanchard, & Bernstein, 
2003).   
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1.1.5 Illness perceptions   
The promise shown by psychological treatments, self-management and 
education based interventions for IBS may be seen as support for a 
supposition that psychological factors play a role in the onset and 
maintenance of IBS.  As has been suggested those affected by IBS may 
be prone to problems with depression, stress and anxiety (Lea & 
Whorwell, 2003).  These factors are implicated in the cause and 
maintenance of symptoms via bi-directional pathways in the brain-gut 
axis (figure 1.1).  It is rare for a patient presenting to their GP with IBS 
symptoms to be screened for such disorders unless they report such 
problems exist.  However, a further important psychological factor in IBS 
is individuals’ beliefs and perceptions about the illness.     
 
Symptom perception is a subjective experience (especially so in the case 
of IBS) so experience of the same symptoms will not necessarily result in 
all individuals seeking healthcare (van Dulmen, Fennis & Bliejenberg, 
1998).   This subjective variation in sensation of pain, discomfort or 
perception of seriousness of the symptoms may help to explain the 
discrepancy between consulters and non-consulters in IBS.  Despite the 
subjectivity involved in symptom perception in IBS, there is evidence that 
shows cognitions and emotions related to the illness are important in the 
prognosis and experience of IBS.   
  
In IBS there may be somatoform disorders present (section 1.1.4.1) and 
exploration of these factors has determined there may be tendency for 
individuals to exhibit more body awareness of visceral symptoms.  Such 
body awareness may result in ‘catastrophising’ (Drossman et al., 1999; 
Lackner, Quigley, & Blanchard, 2004), an emotional reaction that 
symptoms represent a more serious condition (such as cancer).  
Gomborone, Dewsnap, Libby, and Farthing (1995) found that when 
comparing IBS patients with depressed patients, organic GI patients and 
healthy controls, the IBS group reported significantly more bodily 
preoccupation, disease phobia and greater hypochondriacal beliefs.  This 
study suggests that these factors exist independently of psychological 
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morbidity (depression was measured in this study) and presents the 
possibility that such emotional factors may influence symptom 
experience and quality of life in those with IBS.   
 
A number of studies have shown the value of intervening in illness 
related cognitions of referred IBS patients.  Patients were screened for 
somatic abnormalities that may have explained their IBS symptoms.  
These studies found that if Doctor-Patient agreement was high in relation 
to IBS related cognitions and anxiety, future use of primary healthcare 
services was reduced.  If agreement was low, in that patients may 
continue to attribute their symptoms somatically, then use of primary care 
remained high.  It also appears that GPs may reinforce somatic beliefs in 
referring patients for secondary care (van Dulmen, Fennis, Mokkink, & 
Bleijenberg, 1996; van Dulmen, Fennis, Mokkink, van der Velden, & 
Bleijenberg, 1994).  Illness related cognitions and emotions have also 
been associated with healthcare seeking (van Dulmen et al., 1998), so 
providing effective reassurance during medical consultations may help to 
reduce healthcare seeking.  Addressing patient cognitions using portable 
data units over a four week period in 37 individuals with IBS (with 38 in a 
control group), resulted in improvement in quality of life, and reduced 
catastrophising thoughts and pain (Oerlemans, van Cranenburgh, 
Herremans, Spreeuwenberg, & van Dulmen, 2010).  Only reporting fewer 
catastrophising thoughts however, remained stable at three months after 
the intervention (Oerlemans et al., 2010).  
 
There is suggestion that perceptions related to IBS may have greater 
influence on quality of life judgements than actual symptoms.  One study 
of patients attending a referral clinic suggested that health related quality 
of life was more influenced by psychological factors than severity of 
symptoms (Hahn, Kirchdoerfer, Fullerton, & Mayer, 1997) while other 
studies have suggested both symptoms and perception of symptoms 
influence quality of life (Naliboff, Balice, & Mayer, 1998; Spiegel et al., 
2004; Whitehead, Burnett, Cook, & Taub, 1996).   
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Specific illness related cognitions have been shown to be related to self-
reported quality of life in people with IBS.  Rutter and Rutter (2002) found 
weaker beliefs about the consequences of IBS and greater control over 
symptoms were related to better quality of life ratings.  Beliefs in more 
serious consequences were also consistently related to poorer reported 
quality of life over a 12 month period (Rutter & Rutter, 2007).   
 
The evidence presented suggests illness related perceptions are 
important influences on illness experience, quality of life (Chang, 2004; 
Luscombe, 2000) and healthcare seeking (van Dulmen et al., 1994; 
1996; van Dulmen, Fennis, Mokkink, van der Velden, & Bleijenberg, 
1997).  The supposition that illness perceptions influence quality of life 
and healthcare seeking also fits into the biopsychosocial explanation of 
IBS (e.g. Drossman et al., 1999; Lea & Whorwell, 2004).  As previously 
considered, quality of life is significantly impaired in IBS (e.g. Lea & 
Whorwell, 2001).  The lack of biological/organic markers in IBS means 
that many studies utilise self-report measures of quality of life (Lea & 
Whorwell, 2001; Patrick, Drossman, Frederick, DiCesare, & Puder, 1998; 
Rodríguez & Fernández, 2003) as a study outcome or barometer of 
symptom experience.  In IBS, reported quality of life has been shown to 
be poor, even when compared with more serious potentially life 
threatening conditions (Drossman et al., 1999) and when compared with 
healthy controls (Lea & Whorwell, 2001).  This may be indicative of why 
large numbers of those affected with IBS use CAM.  However, despite 
using CAM, reported quality of life in CAM-users has been shown to be 
poorer than that of non-users (i.e. those not using CAM) with IBS (van 
Tilburg et al., 2008).  There is also little known about the processes 
through which illness perceptions may influence reported quality of life in 
IBS. 
 
Evidence also demonstrates that those affected with IBS will have causal 
beliefs, many of which imply psychological factors are instrumental in 
onset and maintenance of symptoms.  From 261 participants diagnosed 
from the Rome criteria, high numbers cited anxiety, diet and depression 
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as causes of their symptoms.  Few (less than 30%) knew that abdominal 
pain was one of the key symptoms in diagnosis (Lacy et al., 2007).  
Stress has also been cited as either one of the main causal factors 
(Hungin et al., 2005) or triggers in IBS (Casiday, Hungin, Cornford, de 
Wit, & Blell, 2009).  Rutter and Rutter (2002) found that beliefs in a 
psychological cause resulted in higher levels of anxiety being reported.  
Individuals with IBS seem to acknowledge that IBS may have a variety of 
causes (Dancey et al., 2009) but successful treatment of IBS is more 
important to those affected than causal explanations (Casiday et al., 
2009; Dancey et al., 2009).  There may also be differences in causal 
beliefs according to gender or type of care being received.  Males with 
IBS in primary care reported similar abdominal complaints, causal 
attributions, related health complaints and had similar demographics to 
IBS outpatients.  Conversely, female outpatients were shown to attribute 
their IBS to somatic causes whereas patients in primary care more 
readily attributed their IBS to stress (van der Horst et al., 1997).   
 
Some affected with IBS will adopt what are considered avoidant, 
maladaptive or dysfunctional coping strategies.  Some demonstrate 
avoidant behaviour of certain activities, or feel so constrained by their 
symptoms that they effectively stop taking part in activities previously 
enjoyed (e.g. Dancey & Backhouse, 1993).  This avoidant behaviour may 
be influenced by perceptions of whether symptoms would cause a 
particular problem, resulting in a response of avoiding the task or action.  
Dancey and Backhouse (1993) also found evidence of self blame in 
those affected by IBS, where individuals appeared to blame themselves 
for their IBS through causal explanations of lifestyle, stress and dietary 
habits.  Self blame has been classified as a maladaptive form of coping 
(e.g. Carver, 1997) and as considered previously such coping styles 
have been associated with poorer outcomes in functional bowel 
disorders (Drossman et al., 1999; Drossman, Leserman, et al., 2000). 
 
In contrast, evidence suggests those affected go to great lengths to cope 
with their IBS by using numerous coping strategies such as relaxation 
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techniques, utilising the support of others and making dietary 
modifications (Casiday et al., 2009; Fletcher, Schneider, Van 
Ravenswaay, & Leon, 2008).  It has also been suggested that individuals 
with IBS perceived they could cope more effectively if they had been 
given more information and had better understanding of IBS (Dancey & 
Backhouse, 1993).  Rutter and Rutter (2002) found different coping 
strategies to be related to illness perceptions in individuals affected by 
IBS further suggesting an important and influential role for illness 
perceptions.  
 
To determine the significance and influence of illness perceptions in IBS, 
it would be logical to examine their influence on quality of life and coping 
strategies.  Evidence from a number of chronic illnesses (e.g. head and 
neck cancer and rheumatoid arthritis) illness related perceptions or 
cognitions have been shown to influence coping strategies (Carlisle, 
John, Fife-Schaw, & Lloyd, 2005; Llewellyn, McGurk, & Weinman, 2007).   
 
1.1.6 Explaining CAM use in IBS  
Symptoms may respond well to a combination of medication and diet 
modification or supplementation of fibre (Hammerle & Surawicz, 2008).  
Reviews of controlled trials however, suggest the efficacy of 
pharmacologic treatment and dietary supplementation is questionable 
(Ford et al., 2008; Lesbros-Pantoflickova, Michetti, Fried, Beglinger, & 
Blum, 2004).  Responses to conventional medical treatments have also 
been shown to be variable and can lack lasting success (Hayee & 
Forgacs, 2007) leading to feelings of frustration (Casiday et al., 2009).  
Pharmacologic treatments have also been associated with negative GI 
side effects thus limiting any benefit (Hussain & Quigley, 2006).  Anti-
depressant medication may be introduced as a second line of treatment 
if first line treatments (table 1.3) are unsuccessful, and have shown 
promising findings (Hayee & Forgacs, 2007).   
 
It is therefore perhaps not surprising that CAM use in IBS is reported to 
be high.  In a sample of 281 participants with IBS, one study found over 
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50% had used some form of CAM (Kong et al., 2005).  Similarly, van 
Tilburg et al. (2008) found CAM use of approximately 35% in a sample of 
1012 individuals with functional bowel disorders (FBD), rising to 38.4% 
when IBS (n=419) was considered independently.  As previously 
considered, there are a small number of studies that suggest some forms 
of CAM may be useful in treating IBS (e.g. Bensoussan et al., 1998; 
Yadav et al., 1989).  Many CAM treatments however, still lack 
demonstration of efficacy based on randomised controlled trials although 
this very premise of demonstrating efficacy of CAM through randomised 
controlled trial is sometimes regarded as an affront to particular CAM 
philosophies (Wersch et al., 2009). 
 
Although defining CAM can be problematic, it is generally accepted that 
CAM modalities include treatments, practices or therapies that tend to 
operate differently to the biomedical model of most conventional medical 
treatment.  Treatment is usually self-funded by the individual as most 
treatments are not covered by state funded healthcare.  Demarcation has 
previously existed between ‘complementary’ treatments typically used in 
conjunction with conventional medication and ‘alternative’ treatments, 
used in place of conventional medicine (Wersch et al., 2009).   Within the 
domain of CAM there is often categorisation of treatments into mind-body 
therapies, biologically based treatment, manipulative treatment, holistic 
practices and energy based healing (Hilsden, Verhoef, Rasmussen, 
Porcino, & DeBruyn, 2011).  Problems in defining CAM are further 
compounded by the extensive variation within different CAM treatments 
where different treatments have differing philosophical orientations 
(Aakster, 1986; Zollman & Vickers, 1999).   Furthermore, there are 
issues with grouping treatments that are purchased over the counter with 
therapies that require contact with a practitioner (Wersch et al., 2009).  
There is also evidence that users of different CAM modalities possess 
different characteristics (Kelner & Wellman, 1997).  This research is not 
an attempt to disseminate such differences but to consider CAM-users 
as a group of individuals who seek treatment for IBS outside of 
conventional medicine.  
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Definitional issues aside, in general populations CAM use appears to be 
extensive.  One large scale survey conducted in the US suggests that 
CAM use in the population grew from 33% in 1990 to 42% in 1997 
(Eisenberg et al., 1998).  In the UK, 10% of people indicated they had 
used CAM in the preceding 12 months, with 90% using CAM at some 
point in their lives (Thomas, Nicholl, & Coleman, 2001).  This is 
contrasted with 41% of those in the US using two or more CAM 
treatments in the preceding year (Tindle, Davis, Phillips, & Eisenberg, 
2005).  In this context, the use of CAM may be seen as one form of 
adaptive coping behaviour (Suarez & Reese, 2000), as it represents a 
move towards attempting to control symptoms.         
 
Despite the extensive use of CAM, there remain concerns with such 
aspects as efficacy and regulation of treatments.  In the UK, government 
legislation (Department of Health, 2001) has sought to prevent unjustified 
health claims by practitioners and those in the conventional medical 
domain have the power to advise if a treatment works or not (Wersch et 
al., 2009).   If CAM treatments are found to show significant effects, 
regulation and further testing are essential as there may be potential for 
harm in an active component of treatment (Wersch et al., 2009).  Even 
without claims of efficacy, there may be potential for harmful interactions 
between pharmacologic treatment and some forms of CAM (Leung, 
Shalansky, Lo, & Jadusingh, 2009; Shane-McWhorter & Geil, 2002; 
Vincent & Furnham, 1997).  Furthermore, current NICE guidelines 
recommend against using reflexology and acupuncture for IBS as current 
findings suggest there is no beneficial effect for either of these 
treatments (NICE, 2008).   
 
One further criticism of CAM treatments is that they may subject to an 
increased placebo (i.e. a perceived or actual) effect, especially in the 
case of a consultation with a CAM practitioner (Kaptchuk, 2002).  Dorn, 
Kaptchuk, Park, Nguyen and Canenguez (2007) compared placebo 
responses in a number of CAM and conventional medication trials.   
Nineteen trials were reviewed with a pooled estimation of placebo rate of 
 46 
42%, and this was found to increase the longer the treatment period 
(Dorn et al., 2007).  This rate may be underestimated as the difference in 
CAM and conventional consultations is well documented to differ on such 
factors as time spent with a client and perceived increased levels of 
empathy in CAM consultations which may ‘enhance’ any placebo effect 
(Kaptchuk, 2002).  Such factors may even ‘pull’ people towards using 
CAM, as an extended consultation may be regarded as a desirable or 
positive aspect of treatment (Vincent & Furnham, 1997).  At this point it is 
worth clarifying that this thesis is not intended to be either a critique or 
endorsement of CAM, but an exploration of the perceptions and beliefs of 
those that use CAM.  
 
CAM availability has increased in the last three decades with several 
GPs now offering CAM treatments directly or referring patients to CAM 
practitioners (Thomas, Nicholl, & Coleman, 2003).  These factors do not 
solely account for the increase CAM use.  Work with non-illness specific 
populations has established being female, having higher disposable 
income and higher educational attainment are all socio-economic factors 
shown to predict CAM use (Astin, 1998; Bishop & Lewith, 2010).  Those 
with chronic health conditions have been shown to be more likely to 
utilise CAM treatments (Astin, 1998; Bishop & Lewith, 2010; Vincent, 
Furnham, & Willsmore, 1995).   
  
Existing research exploring CAM-user beliefs and attitudes has 
suggested having a positive attitude towards CAM, feeling conventional 
treatment has failed to cure or relieve illness, having concerns in relation 
to harmful effects of medication and some unease with communication 
with doctors influence CAM use (Vincent & Furnham, 1996).  Other 
studies have also cited beliefs about the potential harmful effects of 
conventional medication as influences on CAM use (Bishop et al., 2006; 
Horne, Weinman, & Hankins, 1999).  CAM users have also been shown 
to have a holistic (i.e. a whole body) approach to health rather than just 
treating the health problem (Astin, 1998; Testerman, Morton, Mason, & 
Ronan, 2004) as well as seeking greater control in the treatment (Bishop, 
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Yardley, & Lewith, 2007) and being less likely to smoke or drink alcohol 
(Nahin et al., 2007).  Furthermore, positive beliefs regarding CAM appear 
not to be related to outcomes following CAM treatment (Lewith, Hyland, 
& Shaw, 2002). 
 
Illness perceptions have also been shown to be related to CAM use 
(Bishop et al., 2006; Bishop et al., 2007; Searle & Murphy, 2000).   
Beliefs in a psychological cause influenced whether participants adhered 
to a homeopathic treatment regimen (Searle & Murphy, 2000).  However, 
this study only had a small sample (n=30), making it difficult to generalise 
findings.  Bishop et al. (2006) studied a much larger general population 
sample recruited from the internet.  Stronger beliefs in an emotional 
cause, greater understanding of illness and poorer consequences all 
predicted CAM use (Bishop et al., 2006) in a logistic regression model 
that accounted for a moderate 36% of the variance in CAM use.  A 
further study (Bishop, Yardley, & Lewith, 2008) showed much weaker 
associations between illness representations and adherence to CAM 
suggesting illness representations may be more important predictors of 
CAM initiation than repeated use (Bishop et al., 2008). 
   
In chronic fatigue syndrome/myalgic encephalomyelitis and other fatigue 
related illnesses, CAM use has been found to be as high as 77% in a 
sample of 444 participants (Jones, Maloney, Boneva, Jones, & Reeves, 
2007).  This high use was attributed to symptoms and having other 
medical or psychiatric complaints (Jones, Maloney et al., 2007).  In 
organic bowel conditions, such as Inflammatory Bowel Disease (IBD) 
patients have been shown to be more likely to use CAM if they perceive 
their symptoms to be poorer than those of others with IBD and if 
symptoms hindered their everyday life.  Longer illness duration and a 
history of hospitalisation are also factors that have been shown to 
influence CAM use (Hilsden, Scott & Verhoef, 1998; Scott, Verhoef & 
Hilsden, 2003).  One study of 239 UK GI outpatients with IBD found 26% 
were currently using CAM for IBD, with 53% stating it had helped with 
symptoms (Langmead, Chitnis, & Rampton, 2002).  CAM prevalence 
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surveyed from a number of western populations appears to fall within 
21%-60% for IBD, for both present and past CAM use (Hilsden et al., 
2011). 
 
Furthermore, concerns about harmful effects of medication and the 
feeling that conventional medicine was ‘failing’ also predict CAM use in 
IBD (Hilsden et al., 1998) as do concerns about doctor-patient 
communication (Scott et al., 2003).  Other studies with IBD patients 
suggest a poorer reported quality of life increases the likelihood of using 
CAM for symptom relief (Langmead et al., 2002).  Emotional and social 
anxieties are also associated with patients turning to CAM.  Additionally, 
patients with gastrointestinal (GI) disorders have been shown to 
associate perceived profits with CAM use, that is rewards, such as 
decreased stress, anxiety and pain, which outweigh perceived costs 
such as pain, nausea and financial outlay (Giese, 2000). 
 
Conventional healthcare seeking behaviour seems to be prompted by 
discomfort or prolonged symptoms (Talley et al., 1997) and there is 
evidence that conventional healthcare seekers have a more ‘severe’ 
illness experience.  Similarly, Bishop and Lewith (2010) reported CAM-
users as perceiving inferior health status than non-users.  Wilson et al. 
(2004) found consulters of healthcare had poorer quality of life than non-
consulters with IBS.  It is therefore plausible to suggest that those using 
CAM for their IBS will have a more intense illness experience than those 
not using CAM, which is also reflected in the lower quality of life reported 
in CAM-users with IBS (van Tilburg et al., 2008).  To date, no published 
research has examined this possibility.   
 
Examining existing studies that have considered CAM use in those 
affected by IBS may illustrate where the shortcomings in research exist 
and where future research may direct attention.  Therefore as part of this 
research, a systematic review was conducted to examine the prevalence 
of, and factors associated with, CAM use in those affected by IBS.   
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PART 2: 
1.6 Factors associated with complementary and alternative 
medicine use in Irritable Bowel Syndrome: a systematic review 
The aim of the systematic review was to examine and quantify the extent 
of CAM use and reasons for CAM uptake in those affected by IBS.  
 
1.6.1 Method 
1.6.1.1 Search Strategy 
Searches were conducted for articles published from 1978 onwards, 
when the first symptom based criteria, the Manning criteria, for 
diagnosing IBS was published (Manning et al., 1978).  The AMED, 
EMBASE, Cinahl, PubMed, PsychINFO and the Cochrane database for 
systematic reviews were searched to identify all studies that considered 
the prevalence of and factors that influence CAM use in those with IBS.  
This electronic search was carried out using the terms ‘irritable bowel 
syndrome’, ‘complementary’ and ‘alternative’.  Further searches were 
carried out using the terms ‘functional gastrointestinal’ and ‘functional 
bowel’ in conjunction with the terms previously listed.  There were no 
further restrictions on date of publications.   
 
1.6.1.2 Selection process  
Duplicates were removed from the search and all abstracts (n=1264) 
subsequently read.  Selected studies were included if 1) there was 
measurement of the extent of CAM use in the sample and 2) they had 
examined which factors may have a role in those with IBS using CAM 
treatments.  There were no restrictions placed on the type of analysis or 
design the studies used.   Only published, English language studies were 
included.  Where it was unclear if the study would fit the review criteria, 
the paper was obtained in full.  The reference lists of all papers were 
checked for additional studies that met the review’s inclusion criteria.  
The search process is outlined in figure 1.2.  
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1.6.1.3 Data analysis 
Due to the variation in sample size and the differences in measures used 
in the selected studies, meta-analysis was thought to be inappropriate 
and results are presented using a tabular and narrative summary. 
 
 
1.6.2 Results 
Five published studies met the review inclusion criteria.  The resulting 
studies were conducted in the UK (Smart, Mayberry, & Atkinson, 1986), 
Holland (Donker, Foets, & Spreeuwenberg, 1999), Canada (Verhoef, 
Sutherland, & Brkich, 1990), Australia (Koloski, Talley, Huskic, & Boyce, 
2003) and the US (van Tilburg et al., 2008).  Four studies used a 
survey/questionnaire design and one (Donker et al., 1990) used 
quantifiable structured interviews.  A summary of the findings of each of 
the studies can be found in Table 1.4. 
 
All of the studies examined responses (to questionnaires/interviews) of a 
group of participants with a functional bowel disorder (FBD) or focused 
specifically on IBS.  Recruitment varied from postal questionnaires 
(Smart et al., 1986), to general practitioner clinic (Donker et al., 1999) 
and outpatient clinic (Smart et al., 1986; Verhoef et al., 1990).  Two 
studies used data collected from a previous healthcare survey for those 
with FBD (van Tilburg et al., 2008) and previous population surveys 
(Koloski et al., 2003).  All reviewed studies reported a larger number of 
female participants ranging from approximately 60-75% of sample sizes. 
 
1.6.2.1 Methodological comparison 
All studies used group comparisons as a focal point of analysis.  Two 
studies (van Tilburg et al., 2008; Verhoef et al., 1990) used one group of 
IBS/FBD outpatients, analysed in terms of those who had used CAM and 
those that had not, drawing participants from an outpatient clinic. Smart 
et al. (1986) compared 96 IBS patients, 143 patients with other 
unspecified organic upper GI disorders (both from an outpatient clinic) 
with 222 Crohn’s disease patients contacted by post.  The remaining 
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studies (Donker et al., 1999; Koloski et al., 2003) used an IBS group 
compared to a control group of healthy participants.  
 
 
Figure 1.2 Flow chart showing the process of identifying relevant 
studies 
 
 
 
Potentially relevant studies 
identified from databases 
n= 1264 
Studies examined in greater 
detail for inclusion 
n=215 
Studies excluded: focus on 
IBD or conventional care 
seeking          n=8 
Commentaries, reviews, 
pediatric samples and 
duplicates excluded  
n=202 
n= 
Studies not focusing on aims 
of review excluded 
n= 1049 
Studies included in analysis 
n=5 
Possible studies to include in 
analysis 
n=13 
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Table  1.4 Summary of studies included in the systematic review 
 
Key: 
GHQ – General Health Questionnaire                                SSI – Semi-structured interview 
IBS-SS – IBS symptom severity scale                               BIOPRO – Biographical list of problems            
IBS-QOL – Irritable Bowel Syndrome Quality of Life       BSI – Brief Symptom Inventory 
 
Study 
 
Participants Diagnosis of IBS Design Extent of CAM use Reasons for CAM use 
Smart et al. 
(1986)  
(UK) 
n=96 IBS patients (n=67 
female); 
n=143 organic GI (n=84 
female); n=222 Crohn’s 
disease (n=137 female). 
IBS - Manning et 
al. (1978). 
Questionnaire – practices and 
practitioners.  No. of treatments, 
treatment options. 
CAM use: IBS (11%); GI (4%); 
Crohn’s (6%). 
Consulted CAM practitioner: IBS 
(16%); GI (2%); Crohn’s (6%).  
 
CAM use significantly more likely if conventional 
treatment ‘had failed’ those with IBS. 
 
Verhoef et al. 
(1990) 
(Canada) 
n=395 GI adult outpatients 
(n= 237 female) 
(n=63 Functional 
diagnosis) 
Gastroenterologist 
consensus scale 
1(functional) – 5 
(organic). 
Questionnaire CAM use and 
scepticism towards conventional 
medicine. 
50% of CAM users had 
functional diagnoses (13% of 
non users).   41% of CAM use 
not for bowel disorder but other 
health issue. 
 
 
CAM users significantly less satisfied with 
conventional treatment (54% v 85% non users); 
had more stressful life events in previous year 
(70% v 47%); more sceptical of conventional 
medicine (49% v 13%) and less satisfied with 
conventional practitioner answers (77% v 91%). 
Donker et al. 
(1999) 
(Holland) 
 
 
 
Population: n=10787 GP 
registered (age 15+, 51% 
female) n=53 (n=37 
female) IBS patients via 
General practice. 
Diagnosed prior to 
study. 
Questionnaire – experienced 
health; GHQ (30); no of 
complaints (14 days prior); 
BIOPRO scale 
(N=53 interviews). 
32% of those with IBS consulted 
CAM practitioner (15% non-
IBS). 
IBS patients had significantly poorer health (and 
‘other’ complaints); higher GHQ & BIOPRO 
scores compared to population group.   
 
 
Koloski et al. 
(2003) 
(Australia) 
n=207 IBS/FD patients (n= 
143 female); n=100 
controls (no symptoms – 
not included in all 
analyses). 
Abdominal pain > 1 
month; Rome I 
criteria.  IBS or 
functional 
dyspepsia. 
Healthcare seeking SSI; 
symptom status; Psychological 
morbidity. 
86.5% functional GI group 
sought conventional healthcare.  
20.8% had sought alternative 
healthcare. 9% had used CAM 
in previous 12 months. 
Females significantly more likely to use CAM in 
contrast to greater pain and perception of 
symptoms predicting conventional care seeking. 
van Tilburg et 
al. (2008) (US) 
n=1012 patients with IBS 
or other functional 
diagnosis  
(n=248 male).  CAM users 
and non-CAM users 
compared. 
Patient index cards 
screened to 
determine IBS or 
other functional 
diagnosis. 
Questionnaires completed 
including; symptom severity 
(IBS-SS); Quality of life (IBS-
QOL); Psychological distress 
(Brief symptom inventory – BSI); 
Ratings of perceived 
effectiveness of treatment. 
CAM use was 35% over past 
three months in FBD, 38% in 
IBS; ginger, massage and yoga 
were the most popular CAM 
treatments. 
Factors that predicted CAM use were being 
female, higher education level and higher anxiety 
(BSI).  Dissatisfaction with conventional care and 
perception of lack of effectiveness of prescription 
medication were not associated with CAM use. 
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Smart et al. (1986) assessed the frequency of CAM use in patients with a 
diagnosis of IBS according to the Manning criteria (Manning, Thompson, 
Heaton, & Morris, 1978) and for whom a full clinical examination revealed 
no bowel abnormalities. Patients with organic GI disorders were recruited 
from the same outpatient clinic and the Crohn’s patients were contacted 
via post.  All participants completed a questionnaire based on alternative 
medicine consultations.   
 
Verhoef et al. (1990) examined patients who sought alternative treatment 
for the problem which had required a consultation with a GI specialist in 
the past two years.  Differences in demographic and health status 
between those that used CAM and those that did not were compared.  Of 
the 395 GI patients recruited, 55 were classed as having a functional GI 
disorder.  Diagnosis was carried out by four GI specialists who had a high 
agreement rate (89%) for the study.  This study excluded patients who 
used CAM for health problems other than their diagnosed GI disorders.  
Participants completed a questionnaire based on scepticism towards 
conventional medicine and were asked if they had used alternative 
medicines during the last two years.   
 
Donker et al. (1999) focused on the health status of 53 patients with IBS 
recruited from general practices participating the Dutch National Survey 
of Morbidity and Intervention in General Practice and compared their use 
of healthcare services including CAM to the population sample of 10,787.   
Participants were asked about their healthcare use and completed the 
General Health Questionnaire (GHQ) a screening tool for psychiatric 
illness (Goldberg, 1972) and the biographic problem list (BIOPRO) which 
measures social problems (Hosman, 1983). In addition, they were asked 
about any health problems in the two weeks prior to being questioned.  
Additional measures included health related behaviour (e.g. smoking, 
exercise) and the amount of healthcare sought.  This ranged from seeing 
the GP (in the previous three months), a physical therapist (in the 
previous 12 months), a specialist in the last two years and an alternative 
therapist in the previous five years. 
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Using semi-structured interviews and questionnaires, Koloski et al. (2003) 
considered rates of use of both conventional and alternative healthcare in 
207 patients with functional GI diagnoses (IBS or functional dyspepsia).  
Participants were recruited from one of two previous surveys carried out 
by the same authors and separated into consulters or non-consulters for 
both conventional and alternative healthcare.  Participants were given a 
healthcare seeking interview which assessed healthcare use and 
frequency, access to healthcare and satisfaction with their healthcare.  
The structured interview for bowel symptoms was also administered to 
give a functional diagnosis based on the Rome I criteria (Drossman et al., 
1994).  This structured interview also accounts for aspects related to 
quality of life and extent of symptoms.  In addition, participants were 
given the Composite International Diagnostic Interview (World Health 
Organisation, 1997), a structured measure designed to assess past and 
current psychological disturbance.   
 
Drawing on data from previous work, van Tilburg et al. (2008) considered 
the prevalence and types of CAM used in IBS and FBD in 1012 FBD 
patients from an ‘outpatient’ healthcare maintenance organisation in the 
US (the data having been collated during a previous study (Nyrop et al., 
2007).  The study was carried out over six months.  Participants were 
assessed for symptom severity at their ‘baseline’ visit to the clinic using 
the Irritable Bowel Syndrome Severity Scale (IBS-SS) (Francis, Morris, & 
Whorwell, 1997), as well as quality of life (using the Irritable Bowel 
Syndrome Quality of Life scale, IBS-QOL (Patrick et al., 1998), 
psychological distress (using the Brief Symptom inventory, BSI 
(Derogatis, 1977) perceived treatment effectiveness and CAM use.   
 
1.6.2.2 Extent of CAM use  
Smart et al. (1986) found significantly more of those with IBS had visited 
an alternative practitioner compared with the other two groups.  Current 
alternative medicine use was significantly greater in the IBS group with 
herbal treatments and homeopathy as the most frequently used 
treatments (Smart et al., 1986).  Verhoef et al. (1990) reported that 50% 
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of CAM users had FBD (compared to 13% of non CAM users) but only 
9% had used CAM for the condition they presented to a 
gastroenterologist with chiropractors (for conditions other than GI), 
herbalists, naturopaths and reflexologists being the most frequently used 
CAM therapists.  46% of participants had visited more than one type of 
CAM practitioner.   
 
Donker et al. (1999) found the IBS patient group had paid more visits to 
an alternative practitioner than the population group (32% compared with 
15%).   Koloksi et al. (2003) revealed that 86.5% of the functional GI 
group had at some time sought conventional healthcare.  This figure 
dropped to 20.8% when participants were asked about seeking 
alternative healthcare, with only 9% using any CAM in the previous 12 
months with the most frequently accessed treatment being visits to a 
naturopath.  van Tilburg et al. (2008) found 35% of those with FBD and 
38.4% of those with IBS had used CAM with ginger, massage therapy 
and yoga being the most popular treatments. 
 
1.6.2.3 Reasons for CAM use 
i) Demographics and functional diagnosis  
Being female was the sole significant predictor of CAM use in functionally 
diagnosed individuals in one study (Koloski et al., 2003).  Other studies 
(Donker et al., 1999; Smart et al., 1986; Verhoef et al., 1990) did not 
examine the role of gender in CAM use although Donker et al. (1999) 
reported that most IBS patients were female and had significantly lower 
levels of education.  van Tilburg et al. (2008) also found being female 
predicted CAM use but in contrast to Koloski et al. (2003) they found 
higher levels of education were also a predictor of CAM use (van Tilburg 
et al., 2008).   Two studies noted that having a functional diagnosis itself 
was more likely to result in participants using CAM.  Verhoef et al. (1990) 
reported that a functional diagnosis was an independent predictor of CAM 
use compared to those with organic GI disorders.  Similarly, Smart et al. 
(1986) reported more patients with IBS than Crohn’s used CAM.   
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ii) Perception of symptoms  
Donker et al. (1999) reported IBS outpatients also had significantly poorer 
symptoms (abdominal pain and other symptoms such as tiredness, 
backache and headaches) than the population group.  Koloski et al. 
(2003) found that physical aspects of IBS were significant predictors of 
conventional care seeking rather than influencing CAM use.  van Tilburg 
et al. (2008) found a greater perception of symptom severity was 
associated with CAM use but was not a significant predictor of CAM use 
in a logistic regression model that examined predictors of CAM use. 
 
iIi) Patient perception of conventional treatment 
Smart et al. (1986) found that the IBS group was reported to be more 
likely to use alternative treatments if they had perceived conventional 
treatment had failed.  Verhoef et al. (1990) observed that only 54% of 
CAM users with GI disorders (including IBS) were satisfied with 
conventional treatment compared with 85% of participants that did not 
use CAM and that GI patients that used CAM were significantly more 
sceptical of conventional medicine than those that did not use CAM (49% 
compared to 13% of non CAM users).  Further analysis revealed 
associations between a functional diagnosis and scepticism towards 
conventional medicine, and the finding that these variables both 
(independently) significantly predicted the use of CAM.  In relation to 
communication between conventional practitioner and patient, this study 
also identified that CAM users were less satisfied with ‘answers’ from 
conventional practitioners than non CAM users (77% v 91%).  Koloski et 
al. (2003) found dissatisfaction was a non-significant influence on CAM 
use, although there was a reported difference between CAM users and 
non-users.  van Tilburg et al. (2008) found no significant association 
between CAM use and satisfaction with physician care during their 
primary visit and that CAM users did not rate their conventional 
prescription medication as being less effective than non-CAM users.  
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iv) Positive aspects of CAM treatments and therapies 
Only one study reported possible positive aspects of CAM as being a 
reason for IBS patients to use CAM.  The results from Koloski et al. 
(2003) suggest a desire to treat the GI problem with a more natural 
approach, to consider the potential for alternative treatments to work and 
personal recommendation were all factors (albeit not significant) that 
influence CAM use.  However, Donker et al. (1999) reported that 92% of 
CAM users felt that the treatment had helped them.   
 
v) Psychosocial factors 
Verhoef et al. (1990) showed that stressful life events in the previous year 
were a significant predictor of CAM use in those with functional GI 
disorders.  Donker et al. (1999) reported that those with IBS had higher 
scores on the GHQ compared with the population group.  There were 
also differences in the BIOPRO scores between the two samples.  Those 
with IBS had more concerns about the future, self confidence, social 
interactions and relationship issues.  In terms of health behaviour, the IBS 
group reported more occupational absence in the two months prior to the 
study.  Having IBS resulted in significantly more visits to the family GP, a 
physical therapist and a GI specialist.  The significant differences in 
healthcare seeking between the two groups suggest that those with IBS 
may have potentially more psychological disturbances as measured by 
the GHQ and increased social difficulties.  In turn, these factors seem to 
be associated with influencing CAM use in this patient group (Verhoef et 
al., 1990).  Koloski et al. (2003) reported noticeable, although not 
significant, differences between both sets of healthcare consulters (CAM 
and conventional treatment) and non-consulters in psychological 
disturbance and perception of symptoms.  van Tilburg et al. (2003) found 
CAM users had significantly reduced IBS-QOL scores than non-users.  
Similarly there were differences between CAM and non-users on the 
somatisation, anxiety and depression subscales of the BSI.  Logistic 
regression analysis revealed that only anxiety turned out to be a 
significant predictor of CAM use.   
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1.6.3 Discussion 
1.6.3.1 Summary of main findings 
A systematic review of the literature surrounding the use of 
complementary treatments in those with IBS revealed a small number of 
studies.  These ranged from patient group-healthy control population 
comparisons, to comparisons of those with IBS who used CAM and those 
that did not.  The findings suggest that those with IBS and who use CAM 
seem to report (or perceive) more severe symptoms, and may experience 
mild to moderate psychological problems and social issues.  There is also 
some indication that dissatisfaction with conventional care is an important 
and additional factor in whether someone with IBS will turn to CAM 
(Smart et al., 1986; Verhoef et al., 1990) although Koloski et al. (2003) did 
not find dissatisfaction to be a significant factor influencing CAM use and 
van Tilburg et al. (2008) found no significant difference in ratings of 
prescription medication between CAM users and non-CAM users.  As a 
group, the studies indicated prevalence of CAM use at between 9 and 
38.4%, less than the 50% CAM use reported in a study examining the 
prevalence of CAM use in GI illnesses (Kong et al., 2005).    
    
Collectively, the studies reviewed provide an indication that the reasons 
for CAM uptake in those with IBS show some similarities to patterns of 
use observed in non illness specific CAM research.  All of the studies also 
had an overwhelming female representation which is consistent with 
estimates of prevalence in that a greater proportion of females than 
males seek healthcare for IBS/functional GI symptoms (Andrews et al., 
2005; Hungin et al., 2005).  Although consistently, a greater proportion of 
females than males use CAM in general (e.g. Astin, 1998), only two 
studies (Koloski et al., 2003; van Tilburg et al., 2008) found that being 
female was an independent predictor of CAM use in those with a 
functional GI diagnosis. 
 
A distinctive factor with CAM use in IBS compared with CAM use in 
general populations is the number and duration of experienced 
symptoms.   Within each study there were differing levels of focus on 
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symptom experience or perception of symptoms as this seems to be a 
key feature of IBS in terms of chronicity, fluctuation and extent of 
symptoms (Drossman et al., 1999).   Smart et al. (1986) considered other 
factors more important than symptom duration in predicting CAM use in 
IBS as more patients with IBS were currently using CAM than the Crohn’s 
group (who have similar symptoms) (Smart et al., 1986), however 
Verhoef et al. (1990) did not consider participants’ reported symptoms.  
Two of the remaining studies (Donker et al., 1999; van Tilburg et al., 
2008) found reporting of more severe GI symptoms to be associated with 
CAM use as were reduced ratings of quality of life (van Tilburg et al., 
2008).  One study (Koloski et al., 2003) found increased perception of 
symptoms to be more predictive of conventional care seeking rather than 
CAM.  These findings appear consistent with research into IBD as 
increased symptom perception (Scott et al., 2003) and reduced reported 
quality of life can lead to CAM use in IBD patients (Langmead et al., 
2002).    
 
The studies reviewed suggest psychological factors will influence CAM 
use in those affected by IBS and FBD.  This appears to be consistent with 
much of the research into CAM use in both general (Astin, 1998; 
Eisenberg et al., 1998; Testerman et al., 2004; Thomas et al., 2001; 
Vincent, Furnham & Willsmore, 1995) and IBD populations (Hilsden et al., 
1998).  The studies reported that stressful life events (Verhoef et al., 
1990), higher GHQ scores (Donker et al., 1999) and higher levels of 
anxiety (van Tilburg et al., 2008) were all associated with CAM use in 
those with IBS.  Furthermore, social factors also seemed to have some 
influence on CAM use.  Donker et al. (1999) reported those with IBS had 
concerns regarding the future, reduced self confidence, problems with 
social interactions and more relationship issues.  It should be noted 
however, that many studies into CAM use in general populations have not 
examined such psychological factors although the findings in this review 
do concur with what is known about possible psychological influence on 
IBS (section 1.1.1.1). 
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1.6.3.2 Limitations of review 
Across the five reviewed studies, there were common themes why those 
with IBS turn to CAM although aspects of the various methodologies were 
heterogeneous meaning it is difficult to generalise findings.  There also 
appears to be a substantial gap in the literature regarding why those with 
IBS use CAM.  Mention should also be made of the reviewed studies 
being conducted in different countries in that there may be differences in 
healthcare service provision compared with that available in the UK which 
also raises the potential for cultural differences within participant groups.  
Consequently, the impact and understanding of these influences on CAM 
use is hindered somewhat by the lack of research.  Furthermore, the 
variation in participant numbers in each of the studies is a further area of 
concern.  In addition, two studies (Donker et al., 1999; Verhoef et al., 
1990) had relatively small numbers of participants with IBS/FBD.  There is 
also some ambiguity concerning the extent of a functional diagnosis 
(Verhoef et al., 1990) and if all participants had IBS or different functional 
diagnoses (such as functional dyspepsia) (Koloski et al., 2003).  Group 
comparisons in each study were also different.  Both Verhoef et al. (2003) 
and van Tilburg et al. (2008) surveyed those with FBD and IBS patients 
and compared CAM users with non-CAM users.  Smart et al. (1986) 
compared IBS patients with other GI patient groups, while both Donker et 
al. (1999) and Koloski et al. (2003) compared an IBS group with a control 
group of healthy participants.   
 
The findings here suggest a perception by some of those affected by IBS 
that conventional medicine has perceived shortcomings which can lead to 
CAM use.  This can range from unhappiness with communication 
(Verhoef et al., 1990) to feeling that conventional treatment had failed 
(Smart et al., 1986) and CAM users feeling more dissatisfied with 
conventional medicine than CAM (Koloski et al., 2003).   However it 
should be remembered that the nature of IBS and the range of symptoms 
make the disorder difficult to treat thus the relief that conventional 
treatment can offer may be limited by the action of pharmacologic 
treatment targeted towards the most troublesome symptom.  Regardless 
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of the reasons for patient concern, there appears to be some degree of 
dissatisfaction with conventional medicine but some uncertainty remains 
about how it is operationalised, measured and whether it is due to issues 
with treatment or the consultation. 
 
Furthermore, both ‘failure’ of (Smart et al., 1986) and ‘dissatisfaction’ with 
conventional treatment (Koloski et al., 2003) appear to be dimensions of 
the same construct in that they refer to treatment, the consultation or 
both.  In the studies reviewed, measurement of these factors varied.  
Koloski et al. (2003) conducted a healthcare seeking interview, Smart et 
al. (1986) asked participants if they would use alternative treatment if they 
had perceived conventional treatment to have failed them and Verhoef et 
al. (1990) administered a questionnaire assessing scepticism towards 
conventional medicine.  van Tilburg et al. (2008) considered the first visit 
to the healthcare organisation as well as perceived effectiveness of 
prescription medicine.  Moreover, four of the studies reviewed here 
(Donker et al., 1999; Koloski et al., 2003; Smart et al., 1986; Verhoef et 
al., 1990) focused solely on CAM consultations thus neglecting ‘off the 
shelf’ products from their analysis.   
 
1.6.3.3. Implications for the thesis  
Only a small number of studies were identified for inclusion in this review 
based upon the identified criteria.  It is evident from the review that the 
majority of studies lacked a theoretical foundation.  It could be surmised 
from these findings that the implementation of a more robust theoretical 
framework would have enabled a deeper understanding of psychological 
factors that could have potentially been targeted to improve management 
of IBS.  Consequently, further research is needed to fully explore factors 
that influence CAM use in IBS.  CAM use is clearly extensive in an IBS 
context and represents a need for effective treatment.  Future studies 
may focus on why people with IBS are using CAM (both via a practitioner 
and ‘off the shelf’) with reference to symptom perception.  Assessing the 
influence of such illness related perceptions could provide greater 
understanding of the role of these constructs in influencing CAM use in 
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IBS.  Furthermore, treatment beliefs are also important influences on 
whether CAM is actively sought as a treatment option.  Such treatment 
beliefs could be conceptualised as people’s concerns regarding the 
effects of conventional medical treatments and positive beliefs about 
CAM.     
 
Illness perceptions have been shown to be important factors in IBS and 
may have a role in CAM use and influence health related quality of life 
and are worthy of further exploration.  Attention may focus on symptom 
perception and differing dimensions of perceptions people have about 
their IBS treatment and how this may influence use of CAM.  There is 
also further scope for investigation into aspects of quality of life and how 
this may be influenced by CAM use.  In future group comparisons, a 
standard pattern of analysis between CAM-users and non-users may be 
adopted, where differences in beliefs between such groups have been 
observed (Hilsden et al., 1998; Vincent & Furnham, 1995; Verhoef et al., 
1990).  Conducted within those affected by IBS, future research may take 
account of these considerations as the area warrants extensive further 
study to understand the importance of illness perceptions and treatment 
beliefs in IBS.  Subsequently, such findings may be used as a guide to 
influence further study or potentially inform future management 
interventions based on targeting such psychological factors. 
 
1.6.3.4 Conclusions 
In summary, the findings from this review show the extent of CAM use to 
be close to 38.4% of those with IBS and FBD.  Several factors appear to 
influence CAM use.  CAM-users perceive their symptoms as being more 
severe when compared with non-users, they may report more severe 
quality of life, and may have underlying psychological issues such as 
anxiety.  With conventional treatment often limited to the relief of one or 
two symptoms of IBS, the need for a greater understanding of illness 
perceptions in IBS would be beneficial.  Many of the issues considered in 
the reviewed studies such as dissatisfaction, quality of life, and anxiety 
related to the condition could potentially be addressed by future changes 
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in the approach of conventional medical consultations (e.g. van Dulmen 
et al., 1996; 1997).  Future studies may consider such issues, while 
considering a systematic and theoretical approach to measurement of 
these factors to improve the scope of findings using existing reliable and 
valid measures where possible.  The application of a theoretical 
framework to research in this area may also aid translation to practical 
measures of intervention. 
  
1.7 Chapter summary and aim of thesis 
This chapter has outlined the symptoms, prevalence, impact and 
diagnostic process in IBS.  Aetiology has been considered in relation to a 
biopsychosocial conceptualisation of IBS which allows for psychological 
influences in onset and maintenance of symptoms.  The importance of 
illness perceptions has been considered with reference to their influence 
on health related quality of life and CAM use.  The extensive use of CAM 
has been considered in IBS and a systematic review was presented 
which synthesised existing research that has examined influential factors 
on CAM use in IBS.   
 
Research in non-specific illness populations has focused on explaining 
the extent of CAM use and established a number of demographic, health 
related and psychological factors are influential in why people select CAM 
as a treatment option (Astin, 1998; Bishop et al., 2006).  However, in IBS, 
research into why CAM is used has been limited despite CAM use being 
prevalent (Kong et al., 2005; van Tilburg et al., 2008).  It is important to 
determine which factors are related to CAM use in IBS and how these 
factors may influence quality of life.  This will give further understanding 
of the role and importance of cognitive and emotional representations of 
IBS and their influence on the experience and trajectory of IBS.  By 
enhancing the understanding of these factors in IBS improved 
management techniques and approaches to treatment may be formed.   
 
Previous work from both IBS and general populations has established:   
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 Illness perceptions influence health care seeking (including CAM 
use) and quality of life 
 Beliefs about both conventional medicine and CAM will influence 
CAM use  
 The perceived illness experience of CAM-users may be more 
severe than those not using CAM 
 
From the systematic review presented in this chapter, it was further 
ascertained that in individuals affected by IBS, CAM use is influenced by: 
 Perception of IBS symptoms 
 Negative beliefs about conventional medical treatment 
 Positive beliefs about CAM 
 
Current research has lacked structured examination of how illness 
perceptions and treatment beliefs may be structured, organised and 
shown to influence CAM use, in addition to how these factors may 
influence quality of life according to whether CAM is used or not used for 
IBS symptoms.  This provides a strong rationale that exploration of these 
psychological factors in those affected by IBS is warranted.  Furthermore, 
CAM use in those affected by IBS, is also clearly a legitimate area of 
investigation for health psychology research as it appears to be used 
extensively and is influenced by psychological factors. 
 
This thesis therefore examines psychological aspects related to IBS 
within a theoretical framework allowing for comparison between those 
that use CAM to relieve their symptoms and those that do not use CAM 
treatments.  It is envisaged that the illness and treatment beliefs that 
influence CAM use, coping and quality of life may be identified to further 
the understanding of these concepts in those affected by IBS and may 
have influence on future management strategies for those presenting with 
IBS. 
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Furthermore, it is evident that investigation of illness perceptions and 
treatment beliefs in IBS would benefit from a systematic and theoretical 
approach, as research to date, has investigated many similar concepts, 
but using different measurement instruments and approaches.  The 
following chapter outlines the reasoning for and implementation of the 
theoretical approach adopted by the research presented in this thesis. 
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Chapter 2  
 
Theoretical framework 
 
This chapter outlines and justifies the theoretical framework adopted in 
the research presented in this thesis. An ‘extended’ version of the 
common-sense model (CSM) that incorporates illness perceptions and 
treatment beliefs is proposed as the most suitable theoretical framework 
within which to examine these factors in IBS and their relationship with 
CAM use and reported quality of life.  The CSM is outlined with reference 
to measurement issues, and empirical evidence for the components and 
pathways in the proposed model.  Existing applications of the CSM with 
respect to IBS and use of CAM are also considered. 
  
2.1 Theory-based research in health psychology  
Chapter one contended that future research into CAM use in IBS would 
benefit from the adoption of a systematic and theoretical approach in 
future investigations.  Within the field of health psychology research, 
theoretical models such as social cognition models have been widely and 
successfully utilised to explain health and illness phenomena.  These 
models have assisted in isolating variables that influence outcome or 
health and illness related behaviour and have been used to guide 
interventions and self-management strategies (Brewer, Chapman, 
Brownlee & Leventhal, 2002; Conner & Norman, 2005).  A number of 
studies have utilised such social cognition models as the Health Belief 
Model (Becker, 1974), the  Theory of Reasoned Action (Ajzen & Fishbein, 
1980) and the Theory of Planned Behaviour (Ajzen, 1991) as frameworks 
to understand underlying processes of health-related behaviour (e.g. 
Conner & Norman, 2005).  The application of a theoretical framework to 
the research presented in subsequent chapters would provide benefits in 
understanding specific health related behaviour in IBS (e.g. CAM use) 
and may lead to identification of illness perceptions and treatment beliefs 
that subsequently have a strong influence on quality of life judgements.  
One model that may facilitate explaining both CAM use and the influence 
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of illness perceptions on quality of life in IBS is the common-sense model 
(CSM) of illness representation (e.g. Leventhal et al., 1992) and this 
approach was selected as being the most appropriate theoretical 
framework for the research presented in this thesis.  
 
The CSM has had success in explaining the influence of illness 
perceptions on health-related behaviours such as adherence to 
medication (Brewer et al., 2002; Horne & Weinman, 2002; Llewellyn, 
Miners, Lee, Harrington & Weinman, 2003), attendance at rehabilitation 
programmes (French, Cooper, & Weinman, 2006; Whitmarsh, Koutani, & 
Sidell, 2003), and physical and psychological outcomes (Carlisle et al., 
2005; Kaptein et al., 2006; Rutter & Rutter, 2002; 2007) in a number of 
chronic illnesses.   
 
2.2 The common sense model of illness representation 
Chapter one outlined the importance of illness perceptions in IBS and the 
subsequent influence on quality of life (Lea & Whorwell, 2004; Rutter & 
Rutter, 2002; 2007), although there is limited knowledge about which 
aspects of illness perceptions are most important.  Illness representations 
have also been shown to be influential in the use of CAM in general 
populations (Bishop et al., 2006; 2008; Searle & Murphy, 2000).  The 
common-sense model (CSM) of illness representations (also referred to 
as the self-regulatory model, e.g. Leventhal, Brissette, & Leventhal, 
2003), has offered a theoretical framework for the study of how illness 
representations (or perceptions) influence illness outcomes (such as 
quality of life) via adoption of coping strategies across a wide range of 
chronic illnesses (e.g. Brewer et al., 2002; Glattacker, Opitz, & Jäckel, 
2010; Gray & Rutter, 2007; Hagger & Orbell, 2003).  It is argued that this 
model is the most appropriate to address the research aim outlined in the 
previous chapter. 
 
Fundamentally, the CSM (Leventhal et al., 2003) is a multi-stage process 
of self-regulation (see figure 2.1) where individuals firstly respond to a 
health threat by forming emotional and cognitive representations based 
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on threats to health, with the goal of returning to a state of normality (i.e. 
without illness).  The second stage involves the adoption of coping 
strategies to deal with a health threat.  Thirdly, a process of appraisal is 
performed to assess the effectiveness of adopted coping strategies have 
performed in dealing with threats to health (Leventhal et al.,2003).  
Representations of illness are said to influence coping, which in turn, is 
then ‘appraised.’  In this context, coping is said to mediate (i.e. explain) 
the relationship between illness representations and outcome appraisals 
(Hagger & Orbell, 2003; Hale, Trehane & Kitas, 2007).  The CSM is 
described as a ‘dynamic’ model, as illness representations are said to be 
‘updated’ as new information about the illness is obtained and coping 
strategies are evaluated for effectiveness in dealing with the health threat.  
Furthermore, there have been more recent attempts to extend the 
explanatory capabilities of the model by including representations of 
treatment (i.e. treatment beliefs, Horne & Weinman, 2002).  CSM 
research has also led to the development of both health-based 
intervention and self-management recommendations designed to target 
problematic illness representations in chronic illness (e.g. Cameron & 
Jago, 2008; McAndrew et al., 2008).  Identification of such factors would 
be beneficial to both theory and practice in IBS, to enhance 
understanding of the role of illness and treatment representations in IBS 
and to suggest potential pathways for possible future intervention or self-
management programmes.  Furthermore, the examination of distinct 
coping strategies and how these are directed by illness perceptions in 
CSM research is argued to be a crucial aspect of seeking to improve 
patient outcomes (Leventhal et al., 1998).    
 
2.2.1 Illness representations 
Illness representations are formed from different sources of ‘lay’ 
information when individuals are faced with an illness threat (Petrie & 
Weinman, 2006).  Representations may be formed from information 
gained from external agents (such as health care professionals) and may 
be updated with appraisal information from coping strategies (Leventhal 
et al., 1992; 1998; 2003).  Representations may be formed from both 
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‘abstract’ (lay and external information) and ‘concrete’ (e.g. symptoms) 
sources (Leventhal et al., 1998).  Leventhal et al. (1998) outline five 
distinct but interrelated components of illness perceptions related to 
possible causes; identification with symptoms (illness identity); 
consequences of the illness; the duration of the illness (timeline) and the 
extent to which the illness can be controlled or cured (Leventhal et al., 
1992; 1998).   
 
The ‘illness identity’ component of the CSM accounts for representations 
relating to labelling the illness (e.g. IBS) and information about symptoms 
of the illness, for example experiencing bowel pain (Petrie & Weinman, 
2006).  The ‘causes’ component represents an individual’s beliefs 
regarding possible causal factors of their illness (Hagger & Orbell, 2003; 
Leventhal et al., 1998).  Causes may be perceived as biological, e.g. due 
to the immune system, germs or viruses; psychological e.g. stress, 
overwork and personality factors; behavioural e.g. smoking, poor diet or 
environmental e.g. due to pollution or chemical influence (Moss-Morris et 
al., 2002).   
 
Illness ‘consequences’ are concerned with the perceived impact the 
illness will have for the individual in terms of their day to day life and 
functional capacity (Petrie & Weinman, 2006).  The consequences 
component also accounts for a series of comparative estimations of how 
the illness has made things worse since onset (e.g. Hagger & Orbell, 
2003; Moss-Morris et al., 2002).  The ‘timeline’ component refers to the 
perceived trajectory of the illness and whether it is likely to be acute or 
chronic as well as considering the timeline of symptoms (Leventhal et al., 
1998).  In addition, Moss-Morris et al. (2002) proposed that timeline 
perceptions may be thought of in terms of chronicity of the illness and 
whether symptoms are likely to be cyclical which suggests there will be 
periods of relief but awareness that symptoms will return. 
 
The cure/control perceptions refer to beliefs about whether the illness 
may be cured or if there is a feeling of efficacy in being able to deal with 
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the illness based on the performance of coping behaviour (Leventhal et 
al., 1992; 1998).  This component has been subsequently dichotomised 
into two separate constructs (Moss-Morris et al., 2002): the extent to 
which the individual feels able to control the illness (personal control) and 
the extent of whether treatment is perceived as being able to control the 
illness (treatment control) (Petrie & Weinman, 2006).  ‘Illness coherence’, 
i.e. the extent to which illness is understood in a coherent manner, was 
subsequently added to the illness representation components (Moss-
Morris et al., 2002).  
  
Leventhal et al. (1992; 1998; 2003) further proposed the CSM is a 
‘parallel processing’ model meaning that emotional responses to illness 
(e.g. fear or anxiety) are generated alongside cognitive representations 
(Hale et al., 2007).  These responses are instrumental in the formation of 
emotional representations, which have influence on emotional outcomes 
related to the illness.  However research into emotional representations 
has been limited in comparison to cognitive representations (Hagger & 
Orbell, 2003), but, as the CSM stipulates (figure 2.1), emotional 
representations are important factors in responding to health threats and 
have important implications for emotional outcomes in the self-regulatory 
process (Hale et al., 2007; Leventhal et al., 2003).   
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Figure 2.1  Flow diagram of an extended version of Leventhal et al’s. (1992; 1998) Common-Sense Model of Illness 
Representations (adapted from Hagger & Orbell, 2003 and Horne, 1997) 
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2.2.1.1 Evidence for the role of illness representations in IBS and 
CAM use 
The CSM offers a way to systematically conceptualise the illness-related 
perceptions in those affected by IBS and observe which perceptions may 
be influential in CAM use and on quality of life.  Although there is limited 
research utilising the CSM framework in IBS, there is evidence for a role 
of the different components of illness perceptions in IBS.  For example, 
individuals with IBS may identify specific factors as instrumental in onset 
or flare-ups of IBS including anxiety, depression (Lacy et al., 2007) and 
stress (Casiday et al., 2009; Hungin et al., 2005).  Receiving a definite 
IBS diagnosis (NICE, 2008) may result in certain enhanced CSM 
representations as a lack of a clear diagnosis of IBS can prove frustrating 
(Casiday et al., 2008).  Providing illness-related education may also 
enhance control over IBS symptoms, as it has been suggested that 
education provision may result in reduced use of health care services 
(Ringström et al., 2009; 2010).  Those affected with IBS have also been 
shown to have more bodily preoccupation (Gomborone et al., 1995) and, 
if their causal cognitions differ from those of their GP, they will tend to 
use more health care services than if doctor-patient concordance exists 
(van Dulmen et al., 1996; 1997; 1998).  The CSM also refers to 
emotional representations of illness threats (Hagger & Orbell, 2003; Hale 
et al., 2007; Leventhal et al., 2003).  Emotional representations appear 
especially relevant in IBS as such representations may influence 
‘catastrophising’ and beliefs that IBS is a more serious condition 
(Drossman et al., 1999; Lackner et al., 2004).  Such catastrophising 
thoughts may then influence poorer emotional outcome in those with IBS.  
It also is possible that greater emotional distress caused by IBS may be 
a driving factor for individuals to initiate use of CAM.    
 
Research exploring CAM use in IBS has yet to adopt a theoretical 
framework (e.g. van Tilburg et al., 2008; Verheof et al., 2003; section 
1.6.3).  Bishop et al. (2006) and Searle and Murphy (2000) have shown 
that illness representations are important in CAM use and suggest the 
CSM is a useful framework in exploring CAM use in general populations.  
 73 
However, the research presented in this thesis is unique in applying the 
CSM to CAM use in those affected by IBS.  Existing research that has 
utilised the CSM has explored these phenomena, IBS and CAM use, as 
separate entities.  However, these studies demonstrate there is a 
credible and coherent rationale for the use of the CSM dimensions of 
illness representations in the examination of the representations of 
illness in IBS and how representations may influence CAM use and 
reported quality of life.   
 
2.2.1.2 Measurement of illness representations  
The most widely utilised quantitative measures of illness representations 
are the Illness Perception Questionnaire (IPQ, Weinman, Petrie, Moss-
Morris & Horne, 1996) and the revised Illness Perception Questionnaire 
(IPQ-R, Moss-Morris et al., 2002).  The IPQ-R has also been 
compressed into a shorter version, the brief-IPQ-R (Broadbent, Petrie, 
Main & Weinman, 2006) to ease responder burden.  The IPQ is a 
quantitative measure of the five CSM representation components of 
identity, timeline, consequences, cause and cure/control.  These five 
components have shown consistency over a number of illness 
populations in both meta-analysis (Hagger & Orbell, 2003), and in the 
development of the IPQ (Weinman et al., 1996).  The IPQ-R (Moss-
Morris et al., 2002) was developed following refinement and revision of 
the CSM constructs measured by the IPQ.  Illness coherence, the 
division of timeline representations into cyclical and chronic dimensions 
and a number of additional causal items were added (Moss-Morris et al., 
2002).  There was also development of the cure/control dimension into 
separate treatment and personal control scales.   
 
One important addition to the IPQ-R was that of the component of 
emotional representations (Hagger & Orbell, 2005; Hale et al., 2007; 
Moss-Morris et al., 2002).  As previously noted, the CSM stipulates that 
individuals form parallel cognitive and emotional representations of a 
health threat (Leventhal et al., 2003).   As with the IPQ, the IPQ-R has 
demonstrated largely consistent associations between the components 
 74 
across a number of illness populations (Fowler & Baas, 2006; Moss-
Morris et al., 2002).  Stronger emotional representations are related to 
stronger perceptions of consequences and stronger timeline beliefs 
(chronic and cyclical), and negatively related to both personal and 
treatment control (Moss-Morris et al., 2002).  These relationships are 
again consistent with the theoretical stance of the CSM (Leventhal et al., 
2003) as this implies that a greater level of control over illness and 
treatment is intuitively associated with less illness severity, lower 
reported consequences and less emotional distress. 
 
Research adopting the CSM framework has added support to the 
theoretical components within the model by demonstrating that the 
constructs measured by the IPQ and IPQ-R are related in logically 
consistent ways but remain sufficiently theoretically distinct (Hagger & 
Orbell, 2003; Moss-Morris et al., 2002; Weinman et al., 1996).  Moss-
Morris et al. (2002) demonstrated that timeline scales, emotional 
representations and consequences were all positively related.  The two 
control scales and coherence scale were negatively correlated with the 
identity, consequences, emotional representations and timeline scales, 
which is consistent with CSM theory (Moss-Morris et al., 2002).    A 
confirmatory factor analysis of the IPQ-R based on 660 women in a 
cervical screening context, has further added theoretical consistency and 
validity of the IPQ-R (Hagger & Orbell, 2005).  The treatment and 
personal control components, along with the illness coherence scale, 
were negatively related to other scales on the IPQ-R, whereas the 
remaining scales were all positively related (Hagger & Orbell, 2005).  The 
interrelations between the components of the IPQ have been further 
demonstrated as theoretically consistent in a meta-analysis of 45 studies 
that utilised a CSM approach (Hagger & Orbell, 2003).  Subsequent 
studies have added support to these findings (Carlisle et al., 2005; 
Fowler & Baas, 2007; Hagger, Chatzisarantis, Griffin & Thatcher, 2005; 
Gray & Rutter, 2007; Kaptein et al., 2006).  Such studies are evidence 
that illness perceptions are observable components that can be reliably 
captured by the IPQ and IPQ-R.  
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2.2.1.3 Application of the CSM to IBS  
Two studies (Rutter & Rutter, 2002; 2007) have explored components of 
the CSM in an IBS sample.  Rutter and Rutter (2002), using a cross-
sectional design, found relationships amongst illness representations as 
measured by the IPQ that were similar to previous research (e.g. 
Weinman et al., 1996).  Illness identity was positively related to illness 
consequences and timeline perceptions.  Conversely, illness identity was 
negatively related to the cure/control scale.  The timeline scale however, 
was positively related to both the consequences scale and the 
cure/control scale (Rutter & Rutter, 2002), suggesting greater beliefs in 
curing or controlling IBS manifest after a longer perceived duration of 
IBS. 
 
An important omission from the two existing CSM studies in IBS (Rutter 
& Rutter, 2002; 2007) is that of examination of patients’ emotional 
representations of IBS.  Given the potential for those with IBS to 
‘catastrophise’ (Drossman et al., 1999; Lackner et al., 2004), the 
research presented in this thesis included a measure of the component 
of emotional representations as measured by the IPQ-R.   
 
The majority of CSM studies have been conducted using cross-sectional 
designs (Hagger & Orbell, 2003; Rutter & Rutter, 2007; Searle, Norman, 
Thompson and Vedhara, 2007) meaning assessment of representations 
over time is overlooked.  A longitudinal study that considered IBS illness 
representations over time found no difference in measures of the IPQ 
over two time points in a twelve month period (Rutter & Rutter, 2007).  
This is a theoretically contentious point, as the CSM denotes that illness 
representations are updated with new information over time and 
therefore subject to change (Leventhal et al., 2003).  The lack of change 
may be a measurement artefact in that changes in representations may 
be subtle or take place over a longer period.  Alternatively, IBS illness 
representations may actually be stable in the populations sampled.  
However, in patients recovering from traumatic injury, it has been that all 
IPQ-R components apart from the two timeline scales, differed 
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significantly over six months in 114 participants with traumatic injuries  
(Lee, Chaboyer & Wallis, 2010).  Similarly, Kaptein et al. (2010) found in 
241 osteoarthritis outpatients over a six year period that timeline chronic 
and illness coherence scores significantly increased, whereas personal 
control and emotional representations scores decreased.  Patients 
showing negative changes in illness perceptions also had poorer 
outcome over the six year period and this may be due to disease 
progression (Bijsterbosch et al., 2009).  Foster et al. (2008) observed 
change in the IPQ-R component scores of 810 individuals with low back 
pain, although this study set out to examine whether such changes were 
related to both positive and negative outcomes over six months rather 
than change in IPQ-R components in isolation.  Some longitudinal CSM 
research however, has not explored changes in representations over 
time (Llewellyn et al., 2007; Treharne et al., 2008).   
 
CSM based research has not been limited to research in the quantitative 
domain.  Qualitative research has also considered the process of change 
in illness representations over time.  Goodman, Morrissey, Graham and 
Bossingham (2005) conducted an Interpretative Phenomenological 
Analysis (e.g. Smith, Jarman & Osborn, 1999) of semi-structured 
interviews which explored the illness representations of 36 individuals 
diagnosed with Systemic Lupus Erythematosus.  Participants’ 
representations of their illness appeared to change at specific points in 
time or in stages rather than being due to ‘updating’ of representations 
with new information.  This may, in part, be related to illness trajectory.  
Therefore it would be beneficial to explore IBS illness representation 
components longitudinally to investigate possible schematic changes in 
representations over time. 
 
2.2.1.4 Application of the CSM to CAM use 
As the previous chapter indicated, research exists that points to illness 
perceptions influencing CAM use (Bishop et al., 2007; Vincent & 
Furnham, 1996).  Three studies have examined components of the CSM 
in CAM use.  Beliefs in a psychological cause have been shown to 
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influence adherence to homeopathy (Searle & Murphy, 2000), whereas 
Bishop et al. (2008) found weaker relationships between illness 
perceptions and repeated CAM use.  Bishop et al. (2006) found stronger 
beliefs in an emotional cause, greater illness coherence and stronger 
perceptions of consequences all predicted CAM use in a population of 
CAM users (Bishop et al., 2006).   
 
In summary, a body of research provides support for theoretically 
consistent and clear dimensions of illness representations (Hagger & 
Orbell, 2003, Hale et al., 2007).  Given the importance of illness 
representations in IBS and CAM use, the evidence presented here 
demonstrates why the application of the CSM to examine illness 
representations in this research was justified. 
 
2.2.2. Influence of illness representations on coping strategies 
According to the CSM, illness representations direct coping strategies to 
deal with health threats (Leventhal et al., 1998; 2003).  Coping may 
consist of cognitive acts, strategies, procedures or behaviours that may 
help the individual manage health threats in an attempt to maintain or 
return to a state of being free from the threat through self-regulation.  
Coping may be classified as functional (adaptive) or dysfunctional 
(maladaptive) (Carver, Scheier & Weintraub, 1989; Lazarus & Folkman, 
1984). Coping strategies are then appraised for effectiveness and 
information is ‘fed back’ to the representation stage where 
representations may be updated (Hagger & Orbell, 2003; Hale et al., 
2007; Leventhal et al., 2003). 
 
2.2.2.1 Coping strategies and measurement of coping 
In the context of the CSM, coping strategies can be conceptualised as ‘if-
then’ rules (Leventhal et al., 1998; 2003).  The ‘if’ component refers to 
the formation of perceptions of the health threat (e.g. identity, timeline, 
consequences) and what might be expected in terms of outcome after 
the coping strategy had been implemented.  The ‘then’ is the act of 
performing the strategy or procedure.  For example, an individual who 
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has a sudden onset of pain such as a headache will use different 
sources of information to form a representation of the health threat (the 
‘if’). This may include severity and past experience which may be used to 
guide an appropriate coping response to the health threat (Leventhal et 
al., 1998; 2003), which, in the case of a headache, may be to take pain 
reducing medication (the ‘then’).  If the pain medication is successful,   
the reduction of pain would be provided as feedback and the coping 
strategy appraised favourably.  Information about the type of pain and 
the success of the coping strategy would then provide the basis for 
representations to be updated (Leventhal et al., 1998).  
  
In many cases adoption of adaptive or functional coping styles may 
facilitate an improvement in symptoms.  Maladaptive or dysfunctional 
coping may result in denial of a problem or an attempt to mentally block 
out symptoms.  Further categorical distinctions formed from empirical 
investigation into the measurement of coping has cited further domains 
labelled as, for example, problem focused, emotion focused and 
behaviour focused coping (Carver et al., 1989).  Coping has been 
conceptualised and measured in many ways (Carver & Connor-Smith, 
2010), however, the CSM has often examined specific coping behaviours 
or focused on coping checklist measures such as the COPE.  Carver et 
al. (1989) formulated 15 coping procedures for the COPE measure that 
included behavioural disengagement, active coping, use of religion, 
venting of emotions and denial.  Based on such distinctions, a number of 
instruments exist to capture generic coping strategies (Schwarzer & 
Schwarzer, 1996) and several studies using the CSM have opted to use 
the COPE (Carver et al., 1989) and the shortened Brief-COPE (Carver, 
1997) to capture coping procedures.  These studies have included 
relatives of patients with schizophrenia (Fortune, Smith & Garvey, 2005), 
head and neck cancer patients (Llewellyn et al., 2007) and individuals 
affected by IBS (Rutter & Rutter, 2002; 2007) and have explored 
relationships between the components of the CSM (Hagger & Orbell, 
2003).  Such checklists may however be less effective in capturing the 
finer aspects of coping.  However, Leventhal et al. (1998) argue the term 
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coping ‘procedure’ more accurately reflects behaviours performed to 
return to normality when faced with a health threat.   
 
Searle et al. (2007) refer to such checklist measures as measuring 
‘coping cognitions.’  This may be contrasted to specific coping 
behaviours, which may consist of such behaviours as adherence to 
conventional medication, making dietary changes or conducting exercise.  
Several types of coping behaviour have been utilised in CSM research.  
These have included adherence to medical treatment (e.g. Brewer et al., 
2002; Horne & Weinman, 2002), number of visits to doctors (Hagger & 
Orbell, 2003), adherence to homeopathic treatment (Searle & Murphy, 
2000) and repeated use of CAM (Bishop et al., 2008).   
 
A useful distinction between more general coping strategies and coping 
behaviours is supported by evidence from the coping cognitions and 
coping behaviours of those affected with diabetes (Searle et al., 2007).  
Illness perceptions as measured by the IPQ-R predicted coping 
cognitions and coping behaviours.  Coping cognitions however, did not 
mediate (i.e. explain) the relationships between representations and 
coping behaviour.  There was also no relationship between coping 
behaviours and coping cognitions (Searle et al., 2007).  In the context of 
this research, use of CAM may be considered a specific coping 
behaviour (Suarez & Reese, 2000) and coping cognitions (strategies) 
were explored within individuals performing a specific coping behaviour 
(CAM use).   
 
2.2.2.2 Relationships between illness representations and coping 
The CSM stipulates that illness representations will guide cognitive or 
behavioural coping procedures to deal with health threats (Leventhal et 
al., 2003).  The strength of the representation exacts a proportionate 
response in terms of a coping strategy or procedure (Leventhal et al., 
1992; 1998; 2003).  In one of the two studies conducted utilising the 
CSM in participants with IBS (Rutter & Rutter, 2002), there were direct 
relationships between representations and dimensions of coping as 
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measured by the COPE (Carver et al., 1989).  Rutter and Rutter (2002) 
found several correlations between illness perceptions and coping 
strategies, although these associations tended to be weak.  Stronger 
timeline beliefs resulted in greater acceptance of IBS.  Stronger beliefs in 
a psychological cause were related to greater behavioural 
disengagement and greater use of alcohol to cope with IBS.  Stronger 
external cause representations of IBS were associated with more 
positive reinterpretation and restraint coping. Perceptions of stronger 
consequences were related to a greater likelihood of venting emotions, 
restraint coping, less acceptance and mental and behavioural 
disengagement.  Conversely, greater control/cure representations 
resulted in positive associations with active coping, positive 
reinterpretation and planning.  Rutter and Rutter’s (2007) second study 
using the CSM framework in IBS, did not report relationships between 
representations and coping.  
 
The links between representations of illness and coping procedures have 
been supported by a number of cross-sectional and longitudinal studies 
in other chronic illnesses.  Greater illness identity and stronger timeline 
beliefs were weakly positively related to avoidant and resigned coping.  
Stronger consequences were moderately positively related to avoidant 
and resigned coping, while stronger perceptions of control were 
moderately negatively related to avoidant and resigned coping in a 
sample of women with rheumatoid arthritis (Carlisle et al., 2005).  In a 
longitudinal study of head and neck cancer patients, Llewellyn et al. 
(2007) found moderately strong positive relationships between illness 
identity and the coping procedures of self-distraction and venting 
emotions, which also demonstrated a positive association with illness 
consequences.  Greater timeline beliefs were positively associated with 
greater planning.  Stronger emotional representations were positively 
related to more substance use, self-distraction, planning and denial 
(Llewellyn et al., 2007).   
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Hagger and Orbell’s (2003) meta-analysis of 45 CSM studies found 
significant associations between illness representations and coping 
procedures over a number of illnesses.  Control and coherence 
dimensions have been found to be positively related to more adaptive 
coping procedures (Hagger & Orbell, 2003).  Stronger representations of 
illness identity, timeline and consequences of illness are typically 
positively related to maladaptive coping or demonstrate a negative 
association with more adaptive forms of coping (Hagger & Orbell, 2003).  
Searle et al. (2007), examining individuals with diabetes, found several 
illness representations were associated with coping procedures and 
behaviours although there was no relationship between coping 
behaviours and coping cognitions.  This finding seems to support the 
notion that coping procedures, such as ‘active’ coping may be viewed as 
cognitive expressions of coping which may be separate from specific 
coping behaviours (Searle et al., 2007).  Illness perceptions however, 
showed stronger relationships with coping cognitions than many of the 
coping behaviours such as medication and dietary changes (Searle et 
al., 2007).  The influence of illness perceptions on coping behaviours 
also appears consistent when analysed outside of the quantitative 
paradigm.  Meyer, Leventhal & Gutmann (1985) interviewed 230 patients 
diagnosed with hypertension and found evidence that to reduce risk of 
the health threat representations are produced to form strategies to cope 
with the health threat.  In those with hypertension this appears to be 
strongly influenced by prior illness experience (Meyer et al., 1985). 
 
Therefore it can be concluded that illness representations classified as 
more serious (e.g. stronger consequences) are more likely to be 
positively associated with less effective coping procedures or strategies 
(e.g. denial) and negatively associated with adaptive coping strategies.  
In the context of the aims of this research, the intention was to examine 
the relationships between representations and coping strategies in 
addition to assessing the influence of representations on a specific 
coping behaviour. 
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2.2.3 Appraisal of coping procedures 
The final stage of self-regulation in the CSM is the appraisal stage 
(Leventhal et al., 2003).  During appraisal the effectiveness of each 
coping strategy is effectively ‘appraised.’  This is where information is fed 
back to reinterpret the representation to determine if an alternative 
coping procedure needs to be adopted to deal with the health threat 
(Leventhal et al., 1998; 2003).  Within CSM research, the ‘appraisal’ of 
coping has largely been assessed via quantifiable measures of study 
‘outcome’ rather than examining appraisal per se (Hagger & Orbell, 
2003).  Measures of reported quality of life have been used as outcome 
measures in several existing CSM studies including illnesses where 
aetiology has yet to be established,  such as IBS (Rutter & Rutter, 2002; 
2007), chronic fatigue syndrome/myalgic encephalomyelitis (Gray & 
Rutter, 2007) and fibromyalgia (Glattacker et al., 2010) in addition to 
potentially life-threatening diseases such as head and neck cancer 
(Llewellyn et al., 2007).  Given the documented impact of IBS on quality 
of life (Lea & Whorwell, 2004; Lackner et al., 2004) and the important 
influence of illness representations on quality of life (Petrie & Weinman, 
2006), a measure of quality of life was considered to be appropriate for 
use in this research.  However, one possible confounding factor is that 
an individual’s perception of how they perceive their quality of life may 
change through the course of chronic illness.  This represents a problem 
of ‘response shift’ and may potentially explain changes in quality of life 
ratings rather than any change in illness status per se (Ring, Höfer, 
Heuston, Harris, & O’Boyle, 2005; Schwartz & Sprangers, 1999).   
 
Furthermore CAM-users with IBS have been shown to report poorer 
quality of life than those not using CAM (van Tilburg et al., 2008).  
Differences in illness and treatment beliefs between CAM-users and non-
users, was documented in the previous chapter (section 1.1.5).  This 
research consequently presents a unique exploration of pathways of the 
CSM between two groups of participants that have IBS, namely CAM-
users and non-users.    
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Leventhal and Colman (1997) argue that multi-dimension illness specific 
measures of quality of life are preferable in capturing quality of life 
judgements.  Use of such instruments enables pathways to be examined 
from illness representation to formation of quality of life judgements 
(Leventhal & Colman, 1997).  This argument is consistent with illness 
representations being influential on quality of life in IBS (Lackner et al., 
2004; Rutter & Rutter, 2002; 2007).  This provides further strength for the 
decision to use a measure of quality of life as an ‘outcome’ in this 
research (section 3.3).   
 
2.2.3.1 Relationship of illness representations with illness outcomes 
Research using the CSM framework has established links between 
illness representations and illness outcomes (Hagger & Orbell, 2003; 
Leventhal et al., 2003; Rutter & Rutter, 2002; 2007).  Figure 2.1 
illustrates the direct links between illness representations and outcomes 
as well as indirect links between representations and outcomes via 
coping strategies.  These CSM pathways are said to represent a 
mediational model (Baron & Kenny, 1986).  Mediation, in its simplest 
form, occurs when a third variable explains the relationship between two 
other variables.  In the context of the CSM, illness representations 
influence outcome via coping (where coping acts as a mediating 
variable).  Despite the existence of statistical procedures for mediation 
testing (e.g. Baron & Kenny, 1986) formal testing of mediation has not 
always been conducted in CSM research (Hagger & Orbell, 2003), 
meaning processes determining the influence between illness 
representations and outcome are not consistently determined by 
statistical testing.   
 
One of two studies that tested for mediation in an IBS sample was Rutter 
and Rutter’s (2002) study of the illness cognitions of 209 members of a 
UK IBS self help network.  The authors reported relationships between 
several illness perceptions and with outcome.  Greater beliefs about 
serious consequences of IBS and beliefs about a lack of control over 
their IBS both contributed to lower quality of life scores.  Beliefs about 
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serious consequences also contributed to higher scores in anxiety and 
depression.  Lower illness identity (i.e. number of symptoms) resulted in 
greater satisfaction with health.  The study also found evidence that 
certain coping styles mediated between illness representations and 
outcome which was tested via regression based path analyses (Rutter & 
Rutter, 2002).  Greater ‘acceptance’ was found to mediate between 
weaker beliefs about illness consequences and better reported quality of 
life.  With cure/control also included in the model, 32% of the variance in 
quality of life was predicted.  An active coping style mediated between 
stronger cure/control beliefs and greater satisfaction with health.  With 
external causes and illness consequences included in the statistical 
model, 28% of the variance in satisfaction with health was predicted.  
Venting emotions mediated between stronger beliefs in a psychological 
cause and anxiety and between more severe consequences and anxiety, 
predicting 41% of the variance in anxiety.  Restraint coping was 
positively related with illness consequences, but negatively related to 
depression scores demonstrating a further mediation effect.  Also 
included in this statistical model, lower control/cure beliefs were related 
to the mediator ‘behavioural disengagement’ which resulted in a positive 
relationship with greater depression scores.  The model predicted 30% of 
the variance in depression and also included non-significant potential 
mediators ‘emotional support’ and ‘suppression of emotions’ (Rutter & 
Rutter, 2002).  This cross-sectional study illustrates that in IBS there is 
evidence of mediation of coping procedures between pathways from 
representations to outcome. 
 
A subsequent longitudinal study by the same authors (Rutter & Rutter, 
2007) found that over three time points (over 12 months) the most 
consistent predictor of outcomes (anxiety, depression, quality of life and 
satisfaction with health) was a belief in severe consequences of IBS 
which was consistent over three time points.  Other significant predictors 
of outcome were a belief in a psychological cause at time one and two 
and predicted anxiety at time three, while beliefs related to chronicity at 
time two predicted anxiety and satisfaction with health at time three.  
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Cure/control beliefs at time one and two predicted improved quality of life 
at time three.  The same beliefs at time one predicted anxiety and 
satisfaction with health at time three.  Including all the illness perception 
scales in the analyses explained between 24 and 38% of the variance in 
outcome.  In contrast to other studies (e.g. Fortune et al., 2005), Rutter 
and Rutter (2007) found no evidence of coping acting as a mediator 
between illness representations and outcome over three time points over 
12 months.  Similarly, in a group of rheumatoid arthritis patients, 
Treharne et al. (2008) found no evidence of praying/hoping acting as a 
mediator between illness consequences and demographic factors that 
predicted fatigue over one year. 
 
Studies in other illness groups have also found evidence of a mediating 
effect of coping, although the studies are typically cross-sectional.  
Brewer et al. (2002) found evidence of problem-focused coping partially 
mediating the effect between greater illness consequences and more 
cholesterol control in hypercholesterolemia patients.  Fortune et al. 
(2005) studied the relatives of patients with schizophrenia to examine the 
relationships between the relatives’ perceptions of psychosis, coping, 
distress in patients and treatment appraisals.  Greater illness identity and 
stronger carers’ perceptions of personal control (of their relative) were 
related to higher distress.  Greater positive reframing, lower levels of 
reported self blame and greater acceptance mediated these pathways 
predicting 75% of the variance in distress (Fortune et al., 2005).  One 
further study that set out to examine mediation effects in 42 patients with 
Parkinson’s disease at baseline (time one) and after six months (time 
two), Evans and Norman (2009) found evidence of mediation at study 
time one only.   Avoidance mediated the pathway between emotional 
representations and anxiety at time one.  Similarly, acceptance-
resignation mediated the pathways of both emotional representations 
and illness consequences on time one depression. 
 
Direct relationships between representation and outcome have been 
demonstrated in studies across different chronic illnesses that have also 
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demonstrated an absence of any mediation effect.  Heijmans (1998) 
observed patients with Addison’s disease, while Kemp, Morely and 
Anderson (1999) examined coping in those with epilepsy.  Both studies 
found direct associations between illness perceptions and outcome with 
little influence of coping strategies with no indication of mediation being 
present.  Kaptein et al. (2006) found no evidence of mediation of coping 
between illness perceptions and perceived well-being in patients with 
Huntington’s disease.  In diabetic patients, Searle et al. (2007) found no 
evidence of mediation between coping ‘cognitions’ (as measured by a 
coping checklist) and coping behaviours (such as exercise and dietary 
changes).  Llewellyn et al. (2007) also found no evidence of coping 
procedures mediating the relationship between illness perceptions and 
outcome (quality of life) in head and neck cancer patients.  Similarly, 
Scharloo et al. (1998) examined a number of illness groups including 
psoriasis and rheumatoid arthritis, and also reported a lack of mediation 
and limited impact of coping procedures.   This suggests that in some 
instances, illness representations may have stronger direct influence on 
outcomes irrespective of coping (Hagger & Orbell, 2003). 
 
Conversely, in a separate study involving rheumatoid arthritis patients, 
Carlisle et al. (2005) found evidence of partial mediation of avoidant and 
resigned coping between greater reported illness identity, stronger 
disability ratings and greater reported psychiatric morbidity.  The 
resultant regression analyses predicted between 17 and 36% of the 
variance in outcome.  The disparity between the two studies’ results may 
lie in the way coping was measured.  Carlisle et al. (2005) utilised an 
arthritis specific coping measure, while Scharloo et al. (1998) opted for a 
generic coping measure.  Hagger and Orbell (2003) and Leventhal et al. 
(1998) argue that measuring coping can be problematic as researchers 
often use generic coping measures that are removed from the context of 
the illness.   One approach is not to devise domain specific measures of 
coping but to examine coping strategies at a discrete level in terms of 
more specific actions or procedures than ‘avoidant’ or ‘problem-focused’ 
coping (Leventhal et al., 1998).  In this context, a measure such as the 
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Brief-COPE may be appropriate.  The Brief-COPE captures 14 different 
scales and includes semi-specific coping procedures such as the use of 
religion and expressing of emotions (Carver, 1997).  As there is evidence 
for mediation of coping, mainly from cross-sectional designs, this 
research sought to clarify if such coping strategies demonstrate 
mediation effects at both a single and subsequent time point.     
 
There is sufficient evidence to demonstrate that CSM constructs, 
especially illness representations are consistent across a number of 
illness populations (section 2.2.1).  The CSM has also been beneficial in 
enhancing understanding of the role of illness perceptions in influencing 
quality of life in chronic illnesses where establishing aetiology has been 
problematic (e.g. Glattacker et al., 2010; Gray & Rutter, 2007; Rutter & 
Rutter, 2002; 2007).  Moreover, research has identified that stronger 
symptom based and emotional representation components appear to 
influence poorer outcomes, whilst enhanced control and coherence 
components are associated with improved outcomes.  In this thesis the 
role of illness perceptions may be examined by utilising the CSM 
framework in a sample of individuals who have IBS to assess which 
perceptions may influence both CAM use and quality of life.  There is 
also sufficient scope to suggest that CAM-users’ beliefs (section 1.1.5) 
differ from those not using CAM, so pathways from representation to 
outcome may be examined between those that using CAM and those not 
using CAM.   
 
2.3 Extending the common-sense model 
Section 2.2.1 provided evidence to support the use of the CSM to 
examine CAM use in IBS.  However, there has been suggestion that 
alongside illness perceptions, individuals may also form representations 
or beliefs regarding their treatment or treatment in general and these 
beliefs may be important in health related behaviour (e.g. Horne & 
Weinman, 2002).  It has been argued that the inclusion of treatment 
beliefs into the CSM would enhance the model’s explanatory capability 
and offer additional benefits for targeting illness management or 
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intervention strategies (Horne, 1997; Horne & Weinman, 2002).  There is 
evidence that concerns about conventional medication may have 
influence on specific coping behaviours such as patients’ self 
management and adherence to treatment (Horne & Weinman, 1999; 
2002) although the associations between treatment beliefs and quality of 
life over time have been shown to be weak (Llewellyn et al., 2007).  
Exploring the treatment beliefs of those with IBS in a systematic 
framework would therefore be beneficial.  The Beliefs about Medicines 
Questionnaire (BMQ), was designed for use as a measure of the 
cognitive representation of treatment (Horne et al., 1999) and has been 
employed in a number of studies that have adopted an ‘extended’ CSM.   
 
Horne and Weinman (2002) examined the illness perceptions and 
treatment beliefs of individuals with asthma using the IPQ and the BMQ 
specific version in an ‘extended’ CSM framework.  The BMQ specific 
version assesses representations of particular medication in terms of 
necessity of the medication and concerns about taking it.  The study 
found that non-adherence to preventer inhalers was related to low 
necessity beliefs, concerns about possible side effects and more severe 
perceptions of the consequences of asthma.  However, Llewellyn et al. 
(2007) found no influence of illness perceptions and treatment beliefs on 
reported quality of life in head and neck cancer patients six to eight 
months later.  There were however, significant influences of illness 
perceptions on coping at six to eight months later and of treatment 
beliefs on coping at one month later (Llewellyn et al., 2007).   
 
Chapter one illustrated that treatment beliefs have also been implicated 
in the uptake of CAM (e.g. Bishop et al., 2006; 2008).  Feeling 
conventional treatment had failed to cure or relieve illness and having 
concerns about harmful effects of medication have been associated with 
CAM use in a sample of participants with a variety of health complaints 
(Vincent & Furnham, 1996).  Patients with inflammatory bowel disease 
that used CAM were shown to have concerns about harmful effects of 
medication (Hilsden et al., 1998).  Horne et al. (1999) found that 
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individuals who attended a CAM therapist (herbalist or homeopath) had 
higher scores of medication harm and overuse on the BMQ.  Many 
affected by IBS have had the condition for many years (Andrews et al., 
2005) and are likely to have either a long duration of treatment or many 
different treatments to control symptoms.  With this issue in mind, and in 
considering the research into treatment beliefs and CAM use, it is 
plausible to speculate that treatment beliefs may have an important role 
in CAM use and in influencing reported quality of life in IBS.  Therefore 
the examination of treatment beliefs alongside illness perceptions in 
those with IBS may potentially elucidate a greater understanding of 
representations of illness and medication in IBS patients and the factors 
that initiate CAM use and have an impact on quality of life.  Figure 2.1 
highlights the potential role and position of treatment beliefs in the CSM, 
showing the potential influence on coping responses and outcome. 
 
Measurement of treatment beliefs may be further extended to examine 
beliefs about CAM treatments (Bishop, Yardley & Lewith, 2005; Bishop et 
al., 2006; Hyland, Lewith & Westoby, 2003).  As well as evidence and a 
rationale for extending the CSM to include treatment beliefs, there is also 
suggestion that beliefs about CAM may be important in CAM initiation 
(Bishop et al., 2005; Bishop et al., 2006).  CAM-users have more 
‘positive’ views of CAM than non-users (Vincent & Furnham, 1996; 
Furnham & Kirkcaldy, 1996) and more holistic views about health (Astin, 
1998; Testerman, et al., 2004).  Beliefs in holistic health have been found 
to predict CAM use rather than negative beliefs about conventional 
treatment (Bishop et al., 2006).  Kolowski et al. (2003) found patients 
wanted to treat functional GI problems with a more natural approach and 
Bishop et al. (2008) found beliefs in holistic health predicted adherence 
to a CAM treatment regimen. 
 
Such evidence points to CAM beliefs potentially having an important role 
in CAM use and may be considered an important facet of treatment 
beliefs to measure in this research.  It may also be speculated that CAM-
users may get alternative explanations of possible causes of IBS from 
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CAM practitioners given the differences in philosophy between CAM and 
conventional treatment (Zolman & Vickers, 1999).  Differences in causal 
explanations may be reflected in CAM-users having different responses 
to non-users on representations of causes.  Although the relationships 
between treatment beliefs, coping and outcome are less well established 
than in the case of illness representations, the concept of treatment 
beliefs is an important element to this research as such beliefs may be 
important influences on CAM use in IBS.  
 
2.4 Comparison of CSM with social cognition models 
Previous sections have demonstrated the benefit of studying illness 
perceptions across a number of illness domains and how this may be 
especially applicable to the study of IBS.  The CSM is a dynamic model 
of self-regulation and has been successfully used as a framework to 
investigate CAM use (Bishop et al., 2006) and in examining pathways 
between perceptions, coping and outcome in IBS (Rutter & Rutter, 2002; 
2007).  The CSM however, differs from many of the previously 
mentioned social cognition models that have been widely used to explore 
health and illness-related behaviour.  The CSM is considered unique in 
its focus on the role of illness representations and how such 
representations are formed in response to health threats (Leventhal et 
al., 2003).  The subsequent influence on coping and outcome offers the 
potential to identify unhelpful representations and coping and the 
possible development of interventions to improve outcomes (Hale et al., 
2007; Rutter & Rutter, 2002). In the context of this research however, it is 
possible to outline alternative conceptualisations of CAM use in IBS and 
it is worthwhile to briefly consider two such approaches (the Theory of 
Planned Behaviour and the Health Belief Model) to highlight the benefits 
of the CSM framework.   
 
The Theory of Planned Behaviour (TPB) (e.g. Ajzen, 1991) has also 
been widely used to investigate health and illness-related behaviour.  
The TPB denotes that intention to perform behaviour and perceived 
control over the behaviour are the best predictors of an individual 
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carrying out a particular behaviour (Orbell, Hagger, Brown & Tidy, 2006).  
Perceived behavioural control, subjective norms (i.e. the views of 
significant others) and attitudes towards the behaviour are all said to 
influence behavioural intentions.  Like the CSM, the TPB has had limited 
application in exploring CAM use, although the TPB offers an alternative 
framework for investigation of why people will use CAM.  An intention to 
use CAM as well as perceived control over using CAM will influence 
CAM use.  Significant others may hold more pro-CAM feelings and 
beliefs, thus subjective norms may influence intention to use CAM also.  
Feeling able to pursue CAM treatment (perceived behavioural control) 
may also have an influence on intention to use CAM.  One study 
(Furnham & Lovett, 2001) that has utilised the TPB to investigate the use 
of homeopathy found attitudes, subjective norms and perceived 
behavioural control predicted intention to use CAM.  Intentions to use 
CAM also predicted CAM use.  Past behaviour (i.e. those who had used 
homeopathy or other CAM treatments before) was also found to predict 
both intentions to use CAM as well as the use of CAM (Furnham & 
Lovett, 2001).   
 
Therefore the TPB has potential benefit in investigating CAM use, but is 
limited by the lack of theoretical scope to examine pathways to outcome 
in terms of quality of life.  The TPB was also originally developed to 
examine social rather than health-related phenomena and may be limited 
in not being able to explain the more discrete relationships between 
illness representations and performing certain health-related behaviours.  
The TPB does not allow such close inspection of illness representations 
and how these representations may be related to quality of life, whereas 
contextually the CSM is able to offer examination of these factors.  Orbell 
et al. (2006) compared the CSM and TPB in predicting non-completion of 
treatment following screening for cervical cancer.  The study found that 
both illness perceptions and TPB constructs predicted attendance/non-
attendance for treatment, and that the TPB explained more variance in 
outcome (attendance/non-attendance) than illness perceptions.  
However, this study did not include a measure of reported quality of life 
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as an outcome.  Furthermore, Leventhal, Weinman, Leventhal and 
Philips (2008) argue, comparison between the CSM and TPB should not 
be limited to comparison of illness perceptions to all of the TPB 
constructs.  Coping for example, in the CSM could be compared to the 
active parts of the TPB (behaviour).  There is further uncertainty in 
comparing TPB attitudes with illness perceptions when it is likely the two 
constructs are measuring different concepts (Leventhal et al., 2008).  
These as yet unexplored avenues add support to the use of the CSM as 
a theoretical framework for this research.   
 
The Health Belief Model (HBM) also has potential application for 
explaining CAM use in IBS.  The HBM (e.g. Becker, 1974) was originally 
developed to examine the beliefs that influence the performing of health-
related behaviours.  Behaviours are based on the individual weighing the 
need to use a particular mode of treatment for example, against the 
perception that use of such a service will result in benefits to the 
individual (Abraham & Sheeran, 2005).  In terms of CAM use, the 
benefits of using CAM would potentially outweigh the costs (such as 
financial costs).  The perceptions of the illness would also be relevant in 
that such perceptions as symptom severity will influence use of CAM.  In 
the one study to consider CAM use utilising a HBM approach, Wagner et 
al. (1999) conducted a qualitative study into St John’s Wort use in 
depression.  Individuals with less severe symptoms, lower perceived 
barriers to treatment and increased perception of benefits of St John’s 
Wort (e.g. lack of side effects, using a natural treatment) were more likely 
to use St John’s Wort to treat their depression.   
 
One criticism of social cognition models however, is that they fail to take 
account of how individuals make inferences or representations about a 
particular health threat.  The process of how such inferences or 
representations then influence quality of life or the carrying out of a 
particular health-related care behaviour, such as using CAM are 
neglected by the social cognition approaches.  Given the importance of 
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such representations of illness in IBS, a theoretical framework was 
required that focused on the role of illness representations. 
   
A further issue is the lack of conceptualisation of emotional responses to 
illness.  Emotional reactions to IBS have been shown to be important 
(e.g. Lackner et al., 2004), this is a factor of IBS that is worthy of 
exploration that social cognition approaches would not enable.  There is 
further criticism that the HBM views individuals as overly rational in terms 
of their health care decision making, people are said to use cognitive 
information to make decisions about their health rather than being 
influenced by emotions (Conner & Norman, 2005).  Moreover, social 
cognition models tend to be viewed as cost-benefit or expectancy-value 
models, where there is a trade off between costs and benefits of 
conducting certain behaviour (Conner & Norman, 2005).  Whilst the HBM 
is a potentially important model that may examine CAM use, the HBM is 
unhelpful in exploring individuals’ perceptions of their illness and the 
pathways to quality of life.  These points highlight why the CSM has a 
relative advantage over some social cognition models (i.e. the TPB and 
HBM) in addressing the research aims of the thesis.   
 
2.5 Application of CSM research findings 
An underlying theme in this chapter has been the recognition that certain 
representations influence pathways in the CSM that may lead to poorer 
outcomes or poor coping procedures in chronic illness.  Identifying such 
representations presents an opportunity to identify areas where self-
management may be enhanced, adherence to treatment may be 
improved or symptoms better controlled through addressing unhelpful or 
problematic (e.g. stronger perceptions of illness consequences) 
representations.  It is clear from research presented in chapter one that 
the benefits of simple psychological involvement in the treatment process 
in IBS such as more information about IBS, and reassurance about 
symptoms may be beneficial (Ringström et al., 2009; 2010).  Studies by 
van Dulmen et al. (1994; 1996; 1997) and Oerlemans et al. (2010) have 
demonstrated the benefits of doctor-patient concordance on cognitive 
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aspects of IBS such as agreement on causal factors in reducing use of 
health care services.  Horne and Weinman (2002) suggested focusing on 
the necessity of asthma preventer medication and providing better 
information that asthma still requires controlling as it is an ongoing 
condition even when symptoms are not present (i.e. timeline 
perceptions).  The CSM may also allow other types of intervention to 
focus on illness or treatment representations that are related to poorer 
outcomes (Hale et al., 2007; McAndrew et al., 2008). 
 
Petrie et al. (2002) conducted a brief three stage intervention to modify 
more negative illness perceptions in patients who had suffered 
myocardial infarction (MI).  Patients’ responses from the IPQ were used 
to tailor content designed to challenge negative illness perceptions when 
providing information about MI and the heart, about risk factors and 
rehabilitation.  Patients that took part were less likely to have future 
angina attacks, felt more empowered to leave hospital and were quicker 
in returning to work.  This study is a good indicator of both how illness 
perceptions may be altered for the benefit of patients and the necessity 
to investigate illness perceptions in illnesses that are problematic to treat, 
such as IBS.  Petrie, Broadbent and Meechan (2003) cite other CSM 
based interventions in other chronic illnesses such as diabetes, asthma 
and HIV.  These applications suggest CSM research findings are 
successfully able to be applied to self-management strategies in what 
appears to be a buoyant area of enquiry and application.  
 
Such interventions have not been limited to the cognitive arm of the 
CSM.  Cameron and Jago (2008) document interventions designed to 
regulate emotional distress caused by illness.  One such example is a 
writing intervention, whereby the process of writing about individual 
experience is said to be positively appraised and can help provide 
understanding and meaning of symptoms which has similarities to work 
by Pennebaker (1997), where the disclosure of such emotional events 
has been shown to result in improved health.  Similarly Ringström et al's. 
(2009) IBS school study may prompt the same effect of challenging 
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emotional representations through better information about IBS to reduce 
illness-related distress.  Ringström et al. (2009) found their IBS school 
intervention resulted in less use of health care services over time.  This 
suggests that such an intervention may be able to target illness 
representations effectively into guiding more adaptive coping procedures 
that could lead to improved quality of life.  Furthermore, a structured 
patient group appears to work better than written information (Ringström 
et al., 2010). 
 
2.6 Chapter summary and research objectives 
This chapter has outlined the CSM of illness representation and why it 
was the most suitable model to address the research aims.  An outline of 
the model was presented, measurement issues considered and empirical 
evidence for the CSM outlined.  Studies that have used the CSM in IBS 
and CAM use were outlined, although these have, to date, been in 
separate contexts and consist of a small number of studies.  No studies 
have examined CAM use in IBS with the CSM as a theoretical 
framework.  This research also sought to extend the CSM (e.g. Horne & 
Weinman, 2002) to take account of treatment beliefs as well as illness 
representations in influencing CAM use, coping and outcome. 
 
There have also been a number of issues raised in this chapter that 
would benefit from investigation and potential clarification in terms of the 
aims of the study and the theoretical framework.  This research will 
address deficits in existing knowledge regarding illness perceptions in 
IBS and use of CAM, which may be important in the development of 
future management interventions.  Similarly, there has been a lack of 
focus on treatment (and CAM) beliefs in IBS and how these may affect 
coping and outcome.  The clarification of the degree of influence illness 
and treatment representations have on a specific coping behaviour (CAM 
use) and coping strategies or procedures is examined.  Furthermore, 
CSM pathways will be explored between those with IBS that use CAM 
and those not using CAM for IBS wherein the potential mediating role of 
coping between illness perceptions and outcome is examined.  The latter 
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point is, in part, based on theorised differences between CAM-users and 
non-users in illness and treatment representations and reported quality of 
life. 
 
 A consideration of these issues and a theoretical basis for the research 
enabled more specific research objectives to be outlined.  The 
overarching research aim was to investigate the illness-related 
perceptions and treatment beliefs that were influential in CAM use in IBS 
and to explore the CSM pathways within CAM-users and non-users (i.e. 
non-users).  Within this overarching aim, there were specific objectives 
formulated to examine the role of illness representation and treatment 
beliefs in CAM use in IBS.  This included consideration of examining 
CSM components over different time points.  The research aims 
therefore were:  
 
2.6.1. To explore which illness perceptions and treatment beliefs in those 
affected by IBS are influential in CAM use (chapter 4). 
 
2.6.2. To explore the interrelations between the CSM components in 
CAM-users and those not using CAM in those with IBS (chapter 5). 
 
2.6.3. To assess any change in illness representations and treatment 
beliefs over time in CAM-users and non-users with IBS (chapter 6). 
 
2.6.4. To examine if illness perceptions and treatment beliefs influence 
reported quality of life after a minimum of six months in CAM-users and 
non-users with IBS (chapter 6). 
 
With a clear theoretical framework outlined and the rationale for such a 
framework explored, it is necessary to consider the methodological 
aspects of the research.  The following chapter therefore addresses the 
methodological and analytical positions employed to undertake the 
investigation of the research aims presented in chapters four through to 
six with reference to dimensions and components of an extended CSM.   
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Chapter 3  
 
Methodological framework 
 
This chapter presents the rationale for the methodological approach 
adopted for the research.  The choice of study design and measurement 
instruments is reviewed and the rationale for a web-based survey data 
collection method is presented within the empirical context presented in 
chapter 2.   
 
3.1 Design  
This research set out to examine predictive factors from the CSM in CAM 
use and which of these factors were influential in outcome, and how 
these factors differed between CAM-users and those not using CAM 
(non-users).  Previous CSM research (considered in chapter 2) has 
addressed similar questions using a cross-sectional quantitative 
approach in a number of chronic illnesses including IBS (Rutter & Rutter, 
2002).  The design of specialist measures to capture illness perceptions 
(Moss-Morris et al., 2002), meant that utilisation of such measures would 
reliably capture participants’ illness perceptions and allow comparison 
with previous research using the CSM framework.  To examine potential 
changes over time, a follow-up study was also conducted which allowed 
statistical comparison between data collected at study time one and 
study time two (follow-up) as was consistent with previous work utilising 
the CSM in IBS (Rutter & Rutter, 2007).  Therefore, a quantitative 
methodology was considered the most appropriate to address the 
majority of the research aims investigating pathways within the CSM.  As 
considered in the previous chapter, numerous CSM studies have been 
conducted utilising a qualitative philosophy.  Moreover, to cross-validate 
the apparent importance of illness perceptions, the final research aim 
required the collection of qualitative data.  This aspect of the design is 
considered in the next section. 
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3.1.1 Philosophical framework 
The research presented in subsequent chapters is primarily theory driven 
and follows a deductive approach using quantitative web-based survey 
methodology to investigate the research aims presented at the end of the 
preceding chapter (section 2.7).  It can be argued that the nature of 
theory limits the methods that can be used to test or examine that theory 
(Breakwell & Rose, 2006).  In the case of the empirical work presented in 
previous chapters (e.g. Bishop et al., 2006; Rutter & Rutter, 2002; 2007), 
a quantitative design was deemed the most appropriate method to 
examine the components of an extended CSM.  It was therefore deemed 
appropriate to test these components statistically in terms of 
relationships between illness perceptions, treatment beliefs, coping and 
quality of life (e.g. Rutter & Rutter, 2002; 2007) and to determine which 
illness perceptions and treatment beliefs would statistically predict CAM 
use (e.g. Bishop et al., 2006) in those with IBS.  The choice of a 
quantitative methodology was further determined by the following 
consideration of what constitutes knowledge and how different 
approaches to gathering knowledge may potentially be harmonised to 
further the understanding of IBS (e.g. Casebeer & Verhoef, 1997).  
Moreover, the specific method of data collection is considered here in the 
context of the theoretical model, past research and electronic methods of 
data collection.      
 
3.1.1.1 Deductive and inductive approaches to research   
The question of epistemology, that is, what constitutes acceptable 
knowledge in a particular research domain can be considered in terms of 
philosophical orientation, an orientation that forms the foundation of the 
whole research process (Bowling, 2009).  Broadly speaking there are two 
main approaches to epistemology (Bryman, 2008).  One perspective is 
represented by the positivist stance which is characterised by the laws of 
natural science and establishment of facts (Bowling, 2009; Bryman, 
2008).  The positivist approach is said to be opposed to more interpretive 
approaches which seek to ascertain the subjective meaning of social 
actions (Bryman, 2008).  Considering these positions further illustrates 
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that typically the approach to knowledge in research is demarcated on 
whether it is either deductive or inductive in its orientation (Bowling, 
2009; Casebeer & Verhoef, 1997).  A deductive approach is more readily 
associated with the scientific method of theory testing via hypothesis 
formation and an attempt to establish objective, reliable and valid results, 
to prove objectivity or fact (Casebeer & Verhoef, 1997).  This is usually 
carried out by collecting and using numerical data whilst making 
statistical inferences from samples that can be generalised to the 
particular population of interest to the researcher.  Inductive approaches 
however, tend to begin with observations of phenomena which lead to 
theory development (Bowling, 2009).  Inductive research is often 
associated with qualitative methods that seek to explain patterns and 
processes involved in a particular phenomenon.  The resulting 
interpretations lead to the development of theories that best explain the 
phenomena being investigated.  Rather than numerical and statistical 
information being collected and analysed, some form of textual analysis 
(e.g. interview transcripts) or observations are common forms of data 
collection (Marks et al., 2005).  Portions of text are ‘compared’ and 
narrative description is used to try to explain ‘what’ is being studied in 
terms of meaning for the individual (Pope, Ziebland & Mays, 2000).   
 
3.1.1.2 Advantages of harmonising deductive and inductive 
approaches 
The demarcations between approaches in research are typified by 
different understandings about the basis of knowledge or epistemology.  
Quantitative designs loosely fit the idea of positivism in that all human 
experience can theoretically be ‘reduced’ to numerical form and further 
explored by the relationships between the numerical values which can 
both support and generate theory (Bryman, 2004; Casebeer & Verhoef, 
1997).  Qualitative designs tend to oppose this idea of numerical detail 
and seek to study the underlying processes, mechanisms and meanings 
of phenomena to the individual (Bowling, 2009).  However, it is argued 
that these boundaries are superficial and potentially limiting to 
researchers in that one method can be deemed more suitable in terms of 
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gathering knowledge than a differing methodology (Bowling, 2009; 
Casebeer & Verhoef, 1997).  This can place unnecessary restrictions on 
researchers investigating such phenomena as chronic illness (Casebeer 
& Verhoef, 1997).  Bowling (2009) argues that although seemingly 
diametrically opposed, researchers should seek to establish novel ways 
to combine these perspectives within research to gain further insight into 
topics of interest (Bowling, 2009; Casebeer & Verhoef, 1997).  In fact, the 
very tensions within approaches may generate unique insights into 
studied phenomena (Lingard, Albert & Levinson, 2008).  It is now 
accepted that researchers may conduct experimental or quantitative 
survey studies whilst collecting material that may be qualitatively 
analysed.  Such qualitative analysis may help to explain processes or 
outcomes identified by quantitative methods, the meaning of quantitative 
constructs for individuals or guide future investigations (Casebeer & 
Verhoef, 1997; O’Cathain & Thomas, 2004). 
 
The research presented in this thesis, although orientated quantitatively, 
took into account the subjective nature of IBS and the degree to which it 
affects reported quality of life (Amouretti et al., 2006; Dancey & 
Backhouse, 1993).  Based on the arguments of Bowling (2009) and 
Casebeer and Verhoef (1997), an open question was included in the 
survey which stated ‘you may use the space below to comment on 
anything you would like to say about having IBS.’  Responses to this 
question were analysed qualitatively, applying a top-down thematic 
analysis (Boyatzis, 1998; Braun & Clarke, 2006) to provide additional 
substantiation of components of illness perceptions in participant text.  
An analysis of these findings are presented in appendix XV.  It should be 
noted that such an approach to research does not represent a multiple or 
mixed-methods approach, but rather an attempt to obtain qualitative data 
in a ‘novel’ way.  ‘Novel’ is considered in the context of using largely 
quantitative methodology to obtain qualitative data (Bowling, 2009) to 
potentially gain deeper understanding of IBS.  As noted in chapter two, 
much of the foundation work into the CSM was conducted using in-depth 
qualitative interviews (Weinman et al., 1996) and other CSM studies 
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have adopted a qualitative approach (Goodman et al., 2005; Meyer et al., 
1985).  It is possible that such qualitative information may prompt further 
investigation or potentially lead to development in measurement of illness 
perception components.   
 
3.1.2 Data collection 
A web-based survey design was considered the most appropriate 
method of data collection for this research as the method has been used 
in previous research into the CSM and CAM use (Bishop et al., 2006; 
2008) and the internet offers many other advantages to researchers 
using survey based methodology (Ahern, 2005; Duffy, 2002).  There are 
several factors that make the recruitment of participants for internet 
based research a legitimate prospect.   
 
3.1.2.1 The internet: access, health information and e-interventions 
In recent years both internet use and access has increased substantially.  
The Office of National Statistics (ONS) reported that 73% of households 
in the UK have access to the internet, an 8% increase on 2008 (ONS, 
2010).  The number of adults using the internet daily (or almost daily) in 
the UK is estimated at 30.1 million (ONS, 2010).  In the first quarter of 
2011, adult internet use was said to be approximately 82% (ONS, 2011). 
Similar usage is reported for the US and Europe (Internet World Stats, 
2011; Madden, 2006).  Internet connectivity is also not confined to the 
more economically affluent or specific ethnic groups and is widespread 
amongst different cultural and ethnic groups in the UK (Ofcom, 2007).  In 
terms of conducting research online, such data suggest a 
demographically diverse pool of potential participants have internet 
connectivity (Birnbaum, 2004; Gosling, Vazire, Srivastava & John, 2004).      
 
Furthermore, the use of the internet as a primary or supplementary 
source of information for health advice or health related information has 
become widespread (Bansil, Keenan, Zlot, & Gilliland, 2006; Bundorf, 
Wagner, Singer, & Baker, 2006; Powell & Clarke, 2002; Scott, Scott, & 
Auld, 2005).  Websites operated by the NHS give advice about particular 
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symptoms or treatment options.  Studies have shown that using internet 
for health or illness information is common (de Boer, Versteegen, & 
Wijhe, 2007) with patients essentially becoming consumers of health 
information online (McMullan, 2006).  Patients may also feel empowered 
by feelings of immediate benefits of obtaining health and illness 
information instantly (Donnelly, Shaw, & van der Akker, 2008).  Such 
factors arguably make the internet a natural domain for health based 
research to be conducted as participants become more familiar with such 
phenomena taking an electronic format (Ahern, 2005; Cantrell & 
Lupinacci, 2007).   
 
Other developments have taken the form of online health interventions 
and online support.  E-interventions have had an impact in many chronic 
disorders such as eating disorders (Robinson & Serfaty, 2001; 2003), 
self management and improving social support in diabetic patients 
(Glasgow, Barrera, McKay, & Boles, 1999) and breast cancer patients 
(Winzelberg et al., 2003).  In terms of support provision, individuals with 
chronic illnesses, such as IBS, have been shown to use internet based 
forums as a means of support, sharing information and experiences 
regarding their IBS (e.g. Coulson, 2005).  A large number of illness 
specific websites also exist on the internet, often run by charities that 
offer information and support to individuals via electronic support 
information or self management programs or through online community 
message boards, such as the IBS network in the UK.  It is illness or 
health related websites where researchers often seek to recruit 
participants for research participation (Bishop et al., 2006; Duffy, 2002).  
These developments in internet familiarity, connectivity and the online 
provision of health care, support networks and information offer 
extensive opportunity to recruit participants and conduct research online. 
 
3.1.2.2 Web-based surveys  
The increase in electronic media over the last two decades has opened 
up a new domain for researchers.  Surveys can now be completed by 
participants using their computer thus removing the need to see the 
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researcher, to speak to them or to return a completed questionnaire in 
the post.  Such methods have been used successfully in an increasing 
number of studies (Ahern, 2005; Cantrell & Lupinacci, 2007) and a 
number of online Psychology research directories exist that detail current 
web-based studies.  Surveys can be sent to potential participants via 
their email address (in the form of an attachment or invitation to contact 
the researcher) or via linking from web-pages on the internet or email 
(Duffy, 2002).  The latter is often referred to as “internet mediated 
research” (e.g. Hinchcliffe & Gavin, 2008) as the “internet” takes the 
place of the researcher in administering and providing information about 
the research.  Studies carried out in this manner usually attract 
participants by posting details about the survey on other web pages that 
are visited regularly by the target population.  Of these two possible 
recruitment methods, a direct link to the study website is regarded as 
more favourable (Duffy, 2002).  The research presented here worked in a 
similar way, albeit utilising a web-based approach similar to Bishop et al. 
(2006) who conducted their study online using elements of an extended 
(dynamic) CSM to determine factors important in CAM use. 
 
3.1.2.3 Benefits of web-based surveys 
There are several reasons why web-based research should be 
considered a legitimate research tool.  Evidence presented in section 
3.1.2.1 suggests individuals will routinely seek out illness or health 
related information on the internet (Bansil et al., 2006; Bundorf et al., 
2006).  There are other practical benefits to the researcher such as 
access to ‘specialist’ samples (section 3.1.2.3.1) and easy electronic 
transmission of data into statistical packages for analysis.  Potentially 
large numbers of participants may be recruited and disclosure may be 
enhanced by the perception of anonymity in using the internet. 
 
3.1.2.3.1 Access to specialist samples and increased disclosure 
There is also argument that the internet offers a unique opportunity to 
gain access to ‘specialist’ samples of participants that may not be 
accessible via more traditional approaches (Ahern, 2005; Duffy, 2002; 
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Gosling et al., 2004; Hiskey & Troop, 2002).  In the case of face-to-face 
interviewing a high response rate may be obtained, however certain 
factors, such as personal issues, may not be reported due to lack of 
anonymity (Bowling, 2009).  There is also the possibility that the 
interviewer’s presence may effectively ‘lead’ participants into answering 
in a particular way (Boynton & Greenhalgh, 2004).   Face-to-face 
interviewing may also be less financially viable and more time consuming 
than some other methods.  Many of these potentially negative issues 
related to this form of data collection may be addressed by using a web-
based survey.  Web-based survey research may be considered cheaper, 
less intrusive and less time consuming than other more ‘traditional’ 
methods of data collection (Ahern, 2005). 
 
 
3.1.2.3.2 Economic and participant response benefits of online 
research 
A further implication of surveys carried out by telephone call or by post is 
cost.  In the case of the former, one notable expense is that respondents 
very often may not be available for interview, calls may be terminated 
during the interview, remain unanswered or the caller may be involved in 
a long (and therefore more expensive) exchange of dialogue (Boynton & 
Greenhalgh, 2004).   Telephone interviewing can be productive for 
shorter, uncomplicated surveys that will not take up too much of the 
participant’s time (Bowling, 2009) but in general this method still has an 
impact on participant’s time and financial cost to the researcher.  Some 
of these shortcomings may be addressed by conducting postal surveys.  
Self-administered questionnaires, sent to potential participants in the 
post can arguably reduce any social desirability and interviewer bias 
(Bowling, 2009).  One possible method of approaching a large scale 
sample is to send out a questionnaire in the post – with a prepaid reply 
envelope – for the participant to respond to at their convenience.  The 
method can be seen as more economical in terms of expenditure on 
stationery and postage as opposed to potential travel costs (as with face-
to-face interviews) and costs of repeated telephone calls (telephone 
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interviews).  There is also suggestion that participant disclosure is likely 
to be greater due to the greater level of anonymity involved in postal 
questionnaires (Oppenheim, 1992).    
 
Postal surveys however, may suffer from poor response rates as 
participants may decide not to take part or simply forget to return their 
questionnaires (Boynton and Greenhalgh, 2004).  Again, this may be 
addressed by conducting a web-based survey.  Participants have the 
convenience of being able to participate in the research at any time of 
day and evidence suggests completion is either more likely in an online 
format (Kongsved, Basnov, Holm-Christensen & Hjollund, 2007) or no 
worse than paper and pencil format (Wu et al., 2009).    
 
3.1.2.3.3 Practical benefits to the researcher 
Previous commentators have suggested that potentially large numbers of 
participants can be reached in a relatively short time span with using 
web-based surveys (Birnbaum, 2004; Duffy, 2002).  The apparent 
increased anonymity of the internet makes research participation more 
likely (Gosling et al., 2004).  Barry (2001) argues that increased 
participation in research on the internet comes from a feeling of 
familiarity with internet pages, itself coming from experience of general 
internet use.  This can create a situation in which the participant feels 
comfortable in responding to questions at their own pace (Barry, 2001).   
 
Web-based surveys have increased over the last 15 years (Cantrell & 
Lupinacci, 2007), something that is mirrored by the advent of e-
companies offering ‘ready made’ survey software for researchers making 
the process of administering and collecting data relatively uncomplicated.  
Conducting surveys using the internet can be a simple and cost effective 
alternative to other methods of survey administration for researchers 
allowing potentially large numbers of participants to be recruited and 
allowing contact to be made with participants for follow-up studies via 
email (Ahern, 2005; Gosling et al., 2004).  The fact that large numbers of 
participants may be recruited may also establish greater generalisation of 
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findings (Gosling et al., 2004).  A further benefit of internet surveys is that 
participant responses can usually be downloaded in numerical form and 
input into statistical software programs with minimum effort and can 
reduce potential data entry errors (Ahern, 2005).   
 
3.1.2.3 Participant recruitment in web-based surveys 
The favoured approach for contacting participants on the internet is to 
post a clickable link (along with some information) to the study on a 
website that is populated by a sample of the target population (Cantrell & 
Lupinacci, 2007; Duffy, 2002).  This may take the form of a discussion 
forum or a website offering some sort of advice or support.  Cantrell and 
Lupinacci (2007) suggest this issue is considered fully by the researcher 
when designing the study, as it can result in recruitment problems if not 
administered properly.  As the researcher is not present during web-
based studies as there is no direct contact with participants, there may 
be little they can do to influence participation.  However, if they have 
participant details such as if they have placed an advertisement asking 
for potential participants to contact the researcher if they are interested in 
the study, they can send out reminders to participants to take part via 
email (Duffy, 2002).  However, one downside to this approach is that it 
can be time consuming for the researcher to correspond directly with 
large numbers of participants.  Therefore, this study opted to rely on 
advertisements on websites and discussion forums to attract potential 
participants.  Furthermore, in specific illness populations, individuals may 
be motivated to take part in research as they feel as though they are 
‘part’ of the study.  There may also be willingness to take part as 
participants may feel they are gaining something from taking part in the 
study such as helping to further understanding of their illness (McColl et 
al., 2001). 
 
3.1.2.4 Potential issues with web-based surveys 
All aspects of internet research require care and planning.  However 
factors such as security and repeat or nonsense responses require 
specific attention.  As with any personal information researchers need to 
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take care with personal data and ensure that electronic submission and 
storage of personal information is secure.  There is also potential for 
websites to be targeted by repeat or nonsense responses making data 
meaningless (Birnbaum, 2004; Gosling et al., 2004).  However, through 
the use of a specific illness population and careful advertising of the 
survey, responses such as this were not an issue with the research 
presented in this thesis.  Almost all of these concerns were addressed by 
the use of an existing online survey host company where issues of 
secure storage and transmission of data are taken care of.  The 
researcher can make sure that they alone have access to the data 
(Duffy, 2002).  The online survey host used in this study was also able to 
note the IP (internet provider) address of each response.  This was for 
the sole purpose of eliminating possible repeat responses from the 
identical IP addresses.  IP addresses are allocated to individual users by 
internet providers to enable communication between computers on the 
internet.  In this study it was utilised solely to potentially identify multiple 
responses from the same computer or participant. 
 
Furthermore, there has been speculation about the limitations and 
potential weaknesses of research carried out via the internet (Ahern, 
2005, Birnbaum, 2004).  However, empirical data have demonstrated 
many of these concerns to be increasingly unfounded.  Gosling et al. 
(2004) investigated several preconceptions regarding the potential for 
poor quality or non-probabilistic survey data collected on the internet.  
Firstly, internet samples are regarded as more diverse than originally 
thought, although not yet fully representative of the general population.  
Second, there have been concerns that internet data do not yield reliable 
and valid data in established psychological measures (Gosling et al., 
2004).  Such concerns however appear unfounded.  Research has 
shown that psychometrically sound measures are not affected by data 
collected online in a culturally diverse sample (Graham & Papandonatos, 
2008) and in comparisons of internet and mailed questionnaires 
(Birnbaum, 2004; Ritter, Loriq, Laurent, & Matthews, 2004).   
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Findings from studies utilising different presentation formats online also 
seem to demonstrate consistency across formats (Gosling et al., 2004).  
Investigation into standardised psychological measures has shown little 
or no difference between online and paper and pencil samples.  Vallejo, 
Jordan, Diaz, Comeche, and Ortega (2007) compared online and paper 
responses to the General Health Questionnaire-28 (Goldberg & Hillier, 
1979) and the Symptom-Check-List-90-Revised (Derogatis, 1977), both 
tools used for screening of psychopathology.  The study found 
consistency between the methods of administration, where any 
differences found were minor (Vallejo et al., 2007).  Similarly in using the 
Short form-36 (Ware & Sherbourne, 1992), to compare paper and 
internet responses of in women referred for mammography, Basnov, 
Kongsved, Bech, and Hjollund (2009) found consistency across paper 
and online methods of administration.  These studies strengthen the 
argument that the internet is a viable tool for administration of survey 
based research. 
 
3.1.2.5 Summary of issues related to conducting web-based 
surveys 
It is clear there are justifiable reasons for using the internet to conduct 
research.  There is potential for easy access to participants that may be 
out of reach of more traditional methods of data collection as well as the 
potential to contact large numbers of participants who can take part in 
research at their own convenience.  The internet has also grown into a 
tool for both information provision and even electronic intervention in 
many illnesses or health issues.  Research into establishing the reliability 
and validity of existing measures online is promising in that there 
appears to be little or no difference in web-based populations.  Other 
concerns seem to be giving way to a body of literature that suggests 
potential obstacles can be overcome by the implementation of relatively 
straightforward procedures such as checking for repeat responses and 
ignoring incomplete or nonsense replies.  There are numerous online 
survey hosts that simplify survey administration and data collection and 
researchers can now be much more confident that their data are 
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comparable with existing work from more traditional methods of survey 
administration. 
 
Considering the aspects that have been highlighted in the preceding 
sections, it was determined that both the initial cross-sectional study as 
well as the follow-up study would be conducted using survey 
methodology which is common with several other CSM based studies 
(chapter two).  The benefits of conducting web-based research have also 
been considered and in the context of the CSM, web-based research has 
been previously conducted (Bishop et al., 2006; 2008).  These factors 
demonstrate that a web-based survey is both appropriate and effective to 
address the research objectives of the thesis.   
 
3.1.3 Identification of variables for measurement 
Inherent in the CSM is the assumption that certain variables are present 
to be able to assess the model.  In this study, the core components of the 
CSM were measured which were, namely, illness perceptions and 
coping.  As chapter two argued (section 2.2.3), an illness-specific 
measure of quality of life was considered a suitable outcome and 
treatment beliefs (regarding conventional medicine and complementary 
medicine) were included as an extension of the model based on previous 
work (Bishop et al., 2006; Horne et al., 1997; Horne & Weinman, 2002).  
Measurement of CAM use was also considered.  The measures 
considered in relation to the CSM constructs outlined in chapter two are 
considered fully in section 3.3. 
 
3.1.4 Presentation of survey and response format 
It is generally accepted that questionnaires should be presented in an 
appealing, structured way and usually in sections (Bryman, 2008).  An 
aesthetically pleasing questionnaire is more likely to be completed than 
one that looks uninteresting or confusing (Boynton & Greenhalgh, 2004; 
Keeter, Kennamer, Ellis, & Green 2001) and this extends to having a 
straightforward and clear layout (Puleo et al., 2002).  Factors such as this 
are easily implemented using web-based surveys and require minimum 
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expertise if using an online survey host.  Likewise the structure of 
surveys is also important.  Generally an introduction to the research (i.e. 
information about the study) is considered best practice with some non-
intrusive questions to start off the survey (Bowling, 2009; Rattray & 
Jones, 2007; Sapsford, 1999).  This can be followed by the main body of 
the survey, with the detailed demographics at the end of the survey as, if 
placed at the beginning they can contribute to study attrition (Bowling, 
2009).  At the end of the survey, further information may be volunteered 
by the researcher about the study and participants are generally thanked 
for their participation.  As considered earlier, there can also be an ‘open’ 
section for additional comments or responses that may be analysed 
qualitatively (O’Cathain & Thomas, 2004).  The end of the survey is an 
appropriate place to ask participants if they would be interested in taking 
part in any further studies, with the participant offering some form of 
contact to the researcher.  In the case of web-based studies, contact is 
often made via email between researcher and participant (Ahern, 2005; 
Duffy, 2002). 
 
The response formats of the selected questionnaires are outlined in 
section 3.3.  Many of the response formats used in this study come from 
validated measures and take the form of a Likert type scale, usually with 
a mid point.  Participant responses are coded numerically to give a level 
of agreement or disagreement with particular statements.  It is also 
common to treat these data as parametric (interval) data when the 
measure is regarded as reliable and valid (Bowling, 2009; Polgar & 
Thomas, 1995) thus ensuring more powerful statistical analysis using 
parametric tests where appropriate (Rattray & Jones, 2007).   
 
Additional questions may focus on such issues as if (and how long ago) 
a diagnosis took place, or how long someone might spend with their 
Doctor. Such questions may form an important part of subsequent 
analysis of data, or they may help explain characteristics of the sample 
and can be used as non-threatening introductions to more in-depth 
questions (Bowling, 2009; Rattray & Jones, 2007).  Both Likert type and 
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open response formats are usually easy for participants to understand 
and follow, and by offering a mid-point in Likert scales allows participants 
to remain undecided, but still gives the researcher a ‘total’ score to 
examine (Bowling, 2009). 
 
As considered previously, detailed participant demographics relating to 
participants are better positioned towards the end of a survey, thus 
avoiding the potential for study attrition (Bowling, 2009).  Although there 
is no definite guide to what should be included, generally participant 
gender, age, income and education are asked.  Further questions may 
enquire about ethnic background, religious beliefs, employment and co-
morbidity if dealing with a specific illness group, factors which have been 
shown to be influential in CAM use in previous studies (chapter two).  
Demographic information can also act as a means of comparison with 
existing work and may help to argue findings have wider application 
beyond each study sample (Bryman, 2008).  Such claims have particular 
relevance to internet based studies (Birnbaum, 2004; Gosling et al., 
2004).  
 
3.1.5 Study design 
The preceding sections have recognised the major issues in structuring a 
series of questionnaires and how these factors may affect the response 
rate.  It has also considered the benefits and limitations of different 
methods of administering questionnaires and it was decided that the 
survey should be administered via the internet.  The instruments 
described in the following sections of this chapter have been selected on 
the basis of being psychometrically sound measures of each of the 
relevant components (chapter two) of the CSM.  These will be used to 
examine the research objectives outlined in chapter two. 
 
The study was developed taking into account the points considered 
earlier, including the order of questionnaires, response formats, the 
length of the survey overall and how the study looked in terms of 
 112 
presentation to participants.  The structure of the survey is outlined in 
figure 3.1. 
 
Participant recruitment took place via advertisements placed on the 
internet inviting potential participants to take part in the research rather 
than asking them to contact the researcher first to assist the response 
rate and make data collection quicker.  Moreover, by using mostly 
established measures in the research that have undergone thorough 
testing and development it was thought this would minimise any 
problems and aid a smooth completion of questionnaires by participants. 
 
In considering previous CSM research it was thought both a cross-
sectional (chapters four and five) and a follow-up study (chapter six) 
would best address the research objectives effectively.  The initial cross-
sectional study consisted of a large scale web-based survey.  All 
questionnaires were presented to participants via the internet using an 
online survey host.  The main predictor (and explanatory) variables are 
outlined in subsection 3.3 and consisted of measures of illness 
perceptions, treatment beliefs (including beliefs about CAM) and coping.  
There were two main outcome variables consisting of a dichotomous 
measure of CAM use for IBS (yes or no) and a measure of quality of life 
specific to IBS (the IBS-QOL, Patrick et al., 1998).    
 
3.2 Sample size 
To determine an appropriate sample size (Lerman, 1996), a statistical 
power calculation was conducted based on the intended use of logistic 
regression described in section 3.6.2.  A power calculation is able to 
provide researchers with a suggested minimum number of participants 
required to detect statistical significance in a population.  The suggested 
sample size is based on information including desired significance level 
(usually p<.05), number of variables to be analysed and an acceptable 
level of power (usually .8 or 80%, the chance of committing a type II 
error).   
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3.2.1 Determination of sample size 
A statistical power calculation was used to determine the minimum 
sample size.  Statistical power works in reverse to the usual -value of 
.05 (.05 demonstrating the likelihood a researcher is to make a type I 
error or false positive).  The concept of ‘power’ allows the researcher 
(based on previous research and theory) to ‘expect’ an effect to be 
detectable in the sample population (Field, 2009; Tabachnick & Fidell, 
2007).  A calculation of sample size or ‘power’ can be conducted to 
establish the minimum number of participants required to find an 
expected effect in a sample at a power size of .80 (usually denoted by 
=.80) which is sometimes expressed as 80%.   This effectively means 
that there is a .2 or 20% chance of committing a type II error, that is a 
rejection of a potentially significant result when it exists in the population.  
The G-Power1 program (Faul, Erdfelder, Lang, & Buchner, 2007) was 
used to determine the number of participants on an ‘a priori’ basis to find 
an ‘expected’ effect.  Assuming much of the analysis would be exploring 
inter-relationships between components of the CSM, a decision was 
made to primarily focus on the number of factors that would predict CAM 
use in those with IBS to determine the required sample size. 
 
Thus a power calculation was conducted with 22 predictor variables, 
namely 11 scales of the IPQ-R, the 2 scales of the BMQ and the 3 scales 
of the CAMBI.  Also included were approximately six demographic 
variables (such as age, gender and dichotomous measure of prescription 
medication) a minimum sample size of 163 was required for logistic 
regression analysis (to predict CAM use), with alpha set to .05 and a 
power of .80 would give a critical value of ‘F’ in the regression model of: 
F (22, 140) =1.62, p<.05.  Further to the reasons considered earlier in 
relation to a web-based study being the most favoured approach, the 
minimum recommended sample size of 163 from the power calculation, 
suggested that a web-based study would be appropriate to gain this 
number of participants as a minimum. 
                                               
1 This software is available as a free download at:  
http://www.psycho.uni-duesseldorf.de/aap/projects/gpower/  
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3.2.2 Obtained sample size 
In both phases of the study, participants were all adults aged 18 or over 
that have IBS or IBS symptoms.  As stated, recruitment took place via 
the internet.  Phase one of the study attracted 2887 visits to the study 
website, with 1246 participants commencing the study.  Approximately 
53% of those who commenced the study completed all the 
questionnaires meaning a final sample of n=653 participants for the 
cross-sectional part of the study (presented in chapters 4 and 5).  At the 
end of the study, interested participants were given the option to take 
part in a follow-up study by leaving an email address as a point of 
contact.  Participant details for the follow-up study are presented in 
chapter six.   
 
3.3 Measures/materials 
The structure of the survey was broadly organised into four main 
sections based on consideration of the preceding discussion regarding 
surveys.  This followed the pattern of: i) non-intrusive background 
questions (e.g. regarding diagnosis of IBS and time with symptoms), ii) 
questionnaires based on the CSM, iii) questions about CAM use (if 
applicable) and iv) demographic questions. 
 
3.3.1 Background questions 
The first section of the survey was designed to ask participants some 
non-intrusive questions about their IBS (e.g. Bryman, 2008).  This 
included if they had been diagnosed by a health care professional and 
approximately how long ago this was.  They were also asked how long 
they had been with symptoms of IBS.  As the survey was web-based, 
‘branching’ was used so participants were not presented with 
unnecessary questions (e.g. asking participants about how long ago they 
were diagnosed if they had not actually been diagnosed).  
 
3.3.2 Predictive/explanatory measures 
The survey was largely made up of established questionnaires related to 
components of the CSM.  These measures were included to capture 
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participant perceptions of their IBS, their treatment beliefs, their beliefs 
about CAM, how they coped with IBS, their reported quality of life and if 
they used CAM to relieve their IBS.  Further questions asked about 
which CAM treatments had been used.  Specific details of each of the 
measures are presented in the following subsections.   
 
3.3.2.1 Illness perceptions 
The illness perception questionnaire revised version (IPQ-R; Moss Morris 
et al., 2002) was used to measure the main components of illness 
perceptions identified by Leventhal et al. (1998; 1992).  The IPQ-R is a 
reliable and valid measure of nine components of illness perceptions, 
having been used in several illness populations such as asthma patients, 
those with chronic pain and in a cervical screening context (e.g. Hagger 
& Orbell, 2005; Moss-Morris et al., 2002) (see chapter 2) and has been 
used in studies to determine CAM use (Bishop et al., 2006; 2008).  As 
chapter two illustrated, the IPQ-R is a revision of the original five-
component IPQ (Weinman et al., 1996) which itself measured the key 
components of the CSM namely: identity (symptoms that are attributed to 
the illness), timeline (beliefs regarding the duration of the illness), cause 
(beliefs about what caused the illness), consequences (personal 
significance of the illness) and cure/control (the likelihood of the illness 
being controlled or cured).  The nine-component IPQ-R includes the 
addition of a scale of emotional representations related to illness, 
something not considered by the IPQ but part of the CSM in that both 
cognitive and emotional responses to a health threat work in parallel to 
maintain a state of normality (Leventhal et al., 1998).  The IPQ-R 
contains a revised causal scale, including eight additional items and the 
‘control’ dimension was split into patient control and treatment control.  
The IPQ-R also has an additional timeline scale that measures the 
cyclical nature of illness.  There is empirical support that both the IPQ 
and IPQ-R are structurally related to coping (Hagger & Orbell, 2003; 
Rutter & Rutter, 2002), CAM use (Bishop et al., 2006; 2008) and quality 
of life (Rutter & Rutter, 2002; 2007) (see chapter 2).   
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The measure was amended slightly as Moss-Morris et al. (2002) 
recommend that the word ‘illness’ be changed to the illness under 
investigation, therefore the word ‘illness’ was substituted with ‘IBS’ 
throughout the questionnaire (Moss-Morris et al., 2002).  Furthermore, at 
the present time, although many illness specific identity scales exist, 
there is no domain specific scale for IBS.  The identity scale is based on 
fourteen symptoms of which participants respond ‘yes, this symptoms is 
related to my IBS’ or ‘no, this symptom is not related to my IBS’.   
 
The Timeline acute/chronic scale is measured by six items to determine 
perception of an acute or chronic timeframe for IBS.  Items in this scale 
include ‘My IBS will last a short time’ and ‘My IBS is likely to be 
permanent rather than temporary’.  A second Timeline scale (to assess 
beliefs about the cyclical nature of illness) consists of four items including 
‘The symptoms of my IBS change a great deal from day to day’ and ‘My 
IBS is very unpredictable’. 
 
A further six items on the IPQ-R measure ‘consequences’ that is, the 
perceived seriousness of the illness for the individual.  This scale 
includes items such as ‘My IBS has major consequences on my life’ and 
‘My IBS is a serious condition’.  There are two ‘control’ scales on the 
IPQ-R – personal control and treatment control.  Six items measure 
personal ‘control’ which concerns how much control the individual feels 
they have over their illness.  Items in this scale include ‘There is a lot I 
can do to control my symptoms’ and ‘I have the power to influence my 
IBS’.  A further five items measure treatment ‘control’ which relates to 
perceptions of how medication can help control symptoms and illness.  
Treatment control items include ‘’My treatment can control my IBS’ and 
‘The negative effects of my IBS can be prevented (avoided) by my 
treatment’.   
 
A further five items measure patient ‘coherence’ of illness in terms of the 
degree to which individuals feel they understand their condition.  Items 
include ‘The symptoms of my IBS are puzzling to me’ and ‘I have a clear 
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picture or understanding of my IBS’.  Six items measure ‘emotional 
representations’ which ask about how IBS makes participants feel 
emotionally.  Example items include ‘I get depressed when I think about 
my IBS’ and ‘My IBS makes me feel angry’.  All the aforementioned 
scales are formed numerically by firstly reverse scoring appropriate items 
(from the measure guidelines) and then summing the scores for each 
item. 
 
The final scale is that which measures perceived ‘causes’ which consists 
of eighteen items listing a number of possible causes such as ‘stress or 
worry’, ‘diet or eating behaviour’ and ‘my personality’.  Moss-Morris et al. 
(2002) recommend performing principal components analysis (PCA) on 
larger sample sizes to see which items can be statistically grouped 
together.  PCA is a procedure that allows compression of individual 
questionnaire items into ‘components’ or groups of items that may then 
represent a scale, the groupings themselves are based on items being 
strongly correlated (Field, 2009; Tabachnick & Fidell, 2007).  The PCA 
for the causes scale is presented in chapter four.     
 
3.3.2.2 Beliefs about conventional medication  
As the preceding chapter illustrated, there is both theoretical and 
empirical evidence that treatment beliefs can fit into an ‘extended’ CSM 
(Bishop et al., 2006; Horne & Weinman, 2002).  One reliable and valid 
measure to assess such beliefs is the Beliefs about Medicines 
Questionnaire (general version) (Horne, Weinman, & Hankins, 1999) 
which was designed to capture the beliefs of the individual in relation to 
conventional medication being harmful or overused.  This measure is 
deemed psychometrically sound having been used with a variety of 
illness populations (Horne et al., 1999; Horne, 1997) and has been 
shown to be relevant in predicting CAM use (e.g. Bishop et al., 2006). 
 
The Beliefs about Medicines Questionnaire (BMQ-General; Horne et al., 
1999) was used to measure beliefs about conventional treatment for IBS.  
This version of the BMQ (there also exists a specific version which was 
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not used in this study) is an eight item, two scale measure of general 
treatment beliefs and was presented to all participants.  Again, this 
measure has been validated by the authors (Horne et al., 1999) and 
used in subsequent studies utilising an ‘extended’ CSM (e.g. Bishop et 
al., 2006).  The BMQ-General consists of two scales of four items each 
that focus on beliefs about harm and overuse of medicine in general.  
The harm scale includes the items ‘all medicines are poisons’ and ‘most 
medicines are addictive’.  The overuse scale includes items such as 
‘Doctors use too many medicines’ and ‘natural remedies are safer than 
medicines’.   
 
3.3.2.3 Beliefs about CAM  
There has been extensive work on the attitudes and beliefs of those 
individuals who use CAM (Astin, 1998; Eisenburg et al., 1998; Vincent & 
Furnham, 1996) but little of this has been carried out using standardised 
health psychology measures (Bishop, Yardley, & Lewith, 2004).  Bishop 
et al. (2005) argue that there are three key dimensions involved in beliefs 
about CAM.  These dimensions consist of beliefs in holistic health (CAM 
users often believe in healing the whole body), beliefs about natural 
aspects of treatment (CAM is often seen as more ‘natural’) and 
participation in treatment (CAM users often want to be seen as active 
partners in any treatment regime).  One recently developed measure that 
captures these three dimensions is the Complementary and Alternative 
Medicine Beliefs Inventory (CAMBI, Bishop et al., 2005) and over a 
number of studies has been shown to have stable psychometric 
properties in general illness populations (Bishop et al., 2005; 2006; 
2008).  
 
The CAMBI (Bishop et al., 2005) was used to measure three dimensions 
of beliefs about complementary medicine.  The measure consists of 
three scales regarding ‘naturalness’ of treatments, beliefs about holistic 
health and patient/client participation in treatment.  The ‘natural aspects 
of treatment’ scale comprises six items and assess beliefs people have 
about natural treatments and consists of such items such as ‘Treatments 
 119 
should have no negative side effects’ and ‘Treatments should only use 
natural ingredients’.  The holistic health beliefs scale comprises five 
items that assess beliefs relating to the human body being treated as a 
‘whole.’  This scale contains items such as ‘I think my body has a natural 
ability to heal itself’ and ‘Health is about harmonising your body, mind 
and spirit’.  The third scale, participation in treatment, also comprises five 
items that consist of statements such as ‘Patients should take an active 
role in their treatment’ and ‘Treatment providers should treat patients as 
equal partners’.   
 
Scoring the IPQ-R, BMQ and CAMBI scales 
Aside from the IPQ-R identity scale, where the number of ‘yes’ items are 
totalled to give a total score for illness identity, the majority of the 
remaining items on the IPQ-R are assessed using a five point Likert type 
scale ranging from ‘strongly agree’ to ‘strongly disagree’.  The items in 
each scale are summed to give a total score, however to account for 
missing data Moss-Morris et al. (2002) have provided researchers with 
SPSS syntax that allows for up to two items of data to be missing in a 
six-item scale and one missing item of data in a four-item scale.  A 
number of items on the measure also required reverse scoring.  High 
scores on the identity, consequences and timeline (chronic and cyclical) 
dimensions represent stronger beliefs about the number of symptoms 
attributed to the IBS, the chronic nature of IBS, cyclicality of the 
condition, and negative consequences of the IBS illness.  High scores on 
the personal control, treatment control and illness coherence scales 
represent positive beliefs about the controllability of the illness and 
greater personal understanding of the condition.  
   
For each of the two scales of the BMQ, the four items are summed to 
give a total score for that particular scale.  For reasons of consistency 
and to account for missing items, the SPSS syntax used in calculation of 
the IPQ-R scores was adapted for use with the BMQ.  If participants had 
at least three responses in each scale, then a total score was computed.  
Any participants with less than 3 responses were coded as missing data.  
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On both scales, higher scores indicate stronger beliefs in harm and 
concerns with conventional medicine. 
 
The CAMBI is a seventeen item measure of beliefs towards 
complementary treatments and was measured using a 5 point Likert 
scale.  Items in the three scales are totalled giving a score for each.  As 
with the IPQ-R and the BMQ, SPSS syntax was used to incorporate 
participants with up to two missing items on the ‘natural treatments’ and 
‘holistic health’ scales and one missing item on the ‘patient participation’ 
scale.  Participants with more than three items of missing data in each 
scale were coded as missing.  Higher scores on each of the scales 
indicate more positive beliefs about CAM. 
 
3.3.2.4 Brief-COPE 
Chapter two highlighted the Coping Orientation of Problems Experienced 
(COPE) (Carver et al., 1989) as one method used to measure coping in 
CSM research and has been used in studies with IBS (Rutter & Rutter, 
2002; 2007).  With a number of questionnaires already present in the 
research, an alternative measure, the Brief-COPE (Carver, 1997), was 
used in this research due to concerns about response burden.  The Brief-
COPE was devised from many of the same items as the original COPE 
and covers fourteen scales covering the scope of the different forms of 
coping and featuring some revisions to the original COPE measure 
(Carver, 1997).  This measure has also been utilised in CSM research 
previously (e.g. Llewellyn et al., 2007).  
 
The Brief-COPE (Carver, 1997) is a shorter, refined version of the 
original 60 item COPE, with no apparent decline in validity or reliability.   
The measure consists of twenty eight items which make up fourteen 
scales (two questions assess each scale) that encompass questions 
surrounding problem-focused or emotion-focused coping styles although 
some scales in the measure focus on other aspects of coping that may 
be considered as maladaptive/dysfunctional or adaptive/functional.  
These coping strategies include the using humour, or the use of 
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substances such as alcohol or drugs (Carver, 1997).  The scales consist 
of Self-distraction, Active coping, Denial, Substance use, Emotional 
support, use of instrumental support, Behavioural disengagement, 
Venting, Positive reframing, Planning, Humour, Acceptance and Religion.  
A new scale added to the Brief-COPE that was not present on the 
original COPE measure was named ‘Self blame’ (Carver, 1997).  
 
Scoring the Brief-COPE 
Each item on the Brief-COPE is measured on a four-point Likert scale 
ranging from ‘I haven’t been doing this at all’ to ‘I’ve been doing this a lot’ 
in relation to each of the 28 statements.  Carver (1997) states there is no 
overall coping score as researchers are encouraged to explore each type 
of coping. Scores for each coping ‘style’ are summed from each pair of 
items giving a total score for each of the fourteen scales.  Higher scores 
on the 14 Brief-COPE scales indicate a greater likelihood to adopt a 
particular style of coping, be it potentially adaptive or maladaptive.  
 
3.3.3 Outcome measures 
There were two main outcome measures in the research consisting of a 
measure of CAM use (section 3.3.3.1) and a measure of health related 
quality of life (section 3.3.3.2).  Within the former, questions regarding 
number of CAM treatments were asked for those that had used CAM.  It 
should also be noted that ‘CAM use’, in the framework of the CSM, would 
be seen as a specific coping behaviour, however in the context of the 
statistical analysis conducted (see sections 4.2.5.4 & 4.3.6) it was 
considered an outcome variable. 
 
3.3.3.1 CAM use 
Use of complementary and alternative medicines was assessed by firstly 
asking participants if they have ever used complementary or alternative 
treatments to relieve their IBS, for which they could answer ‘yes’ or ‘no.’ 
For those answering ‘yes’, a list of 30 CAM treatments (including 
acupuncture, herbal treatments and aromatherapy – derived from 
Furnham, 2000) was presented so participants were able to select 
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treatments they had used.  In case a new or unusual treatment was 
indicated that was not on the list an option of ‘other’ treatment was 
offered where participants could name the treatment they had used to 
relieve their IBS.  This enabled examination of which CAM treatments 
were most popular and also to calculate the number of CAM treatments 
used.  This variable was also used to group participants into those that 
indicated they used CAM for their IBS at study time one (CAM-users) 
and those not using CAM (non-users).  
 
3.3.3.2 Quality of life 
As considered in chapter two, there is some discussion about whether 
researchers should use general or domain specific measures of quality of 
life.  For this study, a domain specific quality of life measure was utilised 
as firstly, it was thought this would capture information about specific 
ways in which IBS can impact on an individual’s life.  Secondly, a domain 
specific measure was thought to offer something beyond a description of 
‘feeling worse’ and should include such factors as effect on relationships 
and occupational life (Palsson, 2002).  As a domain specific measure of 
quality of life was favoured (chapter two), the Irritable Bowel Syndrome 
Quality of Life (IBS-QOL, Patrick et al., 1998) measure was selected as it 
is psychometrically sound over several studies (Bushnell et al., 2006; 
Drossman et al., 2000; Patrick et al., 1998).  The IBS-QOL also 
measures a number of scales that can be combined to provide an overall 
quality of life score that reflects the multi-faceted nature of quality of life 
in IBS.  Further, the measure has also been validated via electronic data 
capture through a hand held computer device (Bushnell et al., 2006).  
Importantly, the IBS-QOL contains a ‘Dysphoria’ subscale which may be 
utilised as a measure of ‘emotional outcome’ (according to the CSM) 
thus enabling the relationships between emotional representations, 
coping and emotional quality of life to be examined.  The IBS-QOL gives 
a general ‘score’ from 34 items based on quality of life as rated by 
participants (i.e. the higher the score, the better the perceived quality of 
life) which consists of eight subscales – Dysphoria (8 items), Interference 
with activity (7 items), Body Image (4 items), Health Worry (3 items), 
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Food Avoidance (3 items), Social Reaction (4 items), Sexual issues (2 
items) and Relationships (3 items).   
 
Items that make up the Dysphoria subscale measured the emotional 
impact of IBS on the individual with example items including ‘I feel like 
I'm losing control of my life because of my bowel problems’ and ‘I feel my 
life is less enjoyable because of my bowel problems’.  The Interference 
with activity subscale consists of items that measured the impact of IBS 
on normal activities and includes such items as ‘I feel I get less done 
because of my bowel problems’ and ‘I have to avoid stressful situations 
because of my bowel problems’.   Body image assessed the impact of 
IBS on individual body image with items including ‘My bowel problems 
limit what I can wear’, and ‘I feel sluggish because of my bowel 
problems’.  Food avoidance assessed the degree to which foods are 
avoided due to IBS by items that include ‘I have to watch the kind of food 
I eat because of my bowel problems’ and ‘I feel frustrated that I cannot 
eat when I want because of my bowel problems’.  The health worry 
subscale measured beliefs about the impact of IBS on health by items 
including ‘I feel vulnerable to other illnesses because of my bowel 
problems’ and ‘I worry that my bowel problems will get worse’.  The 
social reaction subscale measured the concerns regarding the reaction 
of others to an individual’s IBS with items including ‘I am embarrassed by 
the smell caused by my bowel problems’ and ‘I feel like I irritate others 
because of my bowel problems’.  The impact of IBS on ‘Sex’ is assessed 
by two items; ‘Because of my bowel problems, sexual activity is difficult 
for me’ and ‘My bowel problems reduce my sexual desire’.  Finally, the 
subscale ‘relationships’ assess the impact of IBS on relationships with 
others and includes the items ‘I feel uncomfortable when I talk about my 
bowel problems’ and ‘My bowel problems are affecting my closest 
relationships’.   
 
Scoring the IBS-QOL 
IBS-QOL items are measured using a five point Likert scale ranging from 
‘Not at all’ to ‘Extremely’ or ‘A great deal’.  The IBS-QOL is scored by 
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summing responses which are then averaged for a total score.  This 
score is then transformed into a 0-100 scale where higher scores 
demonstrate better ratings of quality of life (Patrick et al., 1998; 
Drossman et al., 2000).  The sum of the items is subtracted from the 
lowest possible score, the result of which is divided by the range of the 
raw scores.  The obtained value is multiplied by 100.   
 
As with the BMQ, IPQ-R and CAMBI, scores were summed to allow for a 
small amount of missing responses.  The Dysphoria and Interference 
with activity scales, being the two longer scales (eight and seven items 
respectively) were computed with up to two values missing.  The 
remaining scales were all allowed one missing item.  The total QOL 
score was therefore computed from no less than 24 values out of a 
possible 34.  Each subscale total was computed to allow for examination 
between CAM-users and those that not using CAM (non-users) on the 
full range of IBS-QOL dimensions.   
 
As indicated, in terms of examining pathways in the CSM, this research 
utilised the overall IBS-QOL as a measure of outcome alongside the 
Dysphoria subscale of the IBS-QOL as a measure of emotional outcome 
(see chapter 2).  A further reason for taking this approach was because 
of the large number of coping scales involved from the Brief-COPE and 
potentially the greater significance of uncovering differing coping styles 
(between CAM-users and non-users) and their interrelationships with 
perceptions, beliefs and outcome.   
 
3.3.4 Demographics 
Detailed demographics were asked at the end of the questionnaire.  
‘Standard’ questions regarding participant age, gender and total 
household income were asked.  Participants were also asked to indicate 
their level of education ranging from no qualifications to postgraduate 
qualifications.  Further questions that were included asked which 
religious group participants occupied, their geographical location and co-
morbidity (i.e. did participants have any other health complaints other 
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than IBS).  Such questions are standard in much social research 
(Bowling, 2009) and assisted in explaining characteristics of the sample 
in demographic terms.  This was in addition to being able to examine the 
influence of demographic factors on CAM use in those with IBS. 
 
3.4 Procedure  
Details of the study procedure are provided in relation to pilot testing of 
the survey, advertising the study and ethical details. 
 
3.4.1 Pilot procedure 
The majority of measures in the study had been used on a variety of 
illness populations previously.  Some measures (the IPQ-R, BMQ and 
CAMBI), have also been used in a web-based surveys previously 
(Bishop et al., 2006; 2008).  Furthermore, as many survey based studies 
have successfully recruited participants online it was therefore decided to 
run an initial pilot phase of the survey using people not affected by IBS to 
assess if online data capture was feasible.  This involved completing 
several test runs of the survey with the assistance of senior colleagues 
using different computer terminals at different locations.  Responses 
were downloaded from the website into SPSS.  Consequently there were 
no problems with either access to the survey, participation or access to 
data detected at this stage, so the research proceeded with the posting 
of advertisements to commence study recruitment. 
 
3.4.2 Advertisement of study 
As the study was web-based, participants were recruited from a number 
of different health related web pages and discussion forums.  The 
primary source of recruitment was via an online advertisement on the 
website of the IBS Network2 which is the largest IBS charity based 
support network in the UK.  The advertisement invited participants to 
take part in the study, gave some information about the study and 
                                               
2 The IBS Network is the main IBS self help network in the UK and can be located at 
www.theibsnetwork.org, as of March 2011 it was re-named, formerly being known as 
the Gut trust.  There was a small charge for this advertisement which was paid for by 
the University of West London. 
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contained a direct ‘clickable’ link to the study website.  The IBS Network 
was selected for several reasons, namely that the website has a high 
volume of visitors and the organisation has been used to successfully 
recruit participants in previous studies with a psychological orientation 
(e.g. Rutter & Rutter, 2002; Dancey & Backhouse, 1993).  The IBS 
Network website does have some commercial partners but this website 
itself does not contain explicit advertisements of products manufactured 
by these organisations.  At the time the advertisement was placed, it was 
noted that the organisation also carried advertisements calling for 
volunteers to take part in a number of randomised controlled trials for 
newly developed IBS conventional medication. 
 
Additionally, advertisements for the study were also placed on other 
online GI related discussion forums (with the forum administrator’s 
permission), whereby a direct link to the study website was included in 
the message posting3.  One further advertisement for the study was also 
placed on an online directory of psychological research studies4.  
 
The survey was hosted by a specialist internet research company 
(www.questionpro.com) who were selected because of a user-friendly 
website and emphasis on security of responses.  Only the primary 
researcher had access to the responses via username and password.  
 
3.4.3 Participant information and ethical information 
On the study website front page, potential participants were greeted by 
an introductory information page giving necessary ethical information 
about the study.  This included an option to give consent to take part or 
withdraw from the study as well as notification about rights, such as the 
right to stop, withdraw or request that data not be used (British 
Psychological Society, code of ethics and conduct, 2009).  Participants 
                                               
3 Three forums were used to post invitations to participate in the study: the Discovery 
health forum at: http://community.homeandhealthtv.co.uk/eve/forums; the IBS forum at: 
http://www.healingwell.com/community/default.aspx?f=26; and the IBS support group 
at: http://www.ibsgroup.org/forums/ 
4 This can be found at www.onlinepsychresearch.co.uk  
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were also informed that all data and responses were held securely in 
accordance with the Data Protection Act 1998.  The primary researcher’s 
contact details were provided for participants to make contact in the case 
of any questions regarding the research.  As advertisements for the 
study were placed on websites deemed to be offering support to people 
affected by IBS, participants were not offered any formal medical advice 
or support, but the researchers contact details were provided for the 
benefit of participants if they had any questions or issues raised by the 
research.     
 
3.4.4 Survey completion 
Participants were guided through the measures on screen with 
instructions before they began each section and were instructed to click 
on the ‘next’ tab when they had finished entering responses for each of 
the measures listed above.  Selective ‘branching’ was used where 
possible to avoid the accumulation of unnecessary responses being 
collected.  For example where participants were asked about their use of 
CAM if they answered ‘no’ they were asked no more questions about 
CAM (figure 3.1).  A ‘yes’ response, directed participants to further 
questions about their CAM use and the type of CAM they had used.  
Data collection took approximately twelve months between May 2007 
and May 2008 although potentially this time may have been reduced for 
two reasons.  Firstly, the original advertisement was not particularly 
visible on the IBS Network website.  Second, the organisation underwent 
significant re-branding during the data collection period resulting in 
approximately 2 months of downtime in terms of the advertisement being 
absent from the website.  Following commencement of the new website 
and replacement of the advertisement in a prominent position on the 
front page of the website, data collection increased dramatically. 
  
Prior to the end of the study, participants were asked an open ‘question’ 
about their IBS: ‘You may use the space below to comment on anything 
you would like to say about having IBS’ (see appendix XV).  Finally, 
participants were asked if they would be willing to take part in a follow-up 
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study and were offered the chance to enter their email address to be 
contacted to take part.  The email addresses that were collected from 
participants interested in the follow-up study were downloaded and 
stored separately from the remainder of the data set to avoid any 
possibility of identification of participants.  Participants were finally given 
a ‘thank you’ message for taking part in the study.  Any participants who 
contacted the researcher with questions regarding IBS were advised to 
contact their primary care provider.   
 
3.5 Ethical approval  
Ethical approval for all aspects of the study was granted by the (former) 
Faculty of Health and Human Sciences Ethics Committee at the 
University of West London (formerly Thames Valley University) before 
the study commenced.   
 
3.6 Statistical methods 
Data were downloaded from the survey website in comma separated 
variable (CSV) format.  Data were then imported directly into Statistics 
Package for the Social Sciences (SPSS) Release Version (PASW) 17.0 
(© SPSS, Inc., 2008, Chicago, IL, www.spss.com).   CSV files are just 
one of a number of ‘external’ files that SPSS recognises and is able to 
open as a data file (Antonius, 2003).  Prior to data screening, variable 
names were checked and relabelled if required.  
 
3.6.1 Missing data 
Missing data were numerically coded in SPSS as ‘missing’ (using the 
digits ‘999’ as a numerical code) and where possible were excluded from 
the analysis via the ‘listwise’ deletion option available in SPSS (section 
3.3).  This meant that if data were missing anywhere for a particular 
individual, that individual would be excluded from that particular analysis.  
It should be noted that for some procedures such as logistic regression, 
SPSS runs a listwise deletion as a fixed default.  Specific details 
regarding missing data are presented in each of the subsequent 
chapters, four to six. 
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Figure 3.1 Flow chart of participant route through the study web 
pages 
 
 CONSENT TO TAKE PART IN STUDY
 HOW LONG WITH 
 SYMPTOMS  TIME OF DIAGNOSIS 
 DIAGNOSED WITH IBS?
 NO  YES 
 IPQ-R, brief-COPE, IBS-QOL 
 NUMBER OF VISITS TO GP 
 BMQ-GENERAL  
 PRESCRIPTION MEDICATION USED? 
 CAMBI 
 EVER USED CAM FOR IBS? 
 NO  YES 
 WHICH CAM TREATMENTS? 
 DETAILED DEMOGRAPHICS 
 OPEN QUESTION 
 INTEREST IN FOLLOW UP STUDY?
 
 
Explanatory note: Branching was used to distinguish between those who had and had not been 
diagnosed.  If participants indicated they had been diagnosed, they were directed to a further question 
relating to the time of diagnosis before they were asked about duration of symptoms.  If they had not 
been diagnosed, participants were not shown the questions about diagnosis and were directed straight 
to the question about symptom duration.  A similar strategy was used when participants were asked 
about CAM use for IBS.  Those that had used CAM were asked about the different forms of CAM they 
had used prior to the demographics at the end of the study.  Those that did not use CAM were 
directed straight to the demographics section at the end of the study. 
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3.6.2 Distribution of scores 
A large sample size (i.e. over 600 participants) results in statistical 
methods for determining normality of distributions of variables becoming 
less reliable.  Therefore visual checking of histograms is recommended 
in such cases (Field, 2009; Tabachnick & Fidell, 2007). Distribution of 
scales is considered in subsequent chapters with reference to 
robustness of certain parametric tests to violations of normal distribution. 
 
3.6.3 Statistical tests 
A number of statistical tests were required to examine each of the 
specific research questions (chapter 2) namely, to identify which illness 
perceptions and treatment beliefs predict CAM use and which coping 
styles mediate the relationship between illness perceptions (or treatment 
beliefs) and outcome (quality of life).  Further examination of data 
considered differences between CAM-users and non-users and an 
examination of relationships (in CAM-users) between illness perceptions, 
treatment beliefs and number of CAM treatments used.   
 
3.6.3.1 Differences between CAM-users and non-users 
As mentioned parametric testing was favoured as all measures utilised in 
the research were considered to be reliable and valid tools of 
measurement, thus generating parametric (interval level) data.  
Independent t-tests were used to test for differences on scale scores 
between CAM-users and those that not using CAM (non-users) on CSM 
based variables.  The independent t-test is able to detect differences in 
scale variables based on dichotomous group membership and is said to 
be robust against any violation of normality in scale variables, including 
increased potential for Type I errors (Vickers, 2005).   
 
3.6.3.2 Predicting CAM use  
Binary logistic regression analysis was used to predict CAM use in those 
with IBS.  Logistic regression is a procedure that can predict group 
membership from scale and categorical predictors based on the 
likelihood of membership of a particular group whilst controlling for other 
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predictor variables in the model (Field, 2009; Tabachnick & Fidell, 2007).  
Multiple predictors were entered in a block entry binary logistic 
regression model to assess firstly the impact of illness perceptions, 
treatment beliefs and CAM beliefs in predicting CAM use (block one) and 
secondly to examine which demographic factors (block two) predicted 
CAM use, which also determined if predictors significant in block one 
were still predicting CAM use when controlling for demographic variables 
included in the model.  This procedure also allowed examination of the 
importance of each block in terms of variance in outcome predicted.  In 
this context, this test was considered the most appropriate to examine for 
prediction of CAM use in those affected by IBS. 
 
3.6.3.3 Diagnostic tests for logistic regression model  
Diagnostic testing was carried out for the logistic regression model and 
further details are presented in chapter four.  Testing was conducted for 
highly correlated predictor variables, residual outliers and values that 
may have undue effect on the regression model.  Such diagnostic testing 
is considered normal procedure in regression models with a number of 
predictor variables (Field, 2009; Tabachnick & Fidell, 2007). 
 
3.6.3.4 Testing for Mediation 
The CSM proposes that the causal pathways between illness 
perceptions (or treatment beliefs) and outcome are mediated (i.e. 
explained) by coping strategies.  As chapter two illustrated, illness 
perceptions influence coping strategies, which are then said to influence 
outcome.  This means the impact of illness perceptions (or treatment 
beliefs) influences outcome through coping strategies.  Therefore a 
statistical test for mediation may offer support for the CSM and denote 
which processes (i.e. coping strategies) indirectly influence better or 
worse reported outcome.  A widely used strategy to test for mediation 
comes from Baron and Kenny (1986) known as the ‘causal steps’ 
approach which tests for ‘simple’ mediation (i.e. with a single predictor, 
potential mediator and outcome variable).  This approach consists of the 
researcher performing a number of regression analyses and then making 
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inferences regarding whether mediation is present (Baron & Kenny, 
1986; Hayes, 2009; Preacher & Hayes, 2004).  This approach to 
mediation testing is also arguably consistent with the premise of the 
CSM.  It has also been ‘recommended’ that mediation testing has a 
sound theoretical basis (Preacher & Hayes, 2008; Shrout & Bolger, 
2002). 
 
The determination of mediation is based on four equations or pathways 
as illustrated in figure 3.2.  The first pathway c is denoted by a significant 
relationship between predictor and outcome (X  Y).  The predictor 
variable must then significantly influence the mediatior (X  M).  Third, 
the mediator should significantly predict the outcome (M  Y) whilst 
controlling for the predictor (X).  Finally, the pathway c’ between predictor 
and outcome is reduced to non-significance in the presence of the 
mediator, in which case ‘mediation’ is said to be present.  More 
commonly, pathway c’ is reduced quantitatively but not necessarily in 
significance (Preacher & Hayes, 2004).  This situation is said to denote 
partial mediation.  If the latter situation exists, a further issue for the 
investigator is to determine the strength (or statistical significance) of the 
mediation effect without committing type I or type II errors in relation to 
mediation effects detected (Preacher & Hayes, 2004).   
 
Preacher and Hayes (2004) argue for statistical assessment of whether 
the difference between c and c’ (alternatively, the product of ab) is 
significantly different from zero (thus, if different from zero, then 
mediation or partial mediation is present).  One way of testing this is to 
use a Sobel test (Sobel, 1982) which measures the strength of what is 
also referred to as the ‘indirect effect’ (i.e. the difference between c and 
c’) and can be used to assess the degree of mediation.  The Sobel test 
however assumes the difference in values between c and c’ to be 
normally distributed, which can produce questionable interpretation of 
mediation being present (Preacher & Hayes, 2004).  Preacher and 
Hayes (2004) offer an extension of the Sobel test based on 
‘bootstrapping’ which makes estimates of the significance of the ‘indirect 
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effect’ (the effect of predictor, through the mediating variable, on 
outcome) of the same sample size, but based on the researcher’s data.  
The resulting estimate is more accurate than the Sobel test alone 
(Preacher & Hayes, 2004).  Furthermore, Fairchild, Mackinnon, Taborga 
and Taylor (2009) offer an additional test to identify the unique portion of 
variance in the outcome variable accounted for by the mediation effect.  
Further detail and analyses are presented in chapters five and six.   
 
 
Figure 3.2 Illustration of ‘simple’ Mediation 
 
 
 
 
 
 
In order to test for potential mediating effects of coping between illness 
and treatment beliefs and quality of life, a number of simple mediation 
analyses were conducted separately for CAM-users and the non-users 
(those not using CAM).  Firstly, to determine step one of the Baron and 
Kenny (1986) criteria, Pearson’s correlations were examined between 
X Y 
M 
Y 
 
X 
 
c 
c’ 
a b 
Panel A 
Panel B 
In Panel A: path c is a result of X (predictor) significantly affecting Y (outcome).  Panel 
B: X affects Y indirectly through the Mediator (M) with c’ being less than c if 
mediation/partial mediation is present.  Adapted from Preacher and Hayes (2004) 
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illness perceptions, treatment beliefs and quality of life (and the 
Dysphoria scale of the IBS-QOL).  To examine step two of the Baron and 
Kenny (1986) criteria, Pearson’s correlations were examined between 
illness perceptions, treatment beliefs and the scales of the Brief-COPE.  
Significant relationships from these two steps were identified as possibly 
indicating mediation and so were entered into multiple regression models 
to analyse the relationships between the identified variables.  As Baron 
and Kenny (1986) suggest, regression models may contain only the 
three variables of interest (in this thesis, based on CSM theory, see also 
Carlisle et al., 2005), the predictor (IPQ-R, BMQ or CAMBI scale), 
potential mediator (individual scales of the Brief-COPE) and outcome 
variable (IBS-QOL total score or Dysphoria subscale score).   
Considering the theoretical and statistical grounds for simple mediation 
testing, it was reasonable to suggest this method of analysis would not 
result in any increased likelihood of type I errors.  Such errors may be 
commonly associated with performing multiple comparisons on a single 
dependent variable (e.g. Field, 2009), in using multiple t-tests for 
example.  As stated, formal significance testing was conducted where 
simple mediation effects were detected from the Baron and Kenny steps 
(Preacher & Hayes, 2004).  Further, as considered previously, each 
statistical model was analysed based on the theoretical suppositions of 
the CSM (e.g. Leventhal et al., 1998).  In many cases, the predictor–
outcome relationship was reported on successive occasions (and 
remained consistent) to highlight the change in ‘predictor’ Beta coefficient 
values on addition of a single Brief-COPE scale (chapter five).   
 
3.7 Overview and Summary 
This chapter has considered the philosophical orientation of the research 
presented in subsequent chapters.  A number of considerations related 
to what constitutes acceptable knowledge, how best to test the CSM in 
this context and the idea of adapting quantitative survey methodology to 
access qualitative data for analysis all determined the largely quantitative 
approach of this research.  A power calculation and consideration of 
various research methodologies led to the conclusion that a web-based 
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study would be appropriate and the most effective and efficient way to 
gain the required number of participants.  Web-based surveys have the 
additional benefit of relative ease in contacting participants for follow-up 
studies. 
 
Consideration has been given to how the survey was structured online 
and how participants were recruited.  The measures used were all 
considered to be reliable and valid measures of key constructs of the 
CSM (or an ‘extended’ CSM in the case of the BMQ and CAMBI).   
General statistical methods have been highlighted such as the key 
statistical analyses that are presented in later chapters as well as the 
procedure for testing for mediation according to Baron and Kenny (1986) 
and Preacher and Hayes (2004).  Further statistical details are 
highlighted in subsequent chapters where appropriate.  The following 
chapter presents the first part of the empirical research establishing 
which illness perceptions and treatment beliefs were influential in 
determining CAM use in those with IBS. 
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Chapter 4  
 
Applying the common-sense model of illness representations to the 
exploration of CAM use in IBS 
 
This chapter presents findings from the web-based cross-sectional 
survey and thus provides a baseline for the subsequent analyses 
reported in chapters 5 and 6.  Within the ‘extended’ common-sense 
model of illness representations, the chapter records an exploration of 
illness perceptions and treatment beliefs which are influential in CAM use 
and examines differences in representations between CAM-users and 
non-users.  
 
4.1 Introduction 
Chapters one and two have shown there are both empirical and 
theoretical grounds for suggesting components of an extended CSM 
(e.g. Bishop et al., 2006; Horne & Weinman, 2002) can examine illness 
perceptions and treatment beliefs that are important in CAM use in IBS.  
There are no current peer-reviewed published studies that have 
investigated CAM use in IBS using the theoretical framework of the CSM.  
Furthermore, only a small number of studies have utilised the CSM 
framework to investigate CAM use and IBS and these have been 
conducted separately (Bishop et al., 2006; 2008; Rutter & Rutter 2002; 
2007; Searle & Murphy, 2000).  It is currently unknown which specific 
illness perceptions or treatment beliefs will be influential in CAM use in 
those with IBS.   Therefore the research analysis presented in this 
chapter explored CAM use within the theoretical framework of an 
extended CSM to address research aim one (2.7.1), which was to 
explore which illness perceptions and treatment beliefs in those affected 
by IBS were influential in CAM use   
 
The most recent data on CAM use in IBS suggests between 38.4% and 
50% of those with IBS use CAM (Kong et al., 2005; van Tilburg et al., 
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2008).  Prevalence of IBS is between 10-20% in the UK (Wilson et al., 
2004) and with CAM use reported as high as 50%, may suggest 
conventional medical treatment is not perceived as being effective at 
controlling IBS symptoms.  Chapters one and two provided evidence of 
the influence of illness perceptions and treatment beliefs on CAM use in 
general populations (Bishop et al., 2006; 2008; Vincent & Furnham, 
1996).  Chapter one further illustrated that reporting of more symptoms 
(i.e. greater illness ‘identity’ in the context of the CSM) and psychological 
aspects related to the illness, such as anxiety and reported quality of life 
to be influential in CAM use (Donker et al., 1999; van Tilburg et al., 
2008).   
 
Such illness related perceptions (e.g. perceptions of treatment control) 
have also been shown to be important factors in symptom experience 
and maintenance in IBS (Drossman et al., 1999; Gomborone et al., 1995; 
Rutter & Rutter, 2002; van Dulmen et al., 1996; 1997; 1998).  It may be 
theorised that such illness perceptions will influence whether those with 
IBS will use CAM.  In the context of the extended CSM (figure 2.1), CAM 
use can be viewed as a coping behaviour (Searle et al., 2007) which will 
be influenced by representations of illness and treatment. 
 
The main aim of this study was to investigate which illness perceptions 
and treatment beliefs are influential in CAM use.  To fully explore this 
aim, four specific objectives were addressed:  
 
4.1.1 To assess the prevalence of CAM use in IBS. 
4.1.2 To examine which illness perceptions and treatment beliefs were 
related to use of more than one type of CAM. 
4.1.3 To compare the illness perceptions and treatment beliefs of those 
with IBS in terms of those using and not using CAM. 
4.1.4 To examine which illness perceptions and treatment beliefs 
predicted CAM use in IBS. 
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4.2 Method 
This component of the research was conducted according to the 
methodology outlined in detail in chapter three (sections 3.2 to 3.6).  A 
web-based survey was conducted which recruited participants with IBS 
who completed a number of measures that captured illness perceptions 
and treatment beliefs.  Participant responses were analysed for 
prevalence of CAM and associations with CAM use.  Differences in 
CAM-user representations (compared to non-users) were examined and 
a logistic regression analysis was performed to predict which participants 
used CAM for their IBS based on a number of demographic and CSM 
based predictor variables.  
 
4.2.1 Design 
A cross-sectional web-based survey was conducted as this method was 
reasoned to be the most appropriate to explore the study objectives.  
Conducting a web-based study offered the opportunity for large scale 
and diverse participant recruitment as many people use the internet to 
locate illness or health based information about specific health 
complaints and may be more likely to be interested in participating in a 
research study online (section 3.1.2.1).   To address the specific 
objectives of examining components of the CSM, participant data were 
taken from IPQ-R, BMQ and the CAMBI.  Demographic information was 
also collected (section 3.3.4).   
 
4.2.2 Participants 
Six hundred and fifty three participants were recruited online from an IBS 
support network in the UK and IBS online discussion forums.  There 
were a large number of visits recorded to the study website, albeit not 
every visit resulted in a completed survey.  A completion rate figure was 
calculated from subtracting the number of completed surveys (n=653) 
from the number of visits to the study website with incomplete survey 
responses (n=1246, see also section 3.2).  The resulting figure 
represented a completion rate of 53%. 
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4.2.3 Measures  
The predictor and explanatory variables used in this study were 
measures of components of an extended CSM and demographic factors.  
As stated in the preceding chapter (see section 3.3.2), the Illness 
Perception Questionnaire Revised version (IPQ-R; Moss-Morris et al., 
2002) was used as a measure of illness perceptions (which captures 
both cognitive and emotional aspects of illness).  The Beliefs about 
Medicines Questionnaire general version (BMQ-general; Horne et al., 
1999) was utilised to capture general beliefs about conventional 
medicines.  The Complementary and Alternative Medicine Beliefs 
Inventory (CAMBI; Bishop et al., 2005) was used to capture beliefs about 
CAM.  Participants were also asked for demographic information, 
including questions about how long they had IBS and if they had been 
diagnosed (section 3.3.4). 
 
In terms of an outcome variable for the logistic regression analysis 
(section 4.2.5.4), participants were asked if they had used CAM to relieve 
their IBS.  If they replied ‘yes’ they were asked which CAM treatments 
they had used (section 3.3.3.1).  The number of CAM treatments used by 
each participant, who had indicated they had used CAM, was summed to 
help address research objective 4.1.2.   
 
4.2.4 Procedure 
The survey was constructed on the internet using an online survey host.  
Participants were recruited online via advertisements placed on an IBS 
self-help network webpage and other IBS related online discussion 
forums (section 3.4).  The advertisement (and message board postings) 
contained a direct ‘one-click’ link to the study website.  Participants 
completed responses using their computer mouse and were guided 
through the study webpage via ‘next’ icons at the foot of each page of the 
survey.  Full details of the study procedure are provided in section 3.4.   
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4.2.5 Statistical methods 
Scale scores were computed for the IPQ-R, BMQ and CAMBI (section 
3.3.2).  Scales were evaluated by screening for outlying values and 
distributions of scale variables were assessed (Tabachnick & Fidell, 
2007).  Principal Components Analysis was conducted on the IPQ-R 
causal items to reduce the single eighteen items to identifiable scales for 
ease of entry into statistical analysis (section 4.2.5.3).  Inferential 
statistical testing was conducted to assess differences between CAM-
users and non-users (those not using CAM) using unrelated t-tests, 
illness perceptions and beliefs that are related to CAM use (Pearson’s 
correlations) and factors that predicted CAM use in those affected by IBS 
using a logistic regression analysis (section 3.6). 
 
4.2.5.1 Computing instrument scales 
Prior to inferential statistical testing, the IPQ-R, BMQ and CAMBI scales 
were computed (section 3.3.2) which allowed for small numbers of 
missing values on each item.  For the purposes of addressing the third 
question in this study (section 4.1), that is, to assess objective 4.1.2, a 
new variable was created to reflect the amount of CAM treatments that 
had been used.  This variable was created by summing the number of 
specific CAM treatments (as well as any treatments documented in the 
‘other treatment’ category, each of which counted as one treatment) as 
indicated by each of the participants that had used CAM. 
 
4.2.5.2 Data screening  
Data were screened for outlying values that may have unduly influenced 
inferential statistical tests (Tabachnick & Fidell, 2007, see also section 
3.6).  Prior to statistical testing illness perceptions and treatment belief 
IPQ-R, BMQ and CAMBI scales were screened for bivariate outliers 
(CAM-users and non-users).  Outliers were detected in several variables 
visually by using box-plots.  Outlying values were examined for any 
consistent patterns (e.g. the same participants or possible response set).  
All values however were found to be within the correct range of scores.  
To reduce the influence of outlying values on statistical findings, each 
 141 
outlier was manually adjusted to make them ‘less extreme’ (Field, 2009; 
Tabachnick & Fidell, 2007), a process labelled ‘winsorizing’ (Erceg-Hurn 
& Mirosevich, 2008).   The adjustment of outliers was attempted by 
adding or subtracting two standard deviations to (or from) the mean to 
replace outlying values (Field, 2009).  Initial trials with this method 
proved unsuccessful as ‘new’ values did not fit appropriately with the 
range of scores in many cases.  Satisfactory results were found by 
altering each outlying score to the next non-outlying value (Field, 2009).  
This method ultimately can reduce the size of standard errors and thus 
provide a more accurate measure of confidence intervals (Erceg-Hurn & 
Mirosevich, 2008) meaning results can be more successfully 
generalised.    
 
The distributions for the IPQ-R, BMQ and CAMBI scales were assessed 
prior to further analysis (Tabachnick & Fidell, 2007).  This was conducted 
visually by observation of histograms for both the CAM-users and non-
users.  Observation of histograms was conducted as in larger sample 
sizes (e.g. over 200) statistical testing of normality (e.g. the Shapiro-Wilk 
test) are especially sensitive to slight deviations from normality (Field, 
2009; Tabachnick & Fidell, 2007).  Examination of the histograms for the 
IPQ-R, BMQ and CAMBI scales revealed six scales that demonstrated 
skewed distributions.  The two IPQ-R timeline sub-scales (chronic and 
cyclical), and emotional representations revealed a negative skew as did 
the illness coherence scale for CAM-users.  CAM-users’ scores in the 
CAMBI natural treatments and participation in treatment sub-scales also 
showed minor positive and negative deviations respectively.   
 
4.2.5.3 Principal Components Analysis of IPQ-R causal items 
Principal Components Analysis (PCA) was conducted on the IPQ-R 
causal items.  The large sample size of this study denoted that this was 
the best strategy to collapse the 18 items into smaller sub-scales and is 
consistent with previous research (e.g. Moss-Morris et al., 2002). PCA 
enabled causal items which were highly correlated to be grouped into 
‘new’ scales (Tabachnick & Fidell, 2007).   
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In the performance of PCA, IPQ-R causal items were initially screened 
for identifiable correlations present in the data as a means of testing the 
data for suitability for PCA (Tabachnick & Fidell, 2007).  SPSS provided 
a Kaiser-Meyer-Olkin (KMO) statistic of sampling adequacy which 
represented the ratio of the squared correlations between variables 
(scale items) to the squared partial (i.e. controlling for the effect of other 
variables) correlation (Field, 2009; Tabachnick & Fidell, 2007).  A KMO 
statistic of sampling adequacy should be above .5 (from a range of 0-1), 
suggesting that data in this study (KMO=.86) were compact enough to 
yield a reliable set of components (Field, 2009; Tabachnick & Fidell, 
2007).  Further exploration of data suitability for PCA resulted in a 
Bartlett’s (Chi-square) statistical value of 2= 3043.42, df= 136, p<.001 
meaning the data contained correlations suitable for detection through 
PCA.  Bartlett’s test of Sphericity should result in a significant value 
(p<.05) to confirm data has identifiable correlations suitable for PCA 
(Field, 2009).   
 
The number of components that were extracted and retained following 
PCA was determined by a combination of statistical criteria and 
subjective judgement of the researcher (e.g. Field, 2009).  Oblimin 
rotation of the factor solution was selected as it was probable that there 
would be some degree of correlation between groups of causal items of 
the IPQ-R.  Oblimin rotation allows for some correlation between 
resulting components (Field, 2009; Tabachnick & Fidell, 2007).  
Following PCA using Oblimin rotation, a three component resolution to 
the IPQ-R cause scale was determined.  Firstly, the Scree plot (figure 
4.1) was examined to determine the point of inflexion of the graph.  
Second, the number of components with an Eigenvalue (expressing the 
amount of variance explained by that component) greater than one were 
observed.  Third, individual causal items were considered if items loaded 
onto more than one component.  This assisted the researcher in making 
a judgement about which items were inherently related and how many 
factors there should be in the final solution.  Finally, internal reliability 
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(Cronbach’s alpha) was considered.  A Cronbach’s alpha value closer to 
1 (ranging from 0 to 1) means greater internal reliability in a scale.  
Generally, minimum values of .6 to .7 are deemed acceptable (Bryman, 
2008; Field, 2009); however there is some argument that uniform values 
of alpha may be problematic.  Scales consisting of many items often give 
larger alpha values than scales with fewer items.  Kline (1999) argues 
that values below the often accepted norm of .7 can be deemed 
acceptable due to the variation in psychological constructs and number 
of items that make up measure scales  (Kline, 1999).  As there was little 
variation in the numbers of items in each component from the PCA, the 
recommendations on Cronbach’s alpha values from Bryman (2008) and 
Field (2009) were implemented. 
 
Table 4.1 shows the percentage of variance in scores from each of the 
three components.  Causal item two, referring to ‘heredity’ did not load 
strongly on any of the components and so was excluded from further 
analysis. Component one accounted for 29.82% of the variance and 
items associated with a psychological cause.  This component was thus 
labelled ‘Internal causes’ as the items reflect aspects that are all under 
the individual’s control.  The alpha value was also acceptable at .86, and 
between the CAM-users and non-users participants’ alpha reached 
acceptability at .88 and .84 respectively.  Component two accounted for 
13.95% of the variance and contains items that can be considered 
external to the individual such as ‘a germ’ or ‘virus’ and ‘poor medical 
care in the past.’  This component was thus labelled ‘External causes’ 
and had an acceptable alpha value of .64, with similar alpha values for 
CAM-users (.61) and non-users (.67).  The third component accounted 
for 7.34% of the variance with an acceptable alpha value of .68 and 
consisted of items that could be classed as ‘risk factors’ such as 
‘smoking’ or ‘accident or injury.’  The alpha values for CAM-users (.67) 
and non-users (.70) also suggested acceptable internal consistency for 
these scales. 
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As illustrated in table 4.1 a number of items loaded onto more than one 
component, namely items 1, 4, 8, 13, and 18.  An item was judged to be 
loading on a particular component if the figure was greater than the 
corresponding loading on a different component.  Each item also had to 
theoretically ‘fit’ with the other items in the component, which was 
assessed by observing the causal items from the IPQ-R.  Again, this was 
consistent with previous work with the IPQ-R (Moss-Morris et al 2002).  
Consideration of Cronbach’s alpha for each component were deemed 
acceptable with all scales having internal reliability of .61 or greater.  As 
Oblimim rotation was conducted, correlations between components were 
assessed to check they were not too highly correlated where it could be 
inferred components would be measuring the same construct (Field, 
2009; Tabachnick & Fidell, 2007).  The ‘internal’ and ‘external’ causes 
components were weakly positively correlated (.10).  The ‘internal 
causes’ and ‘risk factors’ components showed a weak negative 
correlation (-.34). The ‘external’ causes and ‘risk factors’ components 
demonstrated a similar pattern (-.25).  These low coefficients and 
direction of the negative relationships were sufficient to infer relative 
independence of the three casual components derived from the PCA.  
 
Figure 4.1 Scree plot derived from Principal Components Analysis 
of causal items from IPQ-R 
1716151413121110987654321
Component Number
6
5
4
3
2
1
0
Ei
ge
nv
alu
e
 
 145 
4.2.5.4 Statistical tests 
Section 3.6.3 outlined the rationale for conducting inferential parametric 
tests.  The consistent reliability and validity of the measures used in this 
study and the large sample size enabled parametric testing to be carried 
out.  To ensure greater accuracy, statistical tests were run on a list-wise 
basis.  This meant that any participant with missing data on any of the 
variables included in a particular test was omitted from the analysis (see 
section 3.6.1).   
 
Firstly, prevalence of CAM use was assessed comparing frequencies of 
those who had used CAM and those who had not.  This was explored 
further by gender and by type of CAM.  To address the second question, 
a new variable was computed (applicable only to CAM-users) that 
reflected the total number of CAM treatments used, as many participants 
had indicated they had used more than one type of CAM to relieve their 
IBS symptoms.  This variable was created by summing the number of 
CAM treatments that had been used (in addition to the ‘other’ category) 
to enable associations to be explored between illness perceptions, 
treatment beliefs and number of CAM treatments used.  To examine this 
question a Pearson’s correlation was conducted.  Even though a small 
number of variables demonstrated a slight deviation from normality, a 
Pearson’s correlation was conducted as this test is regarded to be robust 
against the violation of non-normality with sample sizes greater than 40 
(Field, 2009).  There is also argument normality in variable distributions 
is unnecessary in calculating Pearson’s r (Nefzger & Drasgow, 1957). 
 
To address the question of whether the CAM-users and non-users 
(participants who have not used CAM) differed on measures of illness 
perceptions and treatment beliefs independent t-tests were conducted 
(section 3.6).  The t-test was employed as it is considered to be robust 
against violations in the assumption of normal distributions between 
grouping dependent variables (Vickers, 2005) without giving rise to an 
increased likelihood of Type 1 errors.  Where results were significant, 
effect sizes were calculated using Pearson’s r, which offered a 
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standardised estimate of the magnitude of differences between each of 
the paired group means (Field, 2009).  In using Pearson’s r as a 
measure of effect size, Field (2009) states that effect size values are 
typically classified as small (.1), medium (.3) or large (.5). 
 
 
Table 4.1 Pattern coefficients resulting from Principal Components 
Analysis on IPQ-R causal items 
 
 
Component/Factor loadings are indicated in bold.  Factor loadings less than 
.2 are not reported which is consistent with samples of this size (e.g. Field, 2009). 
 
 
A binary logistic regression analysis was performed to illustrate which 
factors predicted CAM use, whilst controlling for other variables in the 
model (Tabachnick & Fidell, 2007).  The dichotomous dependent 
variable in this study was determined from participants being asked if 
they had used CAM to relieve their IBS ever (Yes or No).  The logistic 
regression model was constructed to allow inclusion of illness 
IPQ-R Causal item 
 
Internal 
Cause 
External 
Cause 
Risk  
Factors 
C12 – Emotional state .87   
C10 – Family problems/worry .82   
C9   – Mental attitude .77   
C1   – Stress/worry .75 -.22  
C11 – Overwork  .69   
C17 – Personality  .65   
C8   – Own Behaviour  .54  -.23 
C7   – Pollution in environment  .65  
C6   – Poor past medical care   .62  
C3   – Germ or virus  .66  
C18 – Altered immunity  .65 -.23 
C5   – Chance or bad luck  .38  
C13 – Ageing  .27 .31 -.28 
C14 – Alcohol    -.84 
C15 – Smoking    -.84 
C16 – Accident/Injury    -.65 
C4   – Diet or eating habits .34  -.38 
    
Eigen Value 
 
5.07 2.37 1.25 
% of variance 
 
29.82 13.95 7.34 
Cronbach’s alpha  
Whole sample 
 
CAM-users 
 
Non-users 
 
 
 
.86 
 
.88 
 
.84 
 
.64 
 
.61 
 
.67 
 
.68 
 
.67 
 
.70 
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perceptions and treatment beliefs with the minimum amount of 
demographic variables. It is common with this particular statistical 
procedure to use a ‘minimum’ amount of predictor variables (Tabachnick 
& Fidell, 2007). To minimize the number of demographic variables in the 
regression model, variables that were either heavily biased in one 
category or had very low numbers of information in particular categories 
were not included in the analysis.  Therefore, gender, diagnosis of IBS, 
religious affiliation, ethnicity, geographical location and employment 
status were all excluded from the regression model.  The demographic 
predictor variables that were retained were income, education, age, time 
of diagnosis and co-morbidity reported (yes/no).  Binary logistic 
regression allowed construction of a statistical model that could predict 
the dichotomous outcome of CAM use or no CAM use (see section 3.6) 
by entering variables hierarchically in two blocks.  This allowed the effect 
of demographic variables on CSM measures to be observed statistically.  
Following examination of the findings, diagnostic procedures were 
performed to assess for multicollinearity, outlying and residual values as 
well as any cases with undue influence on the model (Tabachnick & 
Fidell, 2007).  
 
4.3 Results 
This analysis examined which illness perceptions and treatment beliefs in 
IBS were influential in CAM use.  This was achieved by taking participant 
measures from instruments designed to capture illness perceptions (IPQ-
R), treatment beliefs (BMQ-general) and beliefs about complementary 
medicines (CAMBI).  Participants were asked about CAM use and 
demographic information was collected. 
    
The results are presented according to the four objectives in section 4.1.  
Firstly, the prevalence of CAM use was examined (objective 4.1.1).  
Secondly, the relationship of the IPQ-R, BMQ and CAMBI scales with 
number of CAM treatments used in the CAM-users was tested (objective 
4.1.2).  Thirdly, differences between CAM-users and the non-users on 
scales of the IPQ-R, BMQ and CAMBI (and age) were considered 
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(objective 4.1.3).  Finally, a logistic regression analysis of illness 
perceptions and treatment beliefs and demographic factors in predicting 
CAM use in IBS was performed (objective 4.1.4).   
 
4.3.1 Participant demographics 
The age range of participants was 18-83, with 83.6% (n=546) being 
female with 8 missing cases in this category.  The mean age overall was 
37.41 years (SD=12.95).  The mean age for males was 41.97 
(SD=14.13) years, which was higher than females where the mean age 
was 36.48 years (SD=12.53).  A further breakdown of age by gender and 
CAM use is illustrated in table 4.2. 
 
 
Table 4.2 Participant mean ages, split by gender and CAM use 
 
CAM use  Mean (SD)  
Yes No 
Male  41.61  (13.98) 42.31  (14.41) 
Female 36.63  (12.29) 36.26  (12.89) 
Total 37.35  (12.60) 37.47  (13.42) 
 
 
 
Key categorical demographics are illustrated in table 4.3.  Participants 
were asked if they had been diagnosed with IBS by a health care 
professional, with most participants (93.7%, n=610) stating they had 
been diagnosed with IBS.  Two hundred and forty nine (40.8% 
approximately) participants had been diagnosed over 5 years ago, with 
approximately 24.9% (n=124) being diagnosed in the last 12 months to 
asking.  Furthermore, over half (62%, n=402) of participants stated that 
they had been living with IBS symptoms for over 5 years (table 4.3).  
When asked if they were taking prescribed medication for their IBS, 
approximately 56% (n=362) stated ‘yes’ with 285 stating ‘no’.  Table 4.3 
also illustrates that approximately 71.4% (n=455) were employed with 
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the largest percentage of approximately 23.6% (n=137) of participants 
indicating they had £20,000-£29,000 (or equivalent) household income.  
Approximately 78% of participants had educational qualifications ranging 
from GCSEs or ‘O’ levels to first degree.  There were more participants 
that reported suffering from other conditions (co-morbidity) (58.2%, 
n=380) than reported no co-morbidity (41.1%, n=273). 
 
 
Figure 4.2 Pie chart illustrating geographical location of participants 
(percentage of the whole sample) 
 
85.0%
8.7%
1.7%
4.6%
UK (85%)
USA (8.7%)
Canada (1.7%)
Other western
countries (4.6%)
 
In terms of geographical location, most participants were from the UK 
(85%), 8.7% were from the US and 1.7% from Canada (figure 4.2).  
Other countries accounted for less than 1% of the sample individually 
and 4.6% overall.   In terms of ethnic groupings, approximately 94% were 
white British, white Irish or other white background.  Religious groupings 
were either mainly ‘Christian’ (52%) or ‘none’ (34%) with other religious 
groups represented by small numbers of participants.   The large 
proportion of Christian and no-religion in the sample perhaps reflect that 
the majority of participants were of a white ethnic background, many of 
whom were British or Irish. 
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4.3.2 Extent of CAM use in IBS 
Approximately 57% of participants (n=373) reported that they had used 
CAM to relieve the symptoms of IBS either currently or in the past and 
many had used more than one form of CAM (figure 4.3).  CAM use in 
males accounted for 15.3% of CAM-users, with females accounting for 
84.7%.  Table 4.3 also offers a demographic breakdown of CAM use by 
frequency.  Notably, selected categories in income and time of diagnosis 
demonstrated higher CAM use.  This will be explored further in 
subsection 4.3.6.  Over twenty three percent (23.6%) of CAM-users had 
visited a CAM practitioner at least once in the last 12 months.  
Approximately 75% of the CAM group had purchased their own CAM ‘off 
the shelf’ and 34.9% had been directed to take CAM by a CAM 
practitioner.  The most popular CAM treatments with CAM-users were 
herbal treatments (used by 45.3% of CAM-users), massage (27.9%), 
aromatherapy (24.7%) and Bach flower remedies (22%).  Approximately 
20% of participants each used homeopathy, meditation, yoga, talk 
therapies (e.g. counselling) and relaxation techniques.  Fifteen percent of 
CAM-users used acupuncture and nutritional therapy.  Approximately 
13% indicated use of hypnosis and reflexology to relieve their IBS 
symptoms (figure 4.3).  
 
4.3.4 Age, IPQ-R, BMQ and CAMBI scale associations with number 
of CAM treatments used   
To assess relationships between illness and treatment representations 
and CAM use, the total number of CAM treatments used was calculated 
from summing the number of treatments used by each participant in the 
CAM group.  This was to enable further exploration of these data.  Table 
4.4 illustrates the Pearson’s correlations for age, the scales of the IPQ-R, 
BMQ and CAMBI with the number of CAM treatments used in the CAM 
group.   
 
A number of components in the ‘extended’ CSM were found to be related 
to number of CAM treatments used.  Age was positively related to 
number of CAM treatments used (r=.12, p<.05), as was beliefs in 
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overuse of medicines (r=.15, p<.01).  The strongest correlation was 
between the BMQ harm scale and number of CAM treatments used 
(r=.28, p<.001) suggesting stronger beliefs in potential harm of 
conventional medicines led to more CAM use.  Holistic health beliefs 
(r=.24, p<.001), beliefs about active participation in treatment (r=.10, 
p<.05) and that treatments should be natural (r=.24, p<.001) were all 
positively correlated with an increasing number of CAM treatments.  
There were no significant associations between dimensions of the IPQ-R 
and number of CAM treatments used. 
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Table 4.3 Key participant demographic data by category and extent 
of CAM use (n=653)  
 
Variable Category Number 
(%*) 
CAM use%* 
Y             N 
Gender Male  99  (15.3) 49.5 50.5 
 Female 546  (84.7) 58.6 41.4 
Diagnosis Yes 610  (93.7) 57.9 42.1 
 No 41  (6.3) 46.3 53.7 
Time diagnosed Less than 12 months 152  (24.9) 43.4 56.6 
 1-2 years 69  (11.3) 56.5 43.5 
 2-3 years 71  (11.6) 54.9 45.1 
 3-4 years 37  (6.1) 73.0 27.0 
 4-5 years 32  (5.2) 62.5 37.5 
 Over 5 years 249  (40.8) 64.7 35.3 
Time with symptoms Less than 12 months 33  (5.1) 48.5 51.5 
 1-2 years 45  (6.9) 42.2 57.8 
 2-3 years 74  (11.4) 47.3 52.7 
 3-4 years 53  (8.2) 58.5 41.5 
 4-5 years 41  (6.3) 56.1 43.9 
 Over 5 years 402  (62.0) 61.2 38.8 
Currently taking 
prescribed medication 
yes 362  (56.0) 61.8 38.2 
 no 285  (44.0) 53.9 46.1 
Employed yes 455  (71.4) 52.2 47.8 
 no 182  (28.6) 59.3 40.7 
Income up to £9999 58  (10.0) 63.8 36.2 
 £10,000 - 14,999 69  (11.9) 39.1 60.9 
 £15,000 - £19,999 53  (9.1) 73.6 26.4 
 £20,000 - £29,000 137  (23.6) 60.6 39.4 
 £30,000 - £39,999 97  (16.7) 53.6 43.4 
 £40,000 - £49,999 67  (11.5) 53.7 46.3 
 £50,000 and above 100  (17.2) 58.0 42.0 
Education GCSE's, O' levels or 
equivalent 
164  (25.5) 53.7 46.3 
 A Levels or equivalent 167  (25.9) 62.9 37.1 
 First Degree (BA, BSc) 174  (27.0) 59.2 40.8 
 Postgraduate qualification 86  (13.4) 61.6 38.4 
 No qualifications 53  (8.2) 41.5 58.5 
Co-morbidity reported Yes 380  (58.2) 58.9 41.1 
 No 273  (41.8) 54.6 45.4 
            * Percentages are corrected for missing values  
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Figure 4.3 Bar graph illustrating reported use of most popular CAM treatments in CAM-users with IBS (n=373) 
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Table 4.4 Pearson correlations of IPQ-R, BMQ and CAMBI scales 
with number of CAM treatments used (n=361) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
     *p<.05   ** p<.01   ***p<.001 
  
 
4.3.5. Group differences in age, IPQ-R, BMQ and CAMBI scales  
Table 4.5 shows descriptive statistics for illness perceptions and 
treatment beliefs scale variables and t-tests for differences between the 
CAM-users and non-users.  Several BMQ, CAMBI and IPQ-R scales 
were significantly different according to whether CAM was used or not.  
Furthermore, Levene’s test revealed those scales that were significantly 
different based on CAM use/no-CAM use did not violate the assumption 
of equal variances in each group.  Table 4.5 also demonstrates all the 
scales had acceptable alpha values above .6 when examined according 
to the two groups, CAM-users or non-users.  Figures 4.4 and 4.5 
Scale 
 
Pearson Correlation with 
number of CAM treatments used 
 
Age  
 
 .12* 
 
Identity 
 
 .04 
 
Timeline Chronic 
 
-.04 
 
Timeline Cyclical 
 
 .10 
 
Consequences 
 
 .08 
 
Personal control 
 
 .10 
 
Treatment control 
 
 .09 
 
Illness coherence 
 
 .01 
 
Emotional representations 
 
 .05 
 
Internal cause 
 
 .07 
 
External cause 
 
 .08 
 
Cause - risk factors 
 
 .09 
 
BMQ Harm 
 
 .28*** 
 
BMQ Overuse 
 
 .15** 
 
CAMBI Natural treatments 
 
 .21*** 
 
CAMBI treatment participation 
 
 .10* 
 
CAMBI holistic health 
 
 .24*** 
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illustrate bar graphs to show significant mean differences visually with 
error bars highlighting plus or minus one standard deviation relative to 
each group mean. 
 
4.3.5.1 Age and IPQ-R sub-scales 
A significantly stronger illness identity (M=6.40, SD=2.76) was found in 
those with IBS in CAM-users than in non-users (M=5.60, SD=2.76), 
t(608)= -3.54, p<.001 suggesting CAM-users experienced more 
symptoms from the general symptom list from the IPQ-R.  A stronger 
perception of a cyclical timeline was found in the CAM-users (M=15.34, 
SD=2.71) than non-users (M=14.76, SD=2.89), t(608)= -2.56, p<.05.   
CAM-users (M=22.39, SD=4.28) also reported perceived stronger 
consequences of their IBS scoring significantly higher on perceptions of 
consequences of their IBS than non-users (M=20.90, SD=4.63), t(608)= -
4.08, p<.001.  Non-users’ emotional representations of their IBS were 
significantly lower (M=21.54, SD=5.31) than CAM-users (M=22.87, 
SD=4.92), t(608)= -3.21, p<.01.  These figures are shown in table 4.5. 
 
There were several IPQ-R scales that were not significantly different 
based on grouping participants into CAM-users and non-users.  All but 
one of these scales also satisfied assumptions of equal variances when 
compared as groups using Levene’s test.  There were no significant 
differences between CAM-users (M=37.11, SD=12.63) and non-users 
(M=37.33, SD=13.52) in terms of age, t(608)= .21, p>.05ns.  There was 
also no difference between CAM-users (M=24.96, SD=3.81) and non-
users (M=24.65, SD=3.75) in perceptions of chronicity of IBS, t(608)= -
1.03, p>.05ns.  In terms of perceptions about control, non-users 
(M=19.41, SD=4.36) showed no significant difference when compared to 
CAM-users (M=19.65, SD=4.65) on ratings of personal control, t(608)= -
.60, p>.05ns.  On ratings of treatment control, there was also no 
difference between CAM-users (M=14.40, SD=3.93) and non-users 
(M=14.22, SD=3.81), t(608)= -.56, p>.05ns.  Testing the three causal 
dimensions of the IPQ-R also revealed no significant differences 
between the two groups.  There was no significant difference between 
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CAM-users (M=21.82, SD=6.35) and non-users (M=21.16, SD=5.78) on 
perceptions of internal causes (e.g. stress), t(608)= -1.31, p>.05ns.  
Similarly, CAM-users (M=14.86, SD=3.84) and non-users (M=14.84, 
SD=4.02) were not significantly different on ratings of external causes of 
their IBS (e.g. viruses), t(608)= -.08, p>.05ns.  This was also the case for 
perceptions of risk factors (e.g. smoking), where CAM-users (M=9.41, 
SD=3.14) and non-users (M=9.80, SD=3.10) showed no significant 
differences, t(608)= 1.50, p>.05ns.  Levene’s test revealed that the 
illness coherence scale was the only scale to not have equal variances 
between the two groups (F=6.91, p<.01).  The difference between CAM-
users (M=14.17, SD=5.42) and non-users (M=13.92, SD=4.76) on this 
scale was also not significant: t(591.08)= -.60, p>.05. 
 
4.3.5.2 BMQ and CAMBI sub-scales 
Table 4.5 shows CAM-users had stronger beliefs in possible harmful 
effects of conventional medicines (M=13.00, SD=3.14) compared to the 
non-users (M=11.91, SD=3.14), t(608)= -4.18, p<.001.  CAM-users had 
significantly more positive beliefs about natural treatments (M=22.08, 
SD=3.43) than non-users (M=21.40, SD=3.28), t(608)= -2.49, p<.05.  
This was also the case for beliefs regarding participation in treatment, 
where CAM-users had significantly stronger beliefs regarding ‘patient’ or 
client participation in treatment (M=19.66, SD=2.67) than non-users 
(M=19.02, SD=2.73), t(608)= -2.89, p<.01.  Non-users also had 
significantly less strong beliefs about holistic health (M=21.25, SD=3.64) 
than CAM-users (M=22.07, SD=3.48) t(608)= -2.81, p<.01.  Finally, the 
BMQ overuse scale also revealed no significant differences between 
CAM-users (M=10.13, SD=2.87) and non-users (M=9.80, SD=2.87), 
t(608)= -1.43, p>.05ns. 
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Table 4.5 Descriptive statistics and t-tests for differences on scale 
variables between CAM-users and non-users with IBS 
   *p<.05   **p<.01   ***p<.001   (Effect sizes r =.1 weak, r =.3 moderate, r =.5 strong) 
 
Variable 
 
CAM use 
y/n 
 
Cronbach’s 
alpha 
 
Mean 
 
SD 
t-value  
(effect size ‘r’) 
No  (n=260) N/A 37.33 13.52 Age  
 
Yes (n=350) N/A 37.11 12.63 
 
.21 
No   N/A 5.60 2.76 Identity 
 
Yes  N/A 6.40 2.76 
-3.54*** 
(r=.13) 
No   .83 24.65 3.75 Timeline Chronic 
 
Yes  .81 24.96 3.81 
 
-1.03 
No   .68 14.76 2.89 Timeline Cyclical 
 
Yes  .64 15.34 2.71 
-2.56* 
(r=.10) 
No   .82 20.90 4.63 Consequences 
 
Yes  .81 22.39 4.28 
-4.08*** 
(r=.15) 
No   .84 19.41 4.36 Personal control 
 
Yes  .84 19.65 4.65 
 
-.60 
No   .84 14.22 3.81 Treatment 
control 
 Yes  .78 14.40 3.93 
 
-.56 
No   .90 13.92 4.76 Illness coherence 
Yes  .92 14.17 5.42 
 
-.60 
No   .89 21.54 5.31 Emotional 
representations 
Yes  .87 22.87 4.92 
-3.21** 
(r=.13) 
No   .84 21.16 5.78 Internal cause 
 
Yes  .88 21.82 6.35 
 
-1.31 
No   .67 14.84 4.02 External cause 
 
Yes  .61 14.86 3.84 
 
.08 
No   .70 9.80 3.10 Cause - risk 
factors 
 Yes  .67 9.41 3.14 
 
1.50 
No   .77 11.91 3.14 BMQ Harm 
 
Yes  .75 13.00 3.18 
-4.18*** 
(r=.17) 
No   .77 9.80 2.87 BMQ Overuse 
 
Yes  .73 10.13 2.87 
 
-1.43 
No   .83 21.40 3.28 CAMBI Natural 
treatments 
 Yes  .84 22.08 3.43 
-2.49* 
(r=.10) 
No   .73 19.02 2.73 CAMBI treatment 
participation 
 Yes  .69 19.66 2.67 
-2.89** 
(r=.11) 
No   .71 21.25 3.64 CAMBI holistic 
health 
 Yes  .69 22.07 3.48 
-2.81** 
(r=.11) 
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Figure 4.4 Bar graphs illustrating significant differences between CAM-users and non-users on IPQ-R scales 
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Figure 4.5 Bar graphs illustrating significant differences between CAM-users and non-users on BMQ and CAMBI scales 
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In comparing significant differences between CAM-users and non-users, 
CAM-users’ scores reflected reporting of stronger illness perceptions and 
more negative beliefs about harm of conventional medical treatment.  
CAM-users did, however, report significantly more positive beliefs on the 
CAMBI scales.  A measure of effect size (Pearson’s r) was calculated for 
each of the significant differences on scales between CAM-users and 
non-users.  The effect sizes reported (table 4.5) were mostly small which 
is most likely to be a product of the large sample size in this study.  As 
sample sizes increase, typically, measures of effect size will decrease 
(Clark-Carter, 2007). 
 
4.3.6 Predicting CAM use from demographic factors and scales of 
the IPQ-R, BMQ and CAMBI 
Binary logistic regression was conducted to examine which demographic 
factors and scales of the IPQ-R, BMQ and CAMBI may predict CAM use.  
As stated, certain demographic variables were omitted from the analysis 
on the basis of being heavily weighted in one or more sub-categories 
(section 4.2.5).  SPSS version 17 also conducts logistic regression on a 
‘list-wise’ basis.  This resulted in participants being excluded from the 
analysis if there were any missing values on variables included in the 
regression model.  This resulted in n=513 for this analysis.  Categorical 
predictor variables were selected with the first category in each case as 
the reference point using the ‘indicator’ option for categorical variables in 
SPSS. 
 
A summary of the regression coefficients which predicted CAM use can 
be found in table 4.6.  The final regression model was able to predict 
which participants would use CAM and those that were not CAM-users in 
63.4% of the sample.  This meant that 36.6% of participants were 
misclassified as either being a CAM-user when they did not use CAM or 
the opposite was true.  Variables were entered in two blocks.  
Demographic and clinical factors were entered in block one and IPQ-R, 
BMQ and CAMBI scales were entered in block two.   
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4.3.6.1 Relative contribution of demographic and CSM variables 
Block one, which contained demographic and clinical factors was able to 
predict between 9.2 and 12.4% of the variance in CAM use.  To assess 
how well the logistic regression model fitted the data a number of criteria 
were assessed (Field, 2009; Tabachnick & Fidell, 2007).  First, the 
Omnibus test was assessed to detect a relatively low, but statistically 
significant, value of Chi-square (2) which would indicate a good fit for 
the regression model.  The Omnibus test was significant, meaning the 
logistic regression model was a good fit for the data (2(18) = 49.52, 
p<.001).  The Hosmer and Lemeshow (2000) test was also examined 
which assessed linearity between scale predictor variables and the log-
likelihood of the outcome, if linearity was present, the resulting value of 
2 would be statistically non-significant.  In this case, the Hosmer and 
Lemeshow test resulted in a non-significant result: (2(8) = 11.85, p>.05) 
meaning that the required linearity between scale predictors and log-
likelihood of the outcome was present.   
 
The addition of the IPQ-R, BMQ and CAMBI in block two added 
approximately 10% to the variance predicted by the model overall.  The 
combined blocks were able to predict between 17.0% and 22.9% of the 
variance in CAM use.  Both the omnibus (2(34) = 95.68, p<.001) and the 
Hosmer and Lemeshow tests (2(8) =8.14, p>.05) indicated the 
regression model was a good fit for the data.  From these tests it was 
inferred that the required linearity between scale predictors and logit of 
the outcome was present for both blocks in the model.    
 
4.3.6.2 Contribution of demographic variables 
Examination of demographic predictor variables indicated that 
participants with income ranging from £10,000-£14,999 (compared to 
income of up to £9,999) were more likely not to be CAM-users with an 
odds ratio (OR) of .30.  In terms of education, participants with ‘A’ levels 
or equivalent were more likely to be CAM-users than participants with 
GCSE/ ‘O’ level qualifications (OR =1.89) as were participants with 
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postgraduate qualifications compared to GCSE/ ‘O’ levels (OR =2.34).  
Being diagnosed either 3-4 years ago (OR =3.62) or over 5 years ago 
(OR=3.19) (compared to being in the last 12 months) was also an 
indicator of whether someone would use CAM.  Interestingly, the use of 
prescription medication and reporting co-morbidity were not significant 
predictors of CAM use (block one, table 4.6).  Having no qualifications 
(compared to GCSEs or O’ levels) resulted in a lesser likelihood of 
participants using CAM (OR=.93), however the confidence intervals for 
the education category ‘no qualifications’ crossed the value of ‘1’, making 
this particular odds ratio less reliable, therefore this finding should be 
interpreted with caution.  
 
4.3.6.3 Contribution of illness and treatment representations 
The combined model of blocks one and two resulted in the scales of 
identity, timeline cyclical, illness consequences, risk factors and beliefs 
about harm being constant as predictors of CAM use whilst controlling for 
demographic factors (table 4.6).  The illness identity scale contributed an 
odds ratio of 1.07 meaning for every additional symptom reported 
participants were 1.07 times more likely to use CAM.  The cyclical 
timeline scale of the IPQ-R resulted in an odds ratio of 1.08.  This 
indicated that for every unit increase in perceptions regarding a cyclical 
timeline of IBS, participants were 1.08 times more likely to use some 
form of CAM.  The ‘illness consequences’ scale was also a significant 
predictor of CAM use with an odds ratio of 1.07.  This indicated that for 
every unit increase in the scale of illness consequences, there was 1.07 
times greater likelihood that CAM would be used.   
 
Beliefs in risk factors causing IBS (such as dietary factors or smoking) 
resulted in an odds ratio of .93.  Every unit increase of risk as a cause 
resulted in participants being .93 times less likely to use CAM to relieve 
their IBS.  Beliefs that conventional medicines can cause harm produced 
an odds ratio of 1.09, meaning that for every unit increase on the harm 
scale the likelihood of using CAM increase in odds by a factor of 1.09.  In 
general, the odds ratios of demographic factors were larger than those of 
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the IPQ-R, BMQ and CAMBI scales indicating a larger individual 
contribution by the demographic factors to the predictive ability of the 
model.  
 
4.3.7 Accuracy of logistic regression model  
There are several assumptions in logistic regression that were assessed 
to test if the model was a good fit for the data (Field, 2009; Tabachnick 
and Fidell, 2007).  Firstly, multicollinearity amongst predictor variables 
should be absent.  This means there should be no high correlations 
between predictor scale variables.  This was assessed by running the 
analysis as a multiple regression procedure where the ‘collinearity 
diagnostics’ in SPSS could be assessed.  This option gave a variance 
inflation factor (VIF) which should fall below 10 (e.g. Field, 2009).  All 
relationships between scale predictor variables were safely in the 
parameters of this criterion as the VIF minimum and maximum values 
had a range of 1.09 to 2.07. 
 
Second, residual values were assessed for potential outliers.  Such 
values can affect the accuracy of the regression model so it is advisable 
to check the final solution for such values (Tabachnick & Fidell, 2007).  It 
is expected that approximately 5% of values should have a z-score (a 
standardised residual value) of two or more.  The logistic regression 
model presented here indicated only a small number (less than 1%) of 
values had a z-score outside this parameter, suggesting that there were 
no values causing undue influence on the model.  There were however, 
two z-scores with a value greater than three.  In any sample, it would be 
expected that 1% of values would fall into the category of having a 
standardised residual value of three or more (Field, 2009).  Even though 
having two values with a z-score outside this parameter, this fell within 
accepted parameters for normally distributed residual values in 
regression (Field, 2009). Further diagnostic statistics were checked to 
ensure there was no undue influence on the model of these or other 
values. 
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Table 4.6 Summary of logistic regression analysis of IPQ-R, BMQ, 
CAMBI scales and demographic factors in predicting CAM use in 
IBS 
 
Variable Odds 
Ratio 
95% Confidence Interval 
  Lower bound Upper bound 
Block One    
Prescribed medication (yes) .75 .50 1.14 
Age 1.00 .99 1.02 
 
Income up to £9,999 (reference 
category) 
   
Income £10,000-14,999 .30* .12 .73 
Income £15,000-£19,999 1.17 .44 3.08 
Income £20,000-£29,999 .69 .31 1.56 
Income £30,000-39,999 .53 .23 1.22 
Income £40,000-£49,999 .42 .17 1.06 
Income £50,000+ .70 .30 1.66 
 
Education: GCSE/O’levels 
(reference category) 
   
Education: A’levels 1.89* 1.07 3.32 
Education: First degree 1.69 .95 2.98 
Education: Postgrad 2.34 1.12 4.89 
Education: No qualifications .93* .38 2.28 
 
Diagnosed last 12 months 
(reference category) 
   
Diagnosed 1-2 years  1.86 .92 3.77 
Diagnosed 2-3 years 1.84 .94 3.58 
Diagnosed 3-4 years 3.62* 1.43 9.14 
Diagnosed 4-5 years  1.88 .715 4.94 
Diagnosed over 5 years 3.19* 1.86 5.49 
    
Co-morbidity reported (yes) 1.23 .82 1.85 
    
Block Two    
IPQ-R scales:    
Identity 1.10* 1.02 1.19 
Timeline acute/chronic .99 .93 1.06 
Timeline cyclical  1.08* 1.00 1.16 
Consequences  1.07* 1.00 1.14 
Personal control  1.01 .95 1.08 
Treatment control  1.06 .98 1.14 
Illness coherence 1.01 .96 1.05 
Emotional representations 1.02 .97 1.08 
Cause Internal 1.02 .98 1.06 
Cause external .98 .92 1.05 
Cause risk factors .92* .85 1.00 
BMQ Scales:    
Medication harm  1.10* 1.01 1.20 
Medication overuse 1.00 .91 1.09 
CAMBI scales:    
Beliefs in Natural treatments  1.00 .92 1.07 
Participation in treatment 1.01 .92 1.10 
Holistic health Beliefs 1.02 .94 1.10 
       * p<.05    
 165 
The regression model was also assessed using three influence statistics, 
namely Cook’s distance, DFBeta values and leverage (or hat) values 
(Field, 2009).  Cook’s distance measures influence of individual cases on 
the regression model, where cases with little individual influence on the 
model should fall below 1 (Field, 2009).  All cases were found to fit with 
these criteria.  Second, DFBeta values were assessed.  DFBeta 
assesses the regression model without individual cases present and 
gives a value based on the difference between cases being present and 
then being removed from the model.  Values greater than 1 indicate a 
large influence on the model (Field, 2009).  All DFBeta values were 
found to be within acceptable criteria.  Finally, Leverage (or hat) values 
were assessed.  Leverage assesses the influence of outcome cases on 
the predicted values.  Cases should be no greater than the number of 
predictors plus one, divided by the sample size (k+1/n), where k is the 
number of predictors and n the sample size (22+1/513 = 0.05).  Leverage 
values should not fall any higher than three times this value (Field, 2009).  
One value was found to marginally exceed this value.  However 
considering the other diagnostic statistics were reasonably sound, this 
case was kept in the model.  Moreover, it should be noted that larger 
values were not necessarily reliable judges of influence as they are 
measured using the outcome rather than the predictors as with other 
influence statistics (Field, 2009).  The lack of influential cases in the 
regression model provides a clear indication that no cases were placing 
undue influence on the regression model therefore the regression model 
can be regarded as a good fit for the data. 
 
 
4.4 Discussion 
The aim of this analysis was to examine the illness and treatment 
representations in participants with IBS to seek to determine influential 
factors in the use of CAM.  This was conducted within the theoretical 
framework of an extended CSM.  Four specific aims were addressed.  
Firstly, the prevalence of CAM was explored.  Secondly, the illness and 
treatment representations were assessed for associations with more than 
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one CAM treatment.  Thirdly, differences between the CAM-users and 
non-users on measures of illness and treatment representations were 
observed.  In addition, a logistic regression analysis was conducted to 
assess factors that predicted CAM use in IBS.   
 
4.4.1 Prevalence of CAM use in IBS 
More than half of participants with IBS had used CAM to relieve their 
symptoms, and many had used multiple forms of CAM, of which 
numerous treatments appeared to be ‘off the shelf’ products.  Overall, 
CAM use was higher in this study (57%) than reported in previous 
studies in IBS which has ranged from 38.4% to 50% (Kong et al., 2005; 
van Tilburg et al., 2008), and would seem to be comparable with CAM-
user data from the general population (Eisenberg et al., 1998; Thomas et 
al., 2001).   
 
The most popular CAM therapies for IBS were herbal preparations, 
massage, aromatherapy, and Bach flower remedies.  The latter three 
treatments are perhaps not normally associated with IBS relief and not 
widely investigated as treatments.  This may be suggestive of beliefs 
about IBS being caused or IBS being related to stress, so these 
treatments may primarily be taken to relieve stress rather than IBS.  
Taking such a treatment for IBS may be indicative of certain causal 
beliefs in these participants as stress as a cause of, or influence on, IBS 
and such associations in those with IBS have been noted in previous 
work (Casiday et al., 2008; Hungin et al., 2005).  The discrepancy of 
percentages between consulting a practitioner (23.6%) and being 
directed to take CAM by a practitioner (34.9%) is notable.  This may be 
due to participants asking for advice in some form of CAM retail outlet 
rather than undergoing a formal consultation with a CAM practitioner.   
 
4.4.1.1 IPQ-R, BMQ and CAMBI scale correlations with number of 
CAM treatments used 
The second objective (4.1.2) this analysis addressed was concerned 
solely with CAM-users and examined relationships between scale 
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variables (from the IPQ-R, BMQ and CAMBI and participant age) with the 
number of CAM treatments used by participants.  Participant age was 
positively related to number of CAM treatments used which is arguably a 
logical association in a group of CAM-users.  Both BMQ scales were 
positively related with number of CAM treatments, the harm scale having 
the stronger association of the two.  More CAM treatments appeared to 
be used if CAM-users have stronger beliefs about harm or overuse of 
conventional medication.  The number of CAM treatments also increased 
together with more positive beliefs about CAM.  All the CAMBI scales 
were positively related to number of CAM treatments used although the 
treatment participation scale to a lesser extent than the natural 
treatments and holistic health scales.  
 
These findings are consistent with other studies suggesting that positive 
beliefs about CAM are related to CAM use in the general population 
(Astin, 1998; Bishop et al., 2006).  In considering beliefs about 
conventional medicine, there have also been associations between 
negative beliefs about conventional medications with CAM use in IBS 
and the general population (Hilsden et al., 1998; Vincent & Furnham, 
1996).  It appears from this analysis, that both dimensions of 
conventional treatment beliefs (as measured by the BMQ-General) may 
influence decisions in more than one type of CAM being used for IBS.  
However, it should be noted that these relationships between treatment 
beliefs and number of CAM treatments used are only exploratory and 
only offer an indication of why individuals may use different forms of 
CAM after they have already instigated CAM use.  It is also evident that 
none of the IPQ-R scales were significantly related to number of CAM 
treatments used which may suggest perceptions related to IBS are less 
influential in whether or not more than one type of CAM would be used 
once a decision to initiate CAM use has been made.  This is consistent 
with findings from Bishop et al. (2008) who found no illness perceptions 
were associated with continued use of CAM.  However, Searle and 
Murphy (2000) found evidence of causal beliefs influencing adherence to 
homeopathic treatment in a small sample of users that attended a 
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homeopath.  It should be noted however, that both of these studies 
focused on continued use of particular CAM treatments rather than CAM 
in general.  The concordance with Bishop et al’s (2008) findings in 
relation to adherence to CAM, might suggest treatment beliefs become 
more important predictors of adherence (or continued CAM use) after 
treatment is initiated.  This would be consistent in studies that have 
utilised an extended CSM to examine adherence of conventional 
medication (e.g. Horne & Weinman, 2002).   
 
4.4.1.2 Differences between CAM-users and non-users with IBS on 
scale variables 
The third objective (4.1.3) explored by this study was to examine 
differences between CAM-users and non-users on the IPQ-R, BMQ and 
CAMBI scales as well as participant age.  This study found no 
differences between CAM-users and non-users in age.  In terms of 
illness perceptions, CAM-users had a significantly greater number of IBS 
symptoms, stronger perceptions of a cyclical timeline and consequences 
of their IBS.  The emotional representations of CAM-users were 
significantly higher than the non-users, indicating that CAM-users with 
IBS reported greater emotional distress related to their IBS.  These 
findings seem logically consistent with previous work (e.g. Lackner et al., 
2004), although to date little investigation has been conducted on the 
influence of emotional representations on CAM use.  Both Bishop and 
Lewith (2010) and Testerman et al. (2004) reported that CAM-users from 
the general population may report lower health status.  Donker et al. 
(1999) also found that those with IBS report poorer health in comparison 
to the general population and this seems to influence health care 
seeking, including CAM use.  Similarly, Verheof et al. (1990) found CAM-
users with functional bowel disorders reported poorer health status than 
non-users.  There were no differences between the CAM-users and non-
users on scores for the causal scales of the IPQ-R.  This may suggest 
some consensus regarding causal factors for IBS between the two 
groups of participants.   
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Understanding of IBS (illness coherence) also did not differ between 
CAM-users and non-users.  This may suggest that this particular sample 
has similar understanding of their illness regardless of whether CAM is 
used or not.  This is further compounded by the fact the sample came 
from participants using the internet, many of which came to the study 
website via a self help network website.  It could be theorised that this 
sample of participants may be well informed about their condition.  In 
general, up to eighty per cent of those with IBS have been shown to have 
knowledge about their condition (Ringström, et al., 2009) and some will 
use online forums and websites for support and information about IBS 
(Coulson, 2005) and health and illness in general (section 3.1.2.1). 
 
CAM-users reported significantly stronger beliefs in the possibility of 
harmful effects caused by conventional medicines than non-users.  This 
is consistent with previous work (Hilsden et al., 1998; Vincent & 
Furnham, 1996).  Horne et al. (1999) found that participants using 
homeopathic treatments had significantly greater concerns about both 
harm and overuse of conventional medicines than non-users.  However, 
in this study there were no differences between CAM-users and non-
users in ratings of overuse of medication.  This may indicate that 
perceptions of harm caused by conventional medical treatments for IBS 
may be a more important influence on CAM use than a perception of 
medication being over used.      
 
Many studies have emphasised more positive beliefs about CAM as a 
more prominent reason for CAM use in the general population 
(Testerman et al., 2004; Furnham & Kirkaldy, 1996) and in functional GI 
complaints (Koloski et al., 2003).  CAM-users in this study illustrated 
more positive beliefs regarding natural treatments, patient participation in 
treatment and holistic health than non-users and these factors were also 
positively related to a greater number of CAM treatments being used.  
Previous work utilising an extended CSM framework has shown beliefs in 
holistic health to be related to use of number of CAM treatments (Bishop 
et al., 2006).  As this study did not assess any treatment representations 
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prior to CAM use, it is difficult to ascertain whether the more positive 
beliefs about CAM by CAM-users, are a result of their own experience of 
CAM or if such beliefs were instrumental in commencing CAM treatment.        
 
4.4.1.3 Predicting CAM use in IBS from the CSM and demographic 
items 
The final objective (4.1.4) addressed in this analysis was to determine 
which components of the extended CSM and demographic factors 
predicted CAM use.  Several demographic factors were influential in 
CAM use although reporting co-morbidity was not a significant predictor 
of using CAM.   
 
Having an income in the category of £10-14,999 (compared to the 
reference category of ‘up to £9,999’) indicated a lesser likelihood of CAM 
use.  This may suggest some consistency with previous research 
suggesting CAM use is related to higher levels of household income 
(Eisenberg et al., 1998), although in this study, higher levels of income 
did not influence CAM use in the regression model.  Participants with ‘A’ 
levels or postgraduate qualifications were more likely to be CAM-users, 
also suggesting similarities with previous work that has suggested higher 
education levels are a factor influential in CAM use in the general 
population (Astin, 1998; Thomas et al., 2001) and in IBS (van Tilburg et 
al., 2008).  In most cases, a certain level of disposable income would be 
necessary to undertake CAM treatment as most CAM treatment, 
especially in the UK, does not fall under the remit of the NHS.  
Educational attainment and CAM use may be related in some instances 
by increased knowledge of treatment options for IBS or having a feeling 
of wanting to question the effectiveness and use of conventional medical 
treatment (e.g. Astin, 1998).   
 
Participants who were diagnosed over five years ago and 3-4 years ago 
were more likely to use CAM than those diagnosed in the last 12 months 
which again is consistent with other work into CAM use.  It has been 
demonstrated that the chronicity of complaints is important in CAM use 
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(Eisenberg et al., 1998).  Chronicity may also be associated with findings 
that CAM use is influenced if conventional care has offered no relief over 
time (Vincent & Furnham, 1996) or the individual has perceived ‘failure’ 
of conventional treatment (Smart et al., 1986).  One further suggestion 
may be that time of diagnosis alone is not influential in CAM use and that 
other factors such as relief gained from conventional medication or 
perceptions of health care consultations are worthy avenues for future 
exploration. 
 
Logistic regression analysis revealed a number of illness perceptions 
predicted CAM use.  Stronger beliefs in illness identity (number of 
symptoms) meant participants were more likely to use CAM.  Stronger 
beliefs in illness consequences were also shown to predict CAM use.   
These findings allow comparison with previous work.  CAM-users in the 
general population have been shown to report a more severe illness 
experience (Bishop & Lewith, 2010; Testerman et al., 2004) and in those 
affected by IBS and other functional bowel disorders, detrimental health 
status will influence healthcare seeking including CAM use (Donker et 
al., 1999; Verhoef et al., 1990).  One study that has used the IPQ-R, also 
found illness consequences have been shown to predict current CAM 
use in a general population of CAM-users (Bishop et al., 2006).  
Perceptions regarding more serious consequences of IBS being linked to 
CAM use is also consistent with previous work in both IBS and IBD 
populations (Scott, et al., 2003; Talley et al., 1997).   
 
Health status in IBS has also been shown to influence conventional 
health care seeking (Koloski et al., 2001).  The finding that those 
participants who reported stronger illness perceptions (e.g. 
consequences and emotional representations), appear more likely to use 
CAM.  Indirectly, such perceptions may be indicating that conventional 
treatment has not helped alleviate IBS symptoms and this has 
encouraged these individuals to explore other treatments.  The reporting 
of more symptoms (illness identity) may suggest some participants may 
be attributing additional, perhaps unrelated troublesome symptoms to 
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their IBS.  The Rome criteria refer to a number of symptoms, some of 
which are not directly attributed to the bowel, such as fatigue.  An 
‘accumulation’ of such symptoms may also influence a decision to use 
CAM.  
 
Higher scores on the cyclical timeline scale were also associated with a 
greater likelihood of CAM use.  Although not demonstrated in previous 
research into IBS and CAM use, this finding is not unexpected as IBS is 
well documented as a condition with fluctuation of periods of intense 
symptom experience and periods of relief (e.g. Drossman, 1999).  A 
stronger belief in risk factors (e.g. smoking or alcohol use) as a cause of 
IBS indicated a lesser likelihood of CAM use.  The perceptions may 
relate to a belief in a degree of self infliction with risk factor as a causal 
influence on IBS.  It may be that IBS symptoms would be perceived to 
subside or be relieved if smoking or alcohol use ceased or was reduced.  
Nahin et al. (2007) found that those that were less engaged in 
behaviours such as smoking and drinking alcohol were more likely to use 
CAM.  As smoking and drinking habits were not explored in this study, it 
may be that people with IBS smoke fewer cigarettes and drink less 
alcohol than others in the population that are non-users of CAM.  This 
represents an avenue to be explored in future study.  Other studies have 
found evidence of psychological causal representations as being 
influential in CAM use in general populations (Bishop et al., 2006; Searle 
& Murphy, 2000).  This may suggest the attribution of specific causal 
beliefs concerning risk factors such as smoking or drinking alcohol are 
particular to IBS or may be specific to this sample. 
 
Stronger beliefs on the BMQ-harm scale also indicated a greater 
likelihood of participants using CAM.  Previous studies have also 
suggested that beliefs about the potentially harmful effects of 
conventional medicine are influential in CAM use (Hilsden et al., 1998; 
Vincent & Furnham, 1996).   This finding may also be related to previous 
work in IBS that has identified issues with conventional medicines such 
as ‘failure of’ (Smart et al., 1986) and being ‘sceptical of’ conventional 
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medicine (Verhoef et al., 1990).  Although the lack of systematic 
investigation is evident in investigating beliefs about conventional 
medication in this area, the findings from this study are theoretically 
consistent with previous work and expectations.     
 
Many of the IPQ-R scales did not predict CAM use.  Emotional 
representations did not predict CAM use despite showing a difference in 
scores between CAM-user and non-user groups.  Bishop et al. (2006) 
also found emotional representations did not predict current CAM use.  It 
may be that emotional distress unrelated to IBS may be influential in 
CAM use.  Other studies have suggested stressful life events (Verhoef et 
al., 1990), anxiety (van Tilburg et al., 1998) and impaired psychological 
health (Donker et al., 1999; Koloski et al., 2003) as factors related to 
using CAM in IBS.  The illness coherence and two control scales were 
also not predictors of CAM use.  In the case of illness coherence, as 
considered previously, it may be that participants in this study, recruited 
largely from a self-help network website may have a good understanding 
of their IBS.  Similarly, the BMQ-overuse scale was not a significant 
predictor of CAM use.  The regression model predicted 22.9% of the 
variance in outcome, less than reported by Bishop et al. (2006), although 
this study had a large number of participants that did not use CAM unlike 
the Bishop et al. study. 
 
Previous work has emphasised positive beliefs about CAM as a 
prominent reason for CAM use in the general population (Bishop et al., 
2006; Furnham & Kirkaldy, 1996; Testerman et al., 2004) and in FBD 
(Koloski et al., 2003).  CAM-users had more positive beliefs about CAM, 
as illustrated by higher CAMBI scores, than non-users.  However in this 
study, none of the CAMBI scales predicted CAM use when controlling for 
other variables in the logistic regression analysis.   
 
This study addressed CAM as a single entity, although participants were 
shown to use many different types of CAM for their IBS.  Chapter one 
outlined the differing dimensions and philosophies to CAM, not least the 
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distinction between ‘complementary’ and ‘alternative’ treatments (Zolman 
& Vickers, 1999).  It is possible there may be differences in predictive 
factors for different philosophies and groups of CAM (Bishop et al., 
2006).  Vincent & Furnham (1996) for example, found that homeopathy 
patients had stronger beliefs in natural treatments and felt conventional 
treatment to be less effective for their health complaint than osteopathy 
and acupuncture users.   Bishop et al. (2006) found some differences in 
the relationships between illness and treatment representations and 
different CAM philosophies.  Severe consequences for example, 
predicted use of mind-body interventions and biologically based 
therapies.  Stronger beliefs in harm (from the BMQ) resulted in a greater 
likelihood of use of alternative treatments.  These relationships could be 
further explored in future studies in IBS populations, possibly with 
reference to CAM user profiles for each CAM philosophy (Kelner & 
Wellman, 1997).   
 
4.4.2 Theoretical considerations  
This study illustrated the benefits of incorporating treatment 
representations into the CSM to enhance the predictive quality of this 
theoretical approach.  Although previously the extended CSM has been 
typically used in relation to conventional medical treatment adherence 
studies, the literature on CAM use, IBS and existing studies that have 
explored CAM use in IBS suggested that exploring treatment beliefs 
would be a worthwhile endeavour.  Two studies to date have explored 
CAM use by using an extended model based on the CSM with the 
addition of CAM beliefs (Bishop et al., 2006; 2008).  This study added to 
previous work in that the incorporation of conventional medication beliefs 
(Horne & Weinman, 2002) into the CSM both enhanced the model and 
illustrated that a component of conventional treatment beliefs was an 
important predictor of CAM use in IBS.  The inclusion of CAM beliefs in 
the theoretical approach met with limited success in predicting CAM use, 
as none of these dimensions was a predictor of CAM use.  However, 
CAM-users did have stronger beliefs in favour of CAM than non-users.  
More positive CAM beliefs were also associated with use of a greater 
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number of CAM treatments.  This may be an area that may benefit from 
further investigation, as such pro-CAM beliefs may precede or influence 
CAM treatment outcome or reported quality of life.  The relationships 
between CAM beliefs and reported quality of life are explored in the 
following chapter.  
 
Furthermore, exploration of CAM use in this context represents 
examination of the pathways between illness and treatment 
representations and a specific coping behaviour (Searle et al., 2007).  
Horne and Weinman (2002) illustrated that both illness and conventional 
treatment representations were predictors of adherence to asthma 
medication.  Searle et al. (2007) however, found more consistent 
relationships with coping ‘cognitions’ (i.e. strategies or procedures, 
measured by checklist) than coping behaviours.  The following chapter 
will explore the relationships between illness and treatment 
representations, and such coping ‘cognitions’ and strategies further.    
 
4.4.3 Limitations of the study 
In predicting CAM use using a logistic regression model, the 
demographic factors and beliefs about illness and treatment accounted 
for a moderate amount of variance although some of the odds ratios of 
the IPQ-R and BMQ scales were smaller when compared to 
demographic factors.  The moderate amount of variance explained in the 
outcome (CAM use) suggests that other factors not considered in this 
study may be relevant in CAM use in IBS such as perceptions 
concerning health care consultations.  The diagnostics of the model in 
terms of such factors as multicollinearity and influential and residual 
values were all within normal parameters.  The only apparent issue was 
the confidence intervals for ‘no qualifications’ which crossed over 1, 
meaning this particular confidence interval may be unreliable and should 
be interpreted with caution.  
 
Similarly, a number of treatment beliefs were significantly associated with 
number of CAM treatments used but the Pearson’s coefficients were 
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small to moderate.  The significant differences between CAM-users and 
non-users on the IPQ-R, BMQ and CAMBI scales also showed small 
effect sizes.  The study was also cross-sectional, making it more difficult 
to assume causation or direction of influences of illness and treatment 
perceptions on CAM use.  However, the large sample size would suggest 
a degree of robustness in the findings and smaller effect sizes in group 
differences can be seen as a product of the large sample size.   
 
Examination of participant demographics in this study suggests a degree 
of consensus with the ‘CAM-user profile’ (Thomas et al., 2001; Astin, 
1998) in that the majority of participants were female and CAM use was 
influenced by higher income.  The female predominance in IBS 
documented elsewhere (Andrews et al., 2005; Hungin et al., 2005; 
Thompson et al., 2000; Wilson, et al., 2004) was evident in this study,   
although it is still possible that there exists a ‘hidden’ male cohort with 
IBS that may be reluctant to seek health care.  Furthermore, despite 
recruiting a large number of participants, the sample largely consisted of 
white, British participants who where either largely of Christian or no 
religious background.  Such findings may be related to the type of 
individuals who use the internet for information or support with their IBS 
(e.g. Coulson, 2005) rather than being indicative of any sort of 
demographic indication of greater prevalence within these ethnic and 
religious groupings.  Many western countries have similar prevalence 
rates of IBS (Wilson et al., 2004).  Moreover, many will not seek care for 
their IBS (Saito et al., 2002; Thompson et al., 2000) which may suggest 
that such individuals may be less likely to seek out information and 
potentially less likely to participate in a research study.  It may also be 
worthwhile to investigate other ethnic, spiritual or religious groups, who 
were not highly represented in this study, in future studies as this may be 
an important influence on CAM use.  Testerman et al. (2004) found 
beliefs in spirituality as one factor influential on CAM use. 
 
The diversity in geographical location of participants was not thought to 
have affected the findings given the apparent consistency and 
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robustness of CSM research over different western populations (e.g. 
Hagger & Orbell, 2003).  However, it should also be noted that other 
studies showing high prevalence of CAM in IBS (Kong et al., 2005; van 
Tilburg et al., 2008) used a GI outpatient clinic sample and health 
maintenance organisation sample respectively.  It is possible that such 
participants may experience a more severe illness experience than 
individuals who are not currently outpatients or receiving treatment.  
There may also be more subtle differences in the experience of IBS as a 
small number of participants in this study had not been diagnosed by a 
health care professional.  However, table 4.1 illustrates that over half of 
those not diagnosed had still used CAM at some point.  These aspects 
may be investigated further in future work.  
    
The method of administering the survey may have had some effect on 
the findings.  This sample was self-selecting and many participated from 
responding to an advertisement on a self-help network website.  It may 
be assumed that in seeking ‘self help’ many were relatively well informed 
about IBS and this may have had some effect on their representations of 
IBS and treatment.  Potential differences between those that take part in 
research on the internet as opposed to more traditional paper and pencil 
tests have been considered as a potential problem for research 
conducted online (e.g. Ahern, 2005; Duffy, 2002).  However, there is a 
growing body of evidence, established using comparisons based on 
psychometrically sound measures, that any differences are either small 
or do not exist when paper and pencil and internet administration of tests 
are compared (Basnov et al., 2009; Gosling et al., 2004; Vallejo et al., 
2007).  Furthermore, the internal reliability of the scales of measures and 
the age range of participants suggest that the sample compares well with 
previous work using the same measures of illness perceptions and 
treatment beliefs (e.g. Bishop et al., 2006).  It should also be noted that 
there were still significant differences and associations between scores 
and it would perhaps be unrealistic to expect every dimension of the IPQ-
R, BMQ or CAMBI to predict CAM use.   
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Despite these limitations the systematic and theoretical approach to the 
study has yielded some new and important findings.  Studies into CAM 
use in IBS are scarce, but the results here concur, to a degree, with what 
is known about CAM use in general populations.  However, given the 
prevalence of IBS it is possible many CAM-users with unspecified health 
complaints from studies into general populations and CAM use may have 
had IBS.  This study adds to the understanding in that a stronger 
perception of risk factors as causes of IBS, such as alcohol or smoking, 
is less likely to result in CAM use.  This gives some insight into which 
factors are implicated in the use of CAM in a specific illness group.  Also 
evident is that there are differences in many dimensions of illness 
perceptions and treatment beliefs between CAM-users and non-users. 
 
The lack of previous work in this area and using a theoretical framework 
has been partly addressed by this study.  This study has used the 
systematic and theoretical framework of the CSM and the findings 
support the view that an extended CSM (e.g. Bishop et al., 2006; 2008; 
Horne & Weinman, 2002) has utility in exploring CAM use in IBS.  
Several illness perceptions and treatment beliefs regarding harm caused 
by conventional medicines predicted CAM use in those with IBS.  Future 
studies in this area may pay consideration to examining the relationships 
between different categories (based on philosophy and approach) of 
CAM.  The results suggest many with IBS will turn to herbal treatments 
and often other forms of CAM to relieve their symptoms with the 
possibility that this may be to relieve underlying issues such as stress.  
As with conventional care, CAM may be taken to deal with a particular 
facet of IBS that is prominent such as constipation or diarrhoea.  
Additionally, potential distinctions should be made between ‘off the shelf’ 
CAM products and CAM provided by a practitioner.  Most participants in 
this study seemed to indicate they purchased their own CAM treatment in 
contrast to other studies into CAM use in IBS populations (Donker et al., 
1999; Koloski et al., 2003; Smart et al., 1986; Verhoef et al., 1990). 
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4.4.4 Conclusions 
This cross-sectional analysis found that CAM use in participants with IBS 
was over fifty percent.  The use of an extended CSM had the benefit of 
highlighting illness and treatment representations that were related to 
CAM use.  Several dimensions of illness perceptions and beliefs about 
harm caused by conventional medicines predicted CAM use when 
controlling for demographic factors.  There were also a number of 
differences on the IPQ-R, BMQ and CAMBI scales between CAM-users 
and non-users.  Furthermore, there were also significant correlations 
between treatment beliefs and number of CAM treatments used.  The 
findings illustrate the benefits in using an extended CSM to 
systematically investigate the cognitive and emotional aspects of IBS.  
The extended CSM enabled examination of components that are both 
associated with the number of CAM treatments used and that predicted 
CAM use in IBS.  In terms of predicting CAM use, illness identity, 
stronger illness consequences, cyclical timeline and causal risk factors 
all predicted CAM use.  Beliefs about harm caused by conventional 
medication also predicted CAM use in those with IBS.  To develop these 
findings and to examine the possibility that beliefs may change due to 
using CAM, prospective longitudinal studies are needed.   
 
These findings also indicate implications for conventional care, although 
such implications are tentative based on this single cross-sectional study.  
Firstly, perceptions about consequences of IBS could be addressed in 
initial health care consultations.  Such an approach has been shown to 
be beneficial to the prognosis of those with IBS in terms of reduced use 
of health care services (e.g. Oerlemans et al., 2010; van Dulmen et al., 
1996; 1997) and may help to reduce the need for CAM.  Second, 
patients could be provided with information that IBS is a condition that is 
cyclical in nature and they may have periods where symptoms are more 
intense.  As ‘identity’ with symptoms was a predictor of CAM use, 
attention could be paid to addressing those presenting with IBS about the 
variation and cyclical nature of symptoms so they are fully informed 
about their condition.  Finally, as beliefs about harm of conventional 
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medicines predicted CAM use, time could be taken to reassure about the 
possibility of any harmful effects of continued use of medication.   These 
scenarios show how conventional care may potentially target 
troublesome illness perceptions in those presenting with IBS.  As many 
people with IBS will visit their GP before a CAM practitioner, and given 
the suggested role of illness perceptions in IBS, it is logical to consider 
that such perceptions could be routinely addressed by GPs during the 
first consultation alongside a positive diagnosis of IBS.  
 
The differences observed in measures based on an extended CSM 
between CAM-users and non-users are both evident and expected from 
what expectations based on previous work.  These findings have 
provided further basis for the exploration of interrelations between 
constructs of the CSM between CAM-users and non-users separately.  
These interrelations will be addressed by analyses presented in the 
following chapter. 
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Chapter 5  
 
An examination of components of the Common-Sense Model of 
illness between CAM-users and non-CAM users with IBS 
 
This chapter presents further findings from the cross-sectional study and 
thus extends the analysis reported in chapter 4 in which CAM-users and 
non-users were found to differ on a number of illness perceptions and 
treatment beliefs.  The chapter reports an examination of the pathways in 
an extended common-sense model (CSM) of illness representations in 
both CAM-users and non-users with IBS including testing the theorised 
mediating role of coping between illness perceptions (and treatment 
beliefs) and outcome.   
 
5.1 Introduction 
As illustrated in chapter one, IBS is a prevalent functional illness with 
multiple symptoms and of unidentified aetiology.  Consequently IBS is 
difficult to treat and can result in between 35% and 50% of those 
affected, using CAM for symptom relief (Kong et al., 2005; van Tilburg et 
al., 2008).  Findings presented in the previous chapter also showed 57% 
of participants in this cross-sectional study used CAM to treat their IBS.   
 
Evidence presented in chapter one shows illness perceptions are 
important in both IBS and in CAM use.  Rutter & Rutter (2002, 2007) 
demonstrated individuals’ perceptions about IBS are associated with 
impaired quality of life (e.g. Rutter & Rutter, 2002, 2007; Spiegel et al., 
2004).  The findings in chapter four illustrated such illness perceptions, 
as well as treatment beliefs, predicted CAM use in IBS, findings that are 
consistent with the general population (e.g. Bishop et al., 2006).  Chapter 
four also demonstrated the value of utilising an extended CSM 
framework to investigate the influence of illness and treatment 
perceptions on a specific coping behaviour (i.e. CAM use) adopted by 
those affected by IBS.   
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Within the CSM, individuals process both cognitive and emotional 
responses to illness which influence coping strategies undertaken in an 
attempt to maintain a state free from illness or symptoms (Leventhal et 
al., 1998).  Previous research utilising the CSM in IBS has however, 
largely ignored the emotional component of the model (Rutter & Rutter, 
2002, 2007) and the influence on emotional outcomes (Leventhal et al., 
2003).  Those with IBS have been shown to ‘catastrophise’ their 
symptoms (Lackner et al., 2004) and such emotional distress has the 
potential to influence poorer emotional outcomes according to the CSM 
(Leventhal et al., 2003). 
 
As outlined in chapter two, an extended CSM delineates pathways from 
illness or treatment representations to outcome.  These pathways are 
said to be mediated by coping procedures (Hagger & Orbell, 2003).   
Evidence demonstrating mediation of coping however is mixed in many 
cross-sectional studies (Carlisle et al., 2005; Hagger & Orbell, 2003).   
Heijmans (1998), Kemp et al. (1999) and Scharloo et al. (1998) all failed 
to detect mediation effects using cross-sectional designs.  However, 
other studies with a sample of rheumatoid arthritis patients (Carlisle et 
al., 2005) and relatives of people with schizophrenia found evidence of 
mediation of certain coping strategies (Fortune et al., 2005). 
   
In IBS, Rutter and Rutter (2002) found mediation of coping in a cross-
sectional study although any distinction between mediation and partial 
mediation was not clarified.  However, in a longitudinal study of IBS 
patients from a number of general practices, no evidence of mediation of 
coping was detected (Rutter & Rutter, 2007).  Several CSM studies have 
adopted the Baron and Kenny (1986) ‘causal steps’ approach to (simple) 
mediation testing (section 3.6.3) relying on the researchers’ interpretation 
of the degree of mediation (e.g. Carlisle et al., 2005; Rutter & Rutter, 
2002).  The findings presented in this chapter are augmented with a 
formal test of significance for detected mediation effects (section 3.6.3, 
Preacher & Hayes, 2004).   
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Chapter one reported that quality of life is often more impaired in IBS 
compared with other, sometimes more serious conditions (e.g. Amouretti 
et al., 2006).  CAM-users with unspecified health issues also report 
inferior quality of life (Astin, 1998) as they also do in IBS (van Tilburg et 
al., 2008).  It may then be proposed that CAM-users with IBS will report 
lower quality of life than those not using CAM.  Furthermore, taking into 
consideration findings presented in chapter four which show CAM-users 
differ from non-users on a number of illness and treatment perceptions, 
there was a cogent rationale to examine CSM pathways in CAM-users 
and non-users separately.  It is also apparent that to date, no published 
studies have examined an extended CSM in IBS patients across two 
such groups.   
 
The main aim of this chapter therefore is to consider the relationships 
between three main components of an extended CSM namely, 
interpretation (perceptions and beliefs), coping and outcome in the form 
of a self-report health related quality of life measure.  In exploring these 
pathways and interrelations, CAM-users and non-users were considered 
comparatively.  Within this main aim, four specific objectives were 
addressed: 
 
5.1.1 To examine differences between CAM-users and non-users on 
subscale scores of the IBS-QOL 
5.1.2 To examine differences between CAM-users and non-users on 
scale scores of the Brief-COPE 
5.1.3 To explore relationships between measures of illness perceptions 
and treatment beliefs in CAM-users and non-users 
5.1.4 To examine if coping acts as a mediator between illness 
perceptions, treatment beliefs and reported quality of life in CAM-users 
and non-users  
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5.2 Method  
This component of the research was conducted according to the 
methodology detailed in chapter three.  As with the findings reported in 
chapter four, data collection took place online.  A series of independent t-
tests were conducted to examine for differences between CAM-users 
and non-users.  Pearson’s correlations were used to examine 
relationships between measures of illness and treatment representations.  
A combination of Pearson’s correlations and regression analyses was 
used to test for simple mediation effects of coping (Baron & Kenny, 
1986).  Further bootstrapping tests (Preacher & Hayes, 2004) were able 
to give an estimation of the statistical significance and size of each 
mediation effect detected. 
 
5.2.1 Design 
As detailed in the previous two chapters, this component of the research 
was a cross-sectional web-based survey.  This method was selected as 
it offered the opportunity for substantial and diverse participant 
recruitment (section 3.1.2.1).   To address the research objectives 
(section 5.1), participant data were taken from IPQ-R, BMQ and CAMBI.  
Coping was assessed by using the Brief-COPE and reported IBS-specific 
quality of life was assessed with the IBS-QOL.  Participants were divided 
into two groups, either CAM-users or non-users according to whether 
they had used CAM to relieve their IBS or not. 
 
5.2.2 Participants 
Six hundred and fifty three participants were recruited online from an IBS 
support network and IBS discussion forums.  Over half (57%) had used 
CAM and approximately 84.7% were female.  Most participants stated 
they had been diagnosed (93.7%) by a health care professional and 85% 
were from the UK (see section 4.3.1 for a full summary). 
 
5.2.3 Measures  
The measures used to conduct this study are explained fully in section 
3.3.  For the purposes of this study, four measures were considered as 
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predictor or explanatory variables.  The Illness Perception Questionnaire 
Revised version (IPQ-R; Moss-Morris et al., 2002) was used as a 
measure of illness perceptions.  The Beliefs about Medicines 
Questionnaire general version (BMQ-general; Horne et al., 1999) was 
utilised to capture general beliefs about conventional medicines.  The 
Complementary and Alternative Medicine Beliefs Inventory (CAMBI; 
Bishop et al., 2005) was used to ascertain beliefs about CAM.   The 
Brief-COPE (Carver, 1997) was used to capture coping strategies.    
 
The IBS-QOL (Patrick et al., 1998), an illness specific measure of quality 
of life, was used as an outcome measure.  As was highlighted in chapter 
two, outcome in previous CSM research has often taken the form of a 
self-report quality of life measure (e.g. Rutter and Rutter, 2002).  The 
total IBS-QOL score reflects a domain specific, multi-dimensional score 
of several wide ranging factors related to quality of life and was 
considered a suitable outcome measure (Drossman et al., 2000; Patrick 
et al., 1998).  One of the subscales of the IBS-QOL, the Dysphoria 
subscale, was used as a measure of emotional quality of life (emotional 
outcome) enabling the pathway between the emotional representations 
and emotional outcome to be examined.   
 
To address objectives three and four (section 5.1), the dichotomous 
outcome measure of CAM use (section 3.3.3.1) referred to in the 
previous two chapters was used to divide the data file into two groups 
according to whether participants were CAM-users or non-users. 
 
5.2.4 Procedure 
The procedure was carried out as detailed in section 3.4 using an online 
survey host.  Participants were recruited online via advertisements on an 
IBS self-help network group webpage and other IBS related online 
discussion forums.  Participants were presented with a direct ‘one click’ 
electronic link that routed to the study website.   Full details of the 
procedure are provided in the section 3.4.   
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5.2.5 Statistical methods 
Scales were computed for the Brief-COPE and the IBS-QOL (section 
3.3.2).  As was considered in the previous chapter, data were screened 
outlying values and distributions of scale variables assessed (Tabachnick 
& Fidell, 2007).  Following this, inferential statistical testing was 
conducted in SPSS version 17 to assess differences between CAM-
users and non-users using unrelated t-tests on the Brief-COPE and IBS-
QOL.  Relationships between the IPQ-R, BMQ and CAMBI scales (for 
both the CAM-users and non-users) were explored.  Finally, in both 
CAM-users and non-users, tests of simple mediation were conducted 
according to Baron and Kenny’s (1986) causal steps approach (see 
section 3.6.3).  This was followed by testing for statistical significance of 
any mediation effect detected (Preacher & Hayes, 2004). 
 
5.2.5.1 Computing scales 
Prior to inferential statistical testing, the IPQ-R, BMQ, CAMBI scales and 
IBS-QOL scale and subscale were computed (as outlined in section 
3.3.2) allowing for small numbers of missing values on each item.  The 
Brief-COPE was computed without accounting for any missing data as 
each scale of the measure consists of two items only, so a total score 
was computed for participants that had two responses for items of each 
scale.  For the purposes of addressing the third objective in this study 
(section 5.1), to test if coping mediated relationships between the IPQ-R, 
BMQ, CAMBI and the IBS-QOL, the data were split into two separate 
files according to CAM use or no-CAM use (subsequently referred to as 
the CAM-users and non-users).      
 
5.2.5.2 Data screening  
As considered in chapter 4 (section 4.2.5.2), data were checked for 
outlying values that may unduly influence inferential statistical tests 
(Tabachnick & Fidell, 2007, section 3.6).  The IPQ-R, BMQ and CAMBI 
scales were screened prior to analysis in chapter four (section 4.2.5.2).  
The Brief-COPE scales and IBS-QOL subscales were therefore 
screened for outlying values prior to statistical testing.  Box-plots were 
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used to visually identify outliers that were present in several Brief-COPE 
scales and IBS-QOL subscales.  Detected outliers were checked for any 
pattern in responses (e.g. response set).  However all values were found 
to be in the correct scoring range for each scale and demonstrated 
sufficient variation in scores.  With identified outlying values, the 
‘winsorizing’ strategy (Erceg-Hurn & Mirosevich, 2008) adopted in the 
previous chapter to reduce their influence was used by changing these 
values to less extreme figures (section 4.2.5.2).  This involved changing 
the outlying value to the next non-outlying value to reduce the influence 
of these particular cases (e.g. Field, 2009).   The Brief-COPE scale, 
‘substance use’ was unresponsive to trimming of outliers in non-users, so 
this scale was not adjusted, however, the distribution of residual values 
in regression models containing this scale were assessed for normality. 
 
The Brief-COPE scale and IBS-QOL scale and subscale distributions 
were assessed for normality visually by using histograms for both CAM-
user and non-user responses.  Examination of the histograms for the 
Brief-COPE scales and IBS-QOL subscales revealed several scales that 
suggested distributions deviated from normality.  In examining Brief-
COPE scales, there was noticeable non-normality of responses, more so 
in CAM-users where only the self distraction, instrumental support and 
emotional support scales were deemed normal.  In non-users, active 
coping, self distraction, instrumental support, planning and acceptance 
were approximately normally distributed.  Most other scales were 
deemed to show a positive skew apart from planning and active coping in 
CAM-users, which were negatively skewed.  Many of the IBS-QOL 
subscales were normally distributed, although the Dysphoria subscale 
demonstrated a positive skew in CAM-users, as did food avoidance in 
non-users.  In both groups the relationships and sexual subscales 
demonstrated a negative skew.   
 
5.2.5.3 Statistical tests 
Parametric analysis was favoured as the measures used in this study 
were considered psychometrically stable enough to have elicited 
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parametric data (section 3.3.2).  Statistical analysis was also conducted 
on a list-wise basis in SPSS to ensure greater accuracy, meaning any 
case with missing data on any of the measures included in a particular 
analysis was omitted from the analysis (see section 3.6.1).  To address 
the first two study objectives (section 5.1) and taking into account the 
documented robustness of t-tests to non-normality (see sections 3.6.3 
and 4.2.5), independent t-tests were conducted to examine for 
differences in CAM-users and non-users on the total score and 
subscales of the IBS-QOL and scale scores on the Brief-COPE.    
 
To meet the third objective, Pearson’s correlations were used to assess 
relationships between scales of the IPQ-R, BMQ and CAMBI for CAM-
users and non-users.  Parametric testing was favoured and Pearson’s 
correlation is also regarded to be robust against any violation of non-
normality with sample sizes greater than 40 (e.g. Field, 2009) and has 
typically been regarded as robust against violations of normality (Nefzger 
& Drasgow, 1957).  
 
5.2.5.3.1 Process to determine mediation  
Baron and Kenny (1986) specified a number of causal steps to determine 
‘simple’ mediation, where a mediator variable explains the relationship 
between a predictor and outcome.  Statistically, this may be illustrated by 
the mediator variable reducing the effect of a predictor variable on 
outcome to non-significance, or to reduced significance (referred to as 
‘partial’ mediation, see section 3.6.3).  Chapter three (section 3.6.3) 
outlined that the Baron and Kenny (1986) approach to mediation testing 
was judged to ‘fit’ well with the aims of the study and the proposed 
relationships between the CSM components and have a theoretical 
basis.  To statistically determine if coping acted as a mediating variable 
(objective four, section 5.1), data were firstly split into two separate files 
representing CAM-users and non-users.  This enabled testing of the 
relationships between components of the CSM according to the 
pathways identified by Baron and Kenny (1986) in each group.  These 
pathways are assessed by firstly establishing a statistically significant 
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relationship between predictor and outcome.  Second, a significant 
relationship between predictor and potential mediator was assessed.  
Finally, a significant relationship between mediator and outcome whilst 
controlling for the predictor was examined.  As is consistent with previous 
research using the CSM, the process of establishing simple mediation 
(Baron and Kenny, 1986) was conducted by examination of a single 
predictor, a single mediator and an outcome.  As chapters two and three 
have outlined, IPQ-R, BMQ and CAMBI scores were considered 
predictor variables.  Scores from the various scales of the Brief-COPE 
were considered as possible mediating variables and the total score of 
the IBS-QOL was considered as the outcome with the only exception 
being use of the dysphoria subscale of the IBS-QOL as a measure of 
emotional outcome. 
 
Within CAM-users and non-users, Pearson’s correlations were firstly 
conducted to assess relationships between illness perceptions, treatment 
beliefs and IBS-QOL scores (tables 5.5 & 5.6) which constituted step one 
of Baron and Kenny’s criteria.  Secondly, using significant relationships 
identified from tables 5.5 and 5.6, Pearson’s correlations were computed 
between illness perceptions, treatment beliefs and the Brief-COPE 
scales (effectively step two of the Baron and Kenny criteria, where the 
predictor must predict/correlate with the mediator tables 5.7 & 5.8).  The 
findings from significant correlations then denoted which pathways were 
tested for mediation using multiple regression analyses.  This was 
conducted in a consistent way.  For example, within CAM-users, illness 
identity (predictor) was related to IBS-QOL (outcome).  Significant 
relationships were then identified between illness identity (predictor) and 
scales of the Brief-COPE (potential mediators).  Non-significant 
relationships between predictor and potential mediator variables were 
therefore discarded at this stage as further testing for mediation would 
not satisfy the requirements of the Baron and Kenny (1986) criteria 
(section 3.6.3).   
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Significant relationships from the preceding two steps were then tested 
via a number of multiple regression equations to test for ‘simple 
mediation’ in both CAM-users and non-users.  Firstly, each predictor 
variable was regressed on outcome.  Single mediator variables were 
then entered in block two of each regression model to observe the effect 
of the mediator on outcome whilst controlling for the effect of the 
predictor (effectively step three of Baron and Kenny’s criteria).  
Furthermore, the presented outcome of the total regression model in 
each case illustrates where the mediator predicted outcome and the 
effect of the predictor coefficient was reduced from that observed in the 
first regression block.  It may be observed that the inclusion of certain 
predictor variables in multiple places (in both groups) is purely to 
examine the intervening effect of Brief-COPE scales when added to each 
model.  
 
Previous studies utilising the CSM which have tested for mediation have 
often omitted a formal test of significance in relation to mediation.  To 
avoid possible effects of partial mediation being overlooked a test of the 
significance of any potential mediation effect was included (Sobel, 1982).  
Partial mediation may be overlooked where the effect of the predictor 
variable is reduced in the third regression equation but the amount of 
reduction in coefficient value of the predictor may be small in size (the 
difference between pathway c and c’ should be significantly different from 
zero, see figure 3.2).  The Sobel test considers the non-standardised 
regression coefficients (these values are in the original units of 
measurement) alongside their standard errors to estimate the size of the 
mediation effect in the form of a z score.  The Sobel test however, 
assumes that the difference in pathway c and c’ is normally distributed 
(figure 3.2) which may distort the significance of any mediation effect.  To 
rectify this, Preacher and Hayes (2004) provide an SPSS macro (i.e. 
SPSS syntax commands) to estimate the statistical significance of 
mediation by using a procedure known as ‘bootstrapping’.   
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Bootstrapping is a statistical procedure that produces a theoretical 
population distribution, by re-sampling the original data from this 
‘population’ through simulation.  In testing for significance of the 
mediation effect, the difference in pathways c and c’ is tested in a 
number of distributions derived from the original sample and values 
stored.  This process is conducted at least 1000 times (Hayes, 2009) and 
the final estimate of the size of the mediation effect is the mean of all the 
estimates.  The Preacher and Hayes (2004) SPSS macro provides both 
95% and 99% confidence intervals whereby the pathway values are 
sorted into order according to size and a significant mediation effect can 
be interpreted from confidence intervals that do not cross zero and are 
reported here as a z score (Preacher & Hayes, 2004).  The z score may 
be interpreted in the normal way (e.g. ± 1.96 for 95% significance), but 
the probable non-normality of the difference between c and c’ 
occasionally resulted in values less than 1.96 being statistically 
significant.  To illustrate this, Sobel mean estimates are also presented in 
mediation analyses along with 95% or 99% confidence intervals to 
illustrate statistical significance of the mediation effect (tables 5.9 – 5.18). 
 
Fairchild et al. (2009) also introduced SPSS procedures to determine the 
proportion of variance in the outcome explained by the mediation effect.  
This refers to the unique R² attributable to the difference between 
pathway c and c’ (which conversely should equal the product of 
pathways ab, figure 3.2), and the effect of this on outcome (effectively an 
estimate of effect size).  This may be expressed as a percentage of the 
total variance explained in each equation (Fairchild et al.,2009).  The 
Preacher and Hayes (2004) SPSS macro now incorporates this measure 
of R² and is presented alongside the mediation analyses here5.   
 
5.3 Results 
There were four main objectives addressed by this study.  Firstly, 
differences between CAM-users and non-users on the subscales of the 
                                               
5 This SPSS macro is available from Andrew Hayes’ webpage at: http://www.comm.ohio-
state.edu/ahayes/  
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IBS-QOL were considered (5.1.1).  Secondly, differences between CAM-
users and non-users were observed on scale scores of the Brief-COPE 
(5.1.2).  Thirdly, for CAM-users and non-users relationships were 
explored between illness perceptions and treatment beliefs (5.1.3).  
Fourthly, the coping style in each group was assessed for mediation 
between illness perceptions, treatment beliefs and reported quality of life 
(5.1.4).   
 
5.3.1 Differences between CAM-users and non-users: IBS-QOL 
scores   
Firstly, independent t-tests were conducted to examine for differences 
between the CAM-users and non-users on scales of the Brief-COPE and 
IBS-QOL scale and subscales (tables 5.1 and 5.2, and figures 5.1 to 
5.4).  
 
As table 5.1 illustrates, there were significant differences between the 
CAM-users and non-users on all the IBS-QOL subscales.  CAM-users 
with IBS reported significantly lower total IBS-QOL scores (M=43.33, 
SD=20.71) than the non-users group (M=49.17, SD=22.05), t(643)= 3.44, 
p<.01.  CAM-users also rated their emotional quality of life (Dysphoria) 
as inferior (M=39.43, SD=27.21) than non-users (M=44.70, SD=29.20), 
t(643)= 2.36, p<.05.  The CAM-users also reported significantly more 
interference with activity (M=41.20, SD=24.85) than non-users (M=45.92, 
SD=26.08), t(643)= 2.34, p<.05.  CAM-users also reported a poorer body 
image (M=41.20, SD=24.85) than non-users (M=45.92, SD=26.08), 
t(643)= 3.44, p<.01.  More health worries were reported by CAM-users 
(M=51.66, SD=23.55) than non-users (M=55.55, SD=23.66), t(643)= 
2.07, p<.05.  CAM-users also reported greater food avoidance (M=27.47, 
SD=25.31) than non-users (M=35.03, SD=29.12), t(541.36)= 3.45, p<.01 
although the variances in each group were not equal according to 
Levene’s test (F=10.69, p<.01), therefore the SPSS correction was 
reported.   
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CAM-users also had stronger perceptions regarding the reactions of 
others to their IBS on the ‘social reaction’ subscale (M=43.09, SD=26.05) 
than non-users (M=49.46, SD=27.76), t(643) = 2.99, p<.01.  Sexual 
issues were also rated as poorer in those that used CAM (M=56.96, 
SD=33.93) than non-users (M=66.59, SD=33.01), t(643)= 3.61, p<.001.  
Similarly CAM-users also gave stronger ratings for the relationships 
scale (M=56.17, SD=27.71) than non-users (M=62.52, SD=27.34), 
t(643)= 2.89, p<.01. 
 
The general trend in the group differences is clear and is observable in 
figures 5.1 and 5.2.  Those with IBS who use or have used CAM rate 
their quality of life as poorer compared to those that do not use CAM to 
relieve their IBS.  The effect sizes offer an indication of the magnitude of 
difference between the group means with most of the effect sizes being 
small (see section 4.3.5 and table 4.4). 
 
5.3.2 Differences between CAM-users and non-users: Brief-COPE 
scores 
Table 5.2 illustrates that there were only two scales where CAM-users 
and non-users did not differ significantly.  There were no differences 
between CAM-users (M=2.48, SD=.84) and non-users (M=2.42, SD=.79) 
on the substance use scale t(602.268)= -.847, p>.05 (equal variances 
not assumed, F=3.97, p<.05).  There were also no differences between 
CAM-users (M=3.57, SD=1.67) and non-users (M=3.35, SD=1.52) on the 
behavioural disengagement scale t(639)= -1.732, p>.05.  
 
Generally, CAM-users seemed to be more likely to adopt the remaining 
coping strategies than non-users even in the case of potentially 
maladaptive coping strategies.  CAM-users (M=4.66, SD=1.65) used 
self-distraction more often than non-users (M=4.11, SD=1.67), t(639)= -
4.116, p<.001.  Similarly, CAM-users used ‘denial’ (M=2.87, SD=.78) 
more than non-users (M=2.50, SD=1.31), t(639)= -4.45, p<.001.  CAM-
users (M=4.06, SD=1.96) were also more likely to ‘self blame’ 
themselves for having IBS than non-users (M=3.68, SD=1.87), t(639)= -
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2.50, p<.01.  CAM-users also indicated a greater degree of self-
distraction (M=4.66, SD=1.65) than non-users (M=4.11, SD=1.67), 
t(639)= -4.12, p<.001.  In terms of venting emotions, there were also 
significant differences with CAM-users expressing greater levels 
(M=4.10, SD=1.56) than non-users (M=3.64, SD=1.54), t(639)= -3.69, 
p<.001. 
 
 
Table 5.1 Descriptive statistics illustrating differences between 
CAM-users and non-users on IBS-QOL scale and subscales  
 
IBS-QOL 
dimension 
CAM use for IBS 
(y/n)  
Cronbach’s 
alpha 
Mean SD t-value 
(effect size ’r’) 
 
No (n=275) .95 49.17 22.05 Total Score 
Yes (n=370) .95 43.33 20.71 
3.44**  (r =.14) 
No .93 44.70 29.20 Dysphoria 
Yes .93 39.43 27.21 
2.36*   (r =.09) 
No .86 45.92 26.08 Interference with 
activity Yes .84 41.20 24.85 
2.34*   (r =.09) 
No .68 50.71 24.15 Body Image 
Yes .66 44.04 24.50 
3.44**  (r =.13) 
No .49 55.55 23.66 Health worry 
Yes .47 51.66 23.55 
2.07*   (r =.08) 
No .80 35.03 29.12 Food avoidance 
Yes .77 27.47 25.31 
3.45**  (r =.14) 
No .75 49.46 27.76 Social reaction 
Yes .76 43.09 26.05 
2.99**  (r =.12) 
No .84 66.59 33.01 Sexual score 
Yes .82 56.96 33.93 
3.61*** (r =.14) 
No .68 62.52 27.34 Relationships 
score 
 Yes .65 56.17 27.71 
2.89**  (r =.11) 
* p<.05   **p<.01   *** p<.001 
IBS-QOL scores have been transformed to a score out of 100.  Lower scores are 
interpreted to mean poorer reported quality of life 
 
 
CAM-users however seemed to be more adoptive of active coping 
(M=6.01, SD=1.62) than non-users (M=5.24, SD=1.73), t(639)= -5.74, 
p<.001.  Emotional support as a means of coping was also rated higher 
by CAM-users (M=4.78, SD=1.80) than non-users (M=4.26, SD=1.82), 
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t(639)= -3.57, p<.001.  Instrumental support was more readily adopted by 
CAM-users (M=5.40, SD=1.77) than non-users (M=4.90, SD=1.86), 
t(639)= -3.44, p<.01.  CAM-users also rated the use of humour to cope 
with their IBS more highly (M=4.02, SD=1.87) than non-users (M=3.72, 
SD=1.90), t(639)= -1.99, p<.05. 
 
The remaining adaptive coping scales all violated the assumption of 
equal variances between the two groups.  CAM-users were also more 
likely to positively reframe their situation (M=3.86, SD=1.73) than non-
users (M=3.40, SD=1.49), t(623.14)= -3.63, p<.001 where the 
assumption of equal variances was violated (F=5.14, p<.05).  The 
‘planning’ scale also violated the assumption of the equal variances 
between the two groups (F=5.37, p<.05) however CAM-users still rated 
planning more highly (M=5.93, SD=1.62) than non-users (M=5.28, 
SD=1.76), t(552.18)= -4.74, p<.001.  Equal variances were not assumed 
on the acceptance scale (F=4.78, p<.05) where CAM-users rated their 
acceptance of having IBS more highly (M=5.78, SD=1.52) than the non-
users (M=5.45, SD=1.67), t(548.66)= -2.59, p<.01.  The use of religion 
seemed to be more prominent in CAM-users (M=3.14, SD=1.67) than the 
non-users (M=2.44, SD=.78), t(554.61)= -7.06, p<.001, although the 
assumption of equal variances was again violated (F=131.60, p<.001), 
meaning the SPSS correction was reported.  These trends may be 
observed visually in figures 5.3 to 5.4.   
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Figure 5.1 Bar graphs illustrating significant differences between CAM-users and non-users on IBS-QOL subscales (total 
score, dysphoria, interference with activity, body image, health worry and food avoidance) 
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Figure 5.2 Bar graphs illustrating significant differences between CAM-users and non-users on IBS-QOL subscales 
(Social reaction, sexual and relationships subscales) 
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Figure 5.3 Bar graphs illustrating significant differences between CAM-users and non-users on Brief-COPE scales (self-
distraction, active coping, denial, emotional support, instrumental support and venting emotions)  
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Figure 5.4 Bar graphs illustrating significant differences between CAM-users and non-users on Brief-COPE scales 
(Positive reframing, planning, humour, acceptance, religion and self blame)  
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Table 5.2 Descriptive statistics and t-values for differences between 
CAM-users and non-users on Brief-COPE scales  
Brief-COPE scale CAM use for 
IBS (y/n)  
Cronbach’s 
alpha 
 
Mean SD t-value 
(effect size ‘r’) 
No   (n=271) .55 4.11 1.67 Self distraction 
Yes  (n=370) .51 4.66 1.65 
-4.12*** (r =.16) 
No .68 5.24 1.73 Active coping 
Yes .75 6.01 1.62 
-5.74*** (r =.22) 
No .54 2.50 .78 Denial 
Yes .64 2.87 1.31 
-4.45*** (r =.16) 
No .95 2.71 .79 Substance use 
Yes .93 2.78 .84 
-.60 
No .81 4.26 1.82 Emotional support  
Yes .81 4.78 1.80 
-3.57*** (r =.14) 
No .78 4.90 1.86 Instrumental 
support  Yes .78 5.40 1.77 
-3.44**  (r =.14) 
No .64 3.35 1.52 Behavioural 
disengagement Yes .67 3.57 1.67 
-1.73 
No .50 3.64 1.54 Venting emotions 
Yes .55 4.10 1.56 
-3.69*** (r =.14) 
No .70 3.40 1.49 Positive reframing 
Yes .72 3.86 1.73 
-3.63*** (r =.14) 
No .76 5.28 1.76 Planning 
Yes .74 5.93 1.62 
-4.74*** (r =.19) 
No .89 3.72 1.90 Humour 
Yes .86 4.02 1.87 
-1.99*   (r =.08) 
No .71 5.45 1.67 Acceptance 
Yes .56 5.78 1.52 
-2.59**  (r =.10) 
No .90 2.44 .78 Religion 
Yes .84 3.14 1.67 
-7.06*** (r =.25) 
No .76 3.68 1.87 Self blame 
Yes .79 4.06 1.96 
-2.50**  (r =.10) 
* p<.05   **p<.01   *** p<.001 
The range of possible scores was 2 – 8, with higher scores meaning greater adoption of that 
particular coping style. 
 
 
In sum, the observed trend in the differences between the two groups 
was that CAM-users seemed to score more highly on both adaptive and 
maladaptive coping strategies than non-users.  The effect sizes were 
however mostly small (see section 4.3.5 and table 4.4) with only the 
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religion and active coping scale differences approaching a moderate 
effect size.   
 
5.3.3 Relationships between illness perceptions and treatment 
beliefs 
As is common in CSM based research, to assess theoretical consistency 
(Moss-Morris et al.,2002; Rutter & Rutter, 2002) and to address the third 
objective in this study (section 5.1), relationships were explored between 
scales of the IPQ-R.  As this study considered an ‘extended’ CSM, the 
scales of the BMQ-General and CAMBI for CAM-users and non-users 
were also considered (tables 5.3 and 5.4).   
 
5.3.3.1 Non-users 
In non-users (table 5.3), stronger illness identity (reporting more 
symptoms) was positively associated with reporting more consequences 
of IBS (r=.19, p<.01) and having stronger emotional representations of 
illness (r=.14, p<.05).  Stronger illness identity was also related to 
stronger beliefs in natural treatments (r=.29, p<.001), beliefs about 
participation in treatment (r=.17, p<.01) and holistic health beliefs (r=.13, 
p<.05).  Stronger beliefs in a chronic timeline were associated with 
stronger consequences of IBS (r=.41, p<.001) and stronger emotional 
representations (r=.32, p<.01).  Greater beliefs in a chronic timeline of 
IBS were also associated with lesser beliefs about both treatment (r=-
.28, p<.001) and personal control (r=-.42, p<.001), weaker beliefs about 
risk factors as a cause of IBS (r=-.16, p<.01) and weaker beliefs in 
medication harm (r=-.16, p<.05) and overuse (r=-.17, p<.01).  Stronger 
beliefs in a cyclical timeline were associated with beliefs regarding an 
internal (r=.20, p<.01) and external (r=.16, p<.01) cause as well as being 
indicative of a lesser degree of coherence about IBS (r=-.15, p<.05).  
Reporting of stronger consequences was associated with less personal 
control (r=-.27, p<.001), less treatment control (r=-.28, p<.001), less 
understanding (coherence) of IBS (r=-.17, p<.01) and stronger emotional 
representations (r=.62, p<.001).  Stronger consequences also resulted in 
reporting of stronger beliefs in an external cause (r=.17, p<.01).  Having 
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greater personal control over IBS was strongly related to treatment 
control (r=.62, p<.001) as well as being related to greater coherence 
(r=.28, p<.001), beliefs in an internal cause (r=.21, p<.01), beliefs in risk 
factors as a cause (r=.25, p<.001), greater concern that medicines may 
cause harm (r=.21, p<.01), stronger beliefs in participation in treatment 
(r=.17, p<.01) and stronger beliefs in holistic health (r=.29, p<.001).  
Greater personal control also resulted in reporting of greater emotional 
representations (r=-.27, p<.001). 
 
Similarly, stronger beliefs in treatment control resulted in stronger 
emotional representations being reported (r=-.30, p<.001).  Treatment 
control was however associated with stronger beliefs in illness coherence 
(r=.23, p<.001), stronger beliefs in risk factors as a cause of IBS (r=.13, 
p<.05) and stronger beliefs in medication harm (r=.15, p<.05).  Greater 
treatment control also resulted in more positive beliefs about CAM on the 
natural treatments scale (r=.16, p<.05), the participation in treatment 
scale (r=.20, p<.01) and beliefs about holistic health (r=.24, p<.001).  
Stronger beliefs in illness coherence were negatively related to emotional 
representations (r=-.26, p<.001) and beliefs in an external cause (r=-.28, 
p<.001).  Stronger emotional representations resulted in stronger beliefs 
about both internal (r=.23, p<.001) and external causes (r=.17, p<.01) of 
IBS.   
 
The causal scales were all positively related.   A stronger perception of 
an internal cause was positively related to perceptions of an external 
cause (r=.28, p<.001) and more strongly to beliefs regarding risk factors 
(r=.44, p<.001).  External causal beliefs were also related to beliefs in 
risk factors causing IBS (r=.43, p<.001).  Stronger beliefs in an internal 
cause were also related to beliefs regarding the overuse of medication 
(r=.13, p<.05) and holistic health (r=.25, p<.001).  Similarly, external 
causal beliefs were also related to beliefs in overuse of conventional 
medication (r=.20, p<.01).  Stronger beliefs in risk factors causing IBS 
were related to both beliefs about harm (r=.16, p<.01) and more strongly 
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to overuse (r=.26, p<.001) of conventional medication as well as being 
more weakly related to beliefs in holistic health (r=.12, p<.05).  
   
As with the causal beliefs, beliefs about conventional treatment were also 
related.  Beliefs in harm were related to medication overuse (r=.65, 
p<.001) although this was to a greater degree than previous work (e.g. 
Horne et al.,1999).  Beliefs in harm were also related to the three 
dimensions of the CAMBI, beliefs in natural treatment (r=.34, p<.001), 
beliefs regarding participation in treatment (r=.13, p<.05) and beliefs in 
treating the whole body (holistic health) (r=.27, p<.001).  The BMQ 
overuse scale was related to natural treatment beliefs (r=.31, p<.001) 
and holistic health beliefs (r=.17, p<.01).  The CAMBI scales were also 
related showing consistency with Bishop et al. (2005).  Beliefs in natural 
treatments were related to participation in treatment beliefs (r=.28, 
p<.001) and more strongly to holistic health beliefs (r=.46, p<.001).  
Beliefs in treatment participation were also strongly related to holistic 
health beliefs (r=.51, p<.001). 
 
5.3.3.2 CAM-users  
In exploring the relationships between illness perceptions and treatment 
beliefs in CAM-users there were both similar patterns of relationships 
detected as well as different associations when compared with non-
users.  Table 5.4 illustrates that CAM-users’ ratings of illness identity 
were related to illness consequences (r=.29, p<.001) and emotional 
representations (r=17, p<.01) which were both stronger associations than 
observed in non-users.  CAM-users however showed relationships 
between illness identity and both the chronic (r=.16, p<.01) and cyclical 
(r=.11, p<.05) timeline scales and external causes (r=.21, p<.001).  
Greater illness identity was also associated with less personal (r=-.11, 
p<.05) and treatment (r=-.18, p<.01) control.  As with non-users, CAM-
user ratings of a chronic timeline were related to illness consequences 
(r=.31, p<.001), emotional representations (r=.19, p<.001) and negatively 
related to overuse of conventional medication (r=-.11, p<.05).  Higher 
ratings on the chronic timeline scale also indicated less personal (r=-.25, 
 204 
p<.001) and treatment (r=-.43, p<.001) control.  Treatment control beliefs 
aside the trend of these relationships was generally slightly weaker than 
in non-users.  Stronger beliefs in a chronic timeline also resulted in lower 
internal cause beliefs (r=-.15, p<.01) and higher beliefs in participation in 
treatment (r=.13, p<.05).  CAM-users also differed in their perceptions of 
a cyclical timeline which was solely related to stronger beliefs in personal 
control (r=.18, p<.01).  
 
CAM-users showed an almost identical pattern to non-users when 
comparing the IPQ-R consequences scale with other scales although in 
CAM-users generally stronger relationships were observed than in non-
users.  Stronger consequences were related to higher emotional 
representations (r=.60, p<.001) and beliefs in external causes of IBS 
(r=.27, p<.001).  Stronger consequences were also negatively related to 
both personal (r=-.34, p<.001) and treatment (r=-.36, p<.001) control as 
well as illness coherence (r=-.21, p<.001).  The relationships between 
personal control beliefs and other scales were similar to non-users and 
generally stronger relationships were observed.  As with non-users, 
stronger personal control beliefs were associated with greater treatment 
control (r=.67, p<.001), illness coherence (r=.30, p<.001), beliefs in 
internal causes (r=.32, p<.001), beliefs in risk factors as a cause of IBS 
(r=.18, p<.01) and beliefs in holistic health (r=.19, p<.001).  Stronger 
beliefs in personal control were associated with lesser emotional 
representations of IBS (r=-.27, p<.001) and to lesser beliefs about the 
overuse of medication (r=-.13, p<.05) the latter finding being unique to 
CAM-users. 
 
Treatment control ratings also showed similar relationships to non-users.  
Greater treatment control beliefs were related to greater illness 
coherence (r=.25, p<.001) and stronger holistic health beliefs (r=.15, 
p<.01) although this relationship was less strong than in the non-users.  
There was also a slightly stronger negative relationship found between 
treatment control and emotional representations (r=-.34, p<.001) than in 
non-users.  Unique to CAM-users, greater treatment control perceptions 
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were also found to relate to stronger beliefs in an internal cause (r=.25, 
p<.001) and risk factors (r=.15, p<.01) as causes of IBS. 
 
Stronger illness coherence showed a negative relationship with both 
emotional representations (r=-.37, p<.001) and beliefs in an external 
cause (r=-.20, p<.001) although these relationships were stronger and 
weaker respectively when compared to non-users.  In addition to the 
same pattern of relationships found in non-users, CAM-users were found 
to demonstrate lesser beliefs in medication overuse (r=-.13, p<.05) and 
natural treatment beliefs (r=-.13, p<.05) as illness coherence increased.  
Compared to non-users, there was a less strong relationship between 
emotional representations and external causal beliefs in CAM-users 
(r=.12, p<.05).   
 
Again, in a similar pattern to non-users, beliefs about internal causes 
were consistently related to beliefs in external causes (r=.25, p<.001), 
risk factors (r=.43, p<.001) and beliefs in holistic health in CAM-users 
(r=.27, p<.001).  These relationships all demonstrated a similar strength 
to those observed in non-users.  CAM-users also demonstrated a 
relationship between internal causal beliefs and natural treatment beliefs 
(r=.14, p<.01).  External causal beliefs were associated with risk factor 
beliefs (r=.36, p<.001) although to a slightly lesser extent than in non-
users. 
 
Beliefs about conventional treatment and CAM were related in similar 
ways to the non-users, although to a slightly lesser extent where there 
were similar patterns of relationship.  Beliefs about harm were related to 
the overuse scale (r=.60, p<.001).  Beliefs about harm were also related 
to natural treatment beliefs (r=.27, p<.001) and holistic health beliefs 
(r=.23, p<.001).  Beliefs in medication overuse were related to natural 
treatment beliefs (r=.17, p<.01) but to a lesser extent than non-users and 
negatively related to participation in treatment (r=-.23, p<.001).  The 
scales of the CAMBI were also related consistently, although less strong 
than in non-users.  Beliefs in natural treatments were related to both 
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participation in treatment (r=.26, p<.001) and holistic health beliefs 
(r=.37, p<.001).  Participation in treatment was also related to beliefs in 
natural treatments (r=.41, p<.001). 
 
5.3.4 Testing the theorised mediating role of coping 
As outlined previously (section 5.2.5.3) mediation was tested in three 
steps according to criteria set out by Baron and Kenny (1986).  Firstly, 
predictor variables were correlated on outcome.  Secondly, predictor 
variables were correlated with potential mediating variables.  Third, 
multiple regression analyses were used to determine if potential 
mediating variables predicted outcome whilst controlling for predictor 
variables.  Then the Preacher and Hayes (2004) bootstrapping 
procedure was utilised to determine statistical significance of identified 
mediation effects detected in the three steps outlined.   
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Table 5.3 Relationships between IPQ-R, BMQ and CAMBI scales (non-users): Pearson’s r (n=266) 
 2 
 
3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1. Identity 
 
.08 .11 .19**  .05 -.02 -.03  .14*  .18  .05  .06  .05  .03  .25***  .19**  .18** 
2. Timeline 
chronic 
 .07 .40*** -.28*** -.42***  .01  .32*** -.05 -.08 -.17** -.16* -.15* -.02  .01 -.10 
3. Timeline 
cyclical 
   .06  .08 -.01 -.17**  .12  .19**  .15*  .06 -.02  .09  .003  .02  .03 
4. Consequences 
 
   -.25*** -.26*** -.15*  .62***  .03  .18** -.03 -.07  .01  .05  .16**  .07 
5. Personal 
control 
    .61***  .25** -.26***  .22*** -.07  .26***  .17**  .09  .09  .08  .24*** 
6. Treatment 
control 
     .22*** -.30***  .10 -.09  .15*  .13*  .10  .14*  .09  .19** 
7. Illness 
coherence 
      -.25*** -.03 -.26*** -.11  .08 -.10 -.08 -.05  .02 
8. Emotional 
representations 
        .21***  .16*  .05  .01  .07  .11  .06  .09 
9. Internal cause 
 
         .29***  .46***  .10  .15*  .11 -.02  .23*** 
10. External 
cause 
          .43***  .02  .19**  .04 -.06  .02 
11. Risk factors 
 
           .17**  .28***  .05 -.01  .09 
12. BMQ Harm 
 
            .65***  .30***  .09  .24*** 
13. BMQ Overuse 
 
             .30*** -.02  .18** 
14. CAMBI 
Natural 
              .32***  .50*** 
15. CAMBI 
Participation 
               .52*** 
16. CAMBI 
Holistic                
* p<.05   **p<.01   *** p<.001 
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Table 5.4 Relationships between IPQ-R, BMQ and CAMBI scales (CAM-users): Pearson’s r (n=359) 
 2 
 
3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1. Identity 
 
 .16**  .11*  .29*** -.11* -.18** -.03  .18**  .03  .20***  .08  .07  .06  .10  .01 -.02 
2. Timeline 
chronic 
 -.02  .31*** -.26*** -.43***  .0  .19*** -.15** -.06 -.04 -.09 -.11*  .04  .13* -.02 
3. Timeline 
cyclical 
  -.06  .18**  .05 -.06  .06  .05 -.10  .01  .09 -.01  .06  .01 -.01 
4. Consequences 
 
   -.34*** -.36*** -.21***  .60*** -.03  .28***  .02  .02  .10  .10 -.04  .02 
5. Personal 
control 
     .67***  .30*** -.28***  .32*** -.05  .19*** -.01 -.12*  .03  .09  .19*** 
6. Treatment 
control 
      .25*** -.34***  .25***  .01  .15** -.01 -.10  .06  .07  .15** 
7. Illness 
coherence 
      -.37***  .05 -.20*** -.01 -.06 -.14** -.13*  .10 -.01 
8. Emotional 
representations 
        .05  .13*  .01  .07  .09  .01 -.003  .07 
 9. Internal cause 
 
         .26***  .44***  .01  .03  .10 -.003  .27*** 
10. External 
cause 
          .35***  .04  .10*  .05  .01  .08 
11. Risk factors 
 
          -.02  .09  .06 -.13*  .11* 
12. BMQ Harm 
 
            .60***  .36***  .07  .25*** 
13. BMQ Overuse 
 
             .27*** -.19*** -.01 
14. CAMBI 
Natural 
              .17**  .37*** 
15. CAMBI 
Participation 
               .39*** 
16. CAMBI 
Holistic 
               
* p<.05   **p<.01   *** p<.001 
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5.3.4.1 Step one: Predictor–outcome relationship  
Baron and Kenny (1986) suggest the first stage of testing for mediation is 
to determine a significant relationship between predictor and outcome.  
Relationships between illness representations and treatment beliefs and 
total scores from the IBS-QOL were examined for both CAM-users and 
non-users.  This process enabled non-significant relationships to be 
excluded from further testing of mediation as a non-significant correlation 
between predictor and outcome, would not yield a significant regression 
coefficient to be reduced (step three).   
 
Table 5.5 illustrates the relationships between predictors and outcome.  
The general trend that emerged was that ‘negative’ predictors (e.g. 
identity, consequences) resulted in lower reported quality of life scores, 
whereas greater control and understanding resulted in participants 
reporting increased quality of life.  Examination of table 5.5 showed that 
in both non-users and CAM-users illness identity was significantly 
negatively related to total IBS-QOL score (r=-.20, p<.01 and r=-.31, 
p<.001 respectively), suggesting that stronger illness identity is 
associated with impaired quality of life, something more evident in those 
that use CAM.  Both CAM-users (r=-.30, p<.001) and non-users (r=-.29, 
p<.001) showed beliefs in a chronic timeline to be related to lower 
reported quality of life scores.  Strong perceptions of illness 
consequences were strongly and negatively related to reported quality of 
life in both CAM-users (r=-.70, p<.001) and non-users (r=-.66, p<.001).  
Higher ratings of personal control resulted in higher reported quality of 
life in both CAM-users (r=.30, p<.001) and non-users (r=.25, p<.001).  
Similarly, greater control over treatment was positively related to reported 
quality of life in CAM-users (r=.35, p<.001) and non-users (r=.33, 
p<.001).  Greater illness coherence also resulted in higher quality of life 
being reported in CAM-users (r=.26, p<.001) and non-users (r=.19, 
p<.01).  
 
Stronger emotional representations resulted in lower reported quality of 
life in both CAM-users (r=-.65, p<.001) and non-users (r=-.70, p<.001).  
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However stronger beliefs in an internal cause were weakly negatively 
related to reported quality of life in non-users only (r=-.15, p<.05).  
Stronger beliefs in external causal factors were related to lower reported 
quality of life scores in both groups (non-users: r=-.17, p<.01; CAM-
users: r=-.20, p<.001).  Greater beliefs in harm caused by conventional 
medication were related to reduced reported quality of life in both groups, 
which yielded the same coefficient value (r=-.13, p<.05).  Finally, in CAM-
users only, more positive beliefs in natural treatments resulted in lower 
IBS-QOL scores (r=-.11, p<.05).   
 
Table 5.6 presents the relationships between emotional representations 
and emotional outcome (the IBS-QOL Dysphoria subscale).  In both 
groups the relationship between stronger emotional representations and 
poorer reported emotional quality of life was present in both groups 
(CAM-users: r=-.74, p<.001; non-users: r=-.78, p<.001). 
 
The illness perceptions and treatment beliefs that were significantly 
related to IBS-QOL scores (including emotional representations and 
emotional outcome) were then examined for relationships with scales on 
the Brief-COPE (step two of the Baron and Kenny criteria).  
 
5.3.4.2 Step two: predictor–mediator relationship  
Predictor variables that showed significant relationships with outcome 
(tables 5.5 and 5.6) were then examined for significant relationships with 
coping strategies (non-significant relationships were therefore discarded 
at this stage).  This was to establish the second step of the Baron and 
Kenny test for mediation in that each predictor should be significantly 
related to the potential mediator.  Significant relationships were then 
explored further with regression equations to test for step three of the 
mediation criteria (section 5.2.5.3). 
 
5.3.4.2.1 Non-users  
In non-users (table 5.7), stronger illness identity was related to greater 
self blame (r=.16, p<.01).  Those who had a stronger belief in a chronic 
timeline also had higher ratings of behavioural disengagement (r=.21, 
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p<.01).  Stronger perceptions of illness consequences were related to 
greater use of denial (r=.24, p<.001), substance use (r=.13, p<.05), 
behavioural disengagement (r=.25, p<.001), venting emotions (r=.17, 
p<.01) and self blame (r=.28, p<.001).  Greater personal control was 
related to more acceptance (r=.15, p<.05) and related to less use of 
denial (r=-.15, p<.05) and behavioural disengagement (r=-.25, p<.01).  
Higher ratings of treatment control were also related to less use of denial 
(r=-.15, p<.05), behavioural disengagement (r=-.38, p<.001) and self 
blame (r=-.14, p<.05).  More illness coherence was related to greater 
acceptance (r=.17, p<.01) but less use of self blame (r=-.13, p<.05), 
behavioural disengagement (r=-.18, p<.01) and denial (r=-.21, p<.01).  
Stronger emotional representations were positively associated with more 
use of denial (r=.31, p<.001), substance use (r=.14, p<.05), behavioural 
disengagement (r=.34, p<.001), venting emotions (r=.23, p<.001) and 
self blame (r=.40, p<.001). 
 
 
Table 5.5 Relationships between IPQ-R, BMQ, CAMBI scales, IBS-
QOL total score: Pearson’s r     
 
IPQ-R, BMQ & CAMBI scales 
Non-users:  
IBS-QOL (total) (n=266) 
CAM-users: 
IBS-QOL (total) (n=359) 
Identity -.20** -.31*** 
Timeline chronic -.30*** -.29*** 
Timeline cyclical -.07 -.01 
Consequences -.66*** -.70*** 
Personal control  .25***  .30*** 
Treatment control  .33***  .35*** 
Illness coherence  .19**  .26*** 
Emotional representations -.70*** -.65*** 
Internal cause -.15* -.07 
External cause -.17** -.20*** 
Risk factors -.07 -.05 
BMQ Harm -.07 -.07 
BMQ Overuse -.13* -.13* 
CAMBI Natural -.11 -.11* 
CAMBI Participation -.06  .04 
CAMBI Holistic -.06  .01 
   * p<.05   **p<.01   *** p<.001 
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In terms of causal factors, stronger beliefs in internal causes were related 
to more venting of emotions (r=.13, p<.05), greater self blame (r=.31, 
p<.001) but less acceptance of IBS (r=-.13, p<.05).  Greater belief in an 
external cause resulted in more use of denial (r=.19, p<.01) and more 
self blame (r=.14, p<.05).  Stronger participant beliefs in overuse of 
conventional medication resulted in greater substance use (r=.14, p<.05) 
less acceptance of having IBS (r=-.13, p<.05) and greater self blame for 
having IBS (r=.16, p<.05).    
 
 
 
Table 5.6 Relationships (Pearson’s r) between IPQ-R ‘emotional 
representations’ scale and IBS-QOL ‘dysphoria’ subscale 
(emotional outcome) 
 
 Non-users:  
Dysphoria subscale (n=266) 
CAM-users: 
Dysphoria subscale (n=359) 
 
Emotional Representations 
 
 
-.78*** 
 
-.74*** 
   *** p<.001 
 
 
5.3.4.2.2 CAM-users  
CAM-users (table 5.8) showed similarities with non-users in use of 
certain coping strategies.  Stronger illness identity was related to more 
denial (r=.19, p<.001), greater behavioural disengagement (r=.20, 
p<.001) and more self blame for having IBS (r=.18, p<.01).  Stronger 
perceptions of a chronic timeline were related to more behavioural 
disengagement (r=.14, p<.01) and greater acceptance (r=.11, p<.05).  
Stronger perceptions of consequences of IBS was related to more use of 
denial (r=.23, p<.001), more behavioural disengagement (r=.30, p<.001), 
greater venting of emotions (r=.11, p<.05), more self blame (r=.26, 
p<.001) but less acceptance (r=-.11, p<.05).   
 
Higher ratings of personal control resulted in less use of denial (r=-.16, 
p<.01), less behavioural disengagement (r=-.43, p<.001) but more use of 
instrumental support (r=.12, p<.05).  Similarly, stronger treatment control 
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resulted in less denial (r=-.12, p<.05), less behavioural disengagement 
(r=-.36, p<.001) but greater use of instrumental support (r=.12, p<.05) 
and religion (r=.12, p<.05).  More coherence regarding IBS indicated less 
use of denial (r=-.18, p<.01), behavioural disengagement (r=-.18, p<.01), 
less self blame (r=-.13, p<.05) but more acceptance of having IBS (r=.24, 
p<.01).  Stronger emotional representations resulted in more behavioural 
disengagement (r=.30, p<.001) and more self blame (r=.30, p<.001) but 
less use of humour (r=-.11, p<.05). 
 
Stronger participant beliefs in external causes resulted in more denial 
(r=.16, p<.01) and less acceptance of having IBS (r=-.11, p<.05).  
Stronger beliefs in natural treatments resulted in greater self distraction 
(r=.16, p<.01), more active coping (r=.17, p<.01), use of more emotional 
support (r=.19, p<.001), more instrumental support (r=.18, p<.01), more 
venting of emotions (r=.21, p<.001), more positive reframing (r=.11, 
p<.05) and planning (r=.22, p<.001), more acceptance (r=.11, p<.05) and 
greater use of religion (r=.20, p<.001).   
 
Significant relationships between illness perceptions, treatment beliefs 
and coping strategies identified from these correlation tests were used to 
guide which variables were entered into multiple regression analyses to 
test for step three of the mediation criteria.   
 
5.3.4.3 Step three: mediator–outcome relationship, controlling for 
predictor variable  
From testing of the first two steps of the Baron and Kenny criteria for 
simple mediation, significant relationships found between predictors and 
outcome (tables 5.5 and 5.6) guided exploration of relationships between 
predictor and potential mediating variables (tables 5.7 and 5.8).  The final 
stage of testing for mediation determined the scales of the Brief-COPE 
that predicted IBS-QOL scores whilst controlling for predictor variables.  
For a mediation effect to be present a reduction in the effect of the 
predictor variable on the outcome variable needed to be observed.  
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Pathways that satisfied the Baron and Kenny criteria for mediation are 
presented in tables 5.9 to 5.18 (non-significant findings for step three are 
therefore omitted).  These tables illustrate the reduction of the Beta 
coefficient between predictor and outcome and the significant pathway 
between mediator and outcome whilst controlling for each predictor.  This 
is illustrated by providing regression coefficients from pathways XY 
and MY(X) are presented for both CAM-users and non-users.  The 
significance of any mediation effects was tested using the Sobel test and 
bootstrapping estimates (based on a theoretical sample of 1000 
datasets) which are also presented in the following tables. z scores (and 
associated significance) are presented to indicate the statistical 
significance of the mediation effect along with the Sobel test estimate 
and associated confidence intervals from the bootstrapping procedure 
(Preacher & Hayes, 2004).  To illustrate the unique portion of variance in 
each regression model accounted for by the mediation effect, an 
estimate of R² mediation effect is presented (Fairchild et al.,2009). 
 
5.3.4.3.1 Step three of mediation testing: IPQ-R symptom based 
scales (identity, timeline chronic and consequences) and IBS-QOL 
scores 
Step three of establishing mediation was considered for IPQ-R symptom 
based scales that were shown to be significantly related to IBS-QOL 
scores (outcome) and scales of the Brief-COPE (potential mediators).  
Tables 5.9 and 5.10 illustrate regression coefficient values for the 
mediator–outcome pathway, whilst controlling for the predictor (equation 
2 in each table) for each group of participants.  Coefficient values are 
provided for each predictor variable showing coefficient values for the 
direct path to outcome and to illustrate any reduction in effect due to 
inclusion of the mediator in each regression model.   
 
Illness identity  
In non-users (table 5.9), self blame partially mediated (z=-2.48, p<.05) 
the pathway between illness identity (Beta= -.13, p<.05) and IBS-QOL.  
The mediation effect accounted for 2.30 (10.46%) of the total variance 
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explained by the model of 22%.  CAM-users (table 5.10), demonstrated a 
similar pattern although a stronger mediation effect where self blame 
partially mediated (z=-3.28, p<.01) the pathway between illness identity 
(Beta= -.24, p<.01) and IBS-QOL scores.  The variance explained by 
mediation was 4.10 (17.83%) of the total variance explained by the 
model of 23%.  The R² change for both groups showed that self blame 
was contributing over half of the variance explained. 
 
Between the illness identity and IBS-QOL pathway there were two 
additional partial mediators in CAM-users.  Denial partially mediated (z=-
2.40, p<.05) the pathway between illness identity (Beta= -.28, p<.001) 
and IBS-QOL scores adding a small but significant 3% of variance to the 
regression model.  The variance explained by mediation was 4 (19.17%) 
of the total variance explained by the model of 13%.  Behavioural 
disengagement also partially mediated (z=-3.39, p<.01) the pathway 
between illness identity (Beta= -.25, p<.001) and IBS-QOL scores adding 
approximately half (10%) of the variance explained.  The mediation effect 
accounted for 3.98 (21.61%), of the total variance explained of 20%. 
 
Chronic timeline  
In both groups, the coping style behavioural disengagement partially 
mediated the pathway between the IPQ-R chronic timeline scale and 
IBS-QOL scores.  In CAM-users, behavioural disengagement (R² change 
= .10) demonstrated a significant mediation effect (z=-2.53, p<.05) 
reducing the effect of timeline beliefs (Beta= -.23, p<.001) of which the 
mediation effect accounted for 2.47 (13.0%) of the total variance 
explained of 19%.  A stronger partial mediation effect of behavioural 
disengagement (R² change = .11) was detected in non-users (z=-3.12, 
p<.01) with the effect of timeline beliefs reduced (Beta= -.21, p<.001).  
The mediation effect accounted for 3.89 (21.61%) of the total explained 
variance of 18%. 
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Table 5.7  Relationships between IPQ-R, BMQ and CAMBI scales and Coping strategies (non-users): Pearson’s r 
(n=266) 
 
* p<.05   **p<.01   *** p<.001 
 Identity Timeline  
chronic 
Consequences Personal 
control 
Treatment 
control 
Illness 
coherence 
Emotional 
representations 
Internal 
cause 
External 
cause 
Medication 
overuse 
Self distraction 
 
 .12 -.05  .14* -.02 -.03 -.07  .08  .04 -.02 -.02 
Active Coping 
 
 .05 -.01  .17**  .15*  .10  .06  .01 -.13* -.08 -.13* 
Denial 
 
 .12 -.01  .24*** -.15* -.15* -.21**  .31***  .08  .19**  .13* 
Substance use 
 
 .03  .01  .13* -.05 -.03 -.10  .10  .11  .11  .14* 
Emotional 
support 
 .03 -.03  .10  .21**  .18**  .06  .04  .01 -.09 -.19** 
Instrumental 
support 
 .02 -.04  .10  .12*  .16** -.01 -.01 -.04  .02 -.08 
Behavioural 
disengagement 
 .05  .21**  .25*** -.25** -.38*** -.18**  .34***  .14*  .13*  .09 
Venting 
emotions 
 .10  .01  .17**  .06 -.04 -.04  .23***  .13* -.01 -.01 
Positive 
reframing 
-.02 -.10 -.01  .18**  .17**  .12 -.15*  .03 -.01  .11 
Planning 
 
-.02 -.01  .12*  .10  .14* -.01  .05 -.13* -.02 -.13* 
Humour 
 
 .01  .04  .01  .03 -.04  .00  .01  .01  .11 -.11 
Acceptance 
 
 .03  .08 -.07  .15*  .10  .17** -.23*** -.13* -.09 -.13* 
Religion 
 
 .05 -.10  .03  .13*  .13*  .08 -.05  .02  .03 -.02 
Self blame 
 
 .16**  .08  .28***  .05 -.14* -.13*  .40***  .31***  .14*  .16* 
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Table 5.8  Relationships between IPQ-R, BMQ and CAMBI scales and Coping strategies (CAM-users): Pearson’s r 
(n=359) 
 
* p<.05   **p<.01   *** p<.001 
 
 Identity Timeline  
chronic 
Consequences Personal 
control 
Treatment 
control 
Illness 
coherence 
Emotional 
representations 
External 
cause 
Medication 
overuse 
Natural 
treatments 
Self distraction 
 
 .08 -.03  .12*  .05  .07 -.01  .04  .08 -.03  .16** 
Active Coping 
 
-.01 -.06  .10  .20***  .22***  .11* -.08  .03 -.01  .17** 
Denial 
 
 .19*** -.03  .23*** -.16** -.12* -.18**  .09  .16**  .12*  .05 
Substance use 
 
 .07  .02  .10 -.04 -.03 -.04  .10  .04  .01 -.10 
Emotional 
support 
 .06  .04  .03  .15**  .16**  .06 -.004 -.08 -.01  .19*** 
Instrumental 
support 
 .01  .06  .09  .12*  .12* -.03  .05  .01 -.02  .18** 
Behavioural 
disengagement 
 .20***  .14**  .30*** -.43*** -.36*** -.18**  .30***  .08  .10  .02 
Venting 
emotions 
 .09  .03  .11* .003  .05  .03  .16** -.02  .06  .21*** 
Positive 
reframing 
-.003 -.11*  .003  .17**  .22***  .05 -.05  .08  .08  .11* 
Planning 
 
-.06 -.08  .06  .13*  .22***  .03 -.03  .03  .03  .22*** 
Humour 
 
 .12*  .03  .02  .08  .13*  .12* -.11*  .06 -.05  .09 
Acceptance 
 
-.02  .11* -.11*  .07  .08  .24** -.18** -.18** -.11*  .11* 
Religion 
 
 .08 -.02  .21***  .05  .12* -.06  .16**  .03  .08  .20*** 
Self blame 
 
 .18**  .03  .26*** -.06 -.08 -.13*  .30***  .07  .10  .04 
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Illness consequences   
There were a number of coping strategies that partially mediated the 
pathway between the IPQ-R illness consequences scale and IBS-QOL 
scores in both CAM-users and non-users.  In non-users, denial (R² 
change = .04) partially mediated the pathway between illness 
consequences and IBS-QOL scores (z=-3.09, p<.01) reducing the effect 
of illness consequences (Beta= -.62, p<.001).  The mediation effect 
accounted for 9.2 (19.17%) of the overall variance of 48% in IBS-QOL 
scores.  A smaller mediation effect of denial (R² change = .01) was 
detected in CAM-users which partially mediated (z=-1.91, p<.05) 
reducing the effect of illness consequences (Beta= -.68, p<.001) and 
accounting for 4.91 (10.02%) of the overall variance of 49%. 
 
Behavioural disengagement (R² change = .03) partially mediated the 
illness consequences–IBS-QOL pathway in CAM-users (z=-3.78, p<.01) 
reducing the effect of illness consequences (Beta= -.64, p<.001) and 
accounting for 11.24 (21.62%) of the overall variance predicted of 52%.  
A similar mediation effect of behavioural disengagement (R² change = 
.05) was detected in non-users (z=-3.33, p<.01) which explained 10.04 
(20.08%) of the 50% variance predicted and reducing the effect of illness 
consequences (Beta= -.61, p<.001).  Similar mediation effects were 
detected when the role of self blame was assessed.  In CAM-users, self 
blame (R² change = .06) partially mediated the illness consequences–
IBS-QOL pathway (z=-4.20, p<.01) which explained 11.85 (21.55%) of 
the 55% variance predicted and reducing the effect of illness 
consequences (Beta= -.63, p<.001).  The non-users also demonstrated a 
partial mediation effect of self blame (R² change = .08) between illness 
consequences and IBS-QOL scores (z=-3.90, p<.01) which accounted 
for 13.11 (25.21%) of the total variance in the model of 52% and a 
reduction in the effect of illness consequences (Beta= -.58, p<.001). 
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Table 5.9  Mediation tests for IPQ-R symptom based scales (identity, 
timeline chronic and consequences) for non-users (outcome 
variable = total IBS-QOL score) 
 
1)Predictor variable (IPQ-R) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z)  
 
(Sobel estimate and 
Confidence interval) 
R² % for 
mediation 
effect (% of 
total R²)  
1) Illness Identity 
2) Self blame   
F(2, 270)= 39.09*** 
 
 
.22 (.19) 
 
-.13*  (-.20**) 
-.44*** 
-2.48* 
 
(-.54, 95%CI= -.95, -.16) 
2.30 
 
(10.46) 
1) Timeline chronic 
2) Behavioural disengagement 
F(2,272)= 32.05*** 
 
 
.18 (.11) 
 
-.21***  (-.29***) 
-.34*** 
-3.12** 
 
(-.43, 99%CI= -.78, -.08) 
3.89 
 
(21.61) 
1) Illness consequences 
2) Denial  
F(2,271)= 126.32*** 
 
.48 (.04) 
 
-.62***  (-.67***) 
-.20*** 
-3.09** 
 
(-.25, 99%CI= -.49, -.09) 
9.20 
 
(19.17) 
1) Illness consequences 
2) Substance use   
F(2,271)= 118.22*** 
 
 
.46 (.02) 
 
-.64***  (-.66***) 
-.13** 
-1.79* 
 
(-.09, 95%CI= -.20, -.01) 
3.40 
 
(7.39) 
1) Illness consequences 
2) Behavioural disengagement  
F(2,271)= 135.23*** 
 
 
.50 (.05) 
 
-.61***  (-.67***) 
-.24*** 
-3.33** 
 
(-.29, 99%CI= -.58, -.09) 
10.04 
 
(20.08) 
1) Illness consequences 
2) Venting emotions   
F(2,269)= 132.03*** 
 
 
.49 (.05) 
 
-.62***  (-.67***) 
-.23*** 
-2.64** 
 
(-.20, 99%CI= -.44, -.04) 
6.86 
 
(14.0) 
1) Illness consequences 
2) Self blame 
F(2,269)= 132.03*** 
 
 
.52 (.08) 
 
-.58***  (-.67***) 
-.30*** 
-3.90** 
 
(-.39, 99%CI= -.68, -.16) 
13.11 
 
(25.21) 
* p<.05   **p<.01   *** p<.001 
 
 
Key for tables 5.9 to 5.18: 
 
Outcome variable = total IBS-QOL score. 
1) Predictor variable (IPQ-R scale). 
2) Mediator (Brief-COPE scale). 
  
R² change is the change in variance with the addition of the mediator in block two of the 
regression model. 
 
The z-scores represent the significance of the mediation effect and are supplemented 
by the Sobel mean estimate from bootstrapping and either a 95 or 99% confidence 
interval to illustrate how statistical significance of mediation was inferred. 
 
The R² for the mediation effect is illustrative of how much of the outcome variance is 
explained by the mediation effect.  This is also expressed as a percentage of the total 
variance explained by each regression model. 
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Table 5.10  Mediation tests for IPQ-R symptom based scales 
(identity, timeline chronic and consequences) for CAM-users 
(outcome variable = total IBS-QOL score) 
 
1)Predictor variable (IPQ-R) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z)  
 
(Sobel estimate and 
Confidence interval) 
R² % for 
mediation 
effect (% of 
total R²) 
1) Illness Identity 
2) Denial 
F(2,368)= 28.66***  
 
 
.13 (.03) 
 
-.28***  (-.31***) 
-.20*** 
-.2.40** 
 
(-.22, 99%CI = -.49, -.03) 
2.1 
 
(16.15) 
1) Illness Identity 
2) Behavioural disengagement 
F(2,368)= 46.84*** 
 
 
.20 (.10) 
 
-.25***  (-.31***) 
-.33*** 
-3.39** 
 
(-.49, 99%CI= -.94, -.17) 
3.98 
 
(19.90) 
1) Illness Identity 
2) Self Blame  
F(2, 367)= 57.27*** 
 
 
.23 (.13) 
 
-.24**  (-.31***) 
-.38*** 
-3.28** 
 
(-.51, 99%CI= -.99, -. 13) 
4.10 
 
(17.83) 
1) Timeline chronic 
2) Behavioural disengagement 
F(2,367)= 44.71*** 
 
 
.19 (.12) 
 
-.23***  (-.28***) 
-.35*** 
-2.53* 
 
(-.25, 95%CI= -.47, -.06) 
2.47 
 
(13.0) 
1) Illness consequences 
2) Denial 
F(2,368)= 179.72*** 
 
 
.49 (.01) 
 
-.68***  (-.70***) 
-.10* 
-1.91* 
 
(-.09, 95%CI= -.19, -.01) 
4.91 
 
(10.02) 
1) Illness consequences 
2) Behavioural disengagement 
F(2,367)= 197.88*** 
 
 
.52 (.03) 
 
-.64***  (-.70***) 
-.19*** 
-3.78** 
 
(-.27, 99%CI= -.47, -.09) 
11.24 
 
(21.62) 
1) Illness consequences 
2) Venting emotions 
F(2,366)= 178.53*** 
 
 
.49 (.01) 
 
-.68***  (-.70***) 
-.09* 
-1.59ns 
 
(-.05, 95%CI= -.13, .001) 
- 
 
- 
1) Illness consequences 
2) Acceptance 
F(2,366)= 179.57*** 
 
 
.49 (.01) 
 
-.69***  (-.70***) 
-.10* 
-1.60ns 
 
(-.05, 95%CI= -.13, .001) 
- 
 
- 
1) Illness consequences 
2) Self blame 
F(2,367)= 223.17*** 
 
 
.55 (.06) 
 
-.63***  (-.70***) 
-.26*** 
-4.20** 
 
(-.33, 99%CI= -.57, -.15) 
11.85 
 
(21.55) 
* p<.05   **p<.01   *** p<.001 
Outcome variable = total IBS-QOL score 
1) Predictor variable (IPQ-R scales) 
2) Mediator (Brief-COPE)  
 
 
 
A partial mediation effect distinct to non-users was through the coping 
style of substance use (z=-1.79, p<.05; R² change = .02) which explained 
3.4 (7.39%) of the total variance of 46% and reduced the effect of illness 
consequences (Beta= -.64, p<.001).  Similarly, the venting of emotions 
partially (R² change = .05) mediated the consequences–IBS-QOL 
pathway in non-users (z=-2.64, p<.01) which explained 6.86 (14.0%) of 
the total variance of 49% and reduced the effect of illness consequences 
(Beta= -.62, p<.001).  In CAM-users, the three Baron and Kenny 
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mediation criteria were established for venting emotions, however the 
Sobel test revealed no significant effect of mediation (z=-1.59, p>.05ns).  
One further coping strategy in CAM-users, acceptance, also satisfied the 
Baron and Kenny criteria but the effect failed to reach significance (z=-
1.60ns, p>.05ns). 
 
In sum, within the IPQ-R symptom scales, the pathways that 
demonstrated significant mediation effects may be interpreted as thus.  
Stronger symptom based scale scores were largely related to greater 
adoption of maladaptive coping strategies (e.g. self blame, denial).  The 
coping strategies were also related to lower reported quality of life 
scores.  These relationships partially explained the poorer reported 
quality of life in each model for both CAM-users and non-users.  The one 
exception was CAM-users, where stronger illness consequences were 
related to lesser acceptance, which was related to lower reported quality 
of life scores. 
 
5.3.4.3.2 Step three of mediation testing: for IPQ-R control and 
coherence based scales (personal control, treatment control and 
illness coherence) and IBS-QOL scores 
 
IPQ-R Personal control  
As with the symptom based IPQ-R scales, several coping strategies 
were shown to partially mediate the personal control–IBS-QOL pathway 
in both CAM-users and non-users.  Denial (R² change = .04) was found 
to partially mediate the pathway in CAM-users (table 5.12) (z=2.31, 
p<.01) reducing the effect of personal control (Beta= .28, p<.001) and 
accounting for 1.90 (14.62%) of the overall variance predicted of 13%.  A 
similar but slightly stronger partial mediation effect of denial (R² change = 
.11) was detected in non-users (table 5.11) (z=2.46, p<.01) which 
explained 2.70 (15.88%) of the 17% variance predicted and reduced the 
effect of personal control (Beta= .21, p<.001).   
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Behavioural disengagement was found to partially mediate the personal 
control–IBS-QOL pathway in both groups.  In CAM-users, a significant 
partial mediation effect of behavioural disengagement (R² change = .08) 
was detected (z=4.85, p<.01) which reduced the effect of personal 
control (Beta= .18, p<.01) which accounted for 6.84 (40.24%) of the 
overall variance of 17%.  In non-users, behavioural disengagement (R² 
change = .11) demonstrated a slightly less powerful partial mediation 
effect (z=3.56, p<.01) which reduced the effect of personal control (Beta= 
.18, p<.01) and accounted for 4.2 (24.71%) of the overall variance in the 
model of 17%.  Acceptance (R² change = .02) was also found to partially 
mediate the personal control–IBS-QOL pathway but this was distinct to 
non-users.  Acceptance showed a small but significant partial mediation 
effect (z=1.78, p<.05) which reduced the effect of personal 
consequences (Beta= .24, p<.001) and which accounted for 2.69 
(33.63%) of the overall small amount of variance predicted of 8%. 
 
IPQ-R Treatment control  
In both CAM-users and non-users, denial satisfied the Baron and Kenny 
criteria.  However, observation of the 95% confidence intervals (tables 
5.11 & 5.12) shows in both cases the confidence intervals cross zero.  
Therefore no significant effect of mediation for denial was detected in 
CAM-users (z=1.38, p>.05ns) and the non-users (z=1.76, p>.05ns).   
 
Behavioural disengagement however, was found to partially mediate the 
treatment control–IBS-QOL pathway in both groups.  In CAM-users, a 
significant partial mediation effect of behavioural disengagement (R² 
change = .08) was detected (z=4.56, p<.01) which reduced the effect of 
treatment control (Beta= .23, p<.001) which accounted for 6.50 (34.21%) 
of the overall variance of 19%.  In non-users, a significant but slightly 
less strong, partial mediation effect of behavioural disengagement (R² 
change = .08) was detected (z=3.71, p<.01) which reduced the effect of 
treatment control (Beta= .21, p<.001) which accounted for 5.20 (30.59%) 
of the overall variance of 17%.  Unique to non-users, self blame (R² 
change = .17) was shown to partially mediate the treatment control–IBS-
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QOL pathway (z=2.30, p<.05), which reduced the effect of treatment 
control (Beta= .26, p<.001) and accounted for 3.70 (13.70%) of the total 
variance of 27%. 
 
IPQ-R Illness coherence  
The illness coherence–IBS-QOL pathway was partially mediated by a 
number of coping strategies in both CAM-users and non-users.  In CAM-
users a significant partial mediation effect of behavioural disengagement 
(R² change = .08) was detected (z=2.64, p<.01) which reduced the effect 
of illness coherence (Beta= .23, p<.001) and which accounted for 1.99 
(18.09%) of the overall variance of 11%.  The effect was slightly stronger 
in CAM-users (z=3.03, p<.01), where denial (R² change = .10) reduced 
the effect of illness coherence (Beta= .14, p<.05) and accounted for 2.62 
(18.71%) of the total variance of 14%. 
 
Behavioural disengagement was found to partially mediate the illness 
coherence–IBS-QOL pathway in both groups.  In CAM-users, 
behavioural disengagement (R² change = .12) was found to be a partial 
mediator (z=3.16, p<.01) which reduced the effect of illness coherence 
(Beta= .20, p<.001) and accounted for 3.03 (16.83%) of the total 
variance in IBS-QOL scores of 18%.  A lesser partial mediation effect of 
behavioural disengagement (R² change = .13) was detected in non-users 
(z=2.72, p<.01) where the effect of illness coherence was reduced 
(Beta= .15, p<.01) and the mediation effect accounted for 2.46 (14.47%) 
of the total variance of 17%. 
 
Acceptance was also found to partially mediate the illness coherence–
IBS-QOL pathway in both groups.  In CAM-users, the effect of illness 
coherence was significantly reduced (Beta= .23, p<.001) on the addition 
of acceptance (R² change = .02) to the regression model (z=2.07, p<.05).  
The mediation effect accounted for 1.73 (21.63%) of the overall variance 
of 8%.  A similar trend was detected in the non-users where acceptance 
(R² change = .02) partially mediated (z=1.95, p<.05) the illness 
coherence–IBS-QOL pathway and reduced the effect of illness 
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coherence (Beta= .19, p<.01) accounting for 1.31 (21.83%) of the overall 
variance of 6%.   
 
Self blame also demonstrated a similar pattern across both groups.  In 
CAM-users, self blame (R² change = .15) partially mediated the illness 
coherence–IBS-QOL pathway (z=2.28, p<.05) reducing the effect of 
illness coherence (Beta= .21, p<.001) and accounting for 2.38 (10.82%) 
in the total variance in IBS-QOL scores of 22%.  In non-users, a 
significant partial mediation effect of self blame (R² change = .19) was 
also detected (z=2.14, p<.05) where the influence of illness coherence 
was reduced (Beta= .15, p<.01) and the mediation effect accounted for 
2.23 (9.70%) of the total variance predicted by the model of 23%. 
 
Observation of tables 5.11 and 5.12 shows that overall, variance 
predicted by each of the models was generally less than with regression 
models constructed from the symptom based scales (tables 5.9 & 5.10).  
These analyses show that greater treatment and personal control and 
better understanding of IBS (coherence) resulted in better quality of life 
ratings.  In both groups IPQ-R control and coherence scales were 
associated with lesser likelihood of adoption of maladaptive coping 
strategies.   Control and coherence scales led to greater acceptance of 
IBS which influenced stronger quality of life ratings.  The lower variance 
predicted by these regression models may suggest symptom based 
representations are more influential than control and coherence 
representations on reported quality of life.   
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Table 5.11  Mediation tests for IPQ-R control and coherence based 
scales (personal control, treatment control and illness coherence) 
for the non-users 
 
1)Predictor variable (IPQ-R) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z) 
 
(Sobel estimate and 
Confidence interval) 
R² % for 
mediation 
effect (% of 
total R²) 
1) Personal control 
2) Denial 
F(2,271) = 29.29*** 
 
 
.17 (.11) 
.21*** (.27***) 
-.33*** 
2.46** 
 
(.27, 99%CI= .01, .59) 
2.70 
 
(15.88) 
1) Personal control 
2) Behavioural disengagement 
F(2,271)= 29.75***  
 
 
.17 (.11) 
.18** (.27***) 
-.34*** 
3.56** 
 
(.44, 99%CI= .13, .85) 
4.20 
 
(24.71) 
1) Personal control 
2) Acceptance 
F(2,268)= 13.41*** 
 
 
.08 (.02) 
.24*** (.27***) 
.14*** 
1.78* 
 
(.12, 95%CI= .01, .29) 
2.69 
 
(33.63) 
1) Treatment control 
2) Denial 
F(2,275)= 33.40*** 
 
 
.19 (.10) 
.27***  (.30***) 
-.32*** 
1.76ns 
 
(.19, 95%CI= -.03, .43) 
- 
 
- 
1) Treatment control 
2) Behavioural disengagement 
F(2,275)= 28.47*** 
 
 
.17 (.08) 
.21*** (.30***) 
-.30*** 
 
3.71** 
 
(.50, 99%CI= .15, .96) 
5.20 
 
(30.59) 
1) Treatment control 
2) Self blame 
F(2,271)= 51.81*** 
 
 
.27 (.17) 
.26*** (.32***) 
-.42*** 
2.30* 
 
(.34, 95%CI= .02, .66) 
3.70 
 
(13.70) 
1) Illness coherence 
2) Denial 
F(2, 269)= 23.25*** 
 
 
.14 (.10) 
.14* (.21***)  
-.33 
3.03** 
 
(.33, 99%CI= .11, .65) 
2.62 
 
(18.71) 
1) Illness coherence 
2) Behavioural disengagement 
F(2,269)= 28.32*** 
 
 
.17 (.13) 
.15** (.21***) 
-.36*** 
2.72** 
 
(.30, 99%CI= .05 .66) 
2.46 
 
(14.47) 
1) Illness coherence 
2) Acceptance 
F(2,268)= 9.96*** 
 
 
.06 (.02) 
.19** (.22***) 
.16* 
1.95* 
 
(.14, 95%CI= .02, .31) 
1.31 
 
(21.83) 
1) Illness coherence 
2) Self blame 
F(2,269)= 41.31*** 
 
 
.23 (19) 
.15** (.21***) 
-.44*** 
2.14* 
 
(.28, 95%CI= .02, .56) 
2.23 
 
(9.70) 
* p<.05   **p<.01   *** p<.001 
 
 
 
5.3.4.3.3 Step three of mediation testing: for IPQ-R emotional 
representations and causal scales (and IBS-QOL scores) 
Differences between CAM-users and non-users were most noticeable 
when testing for mediation between emotional representations and 
causal scales of the IPQ-R and quality of life scores.  The non-users 
demonstrated a greater number of mediation effects.   
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Table 5.12  Mediation tests for IPQ-R control and coherence based 
scales (personal control, treatment control and illness coherence) 
for CAM-users 
 
1)Predictor variable (IPQ-R) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z) 
 
(Sobel estimate and 
Confidence interval) 
R² % for 
mediation 
effect (% of 
total R²) 
1) Personal control 
2) Denial 
F(2,368)= 27.76*** 
 
 
.13 (.04) 
.28***  (.31***) 
-.19*** 
2.31** 
 
(.14, 99%CI= .003, .32) 
1.90 
 
(14.62) 
1) Personal control 
2) Behavioural disengagement 
F(2,367)= 37.51*** 
 
 
.17 (.08) 
.18** (.31***) 
-.30*** 
4.85** 
 
(.58, 99%CI= .26, .92) 
6.84 
 
(40.24) 
1) Treatment control 
2) Denial 
F(2,369)= 35.05*** 
 
 
.16 (.05) 
.32*** (.34***) 
-.22*** 
1.38ns 
 
(.09, 95%CI= -.05, .24) 
- 
 
- 
1) Treatment control 
2) Behavioural disengagement 
F(2,368)= 44.47*** 
 
 
.19 (.08) 
.23*** (.34***) 
-.30*** 
4.56** 
 
(.54, 99%CI= .27, .92) 
6.50 
 
(34.21) 
1) Illness coherence 
2) Denial 
F(2,362)= 22.40*** 
 
 
.11 (.04) 
.22*** (.26***) 
-.21*** 
2.64** 
 
(.15, 99%CI= .02, .33) 
 
1.99 
 
(18.09) 
 
1) Illness coherence 
2) Behavioural disengagement 
F(2,362)= 41.11*** 
 
 
.18  (.12) 
.20*** (.26***) 
-.35*** 
3.16** 
 
(.25, 99%CI= .03, .49) 
3.03 
 
(16.83) 
1) Illness coherence 
2) Acceptance 
F(2,361)= 15.70*** 
 
 
.08  (.02) 
.23*** (.26***) 
.12* 
2.07* 
 
(.11, 95%CI= .01, .23) 
1.73 
 
(21.63) 
1) Illness coherence 
2) Self blame 
F(2,362)= 51.71*** 
 
 
.22 (.15) 
.21*** (.26***) 
-.40*** 
2.28* 
 
(.18, 95%CI= .02, .35) 
2.38 
 
(10.82) 
* p<.05   **p<.01   *** p<.001 
 
 
Emotional representations  
There were a number of partial mediation effects specific to non-users 
(table 5.13).  Denial (R² change = .02) partially mediated the emotional 
representations–IBS-QOL pathway (z=-2.98, p<.01) reducing the effect 
of emotional representations (Beta= -.66, p<.001) and accounting for 
11.20 (21.54%) of the total variance in IBS-QOL scores of 52%.  Venting 
emotions (R² change = .03) also acted as a partial mediator (z=-2.92, 
p<.01) which reduced the effect of emotional representations on IBS-
QOL scores (Beta= -.67, p<.001) and accounted for 8.65 (16.32%) of the 
total variance explained of 53%. 
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Both behavioural disengagement and self blame partially mediated the 
emotional representations–IBS-QOL pathway in both CAM-users and 
non-users.  In the CAM group behavioural disengagement (R² change = 
.04) acted as a significant partial mediator (z=-3.81, p<.01) which 
reduced the effect of emotional representations (Beta= -.59, p<.001) and 
accounted for 10.57 (22.98%) of the total variance in the model of 46%.  
In non-users, a similar effect was evident where behavioural 
disengagement (R² change = .02) acted as a partial mediator (z=-3.08, 
p<.01) which reduced the effect of emotional representations on IBS-
QOL scores (Beta= -.66, p<.001).  The mediation effect accounted for 
12.32 (23.69%) of the total variance in the model of 52%.  Similar size 
mediation effects were also detected when examining self blame as a 
mediating variable.  In CAM-users, self blame (R² change = .06) partially 
mediated the emotional representations–IBS-QOL pathway (z=-4.33, 
p<.01) reducing the effect of emotional representations (Beta= -.58, 
p<.001) and accounted for 12.16 (25.33%) of the total variance explained 
of 48%.  Similarly, in non-users, self blame (R² change = .04) acted as a 
partial mediator (z=-3.86, p<.01) and reduced the effect of emotional 
representations (Beta= -.63, p<.001).  The mediation effect accounted for 
17.67 (32.72%) of the total variance of 54%. 
 
IPQ-R causal scales  
At the third step of mediation testing, only the non-users demonstrated 
evidence of mediation in the IPQ-R internal causes–IBS-QOL pathway, 
although one of the Brief-COPE scales pathway was found to be not 
significant in terms of mediation.  Acceptance was found to reduce the 
effect of internal causes on IBS-QOL (Beta= -.14, p<.05) but this effect 
was found to be not significant (z=-1.65, p>.05ns).  Venting emotions (R² 
change = .10) however was found to mediate the internal causes–IBS-
QOL pathway (z=-2.08, p<.01) as the effect of internal causes was 
reduced to non-significance (Beta= -.11, p>.05ns).  The mediation effect 
accounted for 1.23 (10.25%) of the total variance of 12%.  Self blame (R² 
change = .19) also fully mediated the internal cause–IBS-QOL pathway 
(z=-4.54, p<.01) reducing the effect of internal cause to non-significance 
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(Beta= -.01, p>.05ns).  This mediation effect accounted for 2.44 (11.62%) 
of the total variance explained of 21%. 
 
In considering the external cause–IBS-QOL pathway, the third stage of 
mediation testing detected that denial was a significant mediator in both 
groups.  In CAM-users, denial (R² change = .04) partially mediated the 
external cause–IBS-QOL pathway (z=-2.72, p<.01) reducing the effect of 
external cause (Beta= -.16, p<.01) and accounted for 1.51 (18.88%) of 
the variance explained in the model of 8%.  In non-users, denial (R² 
change = .12) fully mediated the same pathway (z=-2.63, p<.01) 
reducing the effect of external cause to non-significance (Beta= -.09, 
p>.05ns) and accounting for 1.47 (10.50%) of the total variance of 14%.   
 
There were two remaining mediation effects detected that were specific 
to each group.  In CAM-users, acceptance (R² change = .02) was found 
to partially mediate the external cause–IBS-QOL pathway (z=-2.09, 
p<.01) reducing the effect of external cause (Beta= -.18, p<.01) and 
accounting for 1.06 (17.67%) of the variance explained in the model of 
6%.  In non-users, self blame (R² change = .20) was found to fully 
mediate the external cause–IBS-QOL pathway (z=-2.12, p<.05) reducing 
the effect of external cause to non-significance (Beta= -.10, p>.05ns) and 
accounting for 1.63 (7.41%) of the total variance of 22%.   
 
The mediation effects presented follow a similar pattern to the IPQ-R 
symptom based scales.  The majority of scales are negatively associated 
with maladaptive coping strategies, which themselves are related to 
poorer reported quality of life.  In CAM-users, acceptance was the one 
adaptive coping style that was negatively associated with external cause 
and positively associated with reported quality of life. 
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Table 5.13  Mediation tests for IPQ-R emotional representations and 
causal scales for non-users 
 
1)Predictor variable (IPQ-R) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z) 
 
(Sobel mean estimate 
and CI) 
R² % for 
mediation 
effect (% of 
total R²) 
1) Emotional representations 
2) Denial  
F(2,271)= 151.03*** 
 
 
.52 (.02) 
-.66*** (-.71***) 
-.16*** 
-2.98** 
 
(-.21, 99%CI= -.44, -.05) 
11.20 
 
(21.54) 
1) Emotional representations 
2) Behavioural disengagement 
F(2,271)= 151.32*** 
 
 
.52 (.02) 
-.66*** (-.71***) 
-.16*** 
-3.08** 
 
(-.23, 99%CI= -.46, -.05) 
12.32 
 
(23.69) 
1) Emotional representations 
2) Venting emotions 
F(2,269)= 155.63*** 
 
 
.53 (.03) 
-.67*** (-.71***) 
-.18*** 
-2.92** 
 
(-.18, 99%CI= -.36, -.05) 
8.65 
 
(16.32) 
1) Emotional representations 
2) Self blame 
F(2,270)= 159.57*** 
 
 
.54 (.04) 
-.63*** (-.71***) 
-.21*** 
-3.86** 
 
(-.34, 99%CI= -.64, -.15) 
17.67 
 
(32.72) 
1) Internal cause  
2) Venting emotions 
F(2,269)= 20.27*** 
  
 
.12 (.10) 
-.11ns (-.16*) 
-.33*** 
-2.08** 
 
(-.17, 99%CI= -.40, -.05) 
1.23 
 
(10.25) 
 
1) Internal cause  
2) Acceptance  
F(2,268)= 7.03** 
 
 
.04 (.02) 
-.14* (-.16*) 
.16** 
-1.65ns 
 
(-.08, 95%CI= -.19, .01) 
- 
 
- 
1) Internal cause 
2) Self blame  
F(2,269)= 37.13*** 
 
.21 (.19) 
-.01ns (-.16*) 
-.46*** 
-4.54** 
 
(-.55, 99%CI= -.87, -.30) 
 
2.44 
 
(11.62) 
1) External cause 
2) Denial 
Denial F(2,270)= 22.51*** 
 
 
.14 (.12) 
-.09ns (-.15*) 
-.35*** 
-2.63** 
 
(-.33, 99%CI= -.76, -.01) 
1.47 
 
(10.50) 
1) External cause 
2) Self blame 
F(2,269)= 39.48*** 
 
.22 (.20) 
-.10ns (-.16**) 
-.45*** 
-2.12* 
 
(-.33, 95%CI= -.66, -.02) 
 
1.63 
 
(7.41) 
* p<.05   **p<.01   *** p<.001 
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Table 5.14  Mediation tests for IPQ-R emotional representations and 
causal scales for CAM-users 
 
1)Predictor variable (IPQ-R) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z) 
 
(Sobel mean estimate 
and CI) 
R² % for 
mediation 
effect (% of 
total R²) 
1) Emotional representations 
2) Behavioural disengagement 
F(2,366)= 157.36*** 
 
 
.46 (.04) 
-.59*** (-.65***) 
-.20*** 
-3.81** 
 
(-.25, 99%CI= -.46, -.07)  
10.57 
 
(22.98) 
1) Emotional representations 
2) Self blame 
F(2,366)= 170.35*** 
 
.48 (.06) 
-.58*** (-.65***) 
-.25*** 
-4.33** 
 
(-.31, 99%CI= -.54, -.14) 
 
12.16 
 
(25.33) 
1) External cause 
2) Denial 
F(2,367)= 16.96*** 
 
 
.08 (.04) 
-.16** (-.20***) 
-.22*** 
-2.72** 
 
(-.22, 99%CI= -.44, -.05) 
1.51 
 
(18.88) 
1) External cause 
2) Acceptance 
F(2, 366)= 11.65*** 
 
 
.06 (.02) 
-.18** (-.20***) 
-.14** 
-2.09** 
 
(-.13, 99%CI= -.32, -.01) 
1.06 
 
(17.67) 
* p<.05   **p<.01   *** p<.001 
 
 
 
5.3.4.3.4 Step three of mediation testing: for BMQ and CAMBI scales 
(and IBS-QOL scores)  
Of all the scales of the BMQ and CAMBI, only the BMQ overuse and 
CAMBI natural treatment scales were implicated in being directly related 
to IBS-QOL scores (table 5.5).  Further testing for mediation revealed 
that in both groups, acceptance satisfied the Baron and Kenny 
requirements for mediation in the BMQ overuse–IBS-QOL pathway.  In 
CAM-users however (table 5.15), although the effect of BMQ overuse 
was reduced (Beta= -.12, p<.05) the mediation effect was not significant 
(z=-1.55, p>.05ns).  In non-users, there was evidence of full mediation 
effect of acceptance (R² change = .03; z=-1.78, p<.05) as the effect of 
BMQ overuse on IBS-QOL scores was reduced to non-significance 
(Beta= -.10, p>.05ns).  This mediation effect accounted for a small .05 
(14.75%) of the total variance of 4%.  In non-users, there was evidence 
of a full mediation effect of both self blame and substance use on the 
BMQ overuse–IBS-QOL pathway.  Self blame (R² change = .20) was 
found to demonstrate a significant mediation effect (z=-2.05, p<.05) and 
reduced the effect of BMQ overuse to non-significance (Beta= -.07, 
p>.05ns).  This mediation effect accounted for 1.1 (5.24%) of the total 
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variance of 21%.  Substance use (R² change = .04) demonstrated a full 
mediation effect (z=-1.81, p<.05) with a reduction in the effect of BMQ 
overuse on IBS-QOL scores (Beta=-.11, p>.05ns).  The mediation effect 
accounted for .07 (11.67%) of the total variance explained of 6%.  In the 
only other evidence of mediation in this pathway in CAM-users, there 
was a full mediation effect of denial on the BMQ overuse–IBS-QOL 
pathway.  The mediating effect of denial (R² change = .05) was 
significant (z=-2.33, p<.01) also reducing the effect of BMQ overuse to 
non-significance (Beta= -.10, p>.05ns).  The variance in outcome 
predicted by the model was a small 6% of which the mediation effect 
accounted for .06 (14.75%) of this effect.  
 
The only CAMBI scale implicated in mediation analyses was the CAMBI 
natural treatment scale in non-users.  Initial testing for predictor–outcome 
relationship (table 5.5) revealed no significant relationship between 
natural treatments and IBS-QOL score.  However, as the correlation 
coefficient value was identified as being the same value as the 
correlation coefficient for CAM-users but was not significant (the value 
was significant in CAM-users) the natural treatments scale was still 
considered in mediation analyses.  Self blame (R² change = .20) was 
found to fully mediate (z=-2.68, p<.05) the CAMBI natural treatment–IBS-
QOL pathway and reduced the effect of CAMBI natural treatment (Beta= 
-.05, p>.05ns).  The mediation effect accounted for 1.4 (6.67%) of the 
total variance of 21%.   
 
 
Table 5.15  Mediation tests for BMQ overuse scale for CAM-users 
 
1)Predictor variable (BMQ) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z) 
 
(Sobel mean estimate 
and CI) 
R² % for 
mediation 
effect (% of 
total R²) 
1) BMQ Overuse 
2) Denial 
F(2,369)= 13.19*** 
 
.06 (.05) -.09ns (-.13*) 
-.23*** 
-2.33** 
 
(-.23, 99%CI= -.51, -.05)  
.07 
 
(12.33) 
1) BMQ Overuse 
2) Acceptance 
F(2,367)= 8.31*** 
 
.04 (.03) -.12* (-.13*) 
.16** 
-1.55ns 
 
(-.11, 95%CI= -.28, .02) 
 
- 
 
- 
* p<.05   **p<.01   *** p<.001 
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Table 5.16  Mediation tests for BMQ overuse and CAMBI natural 
treatments scales for non-users 
 
1)Predictor variable (BMQ) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z) 
 
(Sobel mean estimate 
and CI) 
R² % for 
mediation 
effect (% of 
total R²) 
1) BMQ Overuse 
2) Acceptance 
F(2,270)= 6.58** 
 
.04 (.03) -.10ns (-.13*) 
.18** 
-1.78* 
 
(-.19, 95%CI= -.47, -.01) 
.06 
 
(14.75) 
1) BMQ Overuse 
2) Substance use 
F(2,267)= 8.83*** 
 
.06 (.04) 
 
 
-.11ns (-.14*) 
-.21*** 
-1.81* 
 
(-.21, 95%CI= -.48, -.01) 
.07 
 
(11.67) 
1) BMQ Overuse 
2) Self blame 
F(2,271)= 37.18*** 
 
.21 (.20) -.07ns (-.12*) 
-.45*** 
-2.05* 
 
(-.44, 95%CI= -.89, -.01) 
1.10 
 
(5.24) 
1) CAMBI Natural treatments 
2) Self blame 
F(2,271)= 36.85*** 
 
.21 (.20) -.05ns (-.13*) 
-.45*** 
-2.68* 
 
(-.49, 95%CI= -.88, -.14) 
1.40 
 
(6.67) 
* p<.05   **p<.01   *** p<.001 
 
 
The directions of relationships in testing for mediation were consistent 
with observations thus far.  Higher BMQ and CAMBI scores resulted in 
greater use of maladaptive coping strategies (namely denial, substance 
use and self blame) and lesser use of acceptance.  The inverse was true 
for each of the coping strategies’ relationship with reported quality of life.  
Adoption of maladaptive coping led to lower reported quality of life, whilst 
increased acceptance resulted in higher quality of life ratings.  The 
amount of variance predicted in quality of life scores in CAM-users was 
small with most being accounted for by the addition of each coping scale 
to the regression model.  In non-users, the predicted variance was 
noticeably larger in two of the models however this can be attributed to 
the greater effect of self blame on the BMQ overuse–IBS-QOL and 
CAMBI natural treatment–IBS-QOL pathways (table 5.16). 
 
5.3.4.3.5 Step three of mediation testing: for IPQ-R emotional 
representation scale and emotional outcome 
A lack of research exploring emotional representations in IBS led to a 
key objective of this study being to examine for evidence of mediation 
between emotional representations of IBS and reported emotional quality 
of life (represented by utilising the IBS-QOL Dysphoria subscale).  On 
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testing for mediation (step three of Baron and Kenny’s criteria) emotional 
representations were generally found to account for a large amount of 
variance in outcome and mediation effects detected were noticeably 
larger than the majority of effects associated between cognitive 
representations and quality of life.  This component of the research was 
also primarily exploratory to examine if emotional representations guide 
different coping strategies to cognitive representations. 
 
In CAM-users (table 5.17), behavioural disengagement (R² change = .05) 
was found to partially mediate the emotional representation–Dysphoria 
pathway (z=-4.51, p<.01) and reduced the effect of emotional 
representation (Beta= -.67, p<.001).  The mediation effect accounted for 
14.10 (23.50%) of the total variance explained of 60%.  A similar effect 
was found in non-users (table 5.18) where behavioural disengagement 
(R² change = .02) was found to partially mediate (z=-3.01, p<.01) the 
emotional representation–Dysphoria pathway, reducing the effect of 
emotional representation (Beta= -.74, p<.001) and this mediation effect 
accounted for 13.23 (21.0%) of the total variance in dysphoria of 63%.  A 
similar pattern was noted in both groups in the case of self blame.  In 
CAM-users, self blame (R² change = .05) was found to show a partial 
mediation effect (z=-4.49, p<.01) reducing the effect of emotional 
representation (Beta= -.67, p<.001) and accounting for 14 (23.33%) of 
the total variance in the model of 60%.  In non-users, self blame (R² 
change = .01) also demonstrated a partial mediating effect (z=-2.92, 
p<.01) and reduced the effect of emotional representation on Dysphoria 
scores (Beta= -.73, p<.001).  The mediation effect accounted for 16.80 
(26.67%) of the total variance of 63%. 
 
The remaining analyses revealed significant mediation effects that were 
isolated to non-users.  Denial (R² change = .01) was found to partially 
mediate the emotional representation–Dysphoria pathway (z=-2.42, 
p<.01) where the effect of emotional representation was reduced (Beta= 
-.75, p<.001) and the mediation effect accounted for 10.70 (17.26%) of 
the total variance of 62%.  Venting emotions (R² change = .02) was also 
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found to partially mediate the emotional representation–Dysphoria 
pathway in non-users (z=-2.75, p<.01) and reduced the effect of 
emotional representation (Beta= -.75, p<.001).  The mediation effect 
accounted for 8.60 (13.65%) of the total variance in dysphoria scores of 
63%. 
 
Table 5.17 Mediation tests for IPQ-R emotional representation scale 
and emotional outcome for CAM-users 
 
1)Predictor variable (BMQ) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z) 
 
(Sobel mean estimate 
and CI) 
R² % for 
mediation 
effect (% of 
total R²) 
1) Emotional representations 
2) Behavioural disengagement 
F(2,366)= 276.74*** 
 
.60 (.05) -.67*** (-.71***) 
-.24*** 
-4.51** 
 
(-.39, 99%CI= -.65, -.20) 
14.10 
 
(23.50) 
1) Emotional representations 
2) Self blame 
F(2,366)= 274.96*** 
 
.60 (.05) -.67*** (-.74***) 
-.24*** 
-4.49** 
 
(-.39, 99%CI= -.66, -.19) 
 
14.0 
 
(23.33) 
* p<.05   **p<.01   *** p<.001 
 
 
 
Table 5.18 Mediation tests for IPQ-R emotional representation scale 
and emotional outcome for the non-users 
 
1)Predictor variable (BMQ) 
2)Potential mediator (Brief-
COPE scale) 
Adjusted 
R² (R² 
change) 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z) 
 
(Sobel mean estimate 
and CI) 
R² % for 
mediation 
effect (% of 
total R²) 
1) Emotional representations 
2) Denial 
F(2,271)= 223.41*** 
 
.62 (.01) -.75*** (-.78***) 
-.11** 
-2.42** 
 
(-.19, 99%CI= -.43, -.03) 
10.70 
 
(17.26) 
1) Emotional representations 
2) Behavioural disengagement 
F(2,271)= 229.95*** 
 
.63 (.02) -.74*** (-.78***) 
-.14*** 
-3.01** 
 
(-.26, 99%CI= -52, -.06) 
13.23 
 
(21.0) 
1) Emotional representations 
2) Venting emotions  
F(2,269)= 231.33*** 
 
.63 (.02) -.75*** (-.78***) 
-.15*** 
-2.75** 
 
(-.19, 99%CI= -.42, -.05) 
8.60 
 
(13.65) 
1) Emotional representations 
2) Self blame 
F(2,270)= 227.50*** 
 
.63 (.01) -.73*** (-.78***) 
-.13** 
-2.92** 
 
(-.29, 99%CI= -.59, -.07) 
16.80 
 
(26.67) 
* p<.05   **p<.01   *** p<.001 
 
 
Between emotional representations and emotional outcome pathways, 
the variance explained by coping strategies was also minimal but 
statistically significant.  The variance in Dysphoria scores predicted by 
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emotional representations was large.  The subsequent pattern of 
relationships between the variables was also consistent with previous 
observations.  Stronger emotional representations were related to poorer 
emotional quality of life via greater adoption of maladaptive coping 
strategies which included denial and self blame. 
 
 
5.4 Discussion 
This study addressed four objectives.  First, differences were assessed 
between CAM-users and non-users on subscales of the IBS-QOL and 
the total IBS-QOL score.  Second, CAM-user and non-user differences 
were examined on scales of the Brief-COPE.  Third, associations were 
examined between scales of the IPQ-R, BMQ and CAMBI for each of the 
two groups.  Finally, tests of simple mediation were performed on scales 
of the IPQ-R, BMQ, CAMBI (predictor variables), Brief-COPE (potential 
mediator variables) and IBS-QOL scores (the outcome variable).  
Pathways were examined for similarities and differences between CAM-
users and non-users.  Additionally, this final objective also provisionally 
examined the role of emotional representations and emotional outcome 
as a separate (but parallel) branch of the CSM.   
 
5.4.1 CAM-user and non-user differences on IBS-QOL and Brief-
COPE scales 
There were observable differences between CAM-users and non-users 
on scales of the Brief-COPE and IBS-QOL.  Scores on the IBS-QOL 
were found to be lower than reported in previous studies (Bushnell et 
al.,2006; Drossman et al.,2000, van Tilburg et al.,2008) suggesting that 
those with IBS in this study reported lower quality of life scores.  It was 
also detected that CAM-users, as expected, reported lower quality of life 
on all domains of the IBS-QOL.  Similar to findings reported in chapter 
four, effect sizes based on mean differences on IPQ-R, BMQ and CAMBI 
scales were predominantly small.  The results are consistent with 
previous work and expectations in that both CAM-users and those with 
IBS report impaired quality of life as opposed to non-users (Amouretti et 
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al., 2006; Astin, 1998; van Tilburg et al., 2008) and those seeking care 
report a more severe illness experience (Koloski et al., 2001; van der 
Horst et al., 1997).  These findings are also consistent with differences 
between CAM-users and non-users on measures of illness perceptions 
and treatment beliefs detected in the previous chapter.  CAM-users were 
shown to report greater experience of symptoms and stronger emotional 
representations related to their IBS.   
 
Similarly, scores on the Brief-COPE were found to differ across the two 
groups on all but two of the scales (behavioural disengagement and 
substance use).  On scales where there were observed differences, it 
was observed that CAM-users reported higher scores.  The higher 
scores on the Brief-COPE suggest that CAM-users appear more readily 
willing to adopt certain coping procedures to deal with the symptoms of 
IBS, which may be due to these individuals perceiving a more intense 
symptom experience.  This may be viewed as a consistent finding to 
results presented in chapter four, where several illness and treatment 
perceptions predicted CAM use, a specific coping behaviour in the 
context of the CSM. 
 
5.4.2 Relationships between illness representations and treatment 
beliefs   
In both groups, reporting of greater illness consequences was related to 
stronger illness identity and more severe emotional representations.  
Greater illness consequences were also related to low reported personal 
and treatment control and less understanding (coherence) of their IBS.  
There were however, differences in the interrelations among illness and 
treatment representations between the two groups. 
 
In non-users, beliefs in a chronic timeline of IBS were related to reporting 
of greater consequences and stronger emotional representations, and 
beliefs about less personal control, less control over treatment and a 
lesser belief in causal risk factors.  These associations were similar in 
CAM-users although reporting of a chronic timeline was not related to 
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less illness coherence, but was related to a lesser belief in an internal 
cause.  This finding may suggest CAM-users who have had IBS for a 
number of years may be less inclined to believe their IBS is caused by 
psychological factors.  In both CAM-users and non-users, relationships 
between these IPQ-R dimensions demonstrated a degree of consistency 
with previous work with the IPQ-R (Hagger & Orbell, 2005; Moss-Morris 
et al., 2002) and the IPQ (Rutter & Rutter, 2002).   
 
In CAM-users, more reported symptoms (illness identity) were 
associated with stronger emotional representations, stronger timeline 
beliefs (cyclical and chronic), lower personal and treatment control and 
stronger beliefs in an external cause.  This was in contrast to non-users 
who only demonstrated a relationship between identity and emotional 
representations.  This seems to emphasise the link between experienced 
symptoms and emotional distress caused by IBS, with a greater number 
of significant relationships found between these IPQ-R dimensions in 
CAM-users.  Furthermore, within CAM-users, cyclical timeline 
perceptions were not related to any other scales.  In non-users, the 
cyclical timeline scale was related to both greater beliefs in both internal 
and external causal beliefs and lesser understanding of IBS.  In both 
groups, personal control, treatment control and illness coherence were 
all positively related; each of these scales was also associated with 
reporting of lower emotional representations which is consistent with 
previous studies in chronic illness groups (Hagger & Orbell, 2005; Moss-
Morris et al., 2002).  In both groups, higher personal control was 
associated with greater beliefs in both internal and risk factors as causes 
of IBS.  This trend was similar for reported treatment control, although in 
non-users there was no association between treatment control and belief 
in internal cause.  Both groups also reported greater understanding to be 
related to a lesser belief in an external cause.   
 
The comparison of causal factors is generally more difficult to compare 
across different studies as responses and subsequent principal 
component analysis (section 4.2.5.3) are based on individual, often 
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illness specific, samples (Hagger & Orbell, 2003).  Similar patterns were 
evident for both groups in terms of causal perceptions relating to IBS.  
Greater internal causal beliefs were related to stronger emotional 
representations, stronger beliefs in external causes and risk factors.  
Both groups also indicated associations between external causes and 
greater belief in risk factors as a cause of IBS.  As previously considered, 
these relationships are more difficult to compare across studies.  Only 
one study to date (Rutter & Rutter, 2002) has explored relationships 
between causal perceptions in IBS and found no correlation between 
causal dimensions in contrast to the findings in this study of a positive 
association between internal and external causes.  These relationships 
may be accounted for, in part, by the increase in causal items in the IPQ-
R (Moss-Morris et al., 2002) as opposed to the IPQ.     
 
In both groups, the BMQ scales (harm and overuse) were also positively 
associated with each other as demonstrated in previous work (Horne et 
al., 1999).  This trend was similar for the scales of the CAMBI which were 
all related thus demonstrating consistency with previous work (Bishop et 
al., 2005).  There were also several logical associations between the 
BMQ and CAMBI scales.  In both groups, greater beliefs in medication 
harm were associated with stronger beliefs in natural treatments and 
holistic health beliefs.  In non-users, an identical pattern was observed 
between stronger beliefs in medication overuse, natural treatments and 
holistic health beliefs.  In CAM-users, the relationship between overuse 
and natural treatments was still evident, but an association between 
stronger beliefs in medication overuse and lower beliefs in patient 
participation in treatment was observed.   
 
Scales of the BMQ and CAMBI were also related to components of the 
IPQ-R.  In non-users, greater BMQ harm scale scores were associated 
with stronger beliefs in risk factors as a cause of IBS, greater personal 
and treatment control and weaker beliefs in a chronic timeline.  In CAM-
users there were no significant associations between BMQ harm and 
other scales.  Non-users had positive associations between the BMQ 
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overuse scale and all causal scales as well as a negative association 
with chronic timeline perceptions.  CAM-users also showed an 
association between stronger beliefs in medication overuse, weaker 
beliefs in a chronic timeline and were also associated with greater 
external causal beliefs.  Medication overuse was also related to weaker 
personal control and illness coherence.  The negative relationship 
between the overuse scale and chronic timeline perceptions may 
suggest that in IBS, medication concerns become less important over 
time.  This has been shown in other illnesses.  In those with Asthma for 
example, stronger chronic timeline perceptions were associated with 
greater beliefs in necessity of medication (Horne & Weinman, 2002).  
 
In non-users, stronger illness identity was related to higher CAMBI 
scores.  This trend however, was not detected in CAM-users.  In non-
users stronger beliefs in natural treatments were related to greater 
perceived treatment control.  In CAM-users stronger natural treatment 
beliefs were related to lower coherence and greater belief in patient 
participation in treatment was related to stronger illness consequences.  
Furthermore, CAM-users’ stronger beliefs in treatment participation were 
related to greater beliefs in a chronic timeline.  In both CAM-users and 
non-users, stronger internal cause beliefs were related to stronger beliefs 
in holistic health.  Stronger holistic health beliefs were also related to 
stronger treatment and personal control in both groups.  This may imply 
holistic health beliefs influence or are influenced by feelings of control 
over IBS, treatment or certainty in knowing the origin of one’s IBS.    
Many of the relationships between components of illness perceptions 
and treatment beliefs appear logically consistent with previous work as 
well as illustrating some of the unique differences between CAM-users 
and non-users. 
 
5.4.3 Illness and treatment perceptions, coping and quality of life 
The relationships between most illness and treatment perceptions (where 
observed) for the most part resulted in lower IBS-QOL scores across 
both groups.  The exception to this trend being the IPQ-R control and 
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coherence scales, where positive associations were observed.  Where 
the pathway from illness or treatment perceptions to quality of life was 
negative, the relationships between these perceptions and largely 
maladaptive (or avoidant) coping strategies were positive.  The 
subsequent relationships between these coping strategies and quality of 
life were negative.  In terms of mediation, coping strategies therefore in 
most cases partially explained the pathway observed between illness 
and treatment perceptions and quality of life.  In the case of control and 
coherence perceptions, the observed relationships between these 
dimensions of illness perceptions and maladaptive (or avoidant) coping 
scales were negative.  The subsequent relationships between these 
coping strategies and quality of life, was again negative.  In the case of 
these pathways, it appears that stronger control and coherence beliefs 
resulted in less use of maladaptive coping strategies and resulted in 
improved IBS-QOL scores.  In this context, these pathways may be seen 
to have an adaptive outcome.  These patterns, although some 
differences were present, were largely consistent across both groups.   
 
In assessing the influence of illness perceptions on IBS-QOL scores, 
illness identity, timeline (chronic), illness consequences and emotional 
representations were all consistently negatively associated with lower 
IBS-QOL scores in both groups.  These findings appear consistent with 
previous work that has found influences of symptom severity and other 
psychological factors on reported quality of life in those with IBS (Hahn et 
al., 1997; Naliboff et al., 1998; Spiegel et al., 2008; Whitehead et al., 
1996).  There were also slight differences observed in the strength of the 
relationships between participant groups which may reflect differences in 
CAM-users and non-users reported in other studies (Astin, 1998; van 
Tilburg et al., 2008).  In non-users, both internal and external causal 
perceptions were negatively related to lower IBS-QOL scores, however 
in CAM-users, this was isolated to external cause perceptions.  Previous 
work has suggested individuals with IBS may tend to attribute internal 
causal attributions to the onset or as triggering their IBS which may 
include anxiety, depression and stress (Casiday et al., 2008; Hungin et 
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al., 2005; Lacy et al., 2007).  This appears not to be the case in CAM-
users in this sample.  The dimensions of personal and treatment control 
and illness coherence were positively correlated with higher IBS-QOL 
scores.  There appeared to be less influence of treatment beliefs on 
quality of life.  Stronger beliefs in medication overuse were negatively 
associated with lower quality of life scores in both groups.  In CAM-users, 
stronger beliefs in natural treatments were negatively related to quality of 
life scores.  Generally, the relationships between treatment perceptions 
and quality of life were weaker than the associations observed between 
illness perceptions and quality of life.   
 
Exploratory analyses of the effect of emotional representations of IBS on 
emotional outcome (the dysphoria subscale of the IBS-QOL) found 
stronger emotional representations were associated with reduced 
emotional quality of life.  These findings add credence to the idea that 
those with IBS ‘catastrophise’ or have ‘abnormal’ beliefs about their 
illness which may lead to emotional distress (Drossman et al., 1999; 
Gomborone et al., 1995; Lackner et al., 2004).  This evidence represents 
a new finding in terms of research utilising the CSM in IBS and 
represents an opportunity for further investigation over different time 
points or with other measures of emotional outcome.  The influence of 
emotional representations on emotional outcome is consistent with the 
CSM (e.g. Leventhal et al., 2003) and the proposition that psychological 
processes related to the illness are influential on reported quality of life 
(Lea & Whorwell, 2001; 2004; Leventhal & Colman, 1997). 
 
Mediation testing was guided by associations found between illness 
perceptions, treatment beliefs, coping and quality of life within CAM-
users and non-users.  To test ‘simple’ mediation, a single predictor, 
coping scale and total IBS-QOL score were entered into a series of 
multiple regression models at the final stage of testing (see section 
5.2.5.3).   
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There was consistent partial mediation by several (avoidant or 
maladaptive) scales of the Brief-COPE on the pathway between illness 
and treatment perceptions and IBS-QOL scores in both groups.  The 
majority of coping procedures that were found to mediate the predictor–
outcome pathway, were found to be largely maladaptive or avoidant and 
were largely partial mediators.  Self blame, behavioural disengagement, 
denial and venting emotions were all consistently implicated as partial 
mediating variables.  The only adaptive Brief-COPE scale found to 
mediate this pathway was acceptance.  In assessing the illness identity 
and chronic timeline in both groups, self blame and behavioural 
disengagement added more variance to each model than each of these 
illness perceptions, which seems to contradict previous findings that 
argue the pathway of illness perceptions to outcome is stronger than 
coping to outcome (Hagger & Orbell, 2003).  Illness consequences 
predicted most of the variance in both groups, with many regression 
models predicting upwards of 45% in the variance in IBS-QOL scores.  
Illness consequences have also been reported as strong individual 
influences on reported quality of life in IBS (Rutter & Rutter, 2002) and 
rheumatoid arthritis (Carlisle et al., 2005).  Symptom based perceptions 
such as illness consequences, have been identified as strong predictors 
of outcome in a meta-analysis of CSM studies (Hagger & Orbell, 2003). 
 
Despite the small variances added by Brief-COPE scales in CAM-users, 
denial, behavioural disengagement and self blame partially mediated the 
illness consequences–IBS-QOL pathway, with the latter model predicting 
most variance and having the strongest mediation effect.  In non-users 
venting emotions and substance use also acted as partial mediators in 
the same pathway.  The variances predicted by each regression model 
were similar to those of CAM-users, although the strongest mediation 
effect was observable when assessing self blame in non-users.  Even 
conducting ‘simple’ mediation analyses the variances predicted were 
higher in this study than in Rutter and Rutter (2002), who included 
multiple illness perceptions in path analyses to detect mediation of 
coping in IBS.  A similar procedure was adopted in a study in young 
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people with chronic fatigue syndrome, which also reported less variance 
from multiple illness perceptions than is reported here (Gray & Rutter, 
2007).  These findings suggest that these dimensions, especially illness 
consequences are important factors in those with IBS, with a suggestion 
that these are slightly more important issues in non-users.  Carlisle et al. 
(2005) found avoidant and resigned coping partially mediated the 
pathway between illness identity and disability as well as between illness 
identity and psychiatric morbidity in women with rheumatoid arthritis.  
However, the variances in outcome explained in these findings exceed 
those reported by Carlisle et al. (2005).  
 
In testing the control and coherence scales, several coping scales 
partially mediated the predictor–outcome pathway in both groups.  It was 
notable that the variances in outcome predicted by illness perceptions 
from these variables, was notably lower than with the illness identity, 
timeline and consequences scales.  The variance added by each coping 
scale was also larger in many cases.  Again, the maladaptive and 
avoidant coping strategies of denial, behavioural disengagement and self 
blame were the dominant partial mediators in both groups.  Behavioural 
disengagement provided the largest mediation effects, with similar values 
across the two groups.  One adaptive scale, acceptance, was found to 
partially mediate the illness coherence–IBS-QOL pathway in CAM-users 
and non-users, although the variance predicted in each model in these 
cases was small.  In these scales, the relationships of these perceptions 
with IBS-QOL scores were positive and were partly mediated by largely 
negative relationships with coping strategies.  Similarly, Rutter and Rutter 
(2002) found a direct relationship between the cure/control dimension of 
the IPQ and reported quality of life, but found no evidence of mediation of 
any coping strategies.  In chronic fatigue syndrome, Gray and Rutter 
(2007) found focusing on symptoms mediated between illness 
coherence, treatment control and quality of life.  The positive links 
between these illness representations and quality of life, suggest areas 
where possible future intervention may be targeted.  Previous studies 
have shown that increased coherence or understanding in IBS can result 
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in less use of health care services (e.g. Ringström et al., 2009; Robinson 
et al., 2006).   
 
Regression models with emotional representations and Brief-COPE 
scales predicted larger amounts of variance in IBS-QOL scores, more so 
in non-users which reached over 50% of variance.  Behavioural 
disengagement and self blame were partial mediators in this pathway, 
and this effect was slightly more evident in non-users than CAM-users.  
In explaining over 32% of the total variance of 54%, self blame 
accounted for the largest mediation effect in all analyses conducted in 
non-users.  In contrast to CAM-users, non-users also demonstrated 
partial mediation of denial and venting emotions.  This underlines the 
importance of emotional representations in influencing quality of life and 
underlines the likelihood of significant emotional illness related distress in 
those with IBS.  Interestingly, it appears that non-users’ emotional 
representations had greater influence on IBS-QOL scores than CAM-
users.  Similarly, Gray and Rutter (2007) found focusing on symptoms 
mediated the relationship between greater emotional representations 
with poorer reported quality of life in chronic fatigue syndrome which 
predicted (with other variables in the model) 42% of the variance in 
reported quality of life.  The documented emotional distress in those with 
IBS may be grounded, to an extent, in symptom ‘catastrophising’ 
(Lackner et al.,2004).  The fact that this effect appeared to be more 
pronounced in non-users is difficult to explain as it may be expected 
greater illness related emotional distress may be one reason for using 
CAM. Given the types of CAM used for IBS (figure 4.3) it may be that 
CAM-users are receiving formal (or informal) explanations of their 
symptoms from CAM practitioners or retailers which are addressing their 
emotional concerns.    
 
In non-users, acceptance acted as a partial mediator between the 
internal cause–IBS-QOL pathway, whilst venting emotions and self 
blame fully mediated the effects of the internal cause scale on quality of 
life.  The variances in these models however were low.  In examining the 
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external cause–IBS-QOL pathway, denial and self blame fully mediated 
this pathway in non-users and partially mediated the same pathway in 
CAM-users.  In CAM-users, acceptance partially mediated the pathway 
between external cause and quality of life.  Again, the variance predicted 
in quality of life scores was generally low in these cases and most of 
which was accounted for by coping suggesting that causal beliefs have 
less influence than other illness perceptions on reported quality of life in 
both groups.  Rutter and Rutter (2002) found no evidence of mediation 
between causal beliefs and outcome.  Gray and Rutter (2007) found 
maintaining activity mediated the pathway between risk factors and 
physical functioning, although it is likely that the items making up the risk 
factors scale in this case, were different to those reported in this study.  
These illustrations of detected mediation effects are in contrast to other 
cross-sectional studies that found no mediation of coping between the 
direct links connecting illness perceptions and outcome in Addisons 
disease (Heijmans, 1998), epilepsy (Kemp et al., 1999) and Huntington’s 
disease (Kaptein et al., 2006). 
 
In examining the BMQ overuse and CAMBI natural treatments scales for 
both CAM-users and non-users, both scales were negatively associated 
with quality of life and associated positively with the maladaptive coping 
strategies that mediated the pathways.  Acceptance mediated the BMQ 
overuse–IBS-QOL pathway in both groups, however in CAM-users this 
effect was one of partial mediation.  Denial however, fully mediated this 
pathway in CAM-users.  In non-users, self blame demonstrated a full 
mediation effect.  In non-users, the only significant pathway involving the 
CAMBI was the natural treatment–IBS-QOL pathway.  This pathway was 
fully mediated by self blame.  These analyses predicted small amounts of 
variance in outcome with the exception of self blame and treatment 
beliefs in non-users, although the majority of the variance was explained 
by the coping scale of self blame.  Other studies (Heijmans, 1998; Moss-
Morris et al., 1996; Scharloo et al., 1998) have found that coping added 
little variance to regression equations in contrast to some of the findings 
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here, however this may be due to the lack of influence of treatment 
beliefs on outcome in both groups.    
 
Exploratory analyses of the effect of emotional representations of IBS on 
emotional outcome (the Dysphoria subscale of the IBS-QOL) were also 
conducted.  The trends in relationships with emotional outcome and 
maladaptive coping strategies were consistent with earlier findings.  
Stronger emotional representations were associated with reduced 
emotional quality of life and greater adoption of maladaptive coping 
strategies (denial, self blame, behavioural disengagement and venting 
emotions).  Across both CAM-users and non-users, behavioural 
disengagement and self blame both partially mediated the emotional 
representation–Dysphoria subscale pathway.  Specific to non-users, 
denial and venting emotions also partially mediated the same pathway.  
Observation of each of the regression models revealed that emotional 
representations accounted for the majority of the variance with each of 
the coping strategies contributing small but significant amounts of 
variance to each model.  These findings augment the earlier points 
(Drossman et al., 1999; Lackner et al., 2004) that emotional 
representations are important factors in IBS and have connotations for 
emotional well being, seemingly more so in non-users. 
 
5.4.4 Limitations of the study  
In considering the group differences on the Brief-COPE and IBS-QOL 
subscales, significant differences existed although the effect sizes were 
small which is consistent with the examination of the illness perception 
and treatment belief measures presented in chapter four.  It should also 
be noted that the sample used in this study consisted largely of 
participants recruited via an IBS self-help website and that were 
computer literate enough to undertake the research.  Although there is 
evidence that samples recruited via the internet demonstrate little or no 
difference on psychological and other measures (Ahern, 2005; Basnov et 
al., 2009; Vallejo et al., 2007), it may still be recommended that the 
relationships between CSM components be examined in samples of 
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those with IBS recruited from other arenas to add support to the findings 
here.  
 
One further limitation with the study findings is that the study was cross- 
sectional.  This factor makes causal interpretation more difficult as there 
is little certainty that illness and treatment perceptions are directly 
influencing coping strategies to deal with IBS.  Previous studies utilising 
the CSM have often used cross-sectional designs.   These have 
produced mixed results albeit with some evidence of mediation of coping 
(Carlisle et al., 2005; Hagger et al., 2005; Rutter & Rutter, 2002).  Other 
research has found no evidence of mediation (Heijmans, 1998; Kaptein 
et al., 2006; Scharloo et al., 1998).  The limitations of using cross-
sectional designs are evident therefore in seeking to establish causal 
pathways and potentially to have more success in determining greater 
mediation effects, prospective longitudinal research may prove more 
rewarding.   
 
There may also be issues with the amount of mediation detected in the 
present study. It is apparent a small number of regression models 
constructed predicted small portions of variance in outcome and could be 
therefore be discounted as less important findings.  Carlisle et al. (2005) 
imposed criteria of each regression model having to predict at least nine 
percent of the outcome variance to be considered satisfactory.  However, 
to impose such criteria would have resulted in the majority of results in 
this study being retained which would include the strongest statistical 
effects.  Therefore, this would have little impact on the findings of the 
study.  It can be argued that in several cases, the unique variance added 
(R² change) by Brief-COPE scales to regression models was small.  
However, the Beta coefficients for these values were still of moderate 
size suggesting a greater proportion of variance in IBS-QOL scores is 
shared with each illness or treatment representation component.  
Preacher and Hayes (2004) argue that the significance of any mediation 
effect is sufficient to suggest there is an indirect relationship between 
predictor and outcome through the mediating variable.    
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Although there was substantial partial mediation demonstrated in this 
study, there were many pathways between illness perceptions, treatment 
beliefs and reported quality of life where there was no evidence of 
mediation.  Where mediation was present, this was largely classed as 
‘partial’ mediation of which the effect sizes appeared small to moderate.  
This, in part, may be due to many of the regression equations that 
demonstrated mediation where higher variances in outcome were 
predicted by illness representations, the influence of coping on these 
equations appeared to be small.  There is further concern that use of a 
generic coping checklist, as in this study, may not be the best way to 
measure coping strategies to capture responses to cognitive and 
emotional representations of IBS (Hagger & Orbell, 2003; Leventhal et 
al., 1997; 1998).  This may also have influenced the degree of mediation 
detected in each group.  Although the Brief-COPE actually delineates 
fourteen distinct coping strategies, there is suggestion that such 
measures may still lack specificity in terms of the CSM.  Leventhal et al. 
(1997; 1998) have previously argued that coping should be thought of in 
terms of procedures where the individual makes direct attempt to 
address illness related concerns (Leventhal et al., 1998).  However there 
is no current consensus on how coping should be measured in CSM 
studies.  Researchers may provide suggestions on how coping should be 
measured in such studies in the future.  Given the complexity of 
measuring how individuals cope with specific illness threats, it may be 
beneficial to develop or utilise existing coping instruments for specific 
illnesses (e.g. Carlisle et al., 2005).  
 
The predominance of maladaptive or dysfunctional coping strategies 
demonstrating mediation suggests the Brief-COPE could be more suited 
to measuring these particular coping strategies.  Alternatively, in those 
with IBS, coping strategies may be guided towards trying to effectively 
‘block out’ the symptoms and emotions associated with having IBS.  It is 
also possible that there is some artefact in the measurement of coping in 
this, and possibly other studies.  Moreover, in outlining steps for 
mediation Baron and Kenny (1986) recommend that there is little or no 
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measurement error in the mediator variable.  It is recommended that to 
rectify such shortcomings more specific, behavioural measures of coping 
could be assessed in future study (Hagger & Orbell, 2003).  This may 
take the form of examining medication adherence through both self 
report measures (e.g. Horne, 2001) and examining adherence to certain 
CAM treatments or visits to a practitioner (e.g. Bishop et al., 2008).   
 
Observation of some of the regression analyses presented demonstrates 
that in some cases there are several coping strategies that partially 
mediated the relationship between predictor and outcome.  There is 
therefore a possibility that these mediators may interact with each other 
in explaining the predictor–outcome pathway, effectively becoming 
multiple mediators (Preacher & Hayes, 2008).  This may be an avenue 
for future research although it should be noted that in this study, where 
higher variances in outcome were predicted, the additional variance 
explained by each of the mediators was small when added to each 
regression model.  This again, reiterates the stronger relationships 
between illness perceptions and outcome (e.g. Hagger & Orbell, 2003).  
 
5.4.5 Conclusions and implications 
This study adds further new and important findings in relation to the CSM 
and the pathways therein as no published study to date, using an IBS 
population, has examined simple mediation effects with a diverse range 
of coping strategies between CAM-users and non-users.  The fact that 
this study tested for significance of mediation effects was a further 
beneficial aspect of this study, as many previous CSM adopting the 
Baron and Kenny (1986) approach do not report significance testing for 
mediation.  The study also suggests that extending the CSM to 
incorporate treatment beliefs is worthwhile.  Further investigation is 
recommended to assess the influence of treatment beliefs on reported 
quality of life in further IBS and other chronic illness samples.   
 
The findings presented in this chapter give rise to a number of theoretical 
and practical implications.  This research has added support to the CSM 
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and shown that, in many cases coping does mediate the link between 
illness perceptions and outcome, albeit partially.  There is also tentative 
support for extending the CSM to incorporate treatment beliefs into the 
model.  The most noticeable influences on impaired reported quality of 
life, in both groups, appear to be illness identity, consequences and 
emotional representations, and several of these pathways are mediated 
by largely maladaptive or avoidant coping strategies.  It is also perhaps 
interesting to note that substance use was a partial mediator in non-
users only (between illness consequences and IBS-QOL scores).  This 
might suggest non-users are more likely than CAM-users to use alcohol 
for example to try to reduce their IBS symptoms. This is seemingly in 
contrast to previous work in numerous illness populations which has 
indicated that illness identity has the strongest relationship with illness 
outcome (e.g. Hagger & Orbell, 2003), although this may be partly due to 
the lack of exploration into the emotional representations of the IPQ-R.   
The control and coherence scales are implicated in the association of 
better reported quality of life, but when examining variance predicted by 
regression models across the two groups, it is to a lesser extent than 
with the symptom based IPQ-R scales.   
 
As the previous chapter found with the IPQ-R, BMQ and CAMBI, there 
were differences between CAM-users and non-users on several scales 
of the IBS-QOL and the Brief-COPE.  CAM-users with IBS reported lower 
quality of life than non-users.  The coping strategies related to illness 
perceptions and treatment beliefs across both of these participant groups 
were largely maladaptive or dysfunctional.  However where higher (or 
lower) quality of life scores are reported there is opportunity for potential 
intervention and further study.  The study also offers a degree of support 
for an extended CSM in that several coping strategies were shown to 
(partially) mediate the relationship between illness perceptions, and, to a 
lesser degree, some facets of treatment beliefs and reported quality of 
life.  In addition, emotional representations in IBS are important factors.  
Much research into the CSM neglects the emotional component.  
However, this study has shown the importance of emotional influences 
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related to IBS on reported quality of life and emotional quality of life.  
Further study could examine coping strategies that are particular to 
emotional representations.  In this respect, this study represented an 
exploration of relationships with an existing measure of coping perhaps 
more readily associated with cognitive representations of illness.  There 
is further, perhaps more tentative evidence for utilisation of an extended 
CSM that accounts for treatment beliefs and the relationships uncovered 
in this study warrant further investigation. 
 
The findings suggest that those with IBS may report high levels of illness 
consequences, illness identity and stronger emotional representations.  
These representations all had a detrimental influence on reported quality 
of life, through the effect of adopting largely maladaptive or avoidant 
coping strategies.  These effects appear to be slightly stronger in non-
users.  Taking into account the positive relationships between control 
and coherence representations and quality of life, it may be suggested 
that one way to potentially improve quality of life in IBS would be to 
enhance these components.  Relationships between illness perceptions 
in both groups suggest this could be achieved by challenging for 
example, perceptions of consequences and emotional representations, 
especially in those with IBS that have not used CAM.  This may enhance 
the use of more adaptive coping strategies.  
 
In terms of the emotional representation–emotional outcome pathway, 
denial and venting of emotions were unique partial mediators to non-
users.  Examining the relationship between emotional representations 
and emotional quality of life was an important aspect of this study.  It is 
clear that those with IBS report emotional distress related to their 
condition and this appears to have a greater influence on quality of life in 
non-users.  It is possible that some form of intervention to lessen the 
emotional distress caused by IBS could be implemented by self-help 
networks.  Disclosure by writing has been found to help those cope with 
stressful situations brought on by dealing with illness (Cameron & Jago, 
2008; Pennebaker, 1997).   
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To address one of the main limitations of this cross-sectional study, the 
following chapter will examine the stability of illness representations over 
time and if the representations and beliefs measured in this study, will 
predict coping and reported quality of life at a subsequent time point.   
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Chapter 6  
 
A prospective examination of pathways in the Common-Sense 
Model of illness representations between CAM-users and non-users 
with IBS 
 
 
This chapter reports a follow-up study to examine longitudinal changes in 
illness perceptions and treatment beliefs in people with IBS. The web-
based methodology was used to follow-up participants of the cross-
sectional study and thus enables the research to incorporate a 
prospective examination of pathways in the ‘extended’ Common-sense 
model.  This chapter specifically examines the role of coping as a 
mediator in the pathways between illness and treatment perceptions and 
quality of life.   
 
 
6.1 Introduction 
The previous chapter reported a cross-sectional study that suggested a 
degree of empirical support for an extended common-sense model of 
illness representations (Leventhal et al., 1992; 1998).  The study also 
found evidence of mainly partial mediation by largely maladaptive or 
dysfunctional coping procedures between illness and treatment beliefs 
and quality of life.  There were also direct links between illness 
representations and reported quality of life.  The strongest effects on 
outcome, in both CAM-users and non-users, came from regression 
models containing symptom based IPQ-R scales, namely, illness identity, 
consequences and emotional representations.  The variances in IBS-
QOL scores explained by coping procedures in these cases were 
smaller, although these were higher in other cases, namely when 
assessing the effect of treatment beliefs on outcome. 
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To complement the findings of the previous chapter a prospective study 
was conducted to examine for possible influence of illness and treatment 
perceptions over time.   
 
As highlighted in chapter two, illness and treatment perceptions may be 
updated depending on the effectiveness of coping procedures (Leventhal 
et al., 1992; 1998).  This will, in part, come from the appraisal of coping 
procedures.  If it is evident a certain procedure has not worked, then 
information is fed back to the representation stage where illness 
perceptions may influence another form of coping procedure (Leventhal 
et al., 1998).  One of the studies utilising a CSM approach in IBS, found 
illness perceptions as measured by the IPQ, did not significantly change 
over the study duration of 12 months (Rutter & Rutter, 2007).  However, 
research conducted over both six months (e.g. Lee et al., 2010) and six 
years (e.g. Kaptein et al., 2010), found variation in illness perceptions 
over time.  Furthermore, Rutter and Rutter (2007) also found no evidence 
that coping acted as a mediator over time. 
 
To address some of the potential shortcomings of the cross-sectional 
study in chapter five and to investigate if illness and treatment 
perceptions indicated any change over time, a prospective web-based 
study was conducted.  This design was employed to explore evidence for 
directional pathways between components of the CSM (detailed in 
chapter two) and to continue with the examination of differences between 
the two participant groups of CAM-users and non-users.  This included 
consideration of if CAM use over time appeared to improve reported 
quality of life when compared with those not using CAM.   There were 
three specific aims addressed by this research:  
 
6.1.1 To assess any change in CSM variables over time in CAM-users 
and non-users in IBS. 
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6.1.2 To examine if illness perceptions and treatment beliefs influence 
reported quality of life after a minimum of six months in CAM-users and 
non-users with IBS. 
 
6.1.3 To test for evidence of coping mediating pathways between illness 
and treatment perceptions (at time one) and reported quality of life (at 
time two) across CAM-users and non-users. 
 
 
6.2 Method  
This component of the research was largely conducted according to the 
methodology considered and described in chapter three.  As this was a 
prospective follow-up study, participants were recruited via the email 
address that was provided during participation of the previously 
considered cross-sectional study.  Analysis of data firstly considered any 
differences between those taking part in the follow-up and those that 
opted not to, using unrelated t-tests.  As was considered in previous 
chapters, parametric tests (sections 3.6.3, 4.2.5.4 and 5.2.5.3) were 
favoured to perform statistical analyses.  Related t-tests were used to 
assess participant differences between time one and time two ratings on 
scores of illness and treatment perceptions, coping and quality of life.  In 
terms of mediation testing, Pearson’s correlations were used to assess 
relationships between time one illness and treatment perceptions and 
time two IBS-QOL scores.  Time one perceptions were also correlated 
with time two Brief-COPE scores.  Finally, linear regression models and 
Sobel tests (Preacher & Hayes, 2004) were used in the final stage of 
mediation testing (section 3.6.3). 
 
6.2.1 Design 
This study was a prospective web-based survey.  To address the specific 
objectives (section 6.1), participant responses about illness perceptions, 
treatment beliefs and beliefs about complementary treatments were 
taken from the IPQ-R, BMQ and CAMBI respectively.  Coping was 
assessed by using the Brief-COPE and reported IBS-specific quality of 
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life was assessed with the IBS-QOL.  Participant demographics were 
also obtained. 
 
6.2.2 Participants 
Recruited from the previous cross-sectional study, 197 participants took 
part in this study.  In the previous study (chapters four and five) 404 
participants stated their interest in taking part in a follow-up study, from a 
total of 653 that took part in the study reported in the previous two 
chapters.  Data from the survey website showed that there were 372 
visits to the follow-up study website.  86 participants dropped out after 
commencing the study and 283 opted to start but not complete the study.  
From the 283 that commenced the study 197 responses represented a 
69.11% completion rate.   
 
Data show however, that a substantial number of participants that visited 
the study website chose not to take part in the follow-up study.  
Furthermore approximately 40 email addresses from the list of 404, 
returned unsent messages (see section 6.2.4).  Both of these factors 
offer possible reasons for the attrition rate in this study.  It is also 
possible between the two time points of data collection, several 
participants changed email addresses, or incorrect email addresses were 
provided by mistake.  Ultimately, this meant these participants could not 
be contacted and the number of visits to the study website given above 
(372) probably included some duplicate visits from participants.  As the 
attrition rate was a concern, between groups analysis was conducted 
across responders and non-responders for the follow-up study.  Key 
statistical analysis consisted of examining participants that had 
participated in both the cross-sectional and follow-up studies.  As with 
previous analyses, this was conducted by group according to CAM-use 
or no-CAM use (non-users). 
 
6.2.3 Measures  
The measures used in this study are detailed in chapter three (section 
3.3).  As with previous chapters, measures of illness perceptions, 
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treatment beliefs and coping were considered either predictor or 
explanatory variables.   The Illness Perception Questionnaire Revised 
version (IPQ-R; Moss-Morris et al., 2002) which was used as a measure 
of illness perceptions and the Beliefs about Medicines Questionnaire 
general version (BMQ-general; Horne et al., 1999) was utilised to capture 
general beliefs about conventional medicines.  The Complementary and 
Alternative Medicine Beliefs Inventory (CAMBI; Bishop et al., 2005) was 
used to ascertain beliefs about CAM.   The Brief-COPE (Carver, 1997) 
was used to capture coping styles.    
 
The IBS-QOL (Patrick et al., 1998), as in the previous chapter, was used 
as an outcome measure.  The IBS-QOL total score reflects several 
factors related to QOL in IBS.  Again, in concordance with the previous 
chapter, one of the subscales of the IBS-QOL, the Dysphoria subscale, 
was used as a measure of emotional quality of life so pathways leading 
to emotional ‘outcome’ could be examined.   
 
To address the research aims and to allow comparison with findings in 
the previous chapter, participant data was again divided into two groups: 
CAM-users (i.e. have used CAM to relieve their IBS) and non-users (i.e. 
have not used CAM to relieve their IBS) according to their responses to 
CAM use at time one. 
 
6.2.4 Procedure 
The procedure was carried out as detailed in section 3.4 using an online 
survey host.  Participants were contacted via their email addresses that 
were provided when interest in a follow-up study was registered.  Email 
‘invitations’ were sent to participants to take part in the follow-up study, 
as well as thanking them for their time and taking part in the original 
study.  This was done a minimum of six months after the cross-sectional 
study had taken place.  Within the email, participants were presented 
with a direct electronic link to the study website, where participants were 
presented with detailed information about the follow-up study and a 
consent ‘page’ that they had to acknowledge they had read before they 
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could proceed.  As with the cross-sectional study, participants were 
directed through web pages on the study website with the use of ‘next’ 
icons at the foot of each page of responses (section 3.4).  All data were 
captured over a period of approximately six weeks from April 2009.  
Reminders were sent out approximately two weeks later in case any 
participants had missed the original email.  A final reminder email was 
sent a further two weeks later (appendices XII to XIV).   
 
6.2.5 Statistical analyses 
Scale scores were computed for the IPQ-R, BMQ, CAMBI, Brief-COPE 
and in addition to subscale scores for the IBS-QOL (see section 3.3.2).  
Scales and subscales were then screened for outlying values and data 
distribution in these variables was assessed (Tabachnick & Fidell, 2007).  
With the IPQ-R causal items, scales were computed as per the findings 
of the Principal Components Analysis presented in chapter four.  This 
was to allow direct comparison between participants’ causal attributions 
(as measured by the IPQ-R) over time, as well as the alpha values on 
each causal scale reaching acceptable levels (provided in tables 6.5 to 
6.7, see also section 4.2.5.3).   
 
As considered in chapter four, outlying values and distributions of scale 
variables were considered (Tabachnick & Fidell, 2007).  Following this, 
inferential statistical testing was conducted in SPSS version 17 to assess 
differences between responders and non-responders for the follow-up 
study.  This was conducted across CAM-users and non-users using 
unrelated t-tests.  Differences between measure scales (for both CAM-
users and non-users) at time one (the cross-sectional study) and time 
two (this study), were explored using related t-tests.  In addition, 
unrelated t-tests were used to examine differences in IBS-QOL scores 
between CAM-users and non-users at time two, to give a unique 
indication of whether CAM-use influenced IBS-QOL scores over time, 
with indications from this analysis at the cross-sectional stage indicating 
CAM-users reported worse quality of life.  Finally, tests of simple 
mediation were conducted according to Baron and Kenny’s (1986) 
 259 
causal steps approach in CAM-users and non-users (see section 3.6.3).  
The grouping of CAM-users and non-users was conducted according to 
participant responses to their use of CAM (yes or no, section 3.3.3.1). 
 
6.2.5.1 Computing scales 
The IPQ-R, BMQ, CAMBI scales and the IBS-QOL total score and 
subscales were computed from the follow-up data allowing for small 
numbers of missing values on each item (see section 3.3.2).  As stated in 
chapter five, the Brief-COPE was computed without accounting for any 
missing data as each scale of the measure consists of two items only.  
Therefore a total score was computed for participants that had two 
responses for items of each scale.  Data were again split according to 
CAM use for IBS (CAM-users) or no CAM use for IBS (non-users).      
 
6.2.5.2 Data screening  
To ensure accuracy in data analysis and consistency with the cross-
sectional study, data were examined for outlying values (Tabachnick & 
Fidell, 2007, see section 3.6).  Prior to statistical testing IPQ-R, BMQ, 
CAMBI, Brief-COPE scales and IBS-QOL scale and subscales were all 
screened for bivariate outliers (CAM-users and non-users).   
 
Box-plots were used to visually identify outliers that were present in 
several Brief-COPE scales and IBS-QOL subscales.  Detected outliers 
were examined to ensure all values were in the correct scoring range for 
each scale and subscale.  Any outlying values were again modified to 
reduce the influence of these values (Field, 2009; Tabachnick & Fidell, 
2007; see section 4.2.5.2).  Outlying cases were changed to the lowest 
(or highest) next non-outlying value to reduce the influence of these 
particular cases (Field, 2009).   The Brief-COPE scales denial and 
substance use were found to be unresponsive to modification.  This 
meant that the distribution of residual values for influence of outlying 
values was checked in regression models that contained these scales. 
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The distributions for measure scales were then assessed.  This was 
again conducted visually by observation of histograms for both the CAM-
users and non-users.  There was little deviation from normality in the 
IPQ-R, BMQ and CAMBI with most scales being normally distributed.  In 
non-users, the timeline chronic and the illness coherence scales showed 
a positive skew, where ‘risk factors’ deviated negatively.  In CAM-users, 
only the timeline chronic scale was found to be positively skewed.   
  
Several Brief-COPE scales were found to deviate from normality.  In both 
groups behavioural disengagement, venting emotions, positive 
reframing, humour, self blame and religion were all found to be positively 
skewed.  The denial and substance use scales were also positively 
skewed in both groups to the extent that scores suggested these coping 
styles appeared to be little utilised by participants.  In CAM-users, the 
emotional support scale was positively skewed, while in non-users, 
active coping was negatively skewed.  All other scales had normally 
distributed scores.  
 
Most of the eight IBS-QOL subscales were normally distributed in 
addition to the total IBS-QOL score, however in both CAM-users and 
non-users the sexual and food avoidance subscales were negatively and 
positively skewed respectively.  In the non-users, the relationships 
subscale was also negatively skewed.   
 
In using related t-tests the distributions of the differences between pairs 
of scores should be assessed for normality (e.g. Field, 2009).  For the 
purposes of exploring differences between time one and time two 
measures in both groups, differences between time one and time two 
scores were computed.  These distributions were examined in all CSM 
variables in addition to age and were all found to be normally distributed 
showing little evidence of skewness. 
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6.2.5.3 Statistical tests 
Parametric analysis was favoured as the measures used in this study 
were considered psychometrically stable enough to have elicited 
parametric data (see section 3.3.2).  As with the previous two chapters, 
statistical analysis was conducted on a list-wise basis in SPSS to ensure 
greater accuracy, excluding any case with missing data on any of the 
measures (see section 3.6.1).  As previous chapters have illustrated, t-
tests are considered robust to violations of non-normality (see sections 
3.6.2 and 4.2.5).  This extends to situations with unequal group sizes 
where the sample is large (i.e. over 30) where in such situations equality 
of variance tests should be examined (Sawilowsky & Clifford Blair, 1992).  
Therefore, independent t-tests were conducted to examine for 
differences in responders and non-responders for this study.  Related t-
tests were used to examine for differences in measures over the study 
time points on the IPQ-R, BMQ, CAMBI, Brief-COPE and IBS-QOL.  All 
analyses were conducted separately for CAM-users and non-users. 
 
To address the final aims of the study, the approach taken in the 
previous chapter (section 5.2.5.3, see also section 3.6.3) to test for 
‘simple’ mediation was adopted in both CAM-users and non-users.  In 
assessing the Baron and Kenny (1986) steps for simple mediation, as 
this study was a follow-up, firstly simple linear regression models were 
used to assess relationships between scales of the IPQ-R, BMQ and 
CAMBI at time one (predictors) and IBS-QOL scores at time two 
(outcome).  Significant relationships were then used as a guide as to 
which IPQ-R, BMQ and CAMBI scales should be correlated with the 
Brief-COPE (time two).  Finally, a series of linear regression models were 
computed where each predictor variable was regressed on outcome.  
Brief-COPE scales (that were related to predictors) were entered into a 
second block of each regression model.  This was to observe any effect 
of the mediator on outcome whilst controlling for the effect of the 
predictor (step three of Baron and Kenny’s criteria).  Only scenarios 
where the mediator successfully predicted outcome while reducing the 
effect of predictor coefficients are reported.  Significance testing of the 
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mediation effect was conducted using the SPSS macro utilised in the 
previous chapter (Preacher & Hayes, 2004; chapter three, section 3.6.3).  
 
 
6.3 Results 
This study sought to address three objectives.  Firstly, differences 
between the CAM-users and non-users at time one and time two on IPQ-
R, BMQ, CAMBI, Brief-COPE and IBS-QOL scores were considered.  
Secondly, the influence of time one IPQ-R, BMQ and CAMBI scores on 
IBS-QOL (time two) was assessed.  Thirdly, mediation testing was 
conducted (between CAM-users and non-users) for predictor variables 
scores at time one and mediator and outcome scores at time two.  In 
addition to the main aims, the rate of attrition was considered to be one 
potential limitation.  Therefore participant data at study time one was 
examined for differences between responders and non-responders 
according to CAM-use or no-CAM use (section 6.3.2.).  Key participant 
demographic information for responders is also presented from 
responses provided at study time one (6.3.1).   
 
6.3.1 Participant demographics  
The age range of participants for this study was 18-76, with 81.2% 
(n=160) being female with one missing case in this category.  The mean 
age overall was 38.56 years (SD=12.96), which was slightly higher than 
the mean age recorded in the cross-sectional study.  As was found at 
time one, there were slight differences in mean ages by gender.  The 
mean age for males was 40.42 (SD=13.13) years, which was slightly 
higher than females at 38.13 years (SD=12.93).   
 
Key categorical demographics are illustrated in table 6.1.  Participants 
were asked if they had been diagnosed with IBS by a health care 
professional, with most participants (94.9%, n=187) stating they had 
been diagnosed with IBS.  Ninety four (50.3% approximately) participants 
had been diagnosed over 5 years ago, with approximately 20.3% (n=38) 
being diagnosed one to two years ago.  A majority of participants (73.1%, 
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n=144) of participants stated that they had been living with IBS 
symptoms for over 5 years (Table 6.1).  When asked if they were taking 
prescribed medication for their IBS, approximately 48.7% (n=96) stated 
‘yes’ with 101 stating ‘no’.  Table 6.1 also illustrates that approximately 
73.7% (n=143) were employed with the largest percentage of 
approximately 23.9% (n=45) of participants indicating they had £20,000-
£29,000 (or equivalent) household income, which is similar to figures 
reported in table 4.3.  Approximately 76% of participants had educational 
qualifications ranging from GCSEs or ‘O’ levels to first degree.  There 
were more participants that reported suffering from other conditions (co-
morbidity) (62.4%, n=123) than reported no co-morbidity (37.6%, n=74). 
 
 
Figure 6.1 Pie chart illustrating geographical location of participants 
for follow-up study (percentage of the whole sample) 
87.3%
7.6%
2.5%2.6%
UK (87.3%)
USA (7.6%)
Canada (2.5%)
Other western
countries (2.6%)
 
In terms of geographical location, participant data for this study showed 
similarities to data presented in chapter four (section 4.3.1).  Most 
participants were from the UK (87.3%), 7.6% were from the US and 2.5% 
from Canada (figure 6.1).  Participants located in other countries 
accounted for approximately 2.5%.   In terms of ethnic groupings, 
approximately 83% were white British, white Irish or other white 
background.  Religious groupings were either mainly ‘Christian’ (53.1%) 
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or ‘none’ (38.6%) with other religious groups represented by small 
numbers of participants.   The large proportion of Christian and no-
religion in the sample perhaps reflect that the majority of participants 
were of a white ethnic background, many of whom were British or Irish. 
 
Approximately 63.5% of participants (n=125) reported that they had used 
CAM to relieve the symptoms of IBS either presently or in the past, the 
remaining 36.5% (n=72) not using CAM.  Table 6.1 also offers a 
demographic breakdown of CAM use by frequency.  Table 6.1 also offers 
a demographic breakdown of CAM use by frequency.  Notably, selected 
categories in income and time of diagnosis suggested higher CAM use.   
 
Approximately 29% of CAM-users, who were responders at time two, 
reported (at time one) that they had visited a CAM practitioner at least 
once in the last 12 months compared with 23.6% of all CAM-users (i.e. 
including those who only responded at time one).  Seventy three per-cent 
of CAM-users responding at study time two reported (at time one) that 
they had purchased their own CAM ‘off the shelf’, compared to 75% of all 
CAM-users.  Many CAM-user responders had also been directed to take 
CAM (40%) compared with 34.9% of all CAM-users (section 4.3.2).   
 
The use of specific types of CAM treatments by responders (reported at 
time one), again showed similarities across all CAM-users (section 
4.3.2).  Again the most popular treatments in responders were herbal 
treatments (42%), massage (31%) and aromatherapy (28%).  There 
were slight increases in the reported use of talk therapies (25%), yoga 
(26%), relaxation techniques (23%) and homeopathy (21%).   The use of 
bach flower remedies was consistently used in responders compared 
with all CAM-users at time one (23%).  As reported with all CAM-users, 
other popular treatments that responders reported at time one were; 
acupuncture (18%), hypnosis (15%) and nutritional treatments (15%). 
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Table 6.1 Key participant demographic (time one) data by frequency 
and frequency of CAM use in responders (n=197) 
 
Variable Category Number (%*) CAM use at time 1 
%* 
Y             N 
Gender Male  36  (18.3) 56.6 44.4 
 Female 160  (81.2) 65.6 34.4 
Diagnosis Yes 187  (94.9) 63.1 36.9 
 No 10  (5.1) 70 30 
Time diagnosed Less than 12 months 3  (1.6) 33.3 66.7 
 1-2 years 38  (20.3) 50 50 
 2-3 years 23  (12.3) 65.2 34.8 
 3-4 years 13  (7.0) 84.6 15.4 
 4-5 years 16  (8.1) 68.7 31.3 
 Over 5 years 94  (50.3) 64.9 35.1 
Time with symptoms Less than 12 months  -     ( - ) - - 
 1-2 years 11  (5.6) 36.4 63.6 
 2-3 years 15  (7.6) 66.7 33.3 
 3-4 years 16  (8.1) 75 25 
 4-5 years 11  (5.6) 72.7 27.3 
 Over 5 years 144  (73.1) 63.2 36.8 
Currently taking 
prescribed medication 
yes 96 (48.7) 54.2 45.8 
 no 101  (51.3) 72.3 27.7 
Employed yes 143  (73.7) 67.8 32.2 
 no 51  (26.3) 67.8 32.2 
Income up to £9999 16  (8.5) 52.9 47.1 
 £10,000 - 14,999 14  (7.4) 50 50 
 £15,000 - £19,999 17  (9.0) 64.7 35.3 
 £20,000 - £29,000 45  (23.9) 64.4 35.6 
 £30,000 - £39,999 33  (17.6) 72.7 27.3 
 £40,000 - £49,999 24  (12.8) 58.3 41.7 
 £50,000 and above 39  (20.7) 64.1 35.9 
Education GCSEs, ‘O' levels or 
equivalent 
42  (21.5) 42.9 57.1 
 A Levels or 
equivalent 
47  (24.1) 70.2 29.8 
 First Degree (BA, 
BSc) 
62  (31.8) 69.4 30.6 
 Postgraduate 
qualification 
34  (17.4) 70.6 29.4 
 No qualifications 10  (5.1) 60 40 
Co-morbidity reported Yes 123  (62.4) 65.9 34.1 
 No 74 (37.6) 59.5 40.5 
          * Percentages are corrected for missing values  
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6.3.2 Differences between responders and non-responders on CSM 
scale variables and age 
Tables 6.2 to 6.4 show comparisons between CSM variables (and age) 
between those who participated in this follow-up study (responders) and 
those that opted not to (non-responders) according to whether 
participants had reported CAM use in the cross-sectional study (time 
one).  Illness and treatment perception scores showed limited differences 
across both time points (table 6.2), as did Brief-COPE (table 6.3) and 
IBS-QOL scores (table 6.4). 
 
Table 6.2 shows that responders that were non-users showed 
significantly higher scores on illness identity (M=6.20, SD=2.60) than 
non-responders at time two (M=5.40, SD=2.81), t(255)= 2.07, p<.05.  
Equal variances were assumed in each of the two groups (responders 
and non-responders) F=.36, p>.05.  The reverse was found in CAM-
users, where non-responders had reported stronger illness identity 
(M=6.65, SD=2.90) than responders (M=5.98, SD=2.46), however, equal 
variances were not assumed (F=6.73, p<.05), and the resulting SPSS 
adjustment for the violation of equal variances resulted in: t(282.81)= -
2.16, p<.05.  A similar trend was observed where CAM-users who were 
non-responders had significantly stronger external causal beliefs 
(M=15.27, SD=3.76) than responders at time two (M=14.11, SD=3.91), 
t(343)= -2.69, p<.01 and equal variances were observed between 
responders and non-responders (F=.26, p>.05).  Non-responders also 
reported stronger beliefs regarding medication overuse (M=10.41, 
SD=2.90) than responders (M=9.67, SD=2.74), t(343)= -2.31, p<.05 with 
equal variances assumed (F=.43, p>.05).  Both CAM-users and non-
users reported greater beliefs in patient participation in treatment.  In 
CAM-users, responders had higher mean participation in treatment 
scores (M=20.03, SD=2.58) than non-responders at time two (M=19.44, 
SD=2.68), t(343)= 1.99, p<.05, with equal variances being assumed 
(F=.39, p>.05).  In non-users, responders also reported higher 
participation scores (M=19.63, SD=2.71) than non-responders (M=18.77, 
SD=2.72), t(255)= 2.26, p<.05, where equal variances between the 
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groups were observed (F=.01, p>.05).  Significant differences are also 
illustrated in figure 6.2 wherein the error bars represent plus or minus 
one standard deviation relative to each mean.  There were no other 
significant differences between responders and non-responders on 
illness and treatment perception scales. 
 
Table 6.3 illustrates Brief-COPE scores for both responders and non-
responders.  Only CAM-users showed a difference, with non-responders 
scoring more highly on three scales.  Non-responders (M=3.0, SD=1.43) 
scored significantly higher than responders (M=2.62, SD=1.02) on the 
denial scale t(317.94)= -2.92, p<.01, where the assumption of equal 
variances was violated (F=15.37, p<.001).  Non-responders also scored 
more highly on the ‘venting’ of emotions scale (M=4.24, SD=1.56) when 
compared to responders (M=3.84, SD=1.43), t(343)= -2.30, p<.05, where 
equal variances between the two groups were assumed (F=1.14, p>.05).  
In examining the humour scale, non-responders were also found to score 
more highly (M=4.23, SD=1.93) than responders (M=3.70, SD=1.75), 
t(343)= -2.49, p<.05, where equal variances were assumed (F=1.84, 
p>.05).  Significant differences are also illustrated visually in figure 6.3. 
 
Table 6.4 shows that on IBS-QOL scores, only two subscales showed 
differences between responders and non-responders (figure 6.3).  These 
differences were limited to CAM-users only.  Responders scored 
significantly higher (M=62.81, SD=31.64) on the sexual subscale of the 
IBS-QOL when compared to non-responders (M=52.96, SD=34.68), 
t(265.99)= 2.67, p<.01, where the assumption of equal variances 
between the groups was broken as Levene’s test was significant 
(F=5.63, p<.05) so the SPSS correction was employed for this scenario.  
When assessing total IBS-QOL scores, responders using CAM scored 
significantly higher (M=46.18, SD=19.85) than non-responders 
(M=41.39, SD=20.66), t(343)= 2.08, p<.05, assuming equal variances 
between the two groups (F=.40, p>.05).  These two findings suggest that 
responders were reporting better quality of life than non-responders. 
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Tables 6.2 to 6.4 suggest that differences between the two sets of 
responses at time one were minimal.  The most notable difference was 
that of the difference between responders and non-responders on IBS-
QOL scores in CAM-users.  This suggests that those taking part in the 
follow-up study, reported slightly better IBS-QOL scores than those not 
taking part at time two, although the effect sizes calculated show the 
magnitude of these differences to be small (i.e. r<.2).  There were no 
other differences between responders and non-responders on the Brief-
COPE and IBS-QOL.      
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Table 6.2 Descriptive statistics and unrelated t-tests for responder 
/non-responder differences on illness and treatment perception 
scales (and age) between CAM-users and non-users with IBS  
  *p<.05 **p<.01    (Effect sizes r =.1 weak, r =.3 moderate, r =.5 strong) 
 
Variable 
 
CAM use 
y/n 
Mean (SD) 
Responders (non-
users n=70; CAM-
users n=121 ) 
Mean (SD) Non-
Responders (non-
users n=187; CAM-
users n=224) 
 
t-value  
(effect size ‘r’) 
No  (n=257) 37.86 (12.48) 37.11 (13.95) .40 Age  
 Yes (n=345) 36.90 (13.45) 37.21 (12.18) -.21 
No   6.20 (2.60) 5.40 (2.81) 2.07* (.13) Identity 
 Yes  5.98 (2.46) 6.65 (2.90) -2.16* (.13) 
No   24.98 (3.98) 24.49 (3.66) .92 Timeline 
Chronic 
 Yes  25.28 (3.93) 24.80 (3.75) 1.11 
No   14.64 (2.97) 14.80 (2.88) -.39 Timeline 
Cyclical 
 Yes  15.04 (2.69) 15.48 (2.70) 1.44 
No   21.33 (4.22) 20.67 (4.75) 1.03 Consequences 
 Yes  21.82 (4.32) 22.69 (4.25) -1.81 
No   18.86 (4.38) 19.64 (4.33) -1.27 Personal 
control 
 Yes  20.19 (4.51) 19.36 (4.75) 1.58 
No   13.83 (3.81) 14.41 (3.77) -1.09 Treatment 
control 
 Yes  14.55 (3.88) 14.29 (3.98) .57 
No   14.06 (5.05) 13.88 (4.68) .27 Illness 
coherence Yes  14.23 (5.56) 14.16 (5.36) .12 
No   21.86 (5.15) 21.40 (5.37) .62 Emotional 
representations Yes  22.47 (4.65) 23.08 (5.08) -1.09 
No   21.67 (5.59) 20.95 (5.89) 89 Internal cause 
 Yes  21.77 (6.22) 21.86 (6.43) -.13 
No   14.82 (4.65) 14.83 (3.79) -.02 External cause 
 Yes  14.11 (3.91) 15.27 (3.76) -2.69** (.14) 
No   9.24 (2.73) 9.96 (3.21) -1.66 Cause – risk 
factors 
 Yes  9.28 (2.81) 9.57 (3.28) -.87 
No   11.68 (3.09) 12.01 (3.16) -.75 BMQ Harm 
 Yes  12.71 (2.93) 13.17 (3.27) 1.29 
No   9.55 (2.86) 9.90 (2.87) -.88 BMQ Overuse 
 Yes  9.67 (2.74) 10.41 (2.90) -2.31* (.12) 
No   21.63 (3.34) 21.29 (3.25) .74 CAMBI Natural 
treatments 
 Yes  21.79 (3.39) 22.26 (3.47) -1.20 
No   19.63 (2.71) 18.77 (2.72) 2.26* (.14) CAMBI 
treatment 
participation Yes  20.03 (2.58) 19.44 (2.68) 1.99* (.11) 
No   21.65 (3.87) 21.06 (3.54) 1.15  
CAMBI holistic 
health Yes  22.41 (3.36) 21.92 (3.55) 1.24 
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Figure 6.2 Bar graphs to illustrate significant differences between responders and non-responders on IPQ-R, BMQ and 
CAMBI scales for both CAM-users and non-users   
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Table 6.3 Descriptive statistics and unrelated t-tests for responder 
/non-responder differences on Brief-COPE scales between CAM-
users and non-users with IBS 
  *p<.05  **p<.01  (Effect sizes r =.1 weak, r =.3 moderate, r =.5 strong) 
The range of possible scores was 2 – 8, with higher scores meaning greater adoption of a 
particular coping strategy.
 
Brief-COPE 
scale 
 
CAM use 
y/n 
 
Mean (SD) 
Responders (non-
users n=70; CAM-
users n=121) 
 
Mean (SD) Non-
Responders (non-
users n=187; CAM-
users n=224) 
 
t-value  
(effect size ‘r’) 
No  (n=257) 4.06 (1.66) 4.10 (1.65) -.17  
Self distraction 
Yes (n=345) 4.60 (1.60) 4.67 (1.67) -.38 
No   5.33 (1.73) 5.19 (1.72) .56  
Active coping 
Yes  6.02 (1.61) 6.03 (1.58) -.08 
No   2.36 (.68) 2.54 (.81) -1.82  
Denial 
Yes  2.62 (1.02) 3.00 (1.43) -2.92** (.16) 
No   2.50 (1.25) 2.78 (1.59) -1.46  
Substance use 
Yes  2.69 (1.46) 2.86 (1.59) -.98 
No   4.20 (1.95) 4.24 (1.75) -.14  Emotional 
support  Yes  4.71 (1.79) 4.77 (1.79) -.31 
No   4.86 (1.88) 4.86 (1.82) .01  Instrumental 
support  Yes  5.33 (1.83) 5.44 (1.72) -.54 
No   3.20 (1.41) 3.37 (1.52) -.83  Behavioural 
disengagement Yes  3.37 (1.51) 3.72 (1.74) -1.88 
No   3.33 (1.44) 3.73 (1.55) -1.87  Venting 
emotions Yes  3.84 (1.43) 4.24 (1.56) -2.30* (.12) 
No   3.39 (1.52) 3.35 (1.46) .16  Positive 
reframing Yes  3.57 (1.65) 3.94 (1.71) -1.92 
No   5.13 (1.91) 5.28 (1.72) -.62  
Planning 
Yes  5.85 (1.67) 6.02 (1.53) -.93 
No   3.84 (1.88) 3.58 (1.83) 1.03  
Humour 
Yes  3.70 (1.75) 4.23 (1.93) -2.49* (.13) 
No   5.40 (1.56) 5.40 (1.69) .02  
Acceptance 
Yes  5.83 (1.48) 5.78 (1.55) .29 
No   2.47 (.82) 2.42 (.76) .55  
Religion 
Yes  3.12 (1.67) 3.13 (1.67) -.10 
No   3.50 (1.79) 3.74 (1.89) -.93  
Self blame 
Yes  3.97 (1.90) 4.10 (1.98) -.62 
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Figure 6.3 Bar graphs to illustrate significant differences between responders and non-responders on Brief-COPE scales 
and IBS-QOL subscales in CAM-users 
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Table 6.4 Descriptive statistics and unrelated t-tests for responder 
/non-responder differences on IBS-QOL scale and subscales 
between CAM-users and non-users with IBS 
 
 
IBS-QOL 
scale/subscale 
 
CAM use 
y/n 
 
Mean (SD) 
Responders (non-
users n=70; CAM-
users n=121) 
 
Mean (SD) Non-
Responders (non-
users n=187; CAM-
users n=224) 
 
 
t-value  
(effect size ‘r’) 
No  (n=257) 49.74 (21.65) 49.69 (22.22) .01 Total IBS-QOL 
Score Yes (n=345) 46.18 (19.85) 41.39 (20.66) 2.08* (.11) 
No   45.64 (30.01) 44.95 (28.54) .17 
Dysphoria 
Yes  42.66 (26.40) 37.33 (26.94) 1.76 
No   46.49 (26.97) 46.95 (25.71) -.13 Interference 
with activity Yes  43.80 (23.69) 39.23 (25.17) 1.64 
No   49.91 (23.03) 51.57 (24.77) -.49 
Body Image 
Yes  46.30 (24.99) 42.25 (24.45) 1.46 
No   57.80 (22.12) 54.79 (23.41) .93 
Health worry 
Yes  53.48 (22.51) 50.56 (24.06) 1.10 
No   37.02 (28.75) 34.80 (29.16) .55 
Food avoidance 
Yes  30.81 (27.03) 25.37 (24.19) 1.85 
No   50.66 (25.43) 50.12 (28.19) .14 
Social reaction 
Yes  45.64 (25.59) 41.05 (25.73) 1.59 
No   63.21 (36.48) 68.12 (31.49) -.99 
Sexual score 
Yes  62.81 (31.64) 52.96 (34.68) 2.67* (.16) 
No   61.79 (27.71) 63.46 (27.18) -.44 Relationships 
score 
 Yes  58.13 (26.65) 55.17 (27.85) .96 
*p<.05    (Effect sizes r =.1 weak, r =.3 moderate, r =.5 strong) 
 
IBS-QOL scores have been transformed to a score out of 100.  Lower scores mean poorer 
reported quality of life. 
 
 
 
6.3.3 Differences in CSM variable scores at time one and time two 
To assess the proposition of the CSM that illness (and treatment) 
perceptions change over time, scales of the IPQ-R, BMQ and CAMBI 
were assessed for differences across the two study time-points.  This 
was conducted by the use of related t-tests and results are shown for 
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CAM-users and non-users (table 6.5).  Furthermore, changes in scores 
of the Brief-COPE and any change in IBS-QOL scores over time were 
also tested (tables 6.6 & 6.7).  Significant differences are illustrated in 
figures 6.4 to 6.8, where the error bars indicate plus or minus one 
standard deviation.  
 
6.3.3.1 Illness and treatment perceptions 
Table 6.5 shows descriptives and related t-test results for differences 
between time one and time two scores on IPQ-R, BMQ and CAMBI 
scales.  Alpha values for all scales are also shown which suggest all 
scales reached acceptable levels of internal reliability (Bryman, 2008; 
see also section 4.2.5.3).  In non-users, time two identity scores were 
significantly lower (M=6.09, SD=2.62) than time one (M=6.09, SD=2.62), 
t(68)= 2.11, p<.05.  A similar trend was observed for the illness 
consequences scale in CAM-users.  Time two consequences scores 
were significantly lower (M=21.37, SD=4.33) than time one scores 
(M=22.04, SD=4.16) in responders, t(117)= 2.10, p<.05.  The reverse 
was true for personal control scores in non-users.  Time two scores for 
personal control were significantly higher (M=19.92, SD=4.52) than at 
time one (M=18.79, SD=4.43), t(68)= -2.19, p<.05.  The only other 
change noted in illness and treatment perceptions was in emotional 
representations.  Here, scores in both groups were lower at time two.  In 
non-users, time two emotional representations were significantly lower 
(M=20.12, SD=5.65) than at time one (M=21.59, SD=5.23) in responders 
t(68)= 2.60, p<.05.  In CAM-users, time one emotional representations 
were significantly higher (M=22.56, SD=4.63) than at time two (M=21.30, 
SD=4.85), t(117)= 3.33, p<.01.  There were no other significant 
differences in IPQ-R, BMQ or CAMBI scores between the two time-points 
suggesting there was limited change in many of these dimensions 
between the two points of data capture.   Many of the observed effect 
sizes demonstrated small to moderate differences over time which can 
be observed visually in figure 6.4. 
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Table 6.5 Illness and treatment perception differences over the two 
study time-points in CAM-users and non-users 
*p<.05  **p<.01  (Effect sizes r =.1 weak, r =.3 moderate, r =.5 strong) 
 
 
Variable  
 
CAM use 
y/n 
 
Cronbach’s 
alpha  
(time 2) 
 
Mean (SD) time 
1 
 
Mean (SD) time 
2 
t-value  
(effect size 
‘r’) 
No  
(n=69) N/A 6.09 (2.62) 5.28 (2.57) 2.11* (.25) Identity 
 Yes 
(n=118) N/A 6.00 (2.41) 5.56 (2.41) 1.64 
No   .81 24.96 (4.02) 24.48 (4.29) 1.03 Timeline 
Chronic 
 Yes  .87 25.31 (3.89) 24.77 (3.98) 1.49 
No   .75 14.49 (2.99) 14.87 (3.14) -1.01 Timeline 
Cyclical 
 Yes  .73 15.04 (2.72) 15.09 (2.95) -.18 
No   .83 21.25 (4.19) 20.57 (5.15) 1.47 Consequences 
 Yes  .84 22.04 (4.16) 21.37 (4.33) 2.10* (.19) 
No   .85 18.79 (4.43) 19.92 (4.52) -2.19* (.20) Personal 
control 
 Yes  .87 20.19 (4.48) 20.68 (4.56) -1.27 
No   .80 13.81 (3.85) 14.30 (3.57) -1.03 Treatment 
control 
 Yes  .82 14.59 (3.86) 15.06 (4.41) -1.26 
No   .91 14.15 (5.06) 15.17 (5.07) -1.81 Illness 
coherence Yes  .94 14.16 (5.59) 14.75 (5.38) -1.23 
No   .86 21.59 (5.23) 20.12 (5.65) 2.60* (.23) Emotional 
representations Yes  .88 22.56 (4.63) 21.30 (4.85) 3.33** (.29) 
No   .84 21.54 (5.85) 21.47 (5.79) .12 Internal cause 
 Yes  .84 21.79 (6.26) 22.18 (6.33) -.84 
No   .64 14.76 (4.66) 14.63 (3.87) .26 External cause 
 Yes  .61 14.14 (3.90) 14.04 (3.86) .29 
No   .75 9.20 (2.75) 9.94 (2.82) -1.70 Cause - risk 
factors 
 Yes  .61 9.11 (2.79) 9.40 (3.09) -1.13 
No   .67 11.69 (3.04) 12.08 (2.85) -1.26 BMQ Harm 
 Yes  .61 12.71 (2.88) 12.63 (3.14) .34 
No   .63 9.51 (2.85) 9.79 (2.49) -.81 BMQ Overuse 
 Yes  .69 9.54 (2.72) 9.74 (2.69) -1.00 
No   .78 21.51 (3.26) 21.86 (3.13) -.94 CAMBI Natural 
treatments 
 Yes  .79 21.85 (3.38) 21.62 (3.19) .69 
No   .64 19.53 (2.73) 19.76 (2.86) -.62 CAMBI 
treatment 
participation Yes  .71 20.09 (2.61) 20.22 (2.80) -.52 
No   .61 21.66 (3.83) 21.50 (3.07) .34  
CAMBI holistic 
health Yes  .71 22.42 (3.38) 22.43 (3.36) -.03 
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Figure 6.4 Bar graphs to illustrate significant differences between time one and time two responses on IPQ-R scales for 
CAM-users and non-users 
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6.3.3.2 Brief-COPE scales 
Table 6.6 shows the differences over the two time-points in the Brief-
COPE scores where most of the significant differences detected were in 
CAM-users.  In CAM-users, instrumental support scores were found to 
be higher at time one (M=5.40, SD=1.87) than at time two (M=4.81, 
SD=1.74) in responders t(113)= 3.35, p<.01.  This trend was mirrored in 
CAM-users scores on the planning scale, where time one scores 
(M=5.87, SD=1.68) were significantly higher than time two (M=5.39, 
SD=1.72), t(113)= 2.82, p<.01.  CAM-user scores on the self blame scale 
were also significantly higher at time one (M=4.03, SD=3.60) than at time 
two (M=3.60, SD=1.58) in responders, t(113)= 2.42, p<.05.  Time two 
scores on the religion scale (M=2.65, SD=.89) were significantly lower 
than at time one (M=3.21, SD=1.72) in CAM-users, t(113)= 4.38, p<.001.    
The only difference detected in non-users was on the positive reframing 
scale, where time two scores were significantly higher (M=3.91, 
SD=1.64) than at time one (M=3.37, SD=1.46), t(64)= -2.63, p<.01.  
Significant differences are also illustrated in figure 6.5.  As with the IPQ-
R scales, many of the significant differences between Brief-COPE ratings 
at time one and two approached a moderate effect size, again 
suggesting a sizeable difference between ratings over the two time-
points.  
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Table 6.6 Brief-COPE scale differences over the two study time 
points in CAM-users and non-users  
*p<.05  **p<.01  ***p<.001    (Effect sizes r =.1 weak, r =.3 moderate, r =.5 strong) 
 
 
 
 
Brief-COPE 
scale 
 
CAM use 
y/n 
 
Cronbach’s 
alpha  
(time 2) 
 
Mean (SD) 
time 1 
 
Mean (SD) 
time 2 
 
t-value  
(effect size ‘r’) 
No  (n=65) .50 4.03 (1.62) 3.92 (1.72) .57  
Self distraction Yes 
(n=114) .66 4.67 (1.63) 4.54 (1.75) .77 
No .72 5.34 (1.73) 5.22 (1.70) .60  
Active coping Yes .73 6.05 (1.63) 5.87 (1.62) 1.14 
No .77 2.37 (.70) 2.34 (.94) .23  
Denial Yes .59 2.61 (1.03) 2.44 (.89) 1.76 
No .95 2.54 (1.29) 2.63 (1.33) -.54  
Substance use Yes .93 2.68 (1.43) 2.80 (1.51) -.996 
No .87 4.09 (1.91) 4.46 (2.02) -1.70  Emotional 
support  Yes .85 4.79 (1.81) 4.48 (1.82) 1.77 
No .74 4.75 (1.88) 4.67 (1.78) .34  Instrumental 
support  Yes .85 5.40 (1.87) 4.81 (1.74) 3.35** (.30) 
No .90 3.29 (1.42) 3.45 (1.81) -.69  Behavioural 
disengagement Yes .73 3.42 (1.52) 3.25 (1.43) 1.03 
No .59 3.37 (1.44) 3.59 (1.25) -1.08  Venting 
emotions Yes .56 3.98 (1.53) 3.99 (1.54) -.059 
No .75 3.37 (1.46) 3.91 (1.64) -2.63* (.24)  Positive 
reframing Yes .71 3.63 (1.68) 3.84 (1.57) -1.11 
No .77 5.14 (1.89) 5.26 (1.68) -.51  
Planning Yes .76 5.87 (1.68) 5.39 (1.72) 2.82** (.26) 
No .90 3.71 (1.81) 3.77 (1.94) -.29  
Humour Yes .91 3.66 (1.76) 3.86 (1.84) -1.09 
No .48 5.42 (1.53) 5.83 (1.40) -1.75  
Acceptance Yes .68 5.90 (1.51) 5.95 (1.53) -.30 
No .82 2.48 (.81) 2.60 (.93) -1.24  
Religion Yes .92 3.21 (1.72) 2.65 (.89) 4.38*** (.38) 
No .80 3.59 (1.80) 3.17 (1.63) 1.90  
Self blame Yes .78 4.03 (1.90) 3.60 (1.58) 2.42* (.22) 
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Figure 6.5 Bar graphs to illustrate significant differences between CAM-users’ and non-users’ ratings on Brief-COPE 
scales at time one and time two 
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6.3.3.3 IBS-QOL scales 
Table 6.6 shows the differences over the two time-points in IBS-QOL 
scale and subscales, where differences were observed in reported 
quality of life over the two time points in all IBS-QOL dimensions apart 
from the relationships subscale.  These differences were also consistent 
across CAM-users and non-users and suggest reported quality of life had 
improved at time two in both CAM-users and non-users.  However, in 
exploring IBS-QOL scores between CAM-users and non-users at time 
two, there were no significant differences found between the two groups.  
The trends of the group means however, suggested non-users reported 
better quality of life than CAM-users.  
 
In considering CAM-users, total IBS-QOL scores were significantly 
higher at time two (M=53.05, SD=19.70) than at time one (M=45.89, 
SD=19.81), t(124)= -5.97, p<.001.  Scores on the dysphoria subscale 
had also significantly improved at time two (M=51.34, SD=25.38) than at 
time one (M=42.17, SD=26.32) in responders, t(124)= -5.15, p<.001.  
Interference with activity scores were significantly lower at time one 
(M=43.66, SD=23.45) than time two (M=50.56, SD=23.18), t(124)= -5.20, 
p<.001.   Similarly, CAM-users’ scores on the body image IBS-QOL 
subscale were lower at time one (M=46.07, SD=25.15) than time two 
(M=54.40, SD=21.33), t(124)= -4.89, p<.001.   Scores on the health 
worry subscale were also significantly lower at time one (M=53.10, 
SD=22.46) than at time two (M=59.45, SD=22.84), t(124)= -3.33, p<.01.  
One difference unique to CAM-users was that on the food avoidance 
subscale, where time one-scores were significantly lower (M=30.76, 
SD=26.96) than time two (M=37.11, SD=24.42), t(124)= -3.13, p<.01.  
On the social reaction subscale, time one scores were once again 
significantly lower (M=45.23, SD=25.96) than at time two (M=54.67, 
SD=24.56), t(124)= -5.63, p<.001.  On the IBS-QOL sexual subscale, 
time one scores were also significantly lower (M=62.60, SD=32.16) than 
at time two (M=69.42, SD=27.89), t(124)= -2.96, p<.01.      
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In non-users similar trends were observed in IBS-QOL dimensions.  Total 
IBS-QOL scores were significantly lower at time one (M=49.51, 
SD=21.73) than at time two (M=55.23, SD=21.49), t(71)= -3.31, p<.01.  
Scores on the dysphoria subscale had also decreased significantly from 
time one (M=45.67, SD=30.36) to time two (M=54.09, SD=28.60) in 
responders, t(71)= -3.13, p<.01.  Interference with activity scores were 
also significantly lower at time one (M=46.29, SD=27.16) than at time two 
(M=50.88, SD=25.63), t(71)= -2.06, p<.05.   Body image scores were 
lower at time one (M=49.48, SD=23.0) than at time two (M=57.02, 
SD=22.26), t(71)= -4.12, p<.001.   Social reaction ratings were also 
significantly lower at time one (M=50.46, SD=25.64) than time two 
(M=57.02, SD=25.0), t(71)= -3.15, p<.01.  In examining the health worry 
subscale, time one scores were once again rated significantly lower 
(M=57.93, SD=22.71) than time two (M=64.32, SD=21.92), t(71)= -2.54, 
p<.05.  Lastly, in non-user scores on the IBS-QOL sexual subscale, time 
one scores were significantly lower (M=63.89, SD=36.25) than time two 
(M=72.84, SD=28.28), t(71)= -2.49, p<.05.  Many of the calculated effect 
sizes for IBS-QOL subscales were approaching a moderate effect size or 
greater, suggesting a substantial improvement in responder scores at 
study time two.  These significant differences and the magnitude of the 
differences can be observed in figures 6.6 to 6.8. 
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Table 6.7 IBS-QOL scale and subscale differences over the two 
study time points in CAM-users and non-users  
*p<.05  **p<.01  ***p<.001    (Effect sizes r =.1 weak, r =.3 moderate, r =.5 strong) 
¹ t-values represents comparison between CAM-users and non-users IBS-QOL scores at follow-
up (study time two) 
 
 
IBS-QOL 
dimension 
 
CAM use 
y/n 
 
Cronbach’s 
alpha  (time 
2) 
 
Mean (SD) 
time 1 
 
Mean (SD) 
time 2 
 
t-value  
(effect size ‘r’) 
No  
(n=72) .97 49.51 (21.73) 55.23 (21.49) -3.31** (.37) 
Total IBS-
QOL Score 
Yes 
(n=125) .96 45.89 (19.81) 53.05 (19.70) -5.97*** (.47) 
  t-value¹ .72  
No   .95 45.67 (30.36) 54.09 (28.60) -3.13** (.35) Dysphoria 
Yes  .94 42.17 (26.32) 51.34 (25.38) -5.15*** (.42) 
    t-value .70  
No   .90 46.29 (27.16) 50.88 (25.63) -2.06* (.24) Interference with activity 
Yes  .85 43.66 (23.45) 50.56 (23.18) -5.20*** (.42) 
    t-value .09  
No   .77 49.48 (23.0) 57.02 (22.26) -4.12*** (.44) Body Image 
Yes  .71 46.07 (25.15) 54.40 (21.33) -4.89*** (.40) 
    t-value .82  
No   .53 57.93 (22.71) 64.32 (21.92) -2.54* (.29) Health worry 
Yes  .58 53.10 (22.46) 59.45 (22.84) -3.33** (.29) 
    t-value 1.46  
No   .81 36.0 (29.0) 37.93 (25.74) -.59 Food avoidance 
Yes  .80 30.76 (26.96) 37.11 (24.72) -3.13** (.27) 
    t-value .22  
No   .81 50.46 (25.64) 57.02 (25.0) -3.15** (.35) Social reaction 
Yes  .81 45.23 (25.96) 54.67 (24.56) -5.63*** (.45) 
    t-value .64  
No   .85 63.89 (36.25) 72.84 (28.28) -2.49* (.28) Sexual score 
Yes  .83 62.60 (32.16) 69.42 (27.89) -2.96** (.26) 
    t-value .83  
No   .77 60.88 (27.93) 62.71 (26.64) -.66 Relationship score 
 Yes  .62 57.93 (26.71) 60.99 (24.54) -1.73 
    t-value .45  
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Figure 6.6 Bar graphs to illustrate significant differences between CAM-users’ and non-users’ ratings on IBS-QOL scale 
and subscales at time one and time two 
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Figure 6.7 Bar graphs to illustrate significant differences between CAM-users’ and non-users’ ratings on IBS-QOL 
subscales at time one and time two 
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Figure 6.8 Bar graphs to illustrate significant differences between CAM-users’ and non-users’ ratings on IBS-QOL 
subscales at time one and time two 
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6.3.4 Mediation tests of illness and treatment perceptions at time 
one, and Brief-COPE and IBS-QOL scores at time two 
As with the previous chapter, this study followed the Baron and Kenny 
(1986) steps to test for simple mediation effects. This being a follow-up 
study, the first stage was to determine a significant relationship between 
time one predictor variables and outcome at time two.  Relationships 
between illness representations and treatment beliefs and total scores 
from the IBS-QOL were examined for both CAM-users and non-users 
across the two time-points using simple regression analyses (including a 
single predictor and outcome).  This also enabled non-significant 
pathways to be excluded from further testing of mediation.  Non-
significant relationships between predictor and outcome would not satisfy 
stage one of the Baron and Kenny steps. 
 
6.3.4.1 Step one: Predictor (time one) and outcome (time two) 
relationship    
Table 6.8 illustrates the relationships between time one predictors 
(illness and treatment perceptions) and time two outcome (IBS-QOL 
scores) in both CAM-users and non-users.  Similar to the findings of 
chapter five, the trend that emerged was that ‘negative’ symptom-based 
perceptions (e.g. identity, consequences) resulted in poorer reported 
quality of life, whereas greater control and coherence resulted in 
participants reporting better quality of life.  Examination of the 
relationships in table 6.8 showed that in both non-users and CAM-users 
illness identity had no significant association with total IBS-QOL score 
(Beta=-.06, p>.05 and Beta=-.11, p>.05 respectively), in contrast to 
findings reported in the previous chapter.  Both non-users (Beta=-.45, 
p<.001) and CAM-users (Beta=-.24, p<.01) showed stronger chronic 
timeline perceptions at time one were related to lower IBS-QOL scores at 
time two.  Strong perceptions of illness consequences at time one were 
strongly and negatively related to reported quality of life at time two, in 
both CAM-users (Beta=-.67, p<.001) and non-users (Beta=-.62, p<.001).  
Higher ratings of personal control at time one resulted in higher reported 
quality of life at time two, in both CAM-users (Beta=.25, p<.01) and non-
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users (Beta=.45, p<.001).  Similarly, greater treatment control ratings at 
time one were positively related to reported quality of life at time two in 
CAM-users (Beta=.32, p<.01) and non-users (Beta=.28, p<.05).  Greater 
illness coherence at time one also resulted in higher quality of life being 
reported at time two (Beta=.24, p<.01) in CAM-users only.  
 
Stronger emotional representations at time one resulted in reduced 
reported quality of life at time two in both CAM-users (Beta=-.58, p<.001) 
and non-users (Beta=-.51, p<.001).  Stronger beliefs in external causal 
factors at time one were related to poorer reported quality of life in CAM-
users only at time two (Beta=-.18, p<.05).  It is notable that when 
comparing the treatment perceptions at time one with IBS-QOL scores at 
time two, no significant relationships were observed. 
 
 
Table 6.9 presents the linear relationships between emotional 
representations at time one and emotional outcome at time two (the IBS-
QOL Dysphoria subscale).  In both groups the relationship between 
stronger emotional representations and poorer reported emotional quality 
of life was present in both groups albeit slightly less than was observed 
in the previous study (CAM-users: Beta=-.57, p<.001; non-users: Beta=-
.50, p<.001). 
 
The illness perceptions and treatment beliefs that were significantly 
related to IBS-QOL scores (including emotional representations and 
emotional outcome) were then examined for relationships with scales on 
the Brief-COPE (step two of the Baron and Kenny criteria).  
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Table 6.8 Beta coefficients (and R² percentages) between IPQ-R, 
BMQ, CAMBI scales (time one) and IBS-QOL total score (time two) 
for CAM-users and non-users  
 
 
IPQ-R, BMQ & CAMBI scales 
(time one) 
 
Non-users: IBS-QOL time 
two total score (n=72) 
 
 
CAM-users: IBS-QOL time 
two total score (n=123) 
Identity -.06   (.04%) -.11   (1.21%) 
Timeline chronic -.45***   (20.25%) -.24**   (5.76) 
Timeline cyclical -.10   (1.0%) .02   (0.4%) 
Consequences -.62***   (38.44%) -.67***  (44.89%) 
Personal control .45***   (20.25%) .25**   (6.25%) 
Treatment control .28*   (7.84%) .32**   (10.24%) 
Illness coherence .15   (2.25%) .24**   (5.76%) 
Emotional representations -.51***   (26.01) -.58*** (33.64%) 
Internal cause .09   (.81%) -.04   (.16%) 
External cause -.15   (2.25%) -.18*   (3.24%) 
Risk factors .13   (1.69%) -.17   (2.89%) 
BMQ Harm .19   (3.61%) -.10   (1.0%) 
BMQ Overuse .04   (.16%) -.18   (3.24%) 
CAMBI Natural -.04   (.16%) .05   (.25%) 
CAMBI Participation -.03   (.09%) .13   (1.69%)   
CAMBI Holistic -.001    (0%) .06   (.04%) 
   * p<.05   **p<.01   *** p<.001 
 
 
 
 
Table 6.9 Beta coefficients (and R² percentages) between IPQ-R 
‘emotional representations’ scale and IBS-QOL ‘dysphoria’ 
subscale (emotional outcome) 
 
 Non-users:  
Dysphoria subscale 
(n=72) 
CAM-users: 
Dysphoria subscale 
(n=125) 
 
Emotional 
Representations 
 
-.50***   (25%)  
 
-.57***   (34.29%) 
   *** p<.001 
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6.3.4.2 Step two: predictor (time one) and mediator (time two) 
relationships  
Predictor variables that showed significant relationships with outcome 
(tables 6.8 & 6.9) were then examined for significant relationships with 
coping strategies.  Coping strategies that showed no relationship with 
predictor variables from table 6.8 were discarded.  Therefore only Brief-
COPE scales showing significant relationships with illness and treatment 
perceptions are presented.  This analysis was to establish the second of 
Baron and Kenny’s steps to test for mediation in that each predictor 
variable should be significantly related to the potential mediator.  
Significant relationships were then explored further with linear regression 
models in order to test for step three of the mediation criteria (sections 
6.2.5.3 and 5.2.5.3). 
 
6.3.4.2.1 Non-users  
In non-users (table 6.10), those who had a stronger belief in a chronic 
timeline at time one also had higher ratings of acceptance at time two 
(r=.26, p<.05).  Stronger perceptions of illness consequences at time one 
were related to greater use of denial (r=.31, p<.05) and venting emotions 
(r=.28, p<.05) at time two.  Greater personal control at time one was 
related to lower denial ratings (r=-.33, p<.01) and behavioural 
disengagement (r=-.26, p<.05) at time two.  Stronger emotional 
representations at time one were positively associated with more use of 
venting emotions at time two (r=.32, p<.05). 
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Table 6.10 Pearson’s r correlations between IPQ-R (time one) and 
Brief-COPE (time two) scales in non-users  
 
 
Brief-COPE scale (time two) 
 
 
IPQ-R scales 
(time one) 
(n=68) 
 
 
Denial  
 
Behavioural 
disengagement 
 
Emotional 
support 
 
Venting 
 
Acceptance 
Timeline chronic 
 .11 .23 -.03 -.02 .26
* 
Consequences 
 .31* .22 .06 .28
* .11 
Personal Control 
 -.33** -.26* .11 -.24
* .003 
Emotional 
representations .23 .18 .04 .32
** .04 
 
* p<.05   **p<.01    
 
 
 
6.3.4.2.2 CAM-users  
CAM-users (table 6.11) demonstrated a greater number of relationships 
between IPQ-R scales at time one and Brief-COPE scales at time two.  
Stronger perceptions of a chronic timeline at time one were related to 
greater behavioural disengagement (r=.26, p<.01), greater acceptance 
(r=.32, p<.01) and lower positive reframing (r=-.19, p<.05) at time two.  
Stronger perceptions of consequences of IBS at time one were related to 
more use of self-distraction (r=.20, p<.05), more behavioural 
disengagement (r=.23, p<.05) and greater self blame (r=.26, p<.01) at 
time two.  Stronger participant beliefs in external causes at time one 
resulted in greater self blame at time two (r=.20, p<.05).    
 
Higher ratings of personal control at time one resulted in lower 
behavioural disengagement (r=-.27, p<.01), but greater use of 
instrumental support (r=.28, p<.01), active coping (r=.21, p<.05) and 
positive reframing (r=.30, p<.01) at time two.  Similarly, stronger 
treatment control resulted in less use of behavioural disengagement (r=-
.33, p<.01) but greater use of positive reframing (r=.23, p<.05) in ratings 
at time two.  Higher coherence scores at time one were associated with 
less use of denial at time two (r=-.19, p<.05).  Stronger emotional 
representations at time one resulted in more behavioural disengagement 
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(r=.21, p<.05), more self blame (r=.19, p<.05) and greater substance use 
(r=.28, p<.01) at time two.   
 
Significant relationships between illness perceptions at time one and 
coping at time two identified from tables 6.10 and 6.11 were used to 
guide which variables were entered into multiple regression analyses to 
test for step three of the mediation criteria.   
 
6.3.4.3 Step three: mediator–outcome relationship, controlling for 
predictor variable  
 
Correlation matrices in the preceding subsections tested the first two 
steps of the Baron and Kenny criteria for simple mediation.  Significant 
relationships found between predictors at time one and outcome at time 
two (tables 6.8 and 6.9), guided subsequent exploration of relationships 
between predictors and potential mediators (tables 6.10 and 6.11).  The 
final stage of testing for mediation determined which scales of the Brief-
COPE predicted IBS-QOL scores whilst controlling for illness 
perceptions.   
 
Pathways that satisfied the Baron and Kenny criteria for mediation are 
presented in table 6.12 with non-significant regression models omitted.  
The reduction of the Beta coefficient between predictor and outcome and 
the significant pathway between mediator and outcome whilst controlling 
for each predictor is illustrated.  Regression coefficients from pathways 
XY and MY(X) are presented for both CAM-users and in one case, 
non-users.  The significance of mediation effects was tested using the 
Sobel test (Preacher & Hayes, 2004). Z-scores (and associated 
significance) are also presented to indicate the statistical significance of 
the mediation effect.   The Sobel test estimate and associated 
confidence intervals from the bootstrapping procedure are also provided 
(Preacher & Hayes, 2004).  An estimate of R² for the mediation effect in 
each model is also presented (Fairchild et al., 2009). 
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Table 6.11 Pearson’s r correlations between IPQ-R (time one) and Brief-COPE (time two) scales in CAM-users  
 
 
Brief-COPE scale (time two) 
 
 
IPQ-R scale (time 
one)  
 
(n=116) 
 
Self 
distraction 
 
Active 
coping 
 
Denial 
 
Substance 
use 
 
Instrumental 
support 
 
Behavioural 
disengagement 
 
Positive 
reframing 
 
Acceptance 
 
Self blame 
Timeline chronic .05 .05 -.07 .05 .02 .26** -.19* .32** .06 
Consequences 
 .20
* .10 .17 .09 .001 .23* .05 .02 .26** 
Personal control .01 .21* .03 -.02 .28** -.27** .30** .07 .02 
Treatment control -.02 .13 .001 -.10 .17 -.33** .23* -.08 -.07 
Illness coherence -.05 -.09 -.19* -.12 -.11 -.04 .09 .08 -.13 
Emotional 
representations .17 -.01 .14 .28
** .07 .21* -.04 -.04 .19* 
External cause -.04 -.04 .12 .16 -.01 .02 .02 -.16 .20* 
   * p<.05   **p<.01
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6.3.4.3.1 Step three of mediation testing: IPQ-R scales (time one) 
and IBS-QOL scores (time two) 
 
Step three of establishing mediation was considered for IPQ-R symptom 
based scales that were shown to be significantly related to IBS-QOL 
scores (outcome) and scales of the Brief-COPE (potential mediators).  
Table 6.12 illustrates regression coefficient values for the mediator–
outcome pathway, whilst controlling for the predictor (equation 2 in each 
table).  Coefficient values are provided for each predictor variable 
showing coefficient values for the direct path to outcome and to illustrate 
any reduction in effect due to inclusion of the mediator in each regression 
model.  Mediation effects were detected solely in CAM-users with only 
one significant effect observed between behavioural disengagement and 
personal control in non-users. 
 
Chronic timeline  
In CAM-users, the coping strategy of behavioural disengagement fully 
mediated the pathway between the IPQ-R chronic timeline scale at time 
one and IBS-QOL time two scores.  Behavioural disengagement (R² 
change = .19) demonstrated a significant mediation effect (z=-2.56, 
p<.05) reducing the effect of timeline beliefs to non-significance (Beta= -
.13, p>.05) of which the mediation effect accounted for 4.34 (18.08%) of 
the total variance explained of 24%.   
 
Illness consequences   
There were two coping strategies that partially mediated the pathway 
between the IPQ-R illness consequences scale at time one and IBS-QOL 
scores at time two in CAM-users.  Behavioural disengagement (R² 
change = .03) partially mediated the illness consequences–IBS-QOL 
pathway (z=-2.64, p<.01) reducing the effect of illness consequences 
(Beta= -.58, p<.001) and accounting for 13.57 (25.13%) of the overall 
outcome variance predicted of 54%.  A similar mediation effect was 
detected when the role of self blame was assessed.  In CAM-users, self 
blame (R² change = .06) partially mediated the illness consequences–
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IBS-QOL pathway (z=-2.48, p<.05) which explained 12.25 (24.50%) of 
the 50% variance in outcome predicted and reducing the effect of illness 
consequences (Beta= -.60, p<.001).   
 
IPQ-R Personal control  
There was evidence that behavioural disengagement mediated the 
personal control–IBS-QOL pathway in both CAM-users and non-users.  
In CAM-users, a significant full mediation effect of behavioural 
disengagement (R² change = .18) was detected (z=2.82, p<.01) which 
reduced the effect of personal control (Beta= .14, p>.05) to non-
significance.  This effect accounted for 5.34 (22.25%) of the overall 
variance of 24%.  In non-users however, behavioural disengagement (R² 
change = .11), although suppressing the direct effect of personal control 
(Beta= .35, p<.01), the mediation effect was found to be not significant 
(z=1.89, p>.05ns).   
 
IPQ-R Treatment control  
In CAM-users behavioural disengagement was found to partially mediate 
the treatment control–IBS-QOL pathway.  A significant partial mediation 
effect of behavioural disengagement (R² change = .16) was detected 
(z=2.99, p<.01) which reduced the effect of treatment control (Beta= .18, 
p<.05) which accounted for 7.07 (28.28%) of the overall variance in IBS-
QOL scores at time two of 25%.   
 
Emotional representations  
In CAM-users, both behavioural disengagement and self blame partially 
mediated the emotional representations–IBS-QOL pathway.  Behavioural 
disengagement (R² change = .13) was as a significant partial mediator 
(z=-2.37, p<.05) which reduced the effect of emotional representations 
(Beta= -.49, p<.001) and accounted for 10.57 (23.49%) of the total 
variance in the model of 45%.  Similarly, self blame (R² change = .10) 
partially mediated the emotional representations–IBS-QOL pathway (z=-
2.08, p<.05) reducing the effect of emotional representations (Beta= -.51, 
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p<.001) and accounted for 8.46 (20.14%) of the total variance explained 
of 42%.   
 
IPQ-R external cause scale  
In considering the external cause (time one)–IBS-QOL (time two) 
pathway, self blame (time two) was found to be a significant mediator in 
CAM-users.  Self blame (R² change = .16) was found to fully mediate the 
external cause–IBS-QOL pathway (z=-2.06, p<.05) reducing the effect of 
external cause to non-significance (Beta= -.11, p>.05ns) and accounting 
for 2.5 (13.89%) of the total variance of in IBS-QOL scores at time two of 
18%.   
 
The mediation effects detected followed a similar pattern to findings in 
chapter five.  The majority of IPQ-R scales were positively associated 
with maladaptive or dysfunctional coping strategies, which themselves 
were related to lower IBS-QOL scores at time two.  There were no 
mediation effects detected with adaptive coping strategies.  There were 
three models that demonstrated full mediation and more variance in 
outcome appeared to be explained by the addition of coping to models 
than reported in the previous chapter. 
 
6.3.4.3.2 Step three of mediation testing: for IPQ-R emotional 
representation (time one) and emotional outcome (time two) 
As the previous chapter illustrated, emotional representations of IBS 
have an influence on reported emotional quality of life (represented by 
utilising the IBS-QOL dysphoria subscale).  On testing for mediation 
using follow-up Brief-COPE and Dysphoria scores, there was 
substantially less mediation detected than documented in the previous 
chapter.  As proposed in chapter five, this component of the research 
was also largely exploratory, as there is speculation that emotional 
representations will initiate use of different coping strategies to cognitive 
representations of illness (Cameron & Jago, 2008).  The two mediation 
effects detected were again specific to CAM-users. 
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Table 6.12 Mediation tests for IPQ-R scales at time one and 
outcome (time two IBS-QOL scores) at time two for CAM-users 
(non-users are indicated where applicable) 
 
1)Predictor variable (IPQ-R) 
2)Potential mediator (Brief-
COPE scale) 
 
Adjusted 
R² (R² 
change) 
 
Beta Coefficients 
(Predictor without 
mediator) 
 
Mediation effect (z)  
 
(Sobel estimate and 
Confidence interval) 
R² % for 
mediation 
effect (% of 
total R²)  
1) Timeline chronic 
2) Behavioural disengagement 
F(2,122)= 20.34*** 
 
 
.24 (.19) 
 
-.13ns  (-.24**) 
-.45*** 
-2.56* 
 
(-.59, 99%CI= -1.23, -.03) 
4.34 
 
(18.08) 
1) Illness consequences 
2) Behavioural disengagement  
F(2,122)= 73.31*** 
 
 
.54 (.10) 
 
-.58***  (-.67***) 
-.33*** 
-2.64** 
 
(-.40, 99%CI= -.84, -.04) 
13.57 
 
(25.13) 
1) Illness consequences 
2) Self blame 
F(2,122)= 63.14*** 
 
 
.50 (.06) 
 
-.60***  (-.67***) 
-.26*** 
-2.48* 
 
(-.34, 99%CI= -.87, -.04) 
12.25 
 
(24.5) 
1) Personal control 
2) Behavioural disengagement 
F(2,122)= 20.49***  
 
 
.24 (.18) 
.14ns   (.27***) 
-.45*** 
2.82** 
 
(.57, 99%CI= .08, .1.17) 
5.34 
 
(22.25) 
1) Treatment control 
2) Behavioural disengagement 
F(2,122)= 21.82*** 
 
 
.25 (.16) 
.18*  (.32***) 
-.43*** 
 
2.99** 
 
(.69, 99%CI= .21, 1.30) 
7.07 
 
(28.28) 
1) Emotional representations 
2) Behavioural disengagement 
F(2,122)= 51.86*** 
 
 
.45 (.13) 
-.49*** (-.58***) 
-.37*** 
-2.37* 
 
(-.37, 99%CI= -.79, -.03) 
10.57 
 
(23.49) 
1) Emotional representations 
2) Self blame 
F(2,122)= 46.05*** 
 
 
.42 (.10) 
-.51*** (-.58***) 
-.32*** 
-2.08* 
 
(-.30, 95%CI= -.63, -.05) 
8.46 
 
(20.14) 
1) External cause 
2) Self blame 
F(2,122)= 14.75*** 
 
.18 (.16) 
-.11ns (-.19*) 
-.41*** 
-2.06* 
 
(-.44, 99%CI= -1.03, -.01) 
 
2.5 
 
(13.89) 
Non-users: 
 
1) Personal control 
2) Behavioural disengagement 
F(2,69)= 15.57***  
 
 
 
.29 (.11) 
 
 
.35** (.45***) 
-.35** 
 
 
1.89ns 
 
(.45, 95%CI= .06, .98) 
 
 
- 
 
- 
Emotional outcome: 
 
1) Emotional representations 
2) Behavioural disengagement 
 
F(2,122)= 57.91*** 
 
 
 
.48 (.17) 
 
 
-.47*** (-.57***) 
-.42*** 
 
-2.45* 
 
(-.55, 99%CI= -1.23, -.03) 
 
11.43 
 
(23.81) 
Emotional outcome: 
 
1) Emotional representations 
2) Self blame 
 
F(2,366)= 46.59*** 
 
 
 
.42 (.11) 
 
 
-.50*** (-.57***) 
-.34*** 
 
-2.11* 
 
(-.40, 95%CI= -.77, -.06) 
 
 
8.69 
 
(18.10) 
* p<.05   **p<.01   *** p<.001 
 
Key for table 6.12 (see also table 5.9): 
Outcome variable = total IBS-QOL score at time two.  Emotional outcome at time two 
(Dysphoria IBS-QOL subscale) indicated on table. 
1) Predictor variable (IPQ-R scale). 
2) Mediator (Brief-COPE scale). 
 
All figures are for CAM-users except for where indicated as non-users. 
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As shown in table 6.12, behavioural disengagement (R² change = .17) 
was found to partially mediate the emotional representation–Dysphoria 
pathway (z=-2.45, p<.05) and reduced the effect of emotional 
representation (Beta= -.47, p<.001).  The mediation effect accounted for 
11.43 (23.81%) of the total variance explained of 48%.  Self blame (R² 
change = .11) was found to show a partial mediation effect (z=-2.11, 
p<.05) reducing the effect of emotional representations (Beta= -.50, 
p<.001) and accounting for 8.69 (18.10%) of the total variance in the 
model of 42%.   
 
In the case of emotional representations and emotional outcome, the 
variance added by coping styles was noticeably greater than reported in 
the previous chapter.  The variance in dysphoria scores that was 
predicted by emotional representations was large and patterns of 
relationships between the variable was consistent with previous 
observations.  Stronger emotional representations were related to poorer 
emotional quality of life via greater adoption of the maladaptive coping 
strategies of behavioural disengagement and self blame. 
 
 
6.4 Discussion 
This study addressed three objectives.  However with the rate of attrition 
between study time one and time two, drop out was also considered.  
Differences between responders (i.e. those that participated in this study) 
and non-responders on time one measures were examined between 
CAM-users and non-users.  The first main aim of the study examined for 
changes in CSM variables over time in CAM-users and non-users with 
IBS.  Secondly, the influence of illness perceptions and treatment beliefs 
on reported quality of life after a minimum of six months in CAM-users 
and non-users was examined.  Thirdly, statistical testing was conducted 
to assess for evidence of coping strategies (time two) mediating 
pathways between illness and treatment perceptions (at time one) and 
reported quality of life (at time two) across CAM-users and non-users 
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with IBS.  Additionally, this final objective also included examining the 
influence of emotional representations on emotional outcome.   
 
 
6.4.1. Differences between responders and non-responders on CSM 
variables 
In assessing potential differences between participants that opted to take 
part in this research at time one and those that were recruited for follow-
up, there were minimal differences across CSM measures.  Most 
variables suggested there were no significant differences between 
participants taking part in both studies and those only taking part at time 
one.  In CAM-users however, time one scores on illness identity, external 
cause and BMQ overuse scales were all significantly lower in responders 
taking part in the follow-up.  The exception to this trend was noted in the 
CAMBI treatment participation scale in which responders’ scores were 
significantly higher than those of non-responders.  This trend on 
treatment participation scores was again evident in non-users, where the 
only other significant difference between scores was on the illness 
identity scale, where responders reported higher scores than non-
responders.  As reported, the effect sizes in these cases were small 
suggesting the differences were minimal. 
 
There were also minimal differences between responder and non-
responder scores on the Brief-COPE and these were limited to CAM-
users.  Scores on the humour, venting emotions and denial scales were 
all significantly lower in responders when compared to non-responders.  
Again, when comparing IBS-QOL scale and subscale scores in 
responders and non-responders in the two groups, there were two 
subscales where significant differences were found, and these were 
again isolated to CAM-users.  Responders that were CAM-users 
reported significantly higher scores on the sexual subscale of the IBS-
QOL as well as the total IBS-QOL score.  This suggests that reported 
quality of life was significantly better for responders that were CAM-users 
at time one than it was for non-responders.  The calculated effects sizes 
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for these variables were located between small and moderate, 
suggesting the differences were stronger than observed in the IPQ-R 
scales. 
 
These findings suggest, although there were a number of significant 
differences between responders and non-responders detected (in both 
CAM-users and non-users), that any differences overall were minimal.  
There may to an extent also be some effect accounted for by the 
discrepancy in numbers in those taking part at study time one and time 
two.  Furthermore, the similarities between responders and non-
responders who were CAM-users (section 6.3.1) suggest minimal 
differences between responders and non-responders.  These findings 
add weight to the decision to examine only those participants that 
participated at both time points. 
 
6.4.2 Differences in CSM variable scores over time 
In examining differences between scores at time one and time two in 
responders, there were minimal differences observed.  These were also 
isolated to the IPQ-R where the most notable finding was that both CAM-
user and non-user emotional representations significantly ‘improved’ over 
the two study time points.  This may represent a degree of acceptance or 
acclimatising to having IBS so it effectively becomes less distressing 
over time.  Non-user responders also reported significantly lower illness 
identity scores at time two than CAM-users as well as reporting greater 
personal control at time two than CAM-users.  It is plausible that these 
two components may be related although findings from chapter five 
showed they were related in CAM-users only.  It is however possible that 
a declining number of IBS symptoms may be paralleled by an increase in 
reported personal control.  The only other significant difference between 
time one and time two IPQ-R ratings was in CAM-users’ illness 
consequences scores, which were significantly lower at time two, 
suggesting a reduction in strength of perception of wider consequences 
of IBS.  These differences contradict findings from Rutter and Rutter 
(2007), where no differences over time were observed on scores of the 
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IPQ at three time points.  Other studies in other chronic illness 
populations however, have shown similar findings, especially in respect 
of emotional representations. 
 
In contrast to Rutter and Rutter (2007), Lee et al. (2010), examining 
patients recovering from traumatic injury, found that all IPQ-R 
components apart from the two timeline scales differed significantly over 
time.  Similarly, Kaptein et al. (2010) found in those suffering with 
osteoarthritis over a six year period that timeline chronic and illness 
coherence scores significantly increased, whereas personal control and 
emotional representations scores decreased.  Bijsterbosch et al. (2009) 
also found significantly higher scores over a six year period in 
osteoarthritis patients on the timeline chronic and illness coherence 
scales.  Personal control and emotional representation scores were 
found to be significantly lower after six years.  Similarly, Foster et al. 
(2008) observed positive changes in IPQ-R consequences and emotional 
representations in those patients with a positive clinical outcome (from a 
self-report disability measure) in those affected by lower back pain at six 
months.  In those with a negative outcome at six months, increased 
personal and treatment control were observed. 
 
The finding that many IPQ-R scores were relatively static over time may 
suggest that changes in individuals’ illness perceptions take place over a 
longer time period or are more subtle than to be detected by a 
quantitative measure such as the IPQ or IPQ-R in IBS populations.  
Many studies have detected differences in the IPQ-R over time so it is 
suggested that further work is need to establish changes to illness 
perceptions do take place according to the CSM. 
 
There were some observed differences in Brief-COPE scales over time, 
most notably in CAM-users, where it was observed there was 
significantly less use of the coping strategies of religion, planning and 
instrumental support at time two.  In non-users, there was significantly 
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more use of positive reframing at time two.  The trend of less use of what 
may be considered functional or adaptive coping strategies in CAM-users 
has a degree of concordance with Rutter and Rutter (2007) who found 
avoidant coping strategies more prominent in those with IBS over a 12 
month period. 
 
The most noticeable differences were observed in the IBS-QOL scale 
and subscales over time, where differences were observed in both CAM-
users and non-users across the two time points.  In both groups, IBS-
QOL scores had significantly improved on all but the relationships 
subscale (for both groups) and the food avoidance subscale (non-users).  
The findings presented in table 6.4, between responders and non-
responders suggest this improvement in IBS-QOL scores has little to do 
with any factor particular to participants who took part in both time-points 
of the study.  It is possible that scores actually improved over time, a 
degree of response shift has been observed or there may be a potential 
confounding issue with the amount of time participants have had IBS.   
Response shift may take place when individuals’ perceptions of what 
their own quality of life means may have changed during the duration of 
a study (Ring et al., 2005; Schwartz & Sprangers, 1999).  The IBS-QOL 
however, was developed using several dimensions that captured the 
specific influence of IBS on quality of life ratings so response shift may 
be only a partial explanation.  As many in this study reported varying 
lengths of time with symptoms, this may have had some effect on the 
reported improvement in quality of life ratings.  Further study may 
consider if such changes occur in individuals who have been with IBS 
symptoms for a similar length of time and how quality of life may change 
over time. 
 
It was noted that CAM-users reported IBS-QOL scores at time two were 
not significantly different than non-users, in contrast to what was 
observed at time one.  The lack of difference between the groups in 
reported quality of life at study time two may suggest that CAM use over 
time, which in many participants involved the use of several different 
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CAM treatments, does little to positively influence quality of life ratings 
when compared to those with IBS not using CAM.   
 
6.4.3 Illness perceptions, treatment beliefs, coping and outcome 
In assessing the influence of illness and treatment perceptions at time 
one on Brief-COPE and IBS-QOL scores at time two, it was observed 
that no treatment beliefs were significantly related to Brief-COPE and 
IBS-QOL scores at time two.  This was consistent across both CAM-
users and non-users.  As suggested in the previous chapter, this may be 
because treatment beliefs may be more noticeably associated with 
specific coping behaviours such as repeated CAM use (Bishop et al., 
2008) or adherence to conventional medication (Horne & Weinman, 
2002).   
    
In assessing the pathways from illness perceptions at time one to IBS-
QOL scores at time two, it was detected that scores were similar across 
CAM-users and non-users, although external causal perceptions and 
illness coherence (time one) were related to lower and higher IBS-QOL 
scores at time two respectively in CAM-users.  This finding is consistent 
with other studies that have found direct relationships between illness 
perceptions and outcomes in both cross-sectional and longitudinal 
studies (Bijsterbosch et al., 2009; Foster et al., 2008; Hagger & Orbell, 
2003; Kaptein et al., 2010; Rutter & Rutter, 2002; 2007).  These findings 
also show consistency with previous work outside the CSM framework 
that have argued illness related perceptions have an effect on reported 
quality of life in those affected with IBS (Hahn et al., 1997; Naliboff et al., 
1998; Spiegel et al., 2008). 
 
Emotional representations from time one were strongly negatively related 
to IBS-QOL time two scores in both groups, as well as being negatively 
related to emotional outcome (the IBS-QOL Dysphoria subscale).  
Although many studies now utilise the IPQ-R, specific measures of 
emotional outcome are less common.  Bijsterbosch et al. (2009), Foster 
et al. (2008) and Kaptein et al. (2010) all found significant relationships 
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between emotional representations and outcome over time, but omitted 
explicit consideration of emotional outcomes.  Furthermore, the findings 
in this chapter seemingly contradict findings presented in chapter five 
where emotional representations had a greater influence on emotional 
outcomes in non-users.  In both groups it should be noted, the strength 
of relationship between emotional representation and outcome was 
substantially less than in the previous study (chapter five).  These 
relationships do however support the suggestion that those with IBS 
‘catastrophise’ (Drossman et al., 1999; Lackner et al., 2004) their 
symptoms, although the lower emotional representation scores at time 
two suggest this could be to a lesser extent over time. 
 
Findings also showed a smaller number of correlations between time one 
illness perceptions and Brief-COPE scales at time two when compared 
with results in the previous chapter (at time one only).  A greater number 
of relationships however, were detected in CAM-users that suggested 
CAM-users’ illness perceptions are influencing coping strategies over 
time more so than non-users.  However, it should be noted that most of 
the correlation coefficients were fairly small in size and the greater 
number of relationships in CAM-users may be due to the greater number 
of CAM-users compared to non-users.   
 
In terms of mediation testing of pathways between time one illness 
perceptions and time two IBS-QOL scores, mediation effects were only 
detected in CAM-users.  Behavioural disengagement fully mediated the 
pathway from chronic timeline to IBS-QOL, meaning greater timeline 
beliefs were related to greater use of behavioural disengagement, which 
led to lower IBS-QOL scores.  The positive relationship between 
personal control and IBS-QOL scores was also fully mediated by less 
use of behavioural disengagement.  Higher illness consequences scores 
were related to lower IBS-QOL ratings, and this pathway was partially 
mediated by both greater use of self blame and behavioural 
disengagement.  Increased treatment control also led to higher IBS-QOL 
ratings, and this pathway was also partially mediated by less use of 
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behavioural disengagement.  Higher emotional representations were 
related to lower IBS-QOL and Dysphoria (emotional outcome) ratings 
and these pathways were partially mediated by both greater use of 
behavioural disengagement and self blame.  Greater use of self blame 
also fully mediated the pathway between higher external cause 
perceptions and lower IBS-QOL ratings.  It was also observed that 
overall, coping strategies added more variance to the regression models 
testing for mediation than reported in chapter five.  The only coping 
strategy to show a similar effect to the previous study was self blame in 
the illness consequences–IBS-QOL pathway.  Furthermore, in contrast to 
findings in chapter five, self blame fully mediated the external cause and 
IBS-QOL pathway.  In examining the same variables at time one (chapter 
five), this pathway demonstrated no mediation effect in CAM-users.  
These findings seem to contradict other studies that have found no 
mediation over time (e.g. Llewellyn et al., 2007; Rutter & Rutter, 2007; 
Treharne et al., 2008).  This study appears to offer a unique finding in 
that mediation was detected over time in sample of people affected by 
IBS that were using CAM to relieve their symptoms.   
 
It may only be speculated why ‘behavioural disengagement’ and ‘self 
blame’ are implicated as mediating variables in CAM-users.  Based on 
these findings, CAM-users with stronger perceptions of chronic timeline, 
consequences and emotional representations may experience a greater 
degree of ‘giving up’ trying to adopt any behavioural strategies to deal 
with their IBS symptoms.  One possibility is that the use of repeated CAM 
treatments for a number of years has resulted in many reaching a point 
where it is felt nothing will alleviate symptoms.  It may only be speculated 
that the relevance of the coping strategy of self blame may be linked to 
use of many CAM treatments that may be seen to reduce ‘stress’ rather 
than IBS symptoms per se, which may be linked to causal beliefs about 
stress being a cause or maintaining factor in IBS (Casiday et al., 2009; 
Hungin et al., 2004).  These findings may be contrasted with observed 
higher personal and treatment control ratings, which had less influence 
on the use of behavioural disengagement and self blame.  These 
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pathways resulted in more adaptive outcomes where reported quality of 
life was seen to be higher.   
 
6.4.4 Limitations of the study 
Although this study has addressed one of the potential criticisms of 
studies presented in the previous two chapters in conducting a 
prospective follow-up, there still exist some possible methodological 
issues most notably that of participant attrition.  The discrepancy 
between the number of participants in the study reported at time one 
(chapters four and five) and the follow-up study in this chapter is clearly 
evident.  It should be noted that over a third of participants from time one 
opted not to volunteer contact information to take part in the follow-up.  
From those that did take part, a substantial number were not contactable, 
largely due to email address changes, closed email accounts or full 
inboxes.  From those that were successfully contacted, many still only 
visited the study website but did not take part or dropped out during the 
study, as consistent with information participants were given at the study 
outset, participants dropping out would not have their data used in the 
study.  Besides, this, the study was still able to demonstrate unique 
findings in the form of mediation effects being observed in CAM-users. 
 
The observed mediation effects were limited to CAM-users only which 
may suggest a real effect that is evident only in these participants.  
However it should also be pointed out that the CAM-user group did 
outnumber the non-users by just over a third.  This could have facilitated 
observation of significant mediation effects.   Furthermore, there is the 
potential problem of ‘response shift’ in that IBS-QOL total scores 
improved significantly over the two time-points in both groups.  This may 
be down to a change in perception of how individuals judged their quality 
of life or a genuine improvement in reported quality of life has been 
observed.  With this in mind, it is possible over time that individuals 
become more accustomed to fluctuation in IBS symptoms (i.e. flare-ups 
and periods of relief) and are therefore rating their quality of life as ‘less 
worse’ than it was rather than feeling it had improved.  This is one factor 
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that could be examined by further research, possibly by utilising both 
self-report measures and qualitative methodologies to address quality of 
life changes in those affected by IBS over time. 
 
As mediation effects were only present in CAM-users, it is possible there 
may be some issue with the measurement of coping strategies.  
Leventhal et al. (1998) suggest the influence of illness perceptions on 
many different coping ‘procedures’, meaning self-report checklists of 
coping strategies (such as the Brief-COPE) may not be the best way to 
assess coping (Hagger & Orbell, 2003; Leventhal et al., 1998).  However, 
the effects observed in CAM-users would seem to somewhat contradict 
the possibility of measurement issues.  Although mediation effects were 
not common, those that were observed were largely approaching 
moderately strong (table 6.12, illustrates the unique variance in outcome 
accounted for by each mediation effect).  Furthermore, the discrete 
scales of the Brief-COPE were used in full (as observed in chapter five), 
unlike other CSM studies where such discrete categories are combined 
to form more general coping scales (e.g. Rutter & Rutter, 2002; 2007).  It 
may be acknowledged the Brief-COPE may not be the most effective 
measure of coping, it would however, seem to be sensitive enough to 
detect coping strategies in the context of CSM based studies.  The Brief-
COPE is also largely theoretically consistent with the COPE as many 
items and scales from the original COPE measure are included on the 
Brief-COPE.  Furthermore, as considered in the previous chapter, it is 
also possible that several coping strategies may act as multiple 
mediators, however, the significant relationships and pathways observed 
in this study offer areas where intervention or future study could be 
targeted.   
 
To add weight to these findings, future study could seek to control some 
of the possible confounding factors in this study.  Firstly, measurement of 
illness perceptions (and treatment beliefs), coping and outcome could be 
conducted at standalone time points, reducing any priming effect of 
completing similar questionnaires.  Relationships could be examined 
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over longer time points, possibly over a number of years as with some of 
the osteoarthritis studies considered earlier.  Number of CAM treatments 
(and conventional medication treatments) could also be considered at 
both time one and subsequent time-points, to assess any relationship 
between coping strategies and specific coping behaviours (Searle et al., 
2007).  Furthermore, in relation to possible limitations of using an internet 
sample considered in chapters four and five, it may be advisable to 
assess the findings of this study against a sample of participants not 
recruited via the internet, such as from primary care or a GI outpatient 
clinic.  
   
6.4.5 Conclusions and implications  
This study adds both important and original findings in relation to CSM 
pathways in those affected by IBS.  To date, no published studies have 
examined simple mediation effects in a group of CAM-users and non-
users over two time-points.  This study measured a wide range of coping 
strategies and as with the previous chapter tested for significance of any 
detected mediation effects.  The extended CSM, on the basis of the 
findings in this chapter, appears less worthwhile in examining influence 
on reported quality of life over time, although further investigation is 
recommended.  Despite this, the pathways between illness perceptions 
and outcome yielded some unique findings. 
 
There were limited differences between responders and non-responders 
which justified using only responder data from time one which was 
compared with responder data collected at time two.  There was also 
some evidence of changes in some components of illness perceptions 
over the two time-points most notably (in both groups) participants 
emotional representations significantly decreased at time two.  In 
addition, a small number of time two Brief-COPE scores that were 
significantly different from time one.  Several differences were observed 
between IBS-QOL scores at time one and time two in both groups.  As 
considered earlier, further study may investigate if this is due to response 
shift or a genuine change over time.  The positive change in IBS-QOL 
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scores across both groups at study time two when compared with time 
one, appeared not to be associated with CAM use.    
 
This study has also, to a degree, added support to the CSM by 
demonstrating that, in certain cases, coping strategies do (often partially) 
mediate the pathway between illness perceptions and outcome, although 
this was unique to CAM-users.  In this study, the notable influences on 
reported quality of life were illness consequences and emotional 
representations and this was evident in both groups.  As stated, 
mediation effects were unique to CAM-users only, where both self blame 
and behavioural disengagement were implicated as mediating variables.  
This finding contradicts many other longitudinal CSM studies that either 
found no mediation over time (e.g. in IBS Rutter & Rutter, 2007) or did 
not test for mediation effects (e.g. Kaptein et al., 2010).  Emotional 
representations, as found in the previous chapter, were also influences 
on emotional outcome, however this pathway was only partially mediated 
by behavioural disengagement and self blame in CAM-users.   
 
In comparison with findings from the previous chapter, the relationships 
of CAM-users’ and non-users’ illness perceptions (time one) with 
reported quality of life (time two) was substantially less.  It was also 
notable that the variances in outcome predicted by regression models 
testing for mediation were largely comparable in size with findings 
reported in the previous chapter in CAM-users.  This strengthens the 
theory that illness perceptions are important influences on quality of life 
judgements.  In this study, this is especially noticeable in CAM-users, 
where this relationship is sometimes partially explained by the coping 
strategies of self blame and behavioural disengagement.     
    
This study allows a degree of causal influence to be inferred as illness 
perceptions were shown to influence IBS-QOL scores over time.  In both 
groups, although to a greater extent in CAM-users, coping strategies at 
time two were influenced by time one illness perceptions.  In CAM-users, 
self blame and behavioural disengagement measured at time two were 
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found to (largely partially) mediate the relationship between time one 
illness perceptions and time two IBS-QOL ratings.  The inclusion of 
mediation testing allows both a degree of both theoretical and statistical 
support for the CSM in that such coping strategies are key processes in 
how illness perceptions influence reported quality of life in CAM-users 
with IBS.   
 
These findings suggest possible pathways for interventions based on 
changing illness perceptions.  Chapters four and five suggest those using 
CAM to relieve IBS appear to perceive a more severe illness experience 
in IBS (van Tilburg et al., 2008), something also found to be consistent 
with CAM-users with IBD (Langmead et al., 2002).  By focusing on 
reducing emotional representations and illness consequences and by 
enhancing control perceptions, the use of such maladaptive or 
dysfunctional coping strategies may be reduced.  This may enhance 
quality of life ratings in those with IBS that opt to use CAM for symptom 
relief. 
 
This chapter has highlighted the importance of illness perceptions in 
influencing IBS-QOL scores over time.  Mediation effects via coping 
strategies were only evident however in CAM-users.  CAM-users’ illness 
perceptions also seem to influence a greater number of coping strategies 
of which two maladaptive strategies were found to mediate (albeit to 
differing degrees) the pathway between illness perceptions and outcome.  
The following chapter therefore, will consider the results in context and 
provide a general discussion and consideration of findings. 
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Chapter 7  
 
General discussion and conclusions 
 
This chapter presents an overall summary and evaluation of the 
empirical work presented in this thesis and thus synthesises and extends 
the more study-specific discussions and conclusions in chapters four to 
six.  The general discussion highlights the practical and theoretical 
implications of the research, its limitations and its potential future 
directions in relation to both theory and practice.   
 
 
7.1 Introduction 
The theoretical framework adopted in this thesis has established a 
structured and systematic examination of psychological components of a 
functional chronic disorder of the GI system.  Specifically, the research 
focused on: perceptions of illness and beliefs about treatment in people 
affected by IBS, and factors that are important components of self-
regulation as individuals attempt to adjust to living with a chronic illness.  
This research was undertaken utilising a quantitative survey 
methodology.   
 
The findings from this research have identified the genuine need for 
effective management and treatment of IBS and it is argued that 
psychological factors need to be considered as they have been shown to 
have a prominent role in this process.  This chapter explores the 
implications of psychological components and considers CAM use in the 
wider context of health need.  The research findings are considered in 
the context of the course of a chronic illness and have led to 
recommendations being made that are considered to be influential in 
addressing potentially problematic illness perceptions that may 
negatively influence reported quality of life and emotional outcome.  
Moreover, the implications of the research findings are discussed in both 
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practical and theoretical terms.   Finally, overall limitations of the 
research are considered and the future direction of the research 
discussed and conclusions drawn.     
 
7.2 Discussion of research findings 
The aim of the research was to examine which illness perceptions and 
treatment beliefs were influential in CAM use in those affected by IBS 
and to explore differences between CAM-users and non-users in terms 
of the influence these factors had on coping strategies and quality of life.  
This was conducted within an extended CSM framework.  The key 
findings are now highlighted and discussed in relation to the wider issue 
of chronic illness management.   
 
7.2.1 Use of complementary and alternative medicine in IBS 
This research found CAM use was extensive for IBS (57%), higher than 
reported in previous studies (Kong et al., 2005; van Tilburg et al., 2008).  
In addition, just under half of the participants were not taking prescription 
medication for their IBS.  These findings suggest that CAM is being used 
based on evident health need rather than attempting to optimise one’s 
health (Vincent & Furnham, 1997).  Furthermore, findings showed a 
majority of participants (75%) in this research indicated they purchased 
CAM ‘off the shelf’ rather than consulting a CAM practitioner for 
treatment.  This finding was in contrast to other studies of participants 
with other functional bowel disorders and IBS potentially due to previous 
work predominantly focusing on CAM practitioner visits (Donker et al., 
1999; Koloski et al., 2003; Smart et al., 1986; Verhoef et al., 1990).   This 
finding may indicate that financial concerns of people self funding CAM 
(section 1.6) may be less relevant in populations purchasing such 
treatments as they are likely to cost significantly less than consultations 
with a CAM practitioner.  However, a number of participants had visited 
CAM practitioners, suggesting to an extent, financial concerns are still a 
relevant factor for consideration.  In addition, this finding also suggests 
that many people may be self treating via such ‘off the shelf’ treatments.  
These findings suggest that improved management from conventional 
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medical care is needed for those affected with IBS, however the lack of 
established aetiology in IBS can render conventional pharmacologic 
treatment problematic (Hayee & Forgacs, 2007).   
 
The high prevalence of CAM use in this, and other, research in specific 
illness groups and in general populations, means wider concerns with 
CAM treatments remain.  Many CAM treatments lack established efficacy 
and have potential for interaction with pharmacologic treatments (e.g. 
Leung et al., 2009; section 1.1.6).  Patients presenting with IBS 
symptoms and other chronic conditions in conventional care settings 
should be made aware of such issues with CAM, suggesting that it would 
appear to be important for health care practitioners and GPs to discuss 
such issues with patients (NICE, 2008; Vincent & Furnham, 1997).  
Therefore, addressing and challenging psychological illness related 
factors that influence CAM use may substantially reduce the health need 
for CAM use (chapter four). 
 
Demographic influences on CAM use for IBS showed some consistency 
with existing studies and suggested consistency with a ‘CAM-user profile’ 
found in general populations (Astin, 1998; Thomas et al., 2001).  A 
majority of participants who used CAM were female, with a chronic 
condition (IBS) and CAM use was, to an extent, influenced by higher 
income and education levels.  However, it should be pointed out that in 
this research, there was substantially higher female participation, and 
such a female predominance in healthcare seeking in IBS has been 
previously reported (Andrews et al., 2005; Hungin et al., 2005).  
Therefore, a future research objective would be to determine accurate 
prevalence estimates for males with IBS, as this may represent a 
substantial proportion of those not seeking health care (e.g. Saito et al., 
2002).  Moreover, it may be beneficial to examine consistency of gender 
prevalence rates across other functional chronic illnesses to see if female 
predominance in healthcare seeking is a consistent factor.  Such 
investigations may also have implications for health care delivery and the 
role of health care providers in addressing the reported imbalance of 
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males seeking medical treatment (Robertson, Douglas, Ludbrook, Reid, 
& van Teijlingen, 2008).  Future CSM based research may also examine 
the influence of social and economic factors on the formation of cognitive 
and emotional responses to illness and treatment. 
 
The findings imply that in a specific chronic illness group, CAM use is 
prevalent which is corroborated by evidence from other chronic functional 
and organic bowel conditions (e.g. Jones, Maloney et al., 2007; 
Langmead et al., 2002).  Identification of specific illness and treatment 
related factors that compel individuals to use CAM may indicate where 
conventional care may have the greatest impact through psychological 
based intervention (section 1.1.4).  This is especially applicable in 
functional chronic illnesses, such as IBS, where establishing aetiology 
has been problematic. 
 
7.2.2 Illness perceptions and treatment beliefs  
The application of an extended CSM was an important aspect of this 
research as it allowed statistical examination of the process of self-
regulation in response to living with a chronic illness.  In the extended 
CSM, both illness perceptions and treatment beliefs were examined in 
both CAM-users and non-users.  The relationships between IPQ-R 
components suggested theoretical consistency with previous findings in 
a number of chronic conditions (e.g. Hagger & Orbell, 2003).  The 
addition of BMQ and CAMBI scales to the CSM and subsequent analysis 
of relationships between these components and between the IPQ-R 
scales, suggested these measures were also consistent with the 
supposition of an extended CSM.   
 
7.2.2.1 Influence of Illness perceptions and treatment beliefs on 
CAM use 
Several dimensions of illness perceptions were shown to predict CAM 
use whilst controlling for demographic factors.  Stronger illness identity, 
consequences and cyclical timeline beliefs all predicted an increased 
likelihood of CAM use. Such findings may be indicative of perceived 
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more “severe” health status of CAM-users, a factor shown to be 
influential in conventional health care seeking in those with functional GI 
disorders (Koloski et al., 2001).  Previous work found conventional care 
seekers with IBS and FBD report inferior health status to non-care 
seekers (e.g. Verhoef et al., 1990).   This also appears consistent in 
CAM-users in the general population, who have reported poorer health to 
non-users (Bishop & Lewith, 2010; Testerman et al., 2004).   The 
perceived inferior health status in those using CAM was also observed in 
several symptom based IPQ-R scale scores in this research (illness 
identity and consequences, section 4.3.5) which were found to be 
significantly greater than those reported by non-users.  Furthermore, 
CAM-users reported stronger emotional representations, which is 
suggestive of greater emotional distress in CAM-users.  Conversely, 
CAM-users had stronger treatment and personal control and coherence 
scores, albeit these components were not significantly different from non-
users.  In terms of treatment beliefs, stronger beliefs in harm caused by 
conventional medication resulted in a greater likelihood of CAM use and 
this was the solitary component of treatment beliefs that predicted use of 
CAM (section 4.3.6).  
   
Furthermore, findings from the research present a dichotomy in that 
illness related factors appear instrumental in initiation of CAM use while 
concerns with potential harm from conventional medical treatment 
appear more influential in repeated use of CAM (e.g. Bishop et al, 2008).  
This may have implications for conventional health care, as illness 
related factors may prompt health care seeking and treatment initiation, 
while treatment beliefs may have greater influence on adherence (e.g. 
Horne & Weinman, 2002), therefore in conventional medical settings it 
may be beneficial to address concerns regarding harmful effects of 
conventional medication.  In CAM-users, repeated use of CAM was 
related to more positive CAM beliefs.  It is feasible that more positive 
beliefs about CAM, coupled with potentially lower financial impact of ‘off 
the shelf’ treatments may suggest an expectancy-value conceptualisation 
(Conner & Norman, 2005) in relation to CAM use.  CAM is considered in 
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terms of costs and benefits, where in this case, relatively low cost 
treatment and positive beliefs about using CAM may influence repeated 
use.   
 
The presented findings demonstrate evidence of the process of self-
regulation in response to a health threat, where the individual is active in 
dealing with the threat to health.  Psychological schemata constructed 
around the experience of illness and beliefs about treatment, appeared to 
influence an attempt at coping with the health threat (de Ridder & de Wit, 
2006).  In this context, CAM use can be seen as an adaptive or active 
form of coping behaviour (Suarez & Reese, 2000) and represents an 
attempt to self manage or self regulate the symptoms of IBS with the 
goal of removing the threat to health and maintaining normality (e.g. 
Leventhal et al., 1998).  One notable factor inherent in the CSM is the 
lack of explicit recognition of goals in the system of self-regulation (de 
Ridder & de Wit, 2006).  The CSM proposes that individuals appraise 
coping strategies undertaken rather than deeming if explicit goals in 
relation to health have been attained.  In this context, it was important to 
delineate illness and treatment related influences on other forms of 
coping and reported quality of life to explore the process of self-
regulation according to the CSM.   
 
7.2.2.2 Illness perceptions, treatment beliefs, coping and quality of 
life 
Findings provided further evidence to suggest CAM-users’ illness 
experience differs from that of non-users.  Both groups reported the 
impact of IBS as substantial in terms of impaired quality of life (Amouretti 
et al., 2006; Dancey & Backhouse, 1993; Lea & Whorwell, 2001).  CAM-
users reported inferior quality of life to that of non-users, a factor 
consistent with previous work (van Tilburg et al., 2008), despite many of 
them repeatedly using CAM.  This finding may be considered in the 
context of conventional health care seekers with IBS reporting inferior 
quality of life to that of non-seekers (Koloski et al., 2001; van der Horst et 
al., 1997).  Across both groups, IBS-QOL scores were lower than in 
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previous work with IBS populations (Bushnell et al., 2006; Drossman et 
al., 2000; van Tilburg et al., 2008).  This pattern was observed in the 
majority of the IBS-QOL scales including the Dysphoria (emotional 
outcome) scale.   
 
The results presented also suggest that over time, use of CAM for IBS 
was not associated with improvement in quality of life and there was no 
association observed between CAM beliefs and reported quality of life 
(e.g. Lewith et al., 2002).  This was most noticeable at study time two, 
where reported quality of life had significantly improved in both groups 
from time one but there was no significant difference in IBS-QOL scale 
scores between CAM-users and non-users.  Group differences 
suggested non-users reported better quality of life, albeit these 
differences were not statistically significant.  Furthermore, the cross-
sectional study showed that, despite repeated use of CAM in many 
participants, reported quality of life was significantly lower in CAM-users.  
These findings may be seen in the context of the diversity in CAM 
philosophies (Zollman & Vickers, 1999) where repeated CAM use, 
possibly encompassing different CAM modalities, could mask any 
improvement of one particular CAM treatment in quality of life 
judgements.  Possible beneficial effects may have been less visible due 
to the contrast between ‘off the shelf’ CAM and treatment received via a 
CAM practitioner.  Based on the findings presented, it appeared CAM 
use has limited benefit in improving reported quality of life in those 
affected by IBS therefore emphasising the importance of the exploration 
of psychological influences on both CAM use and quality of life.  
 
The research findings have shown where psychological intervention may 
be most effective in targeting particular components of illness 
perceptions.  In particular, from the quantitative analysis, perceptions of 
the consequences of IBS and affective responses to IBS were prominent 
in being stronger influences on quality of life than control and coherence 
components and this was largely consistent across both CAM-users and 
non-users.  It may be between these two components, the relationships 
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from time one, suggest a co-dependent or cyclical relationship exists 
between the cognitive component of perceived consequences and 
emotional responses to illness.  It is an area that may benefit from future 
investigation.  Furthermore, it is also conceivable to suggest, from 
analysis of participant use of certain CAM treatments (figure 4.3; section 
4.4.1), that stress may have a role in individual causal perceptions, 
potentially as a factor that appears to cause or precipitate symptoms.  It 
is notable that the lack of established aetiology potentially allows such 
beliefs to generate.  This research has presented evidence for pathways 
between constructs of the CSM that could be targeted for intervention to 
reduce the effect of such beliefs.  The bi-directional nature of the brain-
gut axis (Drossman et al., 1999) illustrates how causal beliefs may 
influence symptoms and any GI symptoms may reinforce the particular 
causal belief (figure 1.1).  
 
In both groups several trends were established where intervention could 
take place, albeit there were still differences between groups in the 
strength of a number of the associations.  A more severe illness 
experience in terms of perceived consequences, symptoms experienced 
and emotional distress resulted in poorer reported quality of life.  
Conversely, greater control and understanding was associated with 
better quality of life, in line with previous CSM-based work in other 
chronic illness (e.g. Hagger & Orbell, 2003).  Typically, causal 
perceptions and treatment beliefs were found to have less influence on 
quality of life. 
 
Emotional representations in particular were found to be strong 
influences on reported quality of life and emotional outcome (Dysphoria), 
with evidence of stronger influence in non-users.  These new and unique 
findings add authority to the proposition that people affected with IBS 
‘catastrophise’ and may have ‘abnormal’ beliefs about their illness 
resulting in emotional distress (Drossman et al., 1999; Gomborone et al., 
1995; Lackner et al., 2004).   
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Mediation testing, primarily at the cross-sectional stage, revealed 
substantial support for the CSM supposition that coping mediates the 
pathway between perceptions and outcome (Rutter & Rutter, 2002) and 
established which coping processes are important influences on quality 
of life and Dysphoria.  This was consistent with previous work which has 
largely found evidence for mediation in cross-sectional designs (Brewer 
et al., 2002; Evans & Norman, 2009; Kaptein et al., 2006; Llewellyn et al., 
2007; Rutter & Rutter, 2002).  Illness perceptions however, were found to 
be weakly associated with coping strategies and these associations were 
predominantly with maladaptive or dysfunctional coping strategies.  Such 
associations have been reported across a number of chronic illnesses 
(e.g. Hagger & Orbell, 2003).  Behavioural disengagement and self 
blame were strongly implicated as mediating variables.  There is 
evidence to suggest avoidant coping strategies may result in positive 
outcomes.  For example, in people with sports related injuries, 
maladaptive coping strategies have been shown to facilitate regulation of 
emotional states during both short and long term periods of injury 
(Carson & Polman, 2010).  In IBS however, there is evidence of negative 
bias in attending to somatic stimuli (Gomborone, Dewsnap, Libby & 
Farthing, 1993) which suggests the adoption of more adaptive coping 
may be beneficial.   
 
Furthermore, this research found maladaptive coping strategies were still 
associated with potentially problematic illness perceptions.  Such coping 
may influence inferior outcome and psychological morbidity (e.g. 
Drossman, Leserman, et al., 2000).  This further supports the proposal 
that attempting to adjust such perceptions via intervention would have a 
beneficial influence on reported quality of life (e.g. van Dulmen et al., 
1998).  
 
Findings suggested evidence that more adaptive coping could be 
independent of the influence of illness perceptions.  Brief-COPE scores, 
across both studies, suggested that both groups appear to use active 
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coping strategies to help cope with their IBS.  This coping strategy 
appears to be largely independent of any influence of illness perceptions.   
 
The findings demonstrated that both groups showed significant 
improvement in reported quality of life over the two study time points.  
This particular finding suggests a degree of adjustment to having chronic 
illness has taken place.  In theoretical terms this appears inconsistent as 
the change in quality of life status should be reflected in an improvement 
in problematic illness perceptions (see figure 2.1).  Findings showed 
there was limited change in cognitive components of illness perceptions 
in both groups, although illness consequences in CAM-users were 
significantly reduced.  Non-users’ illness identity ratings were significantly 
reduced and personal control ratings were significantly enhanced.  
Emotional representations however, significantly improved in both 
groups.  This would appear to represent a decrease in emotional distress 
associated with IBS over the two study time points.  Such factors as a 
reduction or absence of negative affect, lack of psychological morbidity 
and psychological symptoms (Larsen & Hummel, 2008) are factors 
indicative of positive adjustment to chronic illness.   
 
The findings presented suggest that uncertainty remains over whether 
cognitive components of illness perceptions do update and change over 
time as found in other chronic illnesses (Bijsterbosch et al., 2009; Foster 
et al., 2008; Kaptein et al., 2010) or whether the relative stability shown 
in this study is particular to those affected by IBS.  One further possibility 
concerns the sensitivity of the IPQ-R to assessing change over time.   
  
Mediation effects in the follow-up study were unique only to CAM-users.  
This finding contradicts several longitudinal CSM studies that found no 
evidence of mediation over time (Llewellyn et al., 2007; Rutter & Rutter, 
2007; Treharne et al., 2009).  Self blame and behavioural 
disengagement were again implicated as mediating variables.  When 
viewed in the context of other potentially distinguishing factors about 
CAM-users, such as the perceived more severe illness experience, it 
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may be possible that people who use CAM have a distinct psychological 
profile and this may influence the type of treatment or intervention that 
may have an effect.  This may consist of specific personality factors or 
psychological morbidity (Drossman et al., 1999). 
 
One of the key benefits of the establishment of mediating variables has 
been to demonstrate which processes explain the pathway from illness 
perceptions to quality of life and emotional outcome and that may be 
relevant to designing intervention strategies.  The identification of precise 
pathways and processes can aid in the translation of theory based 
findings to practical self management techniques (Leventhal, Musumeci, 
& Contrada, 2007). 
 
In the context of an extended CSM, the influence of treatment beliefs on 
quality of life was less clear and findings showed these constructs had 
less influence on reported quality of life than coping strategies.  A further 
important factor to consider is that measurement instruments based on 
theoretical constructs may lack specificity where validity, in theoretical 
terms, may not be fully established.  As indicated in previous chapters, 
accurate measurement of coping may be problematic and difficult to 
quantify in terms of the CSM (Leventhal et al., 1998; 2008).  There is 
also the possibility that other factors have a role in regulating the impact 
of illness (Llewellyn et al., 2007) and may be incorporated into an 
extended CSM framework in future studies.  Such factors as self-
efficacy, (de Ridder & de Wit, 2006) and optimism (Scheier & Carver, 
2003) have been associated with illness outcomes.  It is also possible 
that these factors may be important influences on the regulation of 
affective response to illness. 
 
7.3 Implications for theory and practice 
The findings from this research give rise to a number of possible 
implications in terms of translating research to potential practical 
measures to help in managing symptoms (section 2.6), in addition to 
offering support for the CSM. 
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7.3.1 Practical implications   
The theory-based findings presented have offered indication that may 
assist in the formulation of practical strategies for management of IBS 
symptoms.  The observable links between illness perceptions and quality 
of life, via coping strategies, suggest positive change to illness 
perceptions would result in use of fewer maladaptive coping strategies.  
Consequently, quality of life judgements may improve as, even with use 
of more than one type of CAM, CAM-users reported inferior quality of life 
than non-users (chapter five).  As considered in chapter five, the unique 
variance added by Brief-COPE scales to regression equations was small 
although the actual Brief-COPE Beta coefficients suggest the influence 
on shared variance in IBS-QOL scores (with each illness perception 
scale) was considerably higher.  Coupled with the significance of each 
mediation effect (and the size of the unique variance due to the 
mediation effect, Fairchild et al., 2009) it is evident the indirect effect of 
each illness perception component on IBS-QOL scores, via Brief-COPE 
scales is of practical significance.  Interventions focused on positively 
adjusting some of the maladaptive pathways detected in this research 
may then result in more adaptive coping strategies being adopted.  
 
The majority of the components of illness perceptions showed no 
significant change over the two study time points, the most notable 
exception being the emotional representations of both groups.  As 
mentioned previously, IBS-QOL and Dysphoria scores did improve 
significantly over the two study time points.  These findings suggest that 
in most cases illness perceptions are comparatively less susceptible to 
change over time unless potentially and actively challenged by new 
information in the form of practical intervention strategies.   
 
The basis of such strategies would be to attempt to address stronger and 
problematic symptom based illness perceptions indicative of a more 
severe illness experience.  Conversely attempts could be made to 
facilitate strengthening of the illness perception components of control 
and coherence, which are associated with improved quality of life.  
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Problematic illness perceptions (i.e. those associated with poorer 
outcomes) have been challenged by intervention to facilitate an 
improvement in patient outcomes in such conditions as myocardial 
infarction (Petrie et al., 2002), diabetes and asthma (Petrie et al., 2003). 
Interventions have also targeted negative emotional representations of 
illness by using such techniques as written dairy interventions based on 
emotional expression to reduce illness related emotional distress (e.g. 
Cameron & Jago, 2008).  Emotional support may also come from other 
forms such as internet message boards (Coulson, 2005).   It is also 
evident that attempts should be made to address stress in addition to 
providing information that stress is not the sole aetiological factor 
implicated in IBS. 
 
Previous work has shown that if GPs address patient cognitions and 
emotional concerns during early consultations for IBS, then future use of 
health care services may be reduced (e.g. Oerlemans et al., 2010; van 
Dulmen et al., 1994; 1996).  Similarly, providing detailed education about 
IBS has resulted in a reduction of health care service use over time, 
suggesting a reduction in troublesome symptoms via enhancement of 
feelings of control and coherence (Ringström et al., 2009; 2010; 
Robinson et al., 2006).  It was highlighted in chapter one that a positive 
diagnosis of IBS may help the alleviation of emotional distress and forms 
part of the NICE guidelines for IBS management in the UK (NICE, 2008).  
Such findings imply that addressing problematic illness perceptions 
during conventional consultations in a patient centred manner is 
beneficial.  It may even be possible for GPs seeing a patient with 
symptoms for the first time, to address patient cognitions and emotions 
by using IPQ-R scale items as a basis for where patient concern may be 
concentrated.  As GPs’ time is often very constricted, certain aspects, for 
example, the consequences and emotional representation scales as two 
of the most influential scales on quality of life could be addressed.  
Emotional representations were also influential on emotional outcome 
ratings.  
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Challenging problematic illness perceptions need not be limited to health 
care services.  There is scope for development of e-interventions that 
can be delivered over the internet without the need for face-to-face 
interaction (section 3.1.2.1).  This is perhaps one method of delivery 
where detailed information regarding IBS can be provided in a patient 
centred and accessible manner.  The IBS network, where this research 
study advertised for participants, offer their own self-help programme 
designed to facilitate control and understanding of IBS accompanied with 
information provision about treatment options.   
 
By addressing and reducing problematic symptom based illness 
perceptions and emotional representations it may be that potential and 
existing CAM-users may feel that CAM use is less necessary.  This may 
help to reduce factors that may influence CAM use thus reducing any 
potential financial implications of self funding repeated CAM treatments, 
which appear not to improve reported quality of life over time when 
compared with those not using CAM.  Evidence here supports the 
proposition that conventional care may be able to offer more substantial 
and longer lasting symptom relief through simple psychological 
intervention and the findings presented in this thesis provide possible 
discrete pathways where intervention may be best targeted.  
 
It is possible that CAM-users, with poorer reported quality of life (time 
one) and stronger potentially problematic illness perceptions may be a 
group that could be less responsive to GP or self help intervention.  It 
may be recommended that CAM-users would be greater beneficiaries of 
CBT.  Evidence presented in chapter one described how CBT can 
benefit those with IBS (e.g. Lackner et al., 2007) and may be offered as 
part of conventional medical care if individuals show no improvement in 
symptoms after 12 months (NICE, 2008).  In the case of IBS, CBT works 
by reducing the impact of troublesome cognitions and behaviour that 
may increase the likelihood of experiencing and increasing the intensity 
of IBS symptoms.  With this in mind, it is possible that people with IBS 
would benefit from a top-down cognitive based approach (McAndrew et 
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al., 2008) to address illness perceptions with a simultaneous strategy to 
address emotional distress.  Such an approach is weighted in terms of 
providing information and directing behaviours that may improve 
outcomes (McAndrew et al., 2008).  
 
7.3.2 Theoretical implications 
Findings across the two study time points suggest partial support for an 
extended CSM.  Relationships between illness perceptions and 
treatment beliefs, across both groups, appeared consistent with previous 
work and expectations.  In the context of predicting CAM use, a specific 
coping behaviour, the extended model was beneficial.  Several 
dimensions of illness perceptions and beliefs about harm caused by 
conventional medication predicted CAM use in people affected by IBS 
when controlling for several demographic factors.  In predicting quality of 
life however, treatment beliefs were less strongly related to IBS-QOL 
scores than illness perceptions and this was consistent in both CAM-
users and non-users.  Over the two study time points, there was no 
relationship between treatment beliefs at time one and IBS-QOL scores 
at time two.  These findings suggest the extended CSM has value in 
explaining specific coping behaviours (e.g. Horne & Weinman, 2002), but 
further investigation needs to be conducted to establish the effect of 
treatment representations on reported quality of life.  
 
The inclusion of CAM beliefs, as measured by the CAMBI as an 
additional facet of treatment beliefs, appeared to have limited impact in 
enhancing the potential for the CSM to predict CAM use in IBS.  CAM 
beliefs however, were found to be positively related to the number of 
CAM treatments used suggesting additional work needs to be conducted 
in relation to the influence of CAM beliefs on CAM use.  As with the 
BMQ-specific version (Horne et al., 1999) there may be scope to develop 
a specific measure of CAM beliefs which may reflect aspects of individual 
CAM modalities rather than more general beliefs about CAM.  
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Many CSM based studies have neglected study of the role of coping in 
explaining the pathway between illness perceptions and outcome (Rutter 
& Rutter, 2007).  Coping strategies, where considered, have often 
contributed little additional variance explained to outcomes (Hagger & 
Orbell, 2003).  This study included 14 coping strategies as measured by 
the brief-COPE.  In several cases coping contributed greater variance in 
predicting outcome than some illness perceptions and treatment beliefs 
and evidently had in many cases, from observing Beta coefficient values, 
moderate influence on IBS-QOL scores.  The cross-sectional study 
offered substantial support to the CSM supposition that coping mediates 
between the representation and outcome pathway, with numerous 
examples of largely partial mediation across both groups.  Between study 
times one and two, mediation effects of coping however were confined to 
CAM-users with IBS.  Further research may establish if this finding is 
particular to this group of participants or an artefact of observably 
different group sizes.  There may be implications for the refinement of 
measurement of coping (chapter five) or measuring the CSM constructs 
at different points in time from individuals at the same point in illness 
trajectory to establish reliability of these findings. 
 
One unique and important finding of this research was that emotional 
representations in IBS were found to be important influences on both 
reported quality of life and emotional outcome at both study time points.  
Many previous CSM studies have used differing affective measures of 
outcome (e.g. depression, anxiety) without being explicit that emotional 
outcomes were being considered.  The use of the Dysphoria scale of the 
IBS-QOL however, was a unique approach to measuring emotional 
outcome and presents an opportunity to develop measurement of 
domain specific emotional outcome.  In this context, this research was 
exploratory however the findings established a strong influence of 
emotional representations at time one on emotional outcome at time two.  
This pathway was also partially mediated by self blame and behavioural 
disengagement although this was only found in CAM-users.  This again, 
suggests support for the CSM.  
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Over the two study time points, there were quantitative changes in a 
small number of illness perceptions which were specific to each group.  
Across both groups consistently, change was only shown in emotional 
representations.  This appears to largely counter the proposition that the 
CSM is a dynamic model (Hagger & Orbell, 2003) and illness perceptions 
change over time as new information is used in updating representations.  
This lack of change may be particular to IBS.  Rutter and Rutter (2007) 
found illness perceptions remained static over time.  This does not 
discount the possibility that such changes are subtle and less detectable 
by quantitative means.  It may be that future qualitative investigations 
may prove beneficial in this context.  Alternatively, it is equally as 
plausible that illness perceptions in IBS, once formed, remain relatively 
static (Rutter & Rutter, 2007).  This may offer opportunity for direct 
intervention at a specific time point (i.e. early in the illness process) to 
challenge more negative illness perceptions that may negatively 
influence quality of life judgements.   
 
Development of the CSM may enhance its applicability to other chronic 
illnesses with the goal of establishing psychological interventions to 
improve outcomes.  Other theories of self-regulation have cited such 
factors as self-efficacy and optimism as influences on illness trajectories 
and outcomes.  It is also possible that factors such as personality and 
socio-economic influences should be examined in terms of their influence 
on the formation of illness perceptions (Leventhal et al., 1997).  Such 
factors may be incorporated into future studies as these factors invariably 
have an impact on the formation of illness related schema that guide 
health related behaviours.  Socio-economic status in particular may have 
a determinate bearing on if an individual is able to use CAM.   
 
7.4 Limitations of thesis  
The findings found substantial support for the CSM, especially at the 
cross-sectional stage.  The extended CSM appeared limited (i.e. with 
reference to treatment beliefs) in examining influence on quality of life but 
was beneficial in enhancing our understanding of psychological factors 
 327 
that may influence CAM use in those affected with IBS.  It is therefore 
important to replicate these findings in other IBS populations such as GI 
clinic patients and other online samples (e.g. Andrews et al., 2005; Jones 
et al., 2007).  It is paramount to establish if the findings of this research 
can be generalised to other IBS populations.  The majority of participants 
were recruited from the IBS network, a self help organisation for people 
affected with IBS.  In this respect the sample may be considered self-
selecting and thus potentially restrict any application of findings.  
Furthermore, it should be pointed out that the majority of self-
management intervention studies in chronic disease are based upon self-
selected samples where individuals may be well educated and motivated 
to take part in such studies (e.g. Barlow, Cooke, Mulligan, Beck, & 
Newman, 2010) thus not being representative of specific illness 
populations as a whole.  Some of these concerns may however, have 
been offset by the large number of participants recruited for this research 
(e.g. Marks et al., 2005).    
 
Reported quality of life scores across both CAM-users and non-users, 
were found to be lower at study time one than reported in other studies 
(Bushnell et al., 2006; Drossman et al., 2000; van Tilburg et al., 2008).  
Jones et al. (2007) suggest that participants affected by IBS recruited 
online may potentially be more confined to staying in their homes 
meaning both social interaction and employment may be affected.  This 
explanation however needs further investigation to determine if the 
findings from Jones et al. (2007) are consistent across different online 
samples.  Previous research however, has suggested little difference 
between internet samples and paper and pencil respondents when 
comparing responses on established psychological measures (e.g. 
Birnbaum, 2004; Ritter et al., 2004; Vallejo et al., 2007) and this 
appeared to be the trend with other measurement instruments used in 
this research.   
 
In terms of examining the pathways of the extended CSM, the findings 
may be limited by the lack of direct measurement of the appraisal of 
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coping strategies.  A large proportion of the CSM based research 
outlined in chapter two has utilised various measures of illness outcome 
as oppose to appraisal.  To fully test the pathways within the CSM, it may 
be necessary to investigate appraisal of coping that has been directed by 
illness perceptions and treatment beliefs.  This may aid in determining 
how appraisal relates to illness outcome and in influencing illness 
perceptions (and treatment beliefs) as part of the feedback loop of the 
CSM (figure 2.1).  A further limitation, largely due to the lack of specific 
focus on the appraisal stage of the CSM, concerns the point in time at 
which appraisal occurs and how much subsequent feedback there may 
be to the representation stage.  One proposal could be to conduct semi-
structured interviews with participants affected by IBS and ask directly 
about how effective their coping strategies or behaviours are, an 
approach utilised by Leventhal et al. (1985) in people affected by 
hypertension.  In the context of this research, participants could also be 
asked if they feel using CAM has been helpful in the treatment of their 
condition.  Such investigation may further enhance understanding of 
illness appraisal, not just in IBS, but in other chronic illnesses.  This may 
result in improved application of research findings to practical 
interventions and further relieve the burden of chronic illness.    
 
As considered previously, one of the key components of this research 
was to examine the emotional response to having IBS and how this may 
influence coping, reported quality of life and emotional outcome.  It is 
plausible to suggest that negative affect generally may have had some 
influence on such emotional representations however this was not 
addressed in this research.  Previous work however, has suggested a 
conceptual overlap between negative affect and emotional 
representations as measured by the IPQ-R in a number of patient 
samples including those affected by diabetes and asthma (Moss-Morris 
et al., 2002) and this is an area that may be considered more fully in 
future work.  Furthermore, the role of adherence to conventional 
medication has not been considered in this research, again primarily as 
the research aims focused on beliefs and representations in CAM-users 
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as CAM use was found to be prevalent.  It is plausible to suggest that 
adherence to any prescribed medication may have had some influence 
on IBS-QOL scores, emotional outcome (and possibly CAM use), 
although 44% of participants reported they were not taking any 
conventional medication.  This may have allowed for further potentially 
interesting analyses but is beyond the scope of this thesis.  
 
One further potential limitation comes in the form of the measurement 
instruments used for the various parts of the CSM.  The potential 
shortcomings of using the generic Brief-COPE measure for example, 
have already been considered.  In the case of illness perceptions, these 
were captured using the IPQ-R (Moss-Morris et al., 2002).  It is 
suggested that researchers should adopt the IPQ-R to reflect the illness 
under investigation (French & Weinman, 2008), which was the case in 
this research.  Several illness specific versions of the IPQ-R exist, 
however this typically consists of wording changes in addition to the 
symptom list for the identity scale being reflective of the illness under 
investigation.  The fact remains that the identity scale on the IPQ-R 
consists of a summed number of symptoms rather than, as the CSM 
stipulates, recognition that a particular symptom is indicative of a 
particular illness (Hagger & Orbell, 2003), in this case, IBS. 
 
It is important to consider the possibility of statistical limitations within the 
present data.  The procedure for testing for mediation may have 
unintentionally omitted evidence of other mediated pathways.  This 
research implemented the Baron and Kenny (1986) approach to ‘simple’ 
mediation which involved establishing consecutive steps to establish 
mediation effects between a predictor variable and outcome.  This 
research also had the unique approach in CAM use and IBS to 
determine the significance of each statistical model that demonstrated 
mediation and also considered the strength of each mediation effect.  
Few pathways demonstrating mediation were therefore rejected based 
on significance testing as the majority were retained.  Preacher and 
Hayes (2004) however, propose that the Baron and Kenny approach 
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may be outdated as there is little need to establish all ‘causal’ steps.  The 
alternative is to instead simply test for evidence of an indirect effect.  The 
indirect effect refers to the relationship of predictor and outcome through 
a potential mediator (Preacher & Hayes, 2004, section 3.6).  This 
approach was included in this research to test for significance of 
mediation effects, only after the causal steps had been established.  If 
testing the indirect effect was adopted without testing causal steps, it 
may have resulted in a differing number of instances of mediation being 
detected thus adding additional (or less) support to the CSM.  This 
approach may have also uncovered unidentified significant effects 
between treatment beliefs, coping and quality of life.  However, in this 
study, the Baron and Kenny approach was thought to be consistent with 
the CSM theory and allowed comparison with how the CSM constructs 
have been investigated in previous work. 
 
As stated, this research presented a formal test of significance for 
mediation effects (Preacher & Hayes, 2004).  Inferences of mediation 
however, still require a degree of caution.  Firstly, it is assumed that there 
is no measurement error in the mediating variable (Baron & Kenny, 
1986).  As highlighted in previous chapters, there may be issues with the 
Brief-COPE being an accurate measure of domain specific coping.  
Secondly, it is possible that CAM use over time actually represented 
moderated mediation.  Moderators typically represent an interaction 
effect (Baron & Kenny, 1986); in the case of this research, over the two 
study time points, CAM-users demonstrated mediation whereas in non-
users, over time, there was no mediation effects detected.  One of the 
criteria for measuring moderators is that this should be conducted prior to 
study onset (Baron & Kenny, 1986), which did not occur in this research.  
This may be investigated in future by selecting CAM-users and non-
users for recruitment prior to any investigation commencing.  
  
There may have been further implications regarding the timing of 
measures.  Between study times one and two there was a minimum of 
six months, however it is unclear from existing CSM research how the 
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influence of illness and treatment representation delineates over time.  It 
may be inferred however, that the CSM specifies a causal pathway 
between representations and outcome, therefore longitudinal research is 
preferable to test the causal pathways outlined by CSM theory.  It may 
be that in order to provide more specific guidelines on study time points, 
qualitative approaches may prove productive in determining when best to 
assess coping, outcomes and appraisal.  With these issues in mind, it 
may be beneficial to measure the three constructs of the CSM, 
representation, coping and appraisal/outcome, at separate time points in 
future studies. 
 
7.5 Future directions 
One of the primary challenges for conventional medical care is to 
successfully address and manage IBS symptoms.  IBS is a functional 
chronic illness with no established aetiology and people affected are 
burdened with a number of bothersome and distressing symptoms that 
are hard to treat (e.g. Hayee & Forgacs, 2007).  It appears, from the 
research presented here, that CAM-users with IBS perceive a more 
severe illness experience than non-users.  It remains to be established if 
CAM-users have a distinctive psychological profile or personality traits 
that influence their perceived illness experience.  Furthermore, although 
the present research was able to isolate psychological pathways to 
reported quality of life judgements, no investigation was conducted that 
isolated IBS subtypes or those at different timelines of illness.  It is 
recommended that future research examine these important factors to 
assess the impact on the trajectory and experience of IBS.   
 
The prominence of components of illness perceptions in influencing CAM 
use and quality of life in this research suggests where intervention may 
be most successful.  Intervention could attempt to challenge and modify 
components of illness perceptions that influence enhanced or poorer 
quality of life and emotional outcome.  Based on the findings of this 
research, it is recommended as a first point of investigation, to assess 
the impact of intervening in perceived consequences and emotional 
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responses to having IBS, as these components of the illness perceptions 
described by Leventhal et al. (1998) had the consistently strongest 
influence on reported quality of life in both CAM-users and non-users.  
Emotional representations also demonstrated significant associations 
with emotional outcome (Dysphoria).  Consideration of the type of CAM 
treatments used may suggest ‘stress’ is a concern to those with IBS as a 
factor that is perceived to precipitate and potentially worsen IBS 
symptoms.  From the findings presented here it is possible that 
individuals attempt to make subjective inferences regarding causes of 
IBS which may influence the type of CAM treatment sought.  Such causal 
perceptions may be more pronounced in IBS and possibly other 
functional conditions where aetiology is uncertain (e.g. Casiday et al., 
2009; Hungin et al., 2005).  It may be important to challenge such beliefs 
by encouraging more expansive causal beliefs via a range of 
explanations related to aetiology (e.g. Petrie & Weinman, 2002).     
 
Addressing both cognitive and emotional representations in parallel also 
appears of paramount importance.  In previous work for example, where 
attention has focused on dealing with cognitive representations of illness 
in MI patients the lasting effects of intervention were not as pronounced 
for those with negative affect (Cameron, Petrie, Ellis, Buick, & Weinman, 
2005).   
 
There has been little specific CSM based intervention in IBS although 
parallels are drawn with CBT based interventions for IBS (Oerlemans et 
al., 2010).  In previous work problematic cognitions and emotional 
distress have been challenged resulting in reduction in affective reactions 
and use of health care services post treatment (Lackner et al., 2007; 
Oerlemans et al., 2010; van Dulmen et al., 1997; 1998).  In terms of a 
CSM based intervention focusing on the positive modification of 
problematic illness perceptions, evidence from other chronic illnesses 
suggests methodological approaches that can influence positive 
outcomes across a number of illnesses (McAndrew et al., 2008; Petrie et 
al., 2002).  Furthermore, the therapeutic benefits of a positive health care 
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consultation in patients presenting with IBS in reducing future use of 
health care services have been documented previously (Ilnyckyj et al., 
2003).  In addition, NICE guidelines stress the importance of offering a 
positive diagnosis (NICE, 2008).  Improved outcomes to positive 
conventional medical consultations have been recorded in patients with 
non-specific symptoms (Thomas, 1987) and acute tonsillitis (Olsson, 
Olsson, & Tibblin, 1989) and it suggested this may be through a variety 
of pathways including expectancy and therapeutic relationship with the 
health care provider (Hyland, 2003).  Such patient centred approaches 
are well received by the relevant user groups (Little et al., 2001). 
 
One possible route of investigating change in illness perceptions and 
outcome would be to take a multiconvergent approach to treatment (e.g. 
Thomas, Sadlier, & Smith, 2008).  Such an approach incorporates CBT, 
physical activity and meditation and has been found to be beneficial in 
those with chronic fatigue (Thomas et al., 2008) and chronic pain 
(Watson, 2002).  The approach seeks to manage beliefs, emotions and 
behaviour through the introduction of gradual exercise, meditation to 
focus thoughts on the present and to disconnect from symptoms.  CBT is 
used to counteract thought patterns associated with symptoms and has 
shown lasting benefits in enhancing self management of IBS (Moss-
Morris, McAlpine, Didsbury, & Spence, 2010).  In a comparison with 
regular (control group) care and relaxation training, the multiconvergent 
approach was far superior in terms of outcome measurement (Thomas et 
al., 2008).  As chronic fatigue syndrome and chronic pain are both 
disorders where aetiology may be more difficult to establish, it is 
reasonable to assume that such an approach would be beneficial to 
those experiencing more severe IBS, which from the findings in this 
study may be those using CAM.  Shaw et al. (1991), utilising a 
multiconvergent approach for stress management in IBS, found all 35 
participants benefited from fewer IBS symptoms of less severity over the 
following 12 months.  Using a multiconvergent approach with measures 
of illness perceptions, coping and outcome throughout the study, may 
give further important insight into pathways of influence outlined by the 
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CSM and how problematic illness perceptions may be changed in those 
with IBS, potentially resulting in more adaptive coping and improved 
quality of life judgements. 
 
The differences in the way interventions are implemented may affect 
outcomes.  In the case of progressive muscle relaxation training, this 
technique may promote relaxation and as a by-product, enhance 
perceptions of control rather than directly challenging strong emotional 
distress brought on by illness.  However, the interrelations found 
between illness perception components are consistent with other studies 
(e.g. Hagger & Orbell, 2003) and implies that if a specific psychological 
component is challenged (e.g. consequences) related psychological 
components (e.g. personal control) may change and potentially improve.  
Conversely, CBT may seek to directly challenge stronger emotional 
representations thus indirectly enhancing feelings of control.  Such 
influences may be delineated with close examination of the relationships 
between illness perception components at specific time points during an 
intervention study for IBS.  It is proposed that a similar multiconvergent 
approach may be used to test and harness the most effective 
components of a variety of techniques to maximise a positive outcome.  
 
Petrie et al. (2002) suggested one possible methodological approach to 
addressing problematic illness perceptions within a CSM framework and 
this could be adapted with reference to the findings of this thesis.  The 
amendment proposed to Petrie et al’s. (2002) methodological approach 
is presented in figure 7.1., and highlights a three phase cognitive-
behavioural based intervention, where components of illness perceptions 
are challenged and assessed at each phase.  This approach is centred 
upon a top-down, information driven mechanism as previously illustrated 
by McAndrew et al. (2008) as information driven approaches have 
demonstrated positive effects in previous studies (e.g. Oerlemans et al., 
2010; Ringström et al., 2010; Robinson et al., 2006).  It is predicted that if 
more positive outcomes are achieved, the implementation of such an 
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intervention would be beneficial and could be further extended to map 
across stages of chronic illness. 
 
The delivery of an intervention could take place on recommendation from 
General Practitioners or other health care providers if patients are 
deemed suitable.  It is suggested referral to such an intervention occurs 
early in the health care seeking process as the findings from this thesis 
clearly demonstrate that cognitive perceptions of illness appear to remain 
largely static over time even though quality of life judgements improved 
at time point two within the study.  This implies that the perceptions 
formed in the early stages of a chronic disorder remain static.  Therefore 
it is proposed that in the initial phase of the proposed intervention, 
baseline measures of cognitive and emotional representations are 
measured (for example purposes, the measures proposed are 
unchanged from this research, figure 7.1).  Additional screening for 
psychological morbidity would also be undertaken as there is some 
evidence that those with psychological problems, may respond less well 
to such intervention (Hayee & Forgacs, 2007; Whorwell, 2006).  The 
measurement of illness perceptions at baseline may also enable tailoring 
of the intervention to best fit individual needs.   
 
It is essential that attention is paid to both emotional and cognitive 
aspects at phase one of the intervention.  During this phase, information 
may be offered explaining a range of potential causes of IBS in order to 
reduce the focus on stress as a causal factor.  Further information may 
be beneficial outlining the benefits of a balanced diet and taking regular 
exercise.  This would ensure regular activities are maintained and 
provide a more positive focus as opposed to rumination about the causes 
and consequences of living with a chronic functional bowel condition.   
 
An additional initiative would be to develop an action plan encouraging 
exercise and activity, whilst stressing the importance of maintaining 
activity levels again with the goal of reducing focus on illness 
‘consequences’ (Petrie et al., 2002).  In addressing some of the 
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emotional aspects of IBS, reassurance regarding visceral symptoms and 
the nature of functional illnesses could be made more prominent, which 
may supplement a positive diagnosis given by the GP.  The diary writing 
intervention cited by Cameron and Jago (2008) may also have benefit 
here as individuals may articulate their emotional responses to IBS 
through written expression.   
 
To monitor any change in illness perceptions from baseline, 
measurement could be conducted at subsequent intervention time 
points.  Having addressed possible influences on perceptions of 
consequences, cause and emotions, the second phase could focus on 
relieving stress through suggested means of meditation or progressive 
muscle relaxation training (PMRT) which has been shown to have 
benefits in relieving stress, nausea and vomiting in those receiving 
chemotherapy treatment (Burish & Jenkins, 1992; Burish & Tope, 1992) 
and has been shown to have long term benefits in people affected by IBS 
(Lahmann et al., 2010).  The third phase should monitor progress and 
seek to consolidate activity and emotional regulation through written 
expression. 
 
It is proposed that the most effective way to implement such a 
programme would be via the internet.  This is suggested for a number of 
reasons.  Firstly, internet availability and use is widespread; the ONS has 
reported 73% of UK households now have access to the internet (ONS, 
2010).  This research successfully recruited a large number of those with 
IBS to participate in the study through the internet.  Secondly, the 
internet is routinely used by many individuals searching for health based 
information which ranges from searching for illness specific information 
(McMullan, 2006) to seeking support from other individuals through 
online illness discussion forums (e.g. Coulson, 2005).  Thirdly, e-
interventions have already successfully been implemented in other 
chronic conditions (Robinson & Serfaty, 2003; Winzelberg et al., 2003, 
see also section 3.1.2.1).  In people affected by IBS, commencing an 
intervention in individuals’ own time may facilitate a reduction in stress as 
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they would not necessarily have to leave their homes to take part as 
there is further suggestion that those affected by IBS who are recruited 
for online studies have reduced quality of life when compared with 
individuals recruited through other methods (Jones et al., 2007).  Such 
intervention may also be beneficial where IBS is perceived by individuals 
to be less severe.  There is evidence that, where chronic illness is 
regarded as less severe, negative illness perceptions may still be 
associated with a greater number of health care consultations (Petrie & 
Weinman, 2006).   
 
An important feature of this intervention would be to assess changes in 
coping strategies in relation to changes in illness perceptions and quality 
of life through each phase.  Furthermore, it would be beneficial to 
determine which method of intervention works best for known sub groups 
of affected individuals.  It is possible, by using clinical diagnoses, that 
individuals with IBS subtypes IBS-D or IBS-C for example, may be 
offered particular aspects of the intervention deemed effective for their 
subtype.  Additionally, conventional medication beliefs may be addressed 
in the case of prescription medication being used for specific symptoms 
of IBS.   
 
It is plausible to suggest that any intervention may be directed primarily 
towards CAM-users as it appears from findings presented here (sections 
4.3.5 and 5.3.1) and existing work (e.g. Bishop et al., 2006; Langmead et 
al., 2002), that users of such treatments may perceive a more severe 
illness experience.  Baseline testing would be advantageous to examine 
in greater detail the psychological characteristics of CAM-users.  One 
potential reason for the “inferior” perceived illness experience could lie in 
the influence of psychological correlates such as depression, anxiety or 
personality traits (Drossman et al., 1999) that have been implicated in the 
onset and maintenance of IBS.  It is plausible that CAM-users may have 
underlying psychological morbidity (e.g. depression) or personality traits 
that may lead to a distinctive response to IBS symptoms in addition to 
potentially poorer affective responses to IBS where catastrophising 
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thoughts become predominant (e.g Lackner et al., 2004).  Population 
studies conducted over time may be able to delineate if such 
psychological morbidity influences onset or is influenced by IBS. 
 
With such an approach in mind, future work may assess the most 
effective methods of implementing change to perceptions of 
consequences and emotional representations and, by improving these 
components, more adaptive coping may be adopted and consequently 
outcomes may improve.  Harmonising CBT, patient centred health care 
consultations, education based strategies and electronic delivery (via the 
internet) may lead to enhanced care provision to those affected by IBS.  
Furthermore, at present, evidence for CAM is limited for the treatment of 
IBS (e.g. Ernst, 2009; NICE, 2008) so addressing psychological factors 
may reduce use/need for CAM in addition to improving outcome.  Such 
methods of intervention as proposed here would need assessment to 
determine the most effective and efficient means of improving outcomes 
in IBS.  
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Figure 7.1 Provisional study protocol for CSM based pilot intervention for IBS 
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7.6 Conclusion 
The main aim of the thesis was to examine the role of illness perceptions 
and treatment beliefs in influencing CAM use in those affected by IBS 
and how these factors affected reported quality of life in CAM-users and 
non-users.  This thesis has provided robust and unique evidence that 
illness perceptions are important factors in IBS in influencing CAM use 
and reported quality of life in both CAM-users and non-users.  In terms of 
reported quality of life, findings do not support CAM use as a beneficial 
therapy for those affected with IBS.  Moreover, treatment beliefs have 
been found to have a greater influence on CAM use as a specific coping 
behaviour as opposed to directly influencing quality of life. 
 
Further investigation may show that CAM treatments will prove to be 
efficacious in treating IBS and could be incorporated into a 
multiconvergent approach as described within this chapter (e.g. Thomas 
et al., 2008).  However, it is important to note that CAM treatments are 
subject to many of the same problems faced by conventional care, where 
treatments may be seen to potentially have an effect on specific 
symptoms rather than impacting on the overall improvement of this 
chronic disorder.   
 
In addition, the research findings offer support for the theoretical 
supposition of the CSM, opportunities for future study and areas of 
potential intervention to improve outcomes in those with IBS.  The 
research has also provided some unique and beneficial findings to 
supplement existing understanding about the role of illness perceptions 
and treatment beliefs in those affected by IBS.  With the absence of 
effective conventional treatments for IBS, it is hoped this research will 
influence further study and possible development of self-management 
strategies. 
 
Substantial support for the mediating role of coping strategies in both 
CAM-users’ and non-users’ illness perceptions and reported quality of life 
was observed from the cross-sectional study.  Participants’ perceptions 
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of illness consequences and emotional representations were found to be 
strong influences on IBS-QOL scores, with the latter also strongly 
influencing emotional outcome.   Over time, such evidence was limited to 
CAM-users where the coping strategies of self blame and behavioural 
disengagement were shown to act as mediating variables.   
 
If the findings presented in this thesis can be replicated in other groups of 
participants with IBS, then it is hoped intervention and management 
strategies may be formulated.  It is clear from this research that 
perceptions of consequences and emotional representations have a key 
role in the formation of quality of life judgements and represent possible 
points of intervention.  The need to challenge these perceptions appears 
greater in those using or considering using CAM as it is indicative of a 
more severe illness experience.  A CSM based electronic intervention 
has been proposed and it is considered that this may be beneficial to 
those with IBS and may have wider implications for those with other 
functional chronic illnesses.  By addressing the psychological aspects of 
IBS in this manner it is hoped quality of life may improve.  This would 
potentially leave the role of CAM to be one of a complementary treatment 
for those affected with IBS, rather than being used primarily based on 
health need. 
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Appendix I: advertisement posted on the IBS Network website 
 
 
                                 
  
Can you spare some time to participate in an online research study? 
 
Lee Usher, a PhD student at Thames Valley University6, is interested in 
recruiting people with Irritable Bowel Syndrome to take part in an online study 
about what it is like to live with IBS and the types of treatments that they have 
used. 
 
 
If you have IBS and are over the age of 18 then your participation in the study 
would be most welcome. 
 
 
If you can spare around 25-40 minutes to help further the understanding of these 
issues then you will find the study at the link below: 
 
 
Click here to take the survey  
[Advert contained a direct link to the study webpage] 
 
 
If you have any questions about the research or require further information about 
the study you are invited to contact Lee Usher, at Thames Valley University via 
[email address included]   
                                               
6 Since the research was conducted, Thames Valley University has been re-named, the 
University of West London 
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Appendix II: Study information  
 
Exploring the illness and treatment beliefs of those affected by IBS that use 
complementary therapies  
 
Aims of the study 
This study has been developed to discover more about the role of perceptions of 
illness and medication in those people affected by irritable bowel syndrome 
(IBS).   
 
What we hope to achieve with the study 
It is expected that if certain perceptions about illness or medication will relate to 
better coping and this could form the basis of a new strategies to help relieve the 
symptoms of IBS.   
 
How can I help? 
Your responses to the study will be of great value to the outcome and 
implications of the research.  Your help therefore, is greatly appreciated. 
 
What do I do during the study? 
We would like you to navigate through the website answering a series of 
questionnaires as you go along.  These will assess various aspects of your 
perceptions to your illness, medication as well as other aspects related to your 
illness such as your quality of life.  The questions should take no longer than 30-
40 minutes to complete and it would be really appreciated if possible, that you 
answered the questions when you are alone. 
 
Your rights 
It is up to you to decide if you wish to commence and take part.  If you do 
decide to commence you are still free to withdraw from the study at any time by 
simply closing your internet browser window or navigating away from the study 
web pages, this will ensure your data is not used in the study.  Although you 
have provided your email address to get in touch with the researcher, this is in 
no way connected to the responses you will give on this website.  You are also 
advised that this information will be transmitted (via encryption) and stored 
securely on a computer in line with the Data Protection Act 1998.  It will be 
treated as strictly confidential, anonymous and will only be used for research 
purposes.     
 
Contacts and further information 
If you are willing to participate in the study then you are free to move to the 
following page which will ask for confirmation of your consent.  If however, 
you would like to discuss the project further please contact Lee Usher at Thames 
Valley University on (telephone number) or via email at [email address 
included]   
 
I would like to take this opportunity to thank you for your participation in this 
study. 
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Appendix III: Consent to participate and introductory survey 
questions 
 
 
 Please click here 
I confirm that I have read and understood the 
information on the previous page and can contact the 
researcher should I have any questions. 
 
Yes 
I understand that my participation is voluntary and that I 
am free to withdraw from the study at any time. 
 
Yes 
 
I therefore agree to take part in the study. 
 
 
Yes 
 
 
 
 
 
Have you been diagnosed with Irritable bowel syndrome (IBS) by a health 
care professional (such as your doctor or a specialist)? 
 
[Yes]              [No]  
 
 
If yes, how long ago were you diagnosed?  
 
0-6 months  
6-12 months  
12-18 months  
18 months-2 years  
2-3 years  
Over 3 years  
 
 
If no, how long do you feel you have had symptoms of IBS?   
 
0-6 months  
6-12 months  
12-18 months  
18 months-2 years  
2-3 years  
Over 3 years  
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Appendix IV: The illness perceptions questionnaire revised version 
 
Listed below are a number of symptoms that you may or may not have experienced 
since your IBS began.  Please indicate by selecting YES or NO, whether you have 
experienced any of these symptoms since your IBS. Select one answer for each 
symptom listed.  
 
 Yes, I have 
experienced this 
symptom since my 
IBS 
No, I have not 
experienced this 
symptom since my 
IBS 
Pain ❏ ❏ 
Sore throat ❏ ❏ 
Nausea ❏ ❏ 
Breathlessness ❏ ❏ 
Weight loss ❏ ❏ 
Fatigue ❏ ❏ 
Stiff joints ❏ ❏ 
Sore eyes ❏ ❏ 
Wheeziness ❏ ❏ 
Headaches ❏ ❏ 
Upset stomach ❏ ❏ 
Sleep difficulties ❏ ❏ 
Dizziness ❏ ❏ 
Loss of strength ❏ ❏ 
 
 
Listed below are a number of symptoms that may or may not be related to your IBS.  
Please indicate by selecting YES or NO whether you believe that these symptoms are 
related to your IBS.  Select one answer to indicate if you think the symptom is related to 
your IBS. 
 
 Yes, this symptom 
is related to my IBS 
No, this symptom is 
not related to my 
IBS 
Pain ❏ ❏ 
Sore throat ❏ ❏ 
Nausea ❏ ❏ 
Breathlessness ❏ ❏ 
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Weight loss ❏ ❏ 
Fatigue ❏ ❏ 
Stiff joints ❏ ❏ 
Sore eyes ❏ ❏ 
Wheeziness ❏ ❏ 
Headaches ❏ ❏ 
Upset stomach ❏ ❏ 
Sleep difficulties ❏ ❏ 
Dizziness ❏ ❏ 
Loss of strength ❏ ❏ 
 
 
 
We are interested in your own personal views on how you now see your IBS.  Please 
indicate how much you agree or disagree with the following statements about your IBS 
by clicking the appropriate box. 
 
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
My IBS will last a short time ❏ ❏ ❏ ❏ ❏ 
My IBS is likely to be permanent 
rather than temporary ❏ ❏ ❏ ❏ ❏ 
My IBS will last a long time ❏ ❏ ❏ ❏ ❏ 
This IBS will pass quickly ❏ ❏ ❏ ❏ ❏ 
I expect to have IBS for the rest of 
my life ❏ ❏ ❏ ❏ ❏ 
My IBS is a serious condition ❏ ❏ ❏ ❏ ❏ 
My IBS has major consequences on 
my life ❏ ❏ ❏ ❏ ❏ 
My IBS does not have much effect 
on my life ❏ ❏ ❏ ❏ ❏ 
My IBS strongly affects the way 
others see me ❏ ❏ ❏ ❏ ❏ 
My IBS has serious financial 
consequences ❏ ❏ ❏ ❏ ❏ 
My IBS causes difficulties for those 
that are close to me ❏ ❏ ❏ ❏ ❏ 
There is a lot I can do to control my 
IBS symptoms ❏ ❏ ❏ ❏ ❏ 
What I do can determine whether 
my IBS gets better or worse ❏ ❏ ❏ ❏ ❏ 
The course of my IBS depends on 
me ❏ ❏ ❏ ❏ ❏ 
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Nothing I do will affect my IBS ❏ ❏ ❏ ❏ ❏ 
I have the power to influence my 
IBS ❏ ❏ ❏ ❏ ❏ 
My actions will have no affect on 
the outcome of my IBS ❏ ❏ ❏ ❏ ❏ 
My IBS will improve in time ❏ ❏ ❏ ❏ ❏ 
There is very little that can be done 
to improve my IBS ❏ ❏ ❏ ❏ ❏ 
My treatment will be very effective 
in curing my IBS ❏ ❏ ❏ ❏ ❏ 
The negative effects of my IBS can 
be prevented (avoided) by my 
treatment 
❏ ❏ ❏ ❏ ❏ 
My treatment can control my IBS ❏ ❏ ❏ ❏ ❏ 
There is nothing which can help my 
IBS ❏ ❏ ❏ ❏ ❏ 
The symptoms of my IBS are 
puzzling to me ❏ ❏ ❏ ❏ ❏ 
My IBS is a mystery to me ❏ ❏ ❏ ❏ ❏ 
I don’t understand my IBS ❏ ❏ ❏ ❏ ❏ 
My IBS doesn’t make any sense to 
me ❏ ❏ ❏ ❏ ❏ 
I have a clear picture or 
understanding of my IBS ❏ ❏ ❏ ❏ ❏ 
The symptoms of my IBS change a 
great deal from day to day ❏ ❏ ❏ ❏ ❏ 
My symptoms come and go in 
cycles ❏ ❏ ❏ ❏ ❏ 
My IBS is very unpredictable ❏ ❏ ❏ ❏ ❏ 
I go through cycles in which my 
IBS gets better and worse ❏ ❏ ❏ ❏ ❏ 
I get depressed when I think about 
my IBS ❏ ❏ ❏ ❏ ❏ 
When I think about my IBS I get 
upset ❏ ❏ ❏ ❏ ❏ 
My IBS makes me feel angry ❏ ❏ ❏ ❏ ❏ 
My IBS does not worry me ❏ ❏ ❏ ❏ ❏ 
Having IBS makes me feel anxious ❏ ❏ ❏ ❏ ❏ 
My IBS makes me feel afraid ❏ ❏ ❏ ❏ ❏ 
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We are interested in what you consider may have been the cause of your IBS.  As 
people are very different, there is no correct answer for this question.  We are most 
interested in your own views about the factors that caused your IBS rather than what 
others (including Doctors or family) may have suggested to you.  Below is a list of 
possible causes for your IBS.  Please indicate how much you agree or disagree that 
they were causes for you by clicking the appropriate option. 
 
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
Agree 
Stress or worry ❏ ❏ ❏ ❏ ❏ 
Hereditary - it runs in my family ❏ ❏ ❏ ❏ ❏ 
A germ or virus ❏ ❏ ❏ ❏ ❏ 
Diet or eating habits ❏ ❏ ❏ ❏ ❏ 
Chance or bad luck ❏ ❏ ❏ ❏ ❏ 
Poor medical care in my past ❏ ❏ ❏ ❏ ❏ 
Pollution in the environment ❏ ❏ ❏ ❏ ❏ 
My own behaviour ❏ ❏ ❏ ❏ ❏ 
My mental attitude e.g. thinking 
about life negatively ❏ ❏ ❏ ❏ ❏ 
Family problems or worries 
caused my IBS ❏ ❏ ❏ ❏ ❏ 
Overwork ❏ ❏ ❏ ❏ ❏ 
My emotional state e.g. feeling 
down, lonely, anxious, empty ❏ ❏ ❏ ❏ ❏ 
Ageing ❏ ❏ ❏ ❏ ❏ 
Alcohol ❏ ❏ ❏ ❏ ❏ 
Smoking ❏ ❏ ❏ ❏ ❏ 
Accident or injury ❏ ❏ ❏ ❏ ❏ 
My personality ❏ ❏ ❏ ❏ ❏ 
Altered immunity ❏ ❏ ❏ ❏ ❏ 
 
In the boxes below, please list in rank-order the three most important factors that you 
now believe caused your IBS.  You may use any items from the statements above or 
you may have additional ideas of your own. The most important causes for me are:- 
 
 
 The most important causes for me:  
1  
2  
3  
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Appendix V: The Brief-COPE 
 
These items deal with ways you have been coping with the stress in your life since you 
have had IBS.  There are many ways to deal with problems - these items ask you what 
you have been doing to cope with this one (i.e. your IBS).  We are interested in how you 
have tried to deal with it. Each item says something about a particular way of coping.  
We would like to know to what extent you have been doing what the item says.  Please 
only answer as to whether you are doing it or not.  Try to rate each item in your mind 
quickly but separately from the others.  Make your answers as true for you as you can.  
 
 I haven’t been 
doing this at 
all 
I’ve been 
doing this a 
little 
I’ve been 
doing this a 
medium 
amount 
I’ve been 
doing this a lot 
I’ve been turning to work or other 
activities to take my mind off things ❏ ❏ ❏ ❏ 
I’ve been concentrating my efforts on 
doing something about the situation 
I’m in 
❏ ❏ ❏ ❏ 
I’ve been saying to myself this isn’t 
real. ❏ ❏ ❏ ❏ 
I’ve been using alcohol or other drugs 
to make myself feel better ❏ ❏ ❏ ❏ 
I’ve been getting emotional support 
from others ❏ ❏ ❏ ❏ 
I’ve been giving up trying to deal with 
it ❏ ❏ ❏ ❏ 
I’ve been taking action to try to make 
the situation better ❏ ❏ ❏ ❏ 
I’ve been refusing to believe that it has 
happened ❏ ❏ ❏ ❏ 
I’ve been saying things to let my 
unpleasant feelings escape ❏ ❏ ❏ ❏ 
I’ve been getting help and advice from 
other people ❏ ❏ ❏ ❏ 
I’ve been using alcohol or other drugs 
to help me get through it ❏ ❏ ❏ ❏ 
I’ve been trying to see it in a different 
light, to make it seem more positive ❏ ❏ ❏ ❏ 
I’ve been criticizing myself ❏ ❏ ❏ ❏ 
I’ve been trying to come up with a 
strategy about what to do ❏ ❏ ❏ ❏ 
I’ve been getting comfort and 
understanding from someone ❏ ❏ ❏ ❏ 
I’ve been giving up the attempt to cope ❏ ❏ ❏ ❏ 
I’ve been looking for something good 
in what is happening ❏ ❏ ❏ ❏ 
I’ve been making jokes about it ❏ ❏ ❏ ❏ 
I’ve been doing something to think 
about it less, such as going to the 
cinema, watching TV, reading, 
daydreaming, sleeping or shopping 
❏ ❏ ❏ ❏ 
I’ve been accepting the reality of the 
fact that it has happened ❏ ❏ ❏ ❏ 
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I’ve been expressing my negative 
feelings ❏ ❏ ❏ ❏ 
I’ve been trying to find comfort in my 
religion or spiritual beliefs ❏ ❏ ❏ ❏ 
I’ve been trying to get advice or help 
from other people about what to do ❏ ❏ ❏ ❏ 
I’ve been learning to live with it ❏ ❏ ❏ ❏ 
I’ve been thinking hard about what 
steps to take ❏ ❏ ❏ ❏ 
I’ve been blaming myself for things 
that happened ❏ ❏ ❏ ❏ 
I’ve been praying or meditating ❏ ❏ ❏ ❏ 
I’ve been making fun of the situation ❏ ❏ ❏ ❏ 
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Appendix VI: The IBS-QOL 
 
 
The following note was included on the webpage:  
 
 
The Irritable Bowel Syndrome - Quality of Life questionnaire (IBS-QOL) was developed 
by Donald L. Patrick Ph.D. at The University of Washington, Douglas A. Drossman, MD 
at The University of North Carolina, Novartis Pharmaceuticals Corporation, and Novartis 
Pharma AG.  Authors hold joint copyright over the IBS-QOL and all its translations. 
 
 
Due to the above copyright statement, this measure is omitted from the 
appendices in this thesis. 
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Appendix VII: Questions about healthcare   
 
 
We would like to ask you about your consultations with your GP or the health 
care professional you see most often about your IBS (not a complementary 
therapist). 
 
                  
My Doctor is:          [Male]         [Female] 
 
 
 
In the past 12 months, how many times have you seen your Doctor about 
your IBS? 
 
 
None Once or twice Three or four 
times 
Five or six 
times 
Seven or 
more times 
     
 
 
 
On average, how long do you spend with your Doctor?  (Please enter in 
minutes) 
  
 
 
 
 
Is the time you have with your Doctor sufficient for you?   [Yes]      [No] 
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Appendix VIII: The beliefs about medicines questionnaire (general 
version)  
 
 
We would like to ask you about your personal views about medicines in general.  The 
statements below are what other people have made about medicines in general.  
Please indicate the extent to which you agree or disagree with them by clicking the 
appropriate box.  
 
 
There are no right or wrong answers. We are interested in your personal views.  
 
 
 Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
Doctors use too many medicines. ❏ ❏ ❏ ❏ ❏ 
People who take medicines should 
stop their treatment every now 
and then. 
❏ ❏ ❏ ❏ ❏ 
Most medicines are addictive. ❏ ❏ ❏ ❏ ❏ 
Natural remedies are safer than 
medicines. ❏ ❏ ❏ ❏ ❏ 
Medicines do more harm than 
good. ❏ ❏ ❏ ❏ ❏ 
All medicines are poisons. ❏ ❏ ❏ ❏ ❏ 
Doctors place too much trust on 
Medicines. ❏ ❏ ❏ ❏ ❏ 
If Doctors had more time with 
patients they would prescribe 
fewer medicines. 
❏ ❏ ❏ ❏ ❏ 
 
 
 
Are you currently taking any prescribed medication for your IBS symptoms?  
 
[Yes]                [No] 
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Appendix IX: The complementary and alternative medicine beliefs 
inventory  
 
The following questions all relate to beliefs about holistic health, complementary 
medicines and patients participation in treatment.  Please decide the extent to which 
you agree or disagree with each statement and then click the appropriate box.  
Remember there are no right or wrong answers.  Please answer all of the items.  
 
 Strongly 
disagree 
Disagree Neither 
disagree nor 
agree 
Agree Strongly 
agree 
Treatments should have no 
negative side effects. ❏ ❏ ❏ ❏ ❏ 
It is important to me that 
treatments are non-toxic. ❏ ❏ ❏ ❏ ❏ 
Treatments should only use 
natural ingredients. ❏ ❏ ❏ ❏ ❏ 
It is important for treatments to 
boost my immune system. ❏ ❏ ❏ ❏ ❏ 
Treatments should enable my 
body to heal itself. ❏ ❏ ❏ ❏ ❏ 
Treatments should increase my 
natural ability to stay healthy. ❏ ❏ ❏ ❏ ❏ 
Treatment providers should treat 
patients as equal partners. ❏ ❏ ❏ ❏ ❏ 
Patients should take an active role 
in their treatment. ❏ ❏ ❏ ❏ ❏ 
Treatment providers should make 
all the decisions about treatment. ❏ ❏ ❏ ❏ ❏ 
Treatment providers should help 
patients make their own decisions 
about treatment. 
❏ ❏ ❏ ❏ ❏ 
Treatment providers should 
control what is talked about 
during consultations. 
❏ ❏ ❏ ❏ ❏ 
Health is about harmonizing your 
body, mind and spirit. ❏ ❏ ❏ ❏ ❏ 
Imbalances in a person’s life are a 
major cause of illness. ❏ ❏ ❏ ❏ ❏ 
Treatments should concentrate 
only on symptoms rather than the 
whole person. 
❏ ❏ ❏ ❏ ❏ 
Treatments should focus on 
peoples overall well being. ❏ ❏ ❏ ❏ ❏ 
I think my body has a natural 
ability to heal itself. ❏ ❏ ❏ ❏ ❏ 
There is no need for treatments to 
be concerned with natural healing 
powers. 
❏ ❏ ❏ ❏ ❏ 
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Appendix X: Questions about complementary and alternative 
medicine use 
 
 
Do you use now, or have you ever used, any complementary therapies? 
 
[Yes]                [No] 
 
 
[If participants answered ‘no’ they were automatically directed to the 
demographic section of the survey] 
 
[the previous and following questions about CAM use were only asked at study 
time one] 
 
Which of the following complementary or alternative medicines have you used 
to relieve your IBS? (please click the box next to the name of the treatment if 
you have used it at any point and please click all that apply) 
 
 
Treatment Yes/No Treatment Yes/No Treatment Yes/No 
Acupuncture  Acupressure  Aromatherapy 
 
 
Chiropractic  Meditation
  
 Herbs 
 
 
Hypnotherapy  Massage  Shiatsu 
 
 
Osteopathy 
  
 Reiki   Nutritional 
therapy 
 
Reflexology  Homeopathy  Spiritual 
healing 
 
Other (please name/describe):  
 
 
 
Have you been directed to take any complementary medicines by your 
practitioner – such as nutritional supplements or homeopathic solutions/tablets?* 
 
[Yes]                [No] 
 
 
Have you purchased any complementary medicines ‘off the shelf’ from a health 
food shop for example?* 
 
[Yes]                [No] 
 
 
 
[* Note:  If both questions were answered ‘No’, participants were automatically 
to the demographics section]  
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Have you visited a complementary practitioner for a consultation or treatment 
session on more than one occasion in the last 12 months? 
 
                                                   [Yes]          [No] 
 
(If no, participants were automatically directed to demographic questions) 
 
            
 
We would like to ask you about your consultation/treatment session with the 
Complementary practitioner (e.g. acupuncturist or herbalist) you see most often.  
In the table below please indicate how far you agree/disagree with each 
statement. 
 
   
 My Complementary practitioner is:     
      
[Male]    [Female] 
 
 
On average, how long do you spend with your Complementary 
practitioner? 
[     ] minutes 
 
 
Is the time you have with your Complementary practitioner sufficient for 
you?         
[Yes]      [No] 
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Appendix XI: Demographic information and thank you message 
 
 
Are you:                                   [Male]  Female] 
 
 
Please could you give your age       [       ] 
 
 
Which of the following is your highest educational qualification? 
 
Qualification  
GCSE’s O’levels or equivalent 
 
 
A levels or equivalent  
 
 
First degree (e.g. BA, BSc) 
 
 
Postgraduate qualification  
 
 
No qualifications  
 
 
 
 
Are you currently employed?          [Yes]         [No] 
 
 
What is the total annual income for your household? 
 
£0 to £9,999    
£10,000 to £14,999  
£15,000 to £19,999  
£20,000 to £29,999  
£30,000 to £39,999  
£40,000 to £49,999  
£50,000 and above   
 
What is your religion? 
 
Christian  Jewish  
Buddhist  Muslim  
Hindu  None  
Sikh  Other (please name)  
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How would you describe your ethnic group? 
 
White:  Black or Black 
British: 
 
British   Caribbean  
Irish  African  
Other white 
background 
 Other Black 
Background 
 
 
Mixed: 
 Asian or Asian 
British: 
 
White & Black 
Caribbean 
 Indian  
White & Black 
African 
 Pakistani  
White & Asian  Bangledeshi  
Other Mixed 
background 
 Chinese  
Any other ethnic 
group (please list) 
 Other Asian 
Background 
 
 
 
Do you suffer with any other medical complaints apart from your IBS?  These can be 
listed in the boxes below. 
 
 
 
 
 
 
 
 
 
 
 
You may use the space below to comment on anything you would like to say about 
having IBS 
 
 
 
 
 
 
 
 
Thank you for your responses.  Would you be willing to take part in a proposed follow 
up study? 
[Yes]         [No] 
 
[Participants answering ‘yes’ were directed to the space below, if they declined, they 
were presented with a thank you message.  This section was not included in the follow-
up study] 
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Thank you for offering to take part in a proposed follow up study. You can enter your 
email in the box below, so you can be contacted when the study takes place. (Your 
email address will be stored separately from your survey responses) 
 
 
 
 
 
[Thank you message] 
 
I would like to take this opportunity to sincerely thank you for taking part. Your 
responses will be of great value in contributing to a greater understanding of the 
psychological issues that accompany Irritable Bowel Syndrome. 
 
If you have any comments about the survey (if you felt it was too long for example) you 
can use the email address below.  [email address included]   
 
 
 
There is also a possibility that a short follow up study may run later on in the year. If you 
would be willing to take part (and you missed submitting your email address previously) 
then you can also use the email below to register your willingness to participate in this 
follow up study. 
 
Once again, many thanks for your time and participation. 
 
Lee Usher, PhD student, Thames Valley University.  
 
email: [email address included]   
 
 
To close your browser window you can now click on the 'thank you' icon below.  
 
 
 387 
Appendix XII: First email sent to participants regarding the follow-
up study 
 
 
[first email] 
 
Dear Participants, 
  
Hopefully you all received my recent email regarding the follow up study - that 
is, to the one you recently took part in online. 
  
The follow up study website address can be found below (and at the end of the 
email).  You can click the link directly or copy it and then paste into your web 
browser address bar.  Do have a read through the first page - it will hopefully 
answer any questions you may have. 
  
The study link is here:  
http://www.questionpro.com/akira/TakeSurvey?id=1221704 
  
Once again, I am extremely grateful for your time and participation.  And I need 
to thank everyone that responded to my last email (and apologise for not getting 
back to you all).  It has been very interesting hearing about how IBS affects 
people on a personal level.  With this in mind, do use the 'box' at the end of the 
study to enter any additional comments you may want to express. 
  
I just wanted to say a final thank you - and do send me an email if you have any 
questions or queries. 
  
Many thanks, 
  
Lee Usher 
  
Thames Valley University 
School of Human and Psychological Sciences 
  
The follow-up study link is here:  
http://www.questionpro.com/akira/TakeSurvey?id=1221704 
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Appendix XIII: First email reminder sent to participants regarding 
the follow-up study 
 
 
Dear Participants, 
  
I wanted to thank everyone who has taken part in the follow up - thank you (you 
don't need to take part again) - your participation will hopefully go some way to 
influencing future self management programs and General Practitioner 
consultations for those with IBS. 
  
For those of you that have yet been unable to take part - the study will remain 
open for a little longer.  The more responses are collected the more can be 
gained from the study, so if you can spare 20 minutes or so (at any time) - do see 
if you can take the time to take part.  Your responses are highly valued and can 
go a long way to improving health care in the future. 
  
The study website address can be found below (and at the end of the email).  
You can click the link directly or copy it and then paste into your web browser 
address bar.  Do have a read through the first page - it will hopefully answer any 
questions you may have. 
  
The study link is here:  
http://www.questionpro.com/akira/TakeSurvey?id=1221704 
  
Do feel free to pass on the study link to anyone who you know took part in the 
first study but I have been unable to contact. 
   
Once again, I am extremely grateful for your time and participation and do send 
me an email if you have any questions. 
  
Many thanks, 
  
Lee Usher 
  
Thames Valley University 
School of Human and Psychological Sciences 
  
The follow-up study link is here:  
http://www.questionpro.com/akira/TakeSurvey?id=1221704 
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Appendix XIV: Second email reminder sent to participants 
regarding the follow-up study 
 
 
Dear Participants, 
 
I wanted to thank, once again everyone who has taken part in the follow up - 
thank you (you don't need to take part again) and hopefully this is the last email 
you will receive from me (so thank you also for your patience). 
  
If you have so far been unable to take part, were interrupted whilst doing the 
survey or just did not have enough time - the study will remain open for at least 
another 10 days.  As I mentioned, the more responses that are collected, the 
more can be gained from the study - so if you can spare approximately 20-25 
minutes - do see if you can take the time to take part.  As I mentioned, your 
responses are highly valued and can go a long way to improving health care in 
the future. 
  
The study website is below.  You can click the link directly or copy it and then 
paste into your web browser address bar.  Do have a read through the first page - 
it will hopefully answer any questions you may have. 
  
The study link is here:  
http://www.questionpro.com/akira/TakeSurvey?id=1221704 
  
Do feel free to pass on the study link to anyone who you know took part in the 
first study but I have been unable to contact. 
Once again, I am extremely grateful for your time, participation and interest.  Do 
please send me an email if you have any questions. 
  
Many thanks, 
  
Lee Usher 
  
Thames Valley University 
School of Human and Psychological Sciences 
  
The follow-up study link is here:  
http://www.questionpro.com/akira/TakeSurvey?id=1221704 
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Appendix XV:  Write-up for thematic analysis of participants’ open 
text responses  
 
This provisional write up consists of a thematic analysis conducted 
participants’ responses to the open text section of the survey reported in 
chapters four and five.  Participants were asked if there was anything 
else they would like to add about their IBS at the end of the survey.  
Responses were collated and a theory-based top-down thematic analysis 
on participant text was conducted to examine for evidence of perceptions 
of illness according to the CSM. 
 
Introduction 
The results presented in chapter’s four to six have indicated that illness 
perceptions are important factors in influencing specific coping behaviour 
and reported quality of life.  Chapter four showed the benefits of adopting 
an extended CSM (e.g. Horne & Weinman, 2002), which incorporated 
treatment beliefs, in predicting CAM use (i.e. a specific coping behaviour 
in the context of the CSM) in those affected by IBS.  Chapter four also 
illustrated that IPQ-R scores were typically higher in CAM-users than 
non-users. 
 
Chapter five highlighted the influence of illness perceptions and, to a 
lesser degree, treatment beliefs, on reported quality of life.  Many of the 
direct pathways between the components of illness perceptions and 
quality of life were found to be partially mediated by, for the most part, 
maladaptive or dysfunctional coping strategies.  This finding was largely 
consistent across both CAM-users and non-users,  
 
Over time, the influence of treatment beliefs on quality of life appeared to 
diminish (chapter six).  Chapter six examined the influence of illness 
perceptions on reported quality of life over time and delineated 
relationships between illness perceptions measured at time one, and 
reported quality of life at time two in both CAM-users and non-users.  In 
testing for mediation effects however, mediation was only detected in 
 391 
CAM-users, with the coping strategy of behavioural disengagement 
being the most prominent and largely partial mediator.  This may be 
contrasted with the findings of Rutter and Rutter (2007), who found no 
evidence of mediation over three time points in people affected by IBS. 
 
The findings from chapter six in particular suggest that illness 
perceptions have a greater influence than treatment beliefs on quality of 
life in those affected by IBS in both CAM-users and non-users.  
Treatment beliefs may be more (directly) influential on specific coping 
behaviours such as adherence to conventional medication (Bishop et al., 
2008) or use of CAM (chapter four).   
 
These findings informed the rationale of this analysis to investigate 
evidence of illness perceptions, as specified by the CSM, in participants’ 
text responses to the open question at the end of the online survey 
(section 3.1.1.2).  Finding evidence of illness perceptions in participant 
text would further corroborate the benefit of applying the CSM to this 
participant group as well as providing further support for the CSM.  As 
highlighted in chapter two, many early CSM studies derived findings from 
qualitative methodology (e.g. Meyer et al., 1985) and the development of 
the IPQ was conducted using extensive pilot work which included some 
qualitative investigation (Weinman et al., 1996).  In the context of this 
provisional write up, the use of a qualitative approach represented a 
degree of triangulation to substantiate the importance of illness 
perceptions in those affected by IBS.  
 
O’Cathain and Thomas (2004) propose guidelines for including such 
open questioning in quantitative research.  Firstly, there should be a 
clear rationale for including the open question.  There may be issues 
relevant to the study that may be missed by using existing measures.  An 
additional open question may act as an exploratory tool to identify any 
further relevant issues, or in the case of this research, issues particularly 
relevant to individuals with IBS (i.e. illness perceptions) may be further 
substantiated by analysis of open text responses.  Second, enough 
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space should be provided for participants to express their thoughts.  
O’Cathain and Thomas (2004) further recommend the use of 
demographic information in analysing such open text.  Specifically, in this 
research a selection of CAM-users and non-users (i.e. those not using 
CAM) were subject to analysis.   
 
This approach represents a ‘novel’ way of obtaining qualitative data 
rather than what might be considered a formal multiple-methods 
approach (Bowling, 2009; Casebeer & Verhoef, 1997).  Although there 
may be concerns with the quantity and quality of such data collected via 
open questions on largely quantitative measures (O’Cathain & Thomas, 
2004), similarities with other studies that have utilised postings on 
internet message boards may be drawn.  Analysis of internet postings 
often comprises the examination of a substantial quantity of short, often 
concisely written messages, rather than transcriptions of interviews 
where the researcher has directly questioned participants (Bryman, 
2008).  
  
Studies have examined such diverse areas as concerns of cruciate 
ligament surgery patients (Brewer, Raalte & Cornelius, 2007), ethnic 
differences in cancer pain (Im et al., 2009) and those affected by IBS 
(Coulson, 2005) using a thematic analysis approach.  This provisional 
write up therefore, sought to examine participants’ text responses for 
evidence that illness perceptions were present.  
 
The aim of this provisional investigation was to examine participants’ text 
responses to the open question included in the survey (at time one) 
which invited participants to volunteer any information about being 
affected by IBS.  Responses were analysed for themes that may be 
relevant in terms of components of illness perceptions.  This was 
conducted to examine for evidence that illness perceptions were evident 
in participants’ written expression about their IBS according to the CSM 
(Leventhal et al., 2003).  A top-down thematic analysis (Boyatzis, 1998) 
involving the application of illness perception components from Leventhal 
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et al. (1998) and revisions by Moss-Morris et al. (2002) was conducted 
on participant text.     
 
Method:  Design and materials  
From the cross-sectional study reported in chapters four and five (study 
time one) and the procedure outlined in section 3.4, participant 
responses were collected from asking an open question at the end of the 
online survey.  At the end of the survey described in section 3.3, 
participants were asked an open ‘question’ about their IBS: ‘You may use 
the space below to comment on anything you would like to say about 
having IBS’.  Responses were collated alongside demographic 
information so it was possible to describe participants that had 
responded to the open question.  Responses were then analysed using a 
theory-based top-down thematic analysis (Boyatzis, 1998). 
 
Braun and Clarke (2006) argue that thematic analysis may be thought of 
as an approach that underpins much of perhaps more theory-based 
qualitative analysis.  Thematic analysis shares, for example, the 
technique of coding with other more Interpretative techniques such as 
Interpretative Phenomenological Analysis (IPA) (e.g. Smith et al., 1999).  
Thematic analysis may both generate ‘themes’ within participant data, 
representing a ‘bottom-up’ or data-driven approach or, thematic analysis 
is equally able to apply pre-determined codes upon data in a ‘top-down’ 
approach whereupon multiple presences of such codes in participant 
data may then be classified as themes (Braun & Clarke, 2006).  In 
considering the aims of this provisional write up, a top-down deductive 
approach was deemed the most suitable to examine for evidence of the 
components of illness perceptions, which in this context, may be 
considered ‘themes’ that were applied to participant text.   
 
Participants 
Responses were collected from 175 participants who had taken part in 
the survey (at time one).  This consisted of 147 females and 28 males 
and represented 26.8% of the total sample of 653 participants.  159 
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responses came from people in the UK, nine responses from the US, two 
were from Canada and one response each came from participants in 
Denmark, France, Holland, Ireland and Spain.  Approximately 66% 
(n=115) had used CAM to relieve their IBS with sixty participants (34%) 
indicating they had not used CAM.  Over half of participants also felt they 
had been affected by IBS for over five years (n=110).  The demographics 
in the sample of participants used in this study suggest similarities with 
participant data reported in chapters four and five.   Participant ages 
were largely between 20 and 60 years.   
 
 
Analysis 
Participant responses were taken verbatim from the survey and analysed 
using thematic analysis (Boyazatis, 1998; Braun & Clarke, 2006; 
Bryman, 2008).   
 
Process of coding and inter-rater reliability  
Components of illness perceptions were selected as coding categories.  
This namely consisted of perceptions of identity, timeline, consequences, 
control/cure and cause.  As the IPQ-R (Moss-Morris et al., 2002) was 
utilised in studies at time one and time two (chapters four through to six), 
these codes were revised slightly to reflect the development in 
understanding of illness perceptions.  The timeline ‘theme’ was 
expanded to incorporate both chronic and cyclical beliefs.  The control 
component was expanded to include both treatment and personal 
control.  In addition, the ‘theme’ of emotional representations was 
included to examine any reference to emotional distress caused by IBS.  
A summary of codes can be found in table 1. 
 
The primary researcher read all participant responses and indicated 
initial codes, based on the components of illness perceptions illustrated 
in table 1.  Passages of text that reflected each of the codes were 
consequently clustered into themes representative of components of 
illness perceptions.   
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Inter-rater agreement was tested in a similar way to a method described 
by Hruschka et al. (2004), where short open ended survey responses 
were analysed by two researchers.  Approximately 20% of text was 
analysed by more than one researcher, and several revisions of coding 
was conducted until a high level of agreement was reached (Hruschka et 
al., 2004). 
 
A similar approach was conducted in this study with the assistance of a 
senior colleague, who independently analysed 50% of participant 
responses using application of the codes in table 1.  Once completed, 
inter-rater reliability amongst the codes was tested using Cohen’s Kappa 
statistic (Cohen, 1960).  The Kappa statistic adjusts for agreement by 
chance (Hruschka et al., 2004) and typically results in a value of between 
0 (agreement, but no better than chance) to 1 (perfect agreement).  
Values below zero are possible, and represent a degree of disagreement 
(Landis & Koch, 1977).   
 
 
Table 1: Illness perception codes used in the application of 
Thematic Analysis of participants’ text responses 
 
Illness perceptions 
 
Description 
Identity 
 
Naming or labelling of IBS and recognised symptoms 
Timeline 
 
Cyclical: reference to symptoms fluctuating 
Chronic: reference to ongoing symptoms 
 
Consequences 
 
Perceived consequences of IBS 
Control Personal control: reference to self-efficacy, is the 
individual in control of their IBS? 
Treatment control: can medication control IBS? 
 
Coherence 
 
Perceived coherent understanding of IBS  
Emotional representations 
 
Emotional responses to IBS 
Causes 
 
Reference to perceived causal mechanisms 
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Coding data from each rater was entered into SPSS.  Each component 
of illness perceptions was entered on the same data sheet, once for each 
rater.  Data were then coded (numerically) ‘yes’ if the code was observed 
and ‘no’ if the code was not seen to be present in each participant’s text.  
Data from each participant was input into SPSS.  Consequently, a Kappa 
statistic was generated for each component of illness perceptions 
illustrated in table 1.  Results can be found in table 2 below. 
 
Table 2 shows inter-rater reliability was high for all components of illness 
perceptions.  Typically figures of greater than .81 indicate almost perfect 
agreement between coders (Landis & Koch, 1977).  These figures were 
therefore deemed acceptable with no further inter-rater coding required.  
These findings therefore indicate there was strong inter-rater agreement 
on the presence of illness perception components in participant open 
responses. 
 
 
Table 2: Kappa inter-rater reliability values from analysis of 
participant text responses for illness perception components   
  
Illness perceptions 
 
Kappa statistic 
Identity .94*** 
Timeline .91*** 
Consequences .83*** 
Control .80*** 
Coherence .85*** 
Emotional representations .88*** 
Causes .95*** 
               ***p<.001 
 
 
Results  
Evidence of all seven over-arching codes as outlined in table 1, were 
identified from the coding process applied to all 175 responses.    
Responses varied in length from a single line to several lines of text.  
Some participants entered substantially more text, although this was less 
common.  The numerous occurrences of each code from participant 
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responses were clustered into themes.  The themes represented 
components of illness perceptions and suggested that participants do 
perceive their IBS in a structured way according to CSM theory (e.g. 
Leventhal et al., 2003) and the IPQ-R (Moss-Morris et al., 2002) and this 
was apparent in both CAM-users and non-users.  Each theme is outlined 
and illustrated by verbatim quotations from participant text.  A summary 
of themes and short illustrative quotations can be found in table 3.  
Quotations are coded by participant and line number and are provided 
verbatim. Participant responses are provided in full in appendix XVI. 
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Table 3: Table of themes extracted from participant text responses (table continues on next page) 
 
Theme  
 
Description Examples 
 
Identity 
 
 
Reference to naming or labelling of IBS.  
Recognition of IBS symptoms 
 
 
“I have the runs all the time….”  Participant 43, line 37 
 
“My symptoms include frequent visits to the toilet…”  P46, line 2 
 
“during a really bad bout of IBS it is bloating and dhiarrea.”  P77, line 8 
 
 
Timeline 
 
 
Included two sub-categories: cyclical 
(reference to fluctuation of symptoms) and 
chronic (reference to ongoing symptoms) 
 
“My IBS may have large gaps inbetween flare ups”   P34, line 40 
 
“I feel I have had IBS since early on in childhood”  P35, line 38 
 
“constant abdominal pain for nearly four years…”  P90, line 6 
 
 
Consequences 
 
 
Perceived consequences of IBS on day to day 
life such as finance, occupation and social 
activities 
 
 
“It is a dreadful condition that tries to rule your life…..”  P9, line 42 
 
“My IBS is seriously affecting my career…”  P96, line 36 
 
“This has ruined my life…..”  P107, line 50 
 
Control 
 
Included two sub-categories of personal 
control (does the individual feel in control of 
their IBS?) and treatment control (can 
medication control IBS?) 
 
“I feel I’ve managed to control my IBS fairly successfully….”  P28, line 8 
 
“… accidents during the night and cannot control them….”  P40, line 18 
 
“…it will not stop even with my medication…”  P43, line 38 
 
“Some treatments only work for a short time.”  P49, lines 17-18 
 
 
(Continues on next page) 
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Table 3 (continued) Table of themes extracted from participant text responses  
 
 
 
Coherence 
 
 
Perceived coherent understanding of IBS  
 
 
“…I have not been provided with enough information on IBS…”  P70, line 13 
 
“…am really baffled ...so severely.”  P136, lines 35-36 
 
“I knew that I could take an antispasmodic…”  P14, lines 28-29 
 
 
Emotional 
representations 
 
 
Emotional responses to IBS 
 
 
“…very fed up with it.”   P58, line 24 
 
“… feel frustrated about is how my IBS comes in different forms…”  P77, lines 
6 
 
“… felt ashamed, worthless and severely depressed…”  P118, lines 30-31 
 
 
Causes 
 
 
Reference to perceived causal mechanisms 
or what might trigger an ‘episode’ of IBS 
 
 
“I think it is a lot to do with being nervous”  P81, lines 31-32 
 
“I experienced a stomach virus….never came back to normal health.”  P83, 
lines 44-45 
 
“stress triggers my IBS…”  P118, lines 35-36 
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Illness identity 
The CSM stipulates that the component of illness identity is concerned 
with the labelling of symptoms and identifying symptoms as part of an 
illness.  This was primarily reflected in participant text by knowing and 
identifying what the symptoms of IBS were.  This was evident across 
both CAM-users and non-users.  It was also evident that participants 
were affected by both constipation and diarrhoea prominent IBS.  The 
following examples show evidence of illness identity. 
 
P43 (Female, 50, non-user): I have the runs all the time and the pain is 
just awful (Line 37) 
 
P39 (F 59, CAM-user): The most annoying thing is the constipation 
(sometimes a week) then diorreha (sometimes 6 times in day) and the 
wind.  (Lines 14-15) 
 
P77 (F 28, CAM-user):  I hate that on a daily basis I have to worry about 
constipation but then during a really bad bout of IBS it is bloating and 
dhiarrea.  (Lines 6-8) 
 
P140 (F 27, CAM-user):  I have noticed my IBS symptoms are worse in 
the days before my period starts.  I suffer badly from fatigue.  (Lines 7-8) 
 
It was also evident that participants demonstrating the theme of illness 
identity were aware that IBS is not limited to one symptom and may even 
include potentially related symptoms such as fatigue.  The final two 
quotation examples in particular, also demonstrate evidence of an 
awareness of the cyclical timeline of symptoms. 
 
Timeline (cyclical and chronic) 
Both timeline dimensions were observed in participant text.  Many 
participants remarked solely on the symptoms following a cycle or 
periods where they are more intense. 
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P170 (M 33, CAM-user):  the symptoms seem to follow a cycle…. (Line 
6) 
 
P34 (F29, CAM-user):  My IBS symptoms may have large gaps in 
between flare ups.  (Line 40) 
 
Many participants had been affected by IBS symptoms for a number of 
years and seemed to be able to be precise as to how long ago symptoms 
commenced.  The following examples illustrate that IBS was firmly 
perceived as a chronic condition. 
 
P32 (F 46, non-user): I have actually had the condition for over 30 years 
(Lines 31-32) 
 
P74 (F 43, CAM-user):  I have suffered with IBS for 22 years… (Line 35) 
 
P78 (F 40, CAM-user):  20 years I’ve been like this (Lines 19-20) 
 
P63 (F 72, non-user): have had the symptoms since my mid-teens 
(1950’s).  (Lines 7-8) 
 
P113 (M 34, CAM-user):  I still get the odd flare up but it passes as 
quickly as it arrives. (Line 46) 
 
Participants also acknowledged both dimensions of the timeline theme in 
their text, reflecting on both the duration and the propensity for fluctuation 
of symptoms. 
 
P82 (M 34, CAM-user):  It’s a vicious cycle and one that I have not been 
able to deal with for 20 years.  (Lines 39-40) 
 
P104 (F 47, CAM-user):  My IBS is completely random in its frequency.  I 
can have it badly every day for weeks and then it will stop apart from the 
usual menstrual cycle attack.  (Lines 33-35) 
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Consequences 
The consequences of IBS were acknowledged in many responses, being 
one of the most important components of illness perceptions in terms of 
being influential on CAM use and IBS-QOL scores (chapters four and 
five).  Again perceptions of illness consequences were common across 
both CAM-users and non-users. 
 
P9 (F 49, CAM-user):  It is a dreadful condition which tries to rule your 
life and makes all aspects difficult and sometimes embarrassing.  (Lines 
42-43) 
 
P59 (F 20, CAM-user):  It completely affects my quality of life.  I sit and 
think about all the missed opportunities and thing I could have done if I 
didn’t suffer with this disease.  (Lines 27-29) 
 
P69 (M 25, non-user):  I feel that businesses and organisations I have 
been with since having IBS do not understand IBS and the effect it has 
on staff.  They offer little or no support to staff … (Lines 6-8) 
 
P96 (F 28, non-user):  My IBS is seriously affecting my career, due to the 
time off I have had due to my IBS.  (Lines 36-37) 
 
P116 (F 29, CAM-user):  It effects every single area of my life and I hate 
it.  I’m off with it nearly a month every year so it affects my employment 
opportunities.  (Lines 12-14) 
 
P134 (F 38, CAM-user):  …I have had 11 weeks off sick in the past year.  
(Lines 23-24) 
 
Several participants focused on the impact of IBS on their occupation 
and other activities.  There was also reflection on a perceived lack of 
understanding from employers.  This illustrates how external factors may 
influence illness perceptions and subsequently have an effect on the 
coping strategies adopted.  In the case of perceptions of consequences, 
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occupation issues may actually contribute to the cycle of IBS symptoms 
as work related worry or anxiety may also contribute to the experience of 
symptoms.   
 
Control (personal and treatment) 
As with the timeline component, evidence for perceptions of control was 
expressed as representations of two sub-dimensions related to personal 
and treatment control.  Treatment control was evident in terms of both 
having control over symptoms and seemingly desiring control over one’s 
symptoms. 
  
P37 (F 51, CAM-user):  I would like to know how successful my 
medication is compared to other people’s experiences.  (Lines 6-7) 
 
P49 (F 43, CAM-user):  Some treatments only work for a short time.  
(Lines 17-18)  
 
P51 (F 52, CAM-user): …no effective conventional medication for 
bloating swelling … (Line 28) 
 
P170 (M 33, CAM-user):  Imodium has made the single biggest 
improvement, taking it as a preventative measure when needed has 
restored a lot of my confidence and made the condition manageable to 
an extent…. (Lines 10-13) 
 
Many participants reflected on their lack of personal control over their 
situation, perhaps feeling unable or lacking the self-efficacy to do 
anything about their symptoms.  This is clearly reflected in the following 
examples of participant text. 
 
P5 (F 56, CAM-user):  It’s down to me to deal with it, feel helpless at 
times to change the lifestyle.  (Lines 26-27) 
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P28 (F 42, CAM-user):  I feel I’ve managed to control my ibs fairly 
successfully without the continual use of conventional drugs for the past 
15 years… (Lines 8-9) 
 
P113 (M 34, CAM-user):  I undertook a 8 week course of Hypnosis 
recently and my symptoms of IBS have all but disappeared.  (Lines 42-
43) 
 
P17 (F 20, CAM-user):  Living with IBS is waking up every day fighting a 
losing battle.  You can’t beat it.  (Lines47-48) 
 
P115 (F 44, non-user):  I am currently self managing, using stress 
management and relaxation exercises.  (Lines 6-7) 
Many participants demonstrated evidence of both dimensions of control.  
In the text below, it appeared this participant had a degree of personal 
and treatment control over their IBS. 
 
P1 (F 83, non-user):  I treat my IBS attacks with Gravol.  I stay in bed 
and sleep as much as possible until the attack is over.  (Lines 3-4) 
 
Coherence 
The theme of illness coherence, or beliefs representing a coherent 
understanding of IBS was reflected with both positive and negative 
connotations.  It was clear some participants demonstrated they either 
had little understanding or wanted a greater understanding of their IBS.  
This theme or component of illness perceptions was notably the least 
evident in participant text. 
  
P16 (F 60, CAM-user):  I feel as if all the help and focus is on the people 
who suffer with the constant need for the toilet rather than those of us 
who have the chronic constipation side…  (Lines 40-42) 
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P136 (F 21, non-user):  I have never been allergic to anything and am 
really baffled as to why this condition rears its ugly head randomly and so 
severely.  (Lines 35-36) 
 
P42 (F 30, non-user):  The most annoying thing about being diagnosed 
as having IBS, is the lack of advise in trying to help make the problem 
more manageable.  (Lines 29-30) 
 
Several participants expressed a desire for more information about IBS; 
at the same time some participants acknowledged they had conducted 
their own research.  The first participant below stated they had 
conducted their own research and appeared concerned that not 
everyone would take this step. 
 
P44 (F 26, CAM-user):  I feel that I have had little/no formal education on 
diet.  I am concerned that others will not think to complete their own 
research to elivate their symptoms.  (Lines 42-44) 
 
P70 (F 22, non-user):  I feel I have not been provided with enough 
information on IBS… (Line 13) 
  
P134 (F 38, CAM-user):  I would like to understand more about IBS I 
don’t understand why I have the illness and I don’t understand if it will get 
better or not.  (Lines 20-21) 
 
One participant remarked that taking part in the survey actually helped 
their knowledge of IBS by making some aspects of the illness clearer for 
them. 
 
P88 (F 28, CAM-user):  Your survey is very thorough and answering the 
questions makes some things seem more clear…. (Lines 48-49) 
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Emotional representations  
There were many examples of emotional representations detected in 
participant text.  There also appeared to be evidence of influences on 
emotional reactions to IBS based on factors or agents external to the 
illness.   
 
P94 (F 45, CAM-user):  I only go out to work IBS has ruined my life and I 
am very often in tears over it, my relationship is suffering and at present 
no one understands and after 4 years I have had enough.  (Lines 40-42) 
 
P118 (F 38, CAM-user): In fact, one doctor actually counted out the 
number of times that I had been to visit the surgery in one year, in front 
of me, and told me this was unacceptable!  As a result I felt ashamed, 
worthless and severely depressed (no surprises there then!)…..Thank 
you for this opportunity to get my frustrations off my chest.  (Lines 27-31 
& line 44) 
 
P175 (F32, non-user):  …basically you are sent away and told to live with 
it, basically live in misery!!!  I am so ill and exhausted with it and have no 
live!!  (Lines 37-39) 
 
It was also noted there were more extreme emotional reactions in the 
form of apparent despair when participants were thinking about their 
situation and outlining how such feelings may have originated. 
 
P107 (M36, CAM-user):  Doctors don’t listen when I try to explain.  They 
don’t know the effect this illness has on people.  They don’t even 
understand cause.  This has ruined my life and I feel as if there is no help 
available to me.  (Lines 48-50) 
 
P159 (F 76, non-user):  IBS attacks are totally unpredictable and cause 
me a great deal of depression…  (Lines 40-41) 
 
 407 
P141 (F 23, non-user):  had a nervous breakdown because of my IBS 
(Line 11) 
 
There was also some implication of emotions in maintaining symptoms.  
The following male participant suggested emotion was a crucial factor in 
his illness experience.  
 
P133 (M 22, CAM-user):  That the most annoying thing is that it seems to 
be my emotions that control it, like excitement or worry…… emotions 
such as worry are hard to control at the best of times, even more so 
when you feel cramps and you are on a bus half way towards your 
destination.  (Lines 13-17) 
 
Causes 
There were several reflections on possible causes of IBS.  Both stress 
and food or diet related causes were recurrent themes in those 
participants that expressed beliefs in causal agents. 
 
P5 (F 56, CAM-user):  I feel that it is due to lack of exercise.  (Line 25) 
 
P24 (F 36, CAM-user):  very much food related.  (Line 36) 
 
P28 (F 40, non-user):  ...sufferers often find that they are not taken 
seriously with their health issues and the impacts on their mental and 
social well being.  (Lines 3-5) 
 
P50 (F 24, non-user):  Was brought about by a very stressful job and 
overreliance on dairy.  (Line 23). 
 
P54 (F 60, CAM-user):  … I wonder if it’s a nerve pathway that got turned 
on and now won’t turn off….. Also wonder if epigenetics play a role, 
which would include environmental contaminants… (Lines 48-50 & 1-2). 
 
 408 
P7 (F 50, CAM-user):  The symptoms increase with the stress of work 
and decrease when away from work for holidays – my case work related.  
(Lines 34-35) 
 
P149 (F 23, non-user):  I think peoples perception of IBS is a contributing 
factor.  If IBS comes from stress then making people feel nervous and 
anxious about their problems heightens stress levels.  (Lines 46-48) 
 
P170 (M 33, CAM-user):  …gets into a vicious circle of anxiety and that 
triggers it then it gets worse from the symptoms.  (Lines 6-7) 
 
Other participants made reference to specific incidents or illnesses that 
they felt had a role in starting or triggering their IBS.  
 
P65 (M 33, CAM-user):  my IBS started while I was working away from 
home on nights and I got food poisoning from reheated fish.  (Lines 21-
22). 
 
P75 (F 36, CAM-user):  My IBS first occurred after I suffered from a 
spastic duodenum for three months…. I believe this started the IBS 
which has been with me since.  (Lines 45-48) 
 
P81 (M 62, non-user):  I think it is a lot to do with being nervous. (Lines 
31-32)  
 
P83 (M 28, CAM-user):  I experienced a stomach virus while travelling 
and my stomach just never came back to normal health.  I believe I have 
the Post-Viral IBS.  (Lines 44-45) 
 
P99 (F 53, non-user):  I feel contributory factors of the onset of my IBS 
are stress related combined with poor diet and general quality of life.  
(Lines 2-3) 
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One participant, despite stating their colon had been removed, appeared 
confused as to why they were still experiencing symptoms and appeared 
unsure of any specific causal factor.  
 
P85 (F 75, non-user):  …. with an ablation of colon I STILL have IBS 
symptoms?  although I have a cool and relaxed mind and am pleased 
with my quality of life.  (Lines 30-32) 
 
As well as evidence of each of the themes as outlined in table 1, it was 
also clear that many participants had a positive experience of both being 
able to take part in a research study and that there was opportunity to 
express some feelings beyond responding to quantitative measures.  
Many also thanked the researcher for taking the time to conduct a study.  
 
 
Discussion 
Thematic analysis was used to analyse participant responses to the open 
question included in the survey conducted at time one (chapters four and 
five).  This was used as an attempt to highlight the importance of illness 
perceptions in those affected by IBS.  Seven key themes were derived 
from previous work on the CSM (e.g. Leventhal et al., 1992) and work on 
the IPQ-R (Moss-Morris et al., 2002).  The analysis of participant text 
does add support to the CSM theory that individuals do conceive specific 
schematic representations of their IBS.  Each of the themes is 
considered separately. 
 
Illness identity  
Illness identity is concerned with the labelling of symptoms and 
attributing them to IBS rather than any other conditions.  In applying this 
theme to the text analysed, the purpose was to determine how 
participants expressed IBS symptoms and referred to IBS as an illness. 
 
Overall participants expressed their perceptions of their symptoms by 
referring to them as ‘symptoms’ or by specific symptom.  Some 
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participants stated they suffered with a particular sub-type of IBS, either 
constipation or diarrhoea predominant.  The way that symptoms were 
expressed was done so with an apparent implicit reference to the impact 
of IBS on individuals’ quality of life.  This seems to concur with other 
findings that perception of IBS symptoms may influence quality of life 
(e.g. Chang, 2004; Naliboff et al., 1998; Rutter & Rutter, 2002). 
 
Illness identity was also referred to in the context of the timeline of IBS 
symptoms with comments referring to specific symptoms and how long 
they might last or how soon they may be relieved and return.  In other 
illness populations there is suggestion that illness identity is one of the 
most prominent of the components of illness perceptions to influence 
outcome (Hagger & Orbell, 2003), although results from chapter five 
suggested identity to be less important in this sample.  The comments 
were fairly consistent between both CAM-users and non-users as there 
was no noticeable expression of greater illness identity in CAM-users.   
 
Timeline  
The timeline theme reflected the sub-components as outlined by Moss-
Morris et al. (2002), in that participants expressed their IBS in both 
cyclical and chronic terms.  Throughout the text, it was noted that there 
was almost unanimous acknowledgement that IBS is a chronic condition, 
although a small number of participants expressed they were uncertain 
how long symptoms would last for.  Stronger perceptions of a chronic 
timeline were shown to have an influence on impaired quality of life 
ratings (chapter five) and these findings give an indication of how such 
representations may be conceptualised by those affected by IBS.   
 
In representing cyclical beliefs about IBS, participants often referred to 
‘cycles’ or ‘flare-ups’ of symptoms and many seemed aware that this was 
considered normal for someone affected by IBS.  Although implicated as 
less important in influencing reported quality of life (chapter five), 
stronger perceptions of a cyclical timeline were influential on whether 
participants would use CAM to treat their IBS (chapter four).   
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Consequences 
The ‘theme’ of illness consequences has been shown to be important 
both in influencing specific coping behaviour (CAM use, chapter four) 
and on reported quality of life.  There were a number of expressions and 
reflections on the consequences of IBS.  This ranged from the impact of 
symptoms on the various aspects of everyday life and how this was 
considered a hindrance.  Such consequences have been reported in 
previous work (Amouretti et al., 2006; Chang, 2004; Dancey & 
Backhouse, 1993; Luscombe, 2000).   
 
Other participants expressed the consequences theme in respect of their 
occupation or citing concern with a lack of understanding from their 
employers regarding their IBS.  It may appear that for many affected with 
IBS, they perceive their employers as lacking understanding about IBS 
and do not regard the condition as legitimate.  In this instance parallels 
may be drawn with early medical perspectives of IBS, when the medical 
profession failed to acknowledge IBS as a legitimate medical condition 
(Rutter & Rutter, 2002).  It appears a similar boundary is perceived for 
many with their employers. 
 
Control 
Both dimensions of control were observed in participant responses as 
outlined by Moss-Morris et al. (2002).  In terms of expressing treatment 
control, a small number of participants indicated that they managed to 
control their IBS using medication or other treatments they had 
discovered worked well for them.  More frequently found was that many 
participants disclosed that they had not been able to control their 
symptoms with medication they had either purchased themselves or had 
been prescribed.  The fact that many CAM-users also expressed this 
suggests that CAM treatments were no more successful in controlling 
symptoms than conventional treatments.  This seems to add support to 
findings from chapter five where CAM-users reported poorer quality of 
life, which has also been found in previous work (van Tilburg et al., 
2008).  However, in both CAM-users and non-users, those with stronger 
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representations of treatment control, reported better quality of life 
(chapter five). 
 
A similar scenario existed for the theme of personal control.  Many 
participants, including CAM-users, expressed modest or limited control 
over their IBS.  Those that did express a degree of control seemed to 
refer to a specific or personal regimen of either a specific treatment or 
behaviour they would undertake until symptoms had passed.  As with 
treatment control, stronger perceptions of personal control were found to 
be related to better reported quality of life (chapter five).   
 
Coherence 
In terms of the theme of illness coherence, participants expressed this in 
both positive and negative connotations.  Several participants stated that 
they understood their IBS and seemed to know what the condition 
entailed while others seemed uncertain about their IBS.  Several 
participants seemed keen to know more about IBS, especially treatments 
and why they had IBS.  It would appear from participants’ responses that 
there is a need for better information about IBS and to make this 
information universally available.  Findings presented in chapter five, 
showed that, as with the control components, stronger coherence ratings 
were related to better reported quality of life scores. 
 
Emotional representations 
Chapter five showed that emotional representations were important 
influences on both reported quality of life and emotional quality of life 
(Dysphoria).  The reflections from participant text showed the emotional 
distress that those affected by IBS go through.  Many participants 
expressed that they felt miserable and unhappy, which sometimes came 
from lack of interest from their GP.  Other participants expressed more 
severe emotional reactions to their IBS with one participant stating they 
had a nervous breakdown due to their IBS.  Perhaps this is reflection on 
previous understanding that those affected by IBS are liable to 
‘catastrophise’ about their symptoms (Drossman et al., 1999; Lackner et 
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al., 2004).  The excerpts of text do illustrate emotional representations 
are important aspects of the CSM and in forming representations about 
illness (Leventhal et al., 2003). 
 
Causes 
There were several references in participant text to potential causes of 
each case of IBS.  This seemed to range from stress or anxiety to diet or 
food related causes (Casiday et al., 2008; Hungin et al., 2005; Lacy et 
al., 2007).  Some responses indicated a specific incident or illness 
triggered their IBS symptoms and these were sometimes related in the 
text to other components of illness perceptions, such as how long ago 
symptoms started.  Other participants referred to stress and anxiety 
triggering symptoms or an attack.  One of the most prominent beliefs in 
the responses analysed seemed to be that stress is implicated in IBS, if 
not as a cause then as something that could enhance symptoms which 
has been found in existing work (Dancey & Backhouse, 1993; Hungin et 
al., 2005).  This belief may have come from a lack of or conflicting 
information about IBS, in that those affected may be informed to reduce 
stress and subsequently make a connection between such advice and 
forming a causal belief.   
 
Limitations of analysis 
The text analysed for the purposes of this write up illustrated evidence 
that individuals had constructed schematic representations of their IBS in 
line with components of illness perceptions according to the CSM 
(Leventhal et al., 2003).  There are however a number of limitations 
concerning the number of respondents, the length of responses and the 
top down approach to analysis that need to be considered.    
 
Firstly, not all participants responded to this section in the survey.  In 
terms of participation, 26.8% of the sample responded to the open 
survey question at the cross-sectional stage of the research.  It may be 
that in trying to corroborate findings from previous chapters in the thesis 
that crucial data may have been effectively lost.  However, the number of 
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participants whose responses were collated could be considered 
substantial for a qualitative study (Bryman, 2008). 
 
Furthermore, participant responses generally consisted of a few lines of 
text, rather than longer amounts of text that may typically be associated 
with qualitative data from interviews or focus groups (Bryman, 2008).  In 
this context, the collection of additional text from each participant may 
have been beneficial.  However, similar sized extracts of participant text 
have been analysed in previous work which extracted data from internet 
message boards (Brewer et al., 2007; Coulson, 2005; Im et al., 2009).  
O’Cathain and Thomas (2004) also argue that such an approach (i.e. 
utilising an open survey question) is entirely valid in the context of 
carrying out survey research to add a degree of validation to the findings 
of a ‘main’ quantitative study being conducted (Casebeer & Verhoef, 
1997).  Therefore these findings add corroboration and provide 
triangulation to quantitative findings presented in the thesis.  
 
Secondly, there may have been some loss in potential richness of data 
by using a deductive top-down approach (e.g. Boyatzis, 1998) to analysis 
rather than examining themes that emerged from the data in an inductive 
manner.  It is possible interesting or insightful themes in participant data 
may have been ignored by utilising the top-down approach.  This 
potential limitation however can be aligned to the context of the aims of 
the study, in that the study set out to examine evidence of illness 
perceptions in participants’ open responses at the end of the survey.  
 
Moreover, with respect to the top-down strategy to analysis (Braun & 
Clarke, 2006) and the fact that the open responses were recorded at the 
end of the survey may have resulted in a degree of priming.  In this 
context, answering questions about illness perceptions from the IPQ-R 
could have effectively primed participants to thinking about their IBS in a 
structured way.  However, any priming was hopefully minimised by the 
wording of the open question at the end of the survey which allowed 
participants to give both free and open responses about anything related 
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to their IBS.  Furthermore, previous work (e.g. Amouretti et al., 2006; 
Chang, 2004; Dancey & Backhouse, 1993) has identified similar issues 
such as consequences of IBS, without the possibility of priming with the 
IPQ or IPQ-R.  Inter-rater agreement on the themes was also strong, 
which indicated both researchers did detect evidence of illness 
perceptions in participant text. 
 
Finally, as highlighted in previous chapters, participants were largely 
recruited from a self-help website at one time point making it potentially 
more difficult to generalise these findings to the wider population affected 
by IBS.  There were obviously variations in times of diagnosis and 
differences in the duration in which participants had been affected by 
their IBS which may have affected how people expressed feelings about 
their IBS.  Participants may be asked to consider their beliefs about 
treatment, as the original intention of the research in this thesis was to 
explore an extended CSM (Horne & Weinman, 2002).  It appears that 
treatment beliefs are less important influences on participants’ quality of 
life judgements and it was noted that any reference to harm or overuse of 
treatment in responses was confined to a small number of participants.   
 
Furthermore, findings presented in chapter six, suggest the quantitative 
changes in many IPQ-R scores over two time points are minimal, a 
finding consistent with previous work in IBS utilising the IPQ (Rutter & 
Rutter, 2007).  Further qualitative investigation may be conducted over 
several time points to follow up how illness perceptions change over 
time.  The relationships between illness perceptions and coping 
strategies could also be explored by conducting future qualitative study 
over several time points.  
 
Many of these limitations may be addressed by conducting a full 
qualitative, possibly interview or focus group based study.  Such an 
approach may be beneficial to assess components of illness perceptions 
by asking specific questions based on each component (Goodman et al., 
2005; Meyer et al., 1985).  A full qualitative study may also offer 
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additional insights as to which illness and treatment perceptions could be 
subject to intervention to improve self-management of IBS.   
 
Conclusions and implications 
This write up has reported findings from participants’ text responses to 
an open question included in the cross-sectional study reported in 
chapters four and five.  This approach was justified as several existing 
studies have conducted similar top-down analysis using postings from 
internet message boards.  The findings presented here offer a degree of 
triangulation to add support that illness perceptions are important factors 
in IBS as has been found in previous work (Oerlemans et al., 2010; 
Rutter & Rutter, 2002; 2007; van Dulmen et al., 1997; 1998).  The text 
analysed demonstrated that illness perceptions appear to be prominent 
in participants’ thoughts when asked if there was anything they would like 
to express about their IBS.  This appeared to be regardless of whether 
participants used CAM or not to relieve their IBS.  Although each 
component of illness perceptions was encountered in participant text, it is 
possible that this could be primed by previous questions in the survey or 
by making participants think in a more focused manner about their IBS. 
 
The unique aspect of this study in including an open question at the end 
of a quantitative survey has also given some further insight as to where 
intervention could be targeted to assist with management of IBS.  
Specifically, interventions could help to facilitate control and coherence.  
Higher scores on these components (chapter five), were associated with 
greater reported quality of life.  The majority of respondents however, 
seemed to express that their IBS was not under control and they would 
like greater education and information from the medical profession about 
how best to manage their IBS.  Intervention could therefore be targeted 
to improve participant feelings of control and understanding of their IBS.  
This could extend as far as providing information for employers and 
business, as in expressing consequences of IBS, many participants 
referred to occupational issues and a lack of understanding from their 
employers regarding their IBS.   
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From an employers perspective reduced productivity due to IBS is 
problematic (Dean et al., 2005), so attempts to address this problem 
could have significant economic benefits.  One such intervention focused 
on IBD where employees valued the information provided for employers 
and thought it had greater impact if delivered by health care 
professionals or self help groups (Mayberry & Mayberry, 1993).  Cash, 
Sullivan and Barghout (2005) suggest any such workplace intervention 
focusing on IBS should be based on information provision for both 
employers and employees, providing incentives to adhere to treatment, 
and progress of any intervention is monitored at regular points in time.  
 
Emotional representations were also found to be important aspects of 
illness perceptions.  This again concurs with findings in chapter five, but 
which have been omitted from previous CSM research with IBS samples 
(Rutter & Rutter, 2002; 2007).  Addressing emotional representations 
with reassurance and information offers an opportunity to potentially 
reduce emotional distress related to IBS.   
 
The apparent prominence of illness perceptions when individuals were 
asked about their IBS shows the likelihood that these perceptions have 
the potential to influence the type of behaviours or strategies that will 
help them to cope with IBS.  From a theoretical perspective, many of the 
responses also show evidence of external influences on perceptions and 
how such influences may relate to illness perceptions, a factor that the 
CSM acknowledges (Leventhal et al., 1998).  The findings presented 
here highlight the importance of illness perceptions by demonstrating 
their importance in the thoughts of those affected by IBS and has added 
support to findings presented in previous chapters.  Illness perceptions 
may also represent target points for intervention to decrease use of 
health care services via improved management (e.g. van Dulmen et al., 
1996; 1997).   
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Appendix XVI: Participant text from open survey question 
 
[This is raw data, uncorrected and as provided in survey responses] 
 
 
(Participant 1, P1) 
I treat my IBS attacks with Gravol. I stay in bed and sleep as much as possible 
until the attack is over. 
 
P2 
I feel I've wasted about 15 years forever waiting to see Specialists and, because 
of Cancer, these are now speeded up somewhat but ever-changing Doctors and 
no suggestions as to do to alleviate symptons have brought me to research on the 
internet where I found this survey. Also very angry wasting 6 years mis-
diagnosed as a Coeliac - it ruined a lot of occasions. Symptons seem to be 
getting worse as I get older and make me feel very unwell for a lot of the time 
but I keep giving up hoping to find some way to lead a normally active life. 
 
P3 
long waiting lists for referals.doctors not understanding. no support 
 
P4 
I'm often told my condition isn't life threatening so just get on with it, but whilst 
non life threatening it is, it's life limiting and ruins everything 
 
P5 
I feel that it is due to lack of exercise.Something which is hard for me to 
address,due to family commitments.  Its down to me to deal with it, feel helpless 
at times to change the lifestyle. There never seems to be the right time. 
 
P6 
lack of social groups to relate + empathise with where i live 
 
P7 
The symptoms increase with the stress of work and decrease when away from 
work for holidays - my case work related  
 
P8 
the significance of brain cells-vide current research in that field.contribution of 
social interaction 
 
P9 
it is a dreadful condition which tries to rule your life and makes all aspects 
difficult and sometimes embarrassing. Life has to be mind over matter with a 
dteremination not to give in to it. 
 
P10 
I feel my IBS affected me for a term of 3-4 months, since then I have been 
almost satisfactory all but the bouts of annoying constipation, even though I do 
stick to pretty much the 5 a day and drink around 3 pints a water a day. 
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P11 
I'm Dutch (european) and living in the Netherlands. I have a very healthy diet, 
but still get IBS a few times a year :-(  
 
P12 
I would be interested in understanding the link between the brain and IBS. 
  
P13 
I have been in pain since having a tcre operation to reduce my periods 14 
months ago. I was diagnoised wth ibs when i had a scan the long probe like 
camera caused me pain on removal. I saw a gasterenterolist after who asked me 
about my symptoms. I cut out wheat since i met with her but my pain still exists. 
I have since paid for an intolrance test with showed i am wheat and lactose 
intolerant and afew other things but i am still in pain more often than not. Ireally 
have to think about what i am eating. I suffer with pain mainly with occaisional 
bouts of consterpation. I can,t see an end to it nothing seems to give any relief.  
 
P14 
I have only just been diagnosed with ibs 3 days ago, I have tried to answer the 
questions as best I can, I am researching myself to see if I can make it any better, 
I feel my doctor wanted to do what he wanted rather than what I wanted, he only 
prescribed me fibogel and when I asked him what I could take for the pain he 
suggested I take paracetamol (which I have tried and fails to work) I knew that I 
could an antispasmodic he wouldn't prescribe it to me, so instead I have had to 
go out and buy some (at a fiver a pack it's not really cheap, especially when I am 
entitled to free prescriptions) I really do hope I have helped but as I say it's only 
been a matter af days since my diagnosis, I do hope you do well in your research 
 
P15 
How many people have chronic back pain and IC aswell as IBS.Wondering if 
there is a link.Or perhaps with food intolerance 
 
P16 
I feel as if all the help and focus is on the people who suffer with the constant 
need for the toilet rather those of us who have the chronic constaption side 
which and most of the medications just make the pain and cramps worse 
 
P17 
people without ibs don't have a clue how horrible it is. i would rather have 
cancer, there is a cure, you either beat it, or you die. Living with ibs is waking 
up every day fighting a losing battle. you can't beat it. 
 
P18 
I was found to have a gluten intolerance some seven years ago along with 
collagenous colitis,but a recent examination did show that the colitis was not 
present anymore. Following an accident in 1989 i injured my spine which 
resulted in me having several spinal discs removed and having a spinal fusion.I 
was a heavy drinker since my teenage years but have not drunk alcohol for some 
six years 
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P19 
I was diagnosed with two parasitic infections (Entamoebae hystolitica and 
Giardia lamblia) while living in Africa in January 2001. Was recently diagnosed 
with Grave's disease (autoimmune hyperthyroidism) in March 2007. Severe, 
watery diarrhea up to 20x/day when symptoms at worst. Current medical student 
- feel free to contact me with any questions! 
 
P20 
Athough I have only recently been told that I may have IBS I have suffered for 
quite a few years with stomach/bowel disorders 
 
P21 
My IBS began after I had a severe bout of gastro-enteritis. I was well up to that 
point. I then contracted glandular fever resulting in M.E (PVFS). I do not 
believe that my IBS is caused by stress but has a physiological cause which is 
not yet fully understood. 
 
P22 
i am considering a food intolerance test to see if that can help 
 
P23 
After not being able to consume the herbal remedies that i was using; due to not 
being able to buy it in the UK. i haven't had my period in 2 months and i'm not 
pregnant. 
 
P24 
Very much food related 
 
P25 
i have just done an exlusion diet throgh my diabetic consultant, not from my 
doctors, i feel that they never see me when i am bad i have in the past resulted to 
taking photos, so they could see how large my stomach gets through eating. i am 
a 32 year old woman who is a size 10 2 12 and for the past 3-4 years has worn 
control pants, i must be the only person who loves winter for the fact that you 
wear more clothes so people cant see how fat you look,its not good at any age 
but worse when in summer your fella looks a girls wearing skimpy clothes and 
not you sat there with a maternity top on . 
 
P26 
i sometimes think excitement makes it worse as well as stress 
P27 
There is a lack of understanding of IBS. Too often it is proclaimed as a "stress 
related illness". As a result, sufferers often find that they are not taken seriously 
with their health issues and the impacts on their mental and social well being.  
 
P28 
I feel I've managed to control my ibs fairly successfully without the continual 
use of conventional drugs for the past 15 years(-mainly through the use of diet 
and herbal medicine) until very recently when it has become more erratic. I've 
just recently seen my gp about this. 
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P29 
Recovered alcoholic- sober 20yrs.Never used illicit drugs.Semi-addicted to 
prescribed Codeine phosphate 120mg/day-great for IBS,so need laxatives and 
Lepicol too,and colonic irrigation/mnth 
 
P30 
i decided to go down the herbal route, instead of chemicals like spasm control 
tablets as i personaly beliefit inbalances the human body, and to many toxics bad 
for the body.  aloe vera, peppermint oil tea, chinese herbs, ginger, i take 
everyday and find very helpful 
 
P31 
I would be more than happy providing information to help the development of a 
effective treatment for IBS!  I just had an attack and now that tomorrow is going 
to be another painful day... 
 
P32 
i was diognosed at the age of 16 with what was then called spastic bowel and 
now called ibs. so i have actually had the condition for over 30 years, some 
times it is very aggressive others mild but the only time i did not have any 
symptoms for a noticable lenth of time was when i was pregnant. 
 
P33 
VSL#3 Is very helpfull in reducing urgency and Diarohea 
 
P34 
My IBS symptoms may have large gaps inbetween flare ups. I just had one 3 
weeks ago; my last incident was a year and a half previously. I feel "normal" 
when not having an incident, and so far my flare ups have passed quickly with 
use of anti-spasmodic meds. My biggest mystery and concern is trying to figure 
out what causes it to start & stop. 
 
P35 
I feel that I had symptoms of IBS since early on in childhood. 
 
 
P36 
lists of medication people use 
 
P37 
I am surprised the survey did not ask questions about what medication I am 
using on GP's advice. I would like to know how successful my medication is 
compared to other peoples experiences. 
 
P38 
Doctors tend to put everything down to my IBS..I have now been told I also 
have a peptic ulcer and for months was told "it's just your IBS" 
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P39 
The most annoying is the constipation (somestimes a week) then diorreha 
(sometimes 6 times in a day) and the wind 
 
P40 
i do have 1-2 accidents during the night and cannot control them and the amount 
of underwear i have thrown away is unbelieveable, and when it does happen it 
causes me emberassment, and also i dont go out at all unless i know whether 
their is a tiolet nearby. i live like this everyday and feel like my IBS is 
controlling ME all the time. 
 
P41 
Nothing (other than immodium has any effect on my symptoms. I never leave 
the house without it! 
 
P42 
The most annoying thing about being diagnosed as having IBS, is the lack of 
advise in trying to help make the problem more manageable. Apart from the 
advise of 'taking the odd peppermint capsule' (which does nothing for me!). 
Sometimes I wonder if I actualy do have IBS and it wasn't just an easy answer to 
my problem...In other words, more advise and help is needed from doctors etc. 
 
P43 
I have the runs all the time and the pain is awful i have not eaten for 4 days now 
it just will not stop even with my medication i get from the doctor if i move 
about i have to run to the toilet its bad  
 
P44 
I feel that I have had little/no formal education on diet. I am concerned that 
others will not think to complete their own research to elivate their symptoms. 
 
P45 
diet changes have made a big difference 
 
P46 
My symptoms include frequent visits to the toilet, ie. three or four times a day 
 
P47 
Doctors don't seem very interested in trying to alleviate IBS. There are so may 
'alternative remedies' apparently available but no reliable guide on what does 
and doesn't work and what is safe. I have tried umpteen recommended 
supplements only to find that they are then withdrawn as potentially dangerous. 
 
P48 
I think it would be interesting and helpful to ask about different triggers for men 
and women.  
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P49 
I feel GPs need to be better advised of treatment. Some treatments only work for 
a short time. There should be IBS Clinics with diet plans etc. I also believe food 
intolerances play a part and all IBS sufferers should be tested. 
 
P50 
Was brought about by a very stressful job and overreliance on dairy. Can no 
longer tolerate dairy for the most part. 
 
P51 
I feel there is no definitive way in diagnosing ibs  
no effective conventional medication for bloating swelling change of diet helps 
but does not completely cure 
 
P52 
I believe that you should have asked questions about working life as one of the 
biggest causes of my anxiety is my job & the amount of sickness my IBS causes, 
leading to my employer taking disaplinary action against me 
 
P53 
My life changed following the 3 in 1 treatment for stomach ulcer 10 years ago. I 
was left with bloating, really loud stomach noises etc - I'd much rather still have 
the ulcer! 
 
P54 
Watery stools cannot be controlled and cause embarrassing events. You didn't 
ask about accidents. I am also curious that I do not have abd pain and/or cramps 
like most, just diarrhea. I had a 24HR urine test showing a lack of enzymes to 
digest carbohydrates. I take Pancreatic enzymes but it doesn't make any 
difference in diarrhea. An integrative MD says I need to balance my body back 
out. As a RN, I wonder if it's a nerve pathway that got turned on and now won't 
turn off, like in RSD. Also wonder if epigenetics plays a role, which would 
include environmental contaminants like pesticides, ATB, hormones, etc. Just a 
thought. 
 
P55 
I find having ibs very embarrasing even with my closest friends 
 
P56 
I strongly believe that the physical symptoms are caused by worry. I do feel that 
my constant anxiety about the fact that I may need the toilet in a hurry when out 
shopping, with clients or whatever is what maintains the problem. I have 
travelled extensively and have enjoyed holidays. I am now dreading my next trip 
due to the flight - should the seatbelt light come on and I need the toilet, waiting 
at the airport, getting a cab from the airport to the hotel - how long is the 
journey, what if I need the toilet en-route. What about walking around a strange 
city or getting on a tube. This is absolutely destroying my ability to enjoy any 
normal activity. A drive to the country with friends and my dogs was my 
favourite pastime; now it is my hell. 
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P57 
I couldnt work, or ead a semi normal life without loperamide  
 
P58 
I have had IBS since I was 15, I am now 39, and very fed up with it. 
 
P59 
It completelty affects my quality of life. I sit and think about all the missed 
opportunities and thing I could have done if I didn't suffer with this disease. I 
worry about the future. I worry I won't ever be able to have proper relationships 
because people will get frustrated with me and I worry I will be too ill to get a 
job. At 20 years old I hate the fact I have already given up on life. 
 
P60 
my diagnosis until a week ago was confused as being ibs and endometriosis, so 
the emphasis of treatment was put on the endometriosis. i now have re-evaluate 
all my treatments. 
 
P61 
several years ago i had a colonoscopy which suggested that my ibs could be 
connectwd with my monthly cycle.as the symptoms seemed a lot worse they 
have not got any better eventhough i am now going through the 
menopause.ihave tried the activia yogurts advertsed to help with digestive 
problems but they seem to have made mine worse.horrendous wind and the need 
to go to the loo very quickly and with very little warning leaving me very 
bloated and uncomfortable 
 
P62 
I do feel as though things started to go wrong when on holiday, when I ignored 
the urge to defecate for 4-5 days. As a result of this belief I largely blame myself 
for the condition. However, I also believe that all my health problems (IBS, 
Depression, postural problems) are related in some way and that the solutions to 
all lie in a holistic approach, rather than just treating them in isolation. 
 
P63 
First heard of IBS when diagnosed in 2003 but have had the symptoms since my 
mid-teens (l950's)  
 
P64 
I am awaiting to see a gastroentologist but my referral letter was lost en route to 
the hospital which was in July 07. Have since contacted doctor's surgery and 
they've resent letter which the hospital have now received and are putting me on 
waiting list even though original letter was in July and it's now Nov. Symptoms 
have been ongoing for over a year without a proper diagnosis and am 
considering getting a Food sensitivity test done to help with diet. Having a site 
like Gut Trust has been most helpful as I can relate to many of the symptoms.  
 
P65 
my ibs started while i was woring away from home on nights and i got food 
poisoning from reheated fish 
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P66 
It is very difficult to define IBS and I am sure my symptoms are relatively mild, 
so I dont really talk about it with anybody. I spend quite a lot of time in the toilet 
compare with my partner and he jokes about it sometime, even I call myseld 
"wee wee girl". But I dont think he knows about my bowel problem and the 
things happen in the toilet is just not something you would like to talk about 
even with your partner. I dont think I would bring it up with my GP but I will try 
to find some remedies and alternative methods to help me.  
I think it is a dilema. If the symptoms are more serious maybe people will realise 
it is a kind of illness and there's something wrong, and it would be easier to 
bring it up with others. People would understand why you need to go to toilet so 
often or so. But if it is mild and not as obvious, just like being constant bloated 
and having excessive wind, people wont understand that you are in pain or how 
unconfortable it could be.  
 
P67 
It is a very upsetting illness which i feel health professionals brush under the 
carpet and refuse to do extenssive tests to ensure it is ibs and not another disease 
such as cancer.the symptoms aswell do take over your life but you do try and 
control it as best as you can so you dont have to worry when you go out where 
the toilets are all the time just incase but also being a sufferer of ibs you have to 
learn to change your minds behaviour as well as to not to constantly think about 
it so you can have less episodes because to certain extent it also becomes a habit 
which you need to learn to break. 
P68 
i need to know good foods and bad foods.  Food to avoid that could make things 
worse for example! 
 
P69 
I fel that businesses and organisations i have been with since having ibs do not 
understand ibs and the effect it has on staff. They offer little or no support to 
staff regarding this illness and something needs to be done to make business 
aware that this is a real illness and that people can get ill from it 
 
P70 
I feel i have not been provided with enough information on IBS or Tests to see 
what i am intolerant too. 
 
P71 
Fed up with it straight into the loo as soon as i stand upright in the morning 
sometimes as many as 4 times before i leave for work i have done a physically 
demanding job for the last 28 years and this lot is not helping me at all brassed 
off 
 
P72 
i have been in and out of hospital over the last 3 years with very bad upper 
abdominal pain and nausea and vomiting ... ive been told it isnt linked to my ibs 
but i am not convinced i have omeprazole to stop acid reflux as this is something 
i suffer with the vomiting. 
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P73 
I think it may now be related to toilet phobia - I had an accident in town when I 
was very unwell a few months ago and have been phobic of not being able to get 
to a toilet ever since. This has exacerbated my IBS in a vicious cycle. 
 
P74 
I have suffered with IBS for 22 years, over the years I have tried to manage my 
symptoms with little success. I have approached several GP's over the years and 
discussed how a lot of my syptoms seem to be food related with regard to 
tolerance for some foods. As these foods or ingredients are difficult to identify 
without knowing which you canot tolerate I have requested tests to identify 
these, I have always been refused and feel my symptoms are dismissed I am 
currently looking to have these tests carried out by myself. This will Hopefully 
help!?  
 
P75 
My IBS first occured after I suffered from a spastic duodenum for three months. 
This altered my eating and bowel habits until it was diagnosed and treated. I 
believe this started the IBS which has been with me since. 
 
P76 
My doctor has decided to refer me to a consultant. This is over 3 months ago. He 
is not suggesting or wanting to talk about treatments.  
 
P77 
What i feel frustrated about is how my IBS comes in different forms. I hate that 
on a daily basis i have to worry about constipation but then during a really bad 
bout of IBS it is bloating and dhiarrea. I hate the fact that even though i don't 
feel any mental stress at all (i am a very laid back person) during busy work 
times i get a really bad bout of IBS. I also hate the fact that i feel like i will have 
to live with this forever - when i don't want to. 
 
P78 
yes, its constant,its painful, and i feel like i don't want go anywhere or do 
anything, cos i feel uncomfotable,my dr doesnt seem interested, im not even sure 
he's wriitten it in my notes, i've diagnosed myself and told him, he just accepts 
it, but doesnt offer any assistance,tests etc,20 yrs ive been like this and its 
affecting my work! 
 
P79 
I am 16 weeks pregnant and my symptoms have got worse it makes me worry as 
to the safety of my baby. 
 
P80 
I feel the anxiety,nausea and panic attacks and extreme fatigue have change my 
life and disabled me and are by far the worse part of this condition. 
 
P81 
would like something to relax me in mornings when I get up ,I think it is alot to 
do with being nervous 
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P82 
The general consensus on IBS tends to focus on food problems. I think there 
should be more focus on stress-related causes. Mine started when I was 14 and 
was being bullied at school. Each morning I'd suffer from cramps and need to go 
to the toilet. I know associate this (I think) with anxiety. It's a vicious cycle and 
one that I've not been able to deal with for 20 years. 
 
P83 
My IBS started after spending three months travelling around Europe. I 
experienced a stomach virus while travelling and my stomach just never came 
back to normal health. I believe I have the Post-Viral IBS.  
 
Most doctors here in the USA are more concerned about just covering up the 
symptoms of IBS with drugs that have tons of side effects instead of trying to 
find a cure. 
 
I can understand GP and family doctors not knowing a cure about IBS. But what 
I can not understand is in the year of 2007 how GI doctors who spealize in the 
digestive system not only do not know a cure for IBS, colitis, and Chrons but 
they don't even know the cuase or how to prevent such digestive upsets. 
 
I like the idea of natural cures but it's hard for someone to find the right 
combination to actually cure something. 
 
Holistic doctors I don't really trust because most of them turn into salesmen.  But 
even though holistic doctors are salemen, people start trusting them because 
those doctors are more focused on searching for a cure rather than just a band-
aid drug. 
 
GP doctors sometimes seem like nothing more than drug pushers who are 
controlled by drug compaines. And the drugs they give out are only band-aids 
that had bad side effects because they are not natural they alter the human body 
too much.  Sure doctors of the world can't find a cure things like AIDS or 
cancer. But in the year 2007, you would think that a GI stomach-doctor would at 
least have a cure for each case of IBS.  
 
I believe IBS is only "mental" when the adult IBS patient has been suffering 
since childhood or teenage times. Sometimes like that is cause by young mental 
trauma and these people need to retrain themselves, both in the mind and body 
in order to overcome the original tragic events. 
 
Other cases of IBS-A, IBS-C, IBS-D, and PI-IBS that were brought suddently in 
adult life, are due to overuse of aspirin and other OTC medidication, food 
additives destroyed good bacteria, and hidden travel parasites which unbalance 
the gut. 
 
GI doctors need to start to study each case of the patients that visit them and see 
if the IBS was adult onset or from childhood trauma.  
 
Regular GP doctors, especially in the USA, need to start spending more time 
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with each patient and let them ask more question. And they really need to stop 
spending their time being slaves to drug compaines and spend more time really 
reseaching for a cause and cure.  
 
If you read vintage books about IBS from the 1980s and even the late 1990s, 
many of these books (which were written by GI doctors) on talk about this 
mental stuff and they were only dealing with the people who had childhood 
trauma. 
 
The books that came after 2005 about IBS are a little bit better because some GI 
doctors finally started to figure out that each case of IBS is sort of indivdual. 
The GI docotr SHOULD ASK WHEN the IBS problems actually started. 
 
The books that came after 2005 are better also because finally they started to talk 
about probiotics and real natural things that can put the stomach back into 
balaence. 
 
IBS-childhood-trauma cases are the people who need anti-depression medicine 
and to spend time meditating.  Other IBS cases not caused by childhood trauma 
need the gut balanece corrected and the hidden parasites knocked out. The 
depression and aniexty that these IBS cases expereince was onset because of the 
fraustration of having no cure. 
 
The IBS-childhood-trauma cases have been experience on and off depression 
and aniexty since they experience the childhood or youthful trauma. 
 
Maybe one day, I hope, GI doctors will actually find a for something. I don't 
know how these stomach-doctors get paid for not being able to cure anything! 
How do they feel each time when they tell someone with IBS or an IBD that 
there is no cause and no cure? Do they feel bad, or is it just another day of the 
job? 
 
P84 
my ibs affects me in the mornings mainly , i feel as if i dont stop going and for a 
while i feel as if i need to go even if i dont . i do tend to panick if i cant get to a 
loo in time which makes going out quite a misery. 
 
P85  
explain why ?? with an ablation of colon I STILL have IBS symptoms ? 
although I have a cool and relaxed mind and am pleased with my quality of life. 
I am french,(no problem) ? 
 
P86 
Had radical hysteretomy 4 months ago for gyne problems. I feel that my recent 
hysterectomy and my problem scoliosis is the cause of my bowel problems and 
loss of bowel control and back and tummy pain. symptoms appeared 3 weeks 
after hysterectomy, possibly not helped by my doing too much physical activity 
within 2 weeks of my hysterectomy and my using herbal laxetives to purge.  
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P87 
Re the follow-up survey I'd be willing to take part but I'm not a UK resident so 
possibly I filled in teh wrong box for ethnicity...I am white Irish but not from the 
UK.  
 
P88 
Your survey is very thorrough and answering the questions makes some things 
seem more clear (such as the poor manner in which my consultant deals with 
me).  Thanks and all the best 
P89 
I have numerous day off from work because of IBS . which of course is a 
problem & have lost more than one job because of IBS. 
 
P90 
Currently I have been in contant abdominal pain for nearly four years and am at 
the point of trying to harm myself again as i see no end to this horriffic and 
dibilitating condition. I would also like to point out that anti depressants do not 
help the IBS and actally cause more contipation and pain as my doctor sugested. 
I managed to get off the mirtazapine for a while and felt much better which is 
further proof of this but then had to go back on it again due to poor sleeping so 
the vicious cicle of never being pain free continues. 
 
P91 
where can i get help with my IBS please ? 
 
P92 
it is very,very painful 
 
P93 
It really does control my life 
 
P94 
Most people assume IBS is only about diarrhoea and don't realise that painful 
constipation is also a symptom. 
 
P95 
I have suffered from this condition for 23 years. Now in the menopause and 
have put on about a stone in weight during the past two years.During my last 
pregnancy {aged 35}my symptoms went. after the birth they began again. It is a 
miserable contition and I am currently excluding wheat from my diet as a trial.  
 
P96 
My IBS is seriously affecting my career, due to the time off I have had due to 
my IBS. 
 
P97 
I only go out to work IBS has ruined my life and I am very often in tears over it, 
my relationship is suffering and at present no one understands and after 4 years I 
have had enough 
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P98 
Thank-you for the chance for having my voice heard, as a Psychology student I 
understand the importance of people particiapting in studies. I hope you find the 
answers you are looking for. Good Luck 
 
P99 
I feel contributory factors of the onset of IBS are stress related combined with 
poor diet and general quality of life. 
 
P100 
i feel that ibs may mask other health problems, and that worries me, other 
symptoms don't seem to fit the box. 
 
P101 
The symptoms and pain connected with IBS especially at night is very 
debilitating 
 
P102 
Late onset IBS symptoms (at age 57) started c10 months after cholecystectomy. 
GP is not at all convinced that this is the cause. He would prefer me to try a 
course of anti-depressants as he feels my 'social circumstances' (eg disabled 35 
year old daughter - living in special unit, elderly disabled mother - receiving 
domicillary care) mean that excessive stress is the cause. Whilst I acknowledge 
the stress, I am reluctant to take anti-depressants as the potential side effects 
could make me feel worse! I feel that my theory that the IBS is as a result of the 
operation should be given some consideration, but he would prefer me to try the 
anti-depressants route. I fear we are at an impasse! 
 
P103 
There seems to be an attitude of very much giving up among doctors. They send 
you to see a specialist and you try a couple of prescribed medicines but if they 
don't work then it's just "oh well, you just have to live with it then". 
 
P104 
My IBS is completely random in its frequency. I can have it badly every day for 
weeks and then it will stop apart from the usual menstrual cycle attack. No 
matter how much I analyse what I have eaten, been stressed by or any other 
factor in my life, the attacks of IBS appear to be random and impossible to 
predict ( other than the once a month ones and if a really major event happens to 
stress or upset me, eg: my mother and fathers deaths) 
 
P105 
ibs runs and ruins your life! 
 
P106 
I couldn't answer any question concerning hereditery as I was adopted 
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P107 
Doctors dont listen when I try to explain. They dont know the effect that this 
illness has on people. They dont even understand the cause. This has ruined my 
life and I feel as if there is no help available to me. 
P108 
it is extremly painful without treatment i would not wish it on anyone! 
 
P109 
Very little advice or direction was provided by NHS, I was basically told I had 
IBS, live with it. Don't eat things that upset it and avoid stress. I was offered no 
treatment and was told that I couldn't see a nutricianist as the waiting list was too 
long. When I have approached my doctor in the past I have found no help what 
so ever. I insisted that the tests where carried out to confirm IBS as my family 
has a history of coeliac disease. It has been through my own hit and miss trails 
of food and emotion diary entries that I have found (some) of the triggers. 
People think your being fussy or awkard when you decline food or try and 
explain you feel unwell. Even close family members sometimes look at you as 
though your making a mountain out of a mole hill. I have to carry spare clothes 
and toiletries with me because you never know when an attack may occur. 
Numerous times I have messed myself while shopping, it is extremley 
embrassing as well as inconvienent, especially trying to find a toilet to sort 
yourself out. Sorry! No-one else to rant to!  
 
P110 
urinary urgency plays a big part in my symptoms particularly when constipated. 
diareah often at the begining of period.  worry sets me off 
 
P111 
I dont feel that the questions had much relevance to my condition.This occurs 
three/four times a year.The severe and almost like childbirthpain is unbearable 
and lasts always 12 hours and the last time 17 hours.The Buscupan did not help 
at all this last time.  I dont know what starts it and I feel unwell for up to a week 
afterwards.  
 
P112 
I was told my the top professionals in my state that I had one the hardest to 
diagnose and most severe cases of IBS they had ever seen. I was also told 
frequently by many of the different healthcare professionals that it was all in my 
head and that I was crazy until I finally saw a specialist that recognized the 
symptoms. 
 
P113 
I undertook a 8 week course of Hypnosis recently and my symptoms of IBS 
have all but disappeared.  I costantly used to take Peppermint oil, charcoal 
tablets and always have Imodium and Mortilium tablets handy just in case of 
flare ups.  
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I still get the odd flare up but it passes as quickly as it arrives. Hypnosis is 
(hopefully) the best thing I could have done as I have more energy and am 
enjoying life alot more after the treatment. 
 
P114 
I find the website www.helpforibs.com useful for support and understanding. 
 
P115 
i am currently self managing, using stress management and relaxation exercises. 
 
P116 
My IBS is pain predominent. Every 3 months or so its so bad the only thing to 
ease the pain is morphine so i have my own supply from doctors. It effects every 
single area of my life and I hate it. Im off with it nearly a month every year so it 
effects my employment opportunities and i have to reply on my parents often to 
care for me. I suffer everyday and yet most people regard IBS as nothing, its 
nothing to me, its very severe and serious. 
 
P117 
feel doctors in this country are very reluctant to examine patients properly with 
IBS diagnosis. In the US they do colonoscopys etc, here they prod your stomach 
and say it's 'probably ibs'. had to fight to get referred to a gastroenterologist. (and 
still they only did 1 blood test) surely it's important to rule out coeliac, cancer 
and all other gut complaints before starting a course of treatment? 
 
P118 
I generally feel as though I am wasting the doctors time. In fact, one doctor 
actually counted out the number of times that I had been to visit the surgery in 
one year, in front of me, and told me this was unacceptable! As a result I felt 
ashamed, worthless and severely depressed (no surprises there then!) It has been 
a while since I suffered this bad with the symtoms, hence spending a Saturday 
night searching the web for help. (I am so relieved to have found this site...thank 
you). In fact, I have completed this questionnaire in tears! I have a stressful job 
managing a small but fantastic charity. Stress triggers my IBS which I find 
incrediby frustrating. I am currently in physical pain, I feel unattractive, 
unsociable and completely misunderstood! My partner is fed up with me 'always 
being ill' (he has now gone to the pub!). I now feel isolated and utterly fed up. I 
find myself becoming increasingly self-pitying and dramatic about it all ... 
'When will I finally learn to be a 'better' person and be able to control my IBS 
and live a normal life!' (Actually, writing this is making me laugh!) Deep down I 
know that I've just got to get on with it. 
Thank you for this opportunity to get my frustrations off my chest. I've stopped 
crying now. :) 
 
P119 
I truely wish they could find a cure or medication that will help as I don't beleive 
that they realize how much it effects your quality of life! 
 
P120 
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My I.B.S has taken my life away. I now have verry little quality of life. I now 
can only leave the house rarely, due to pain, wind, mucus, dihorear, & 
constipation 
 
P121 
I feel my Dr is not interested and I'm nnot sure where to go for help or what else 
to try 
 
P122 
I think when doctors first diagnose the person with ibs, they should provide 
support. All I got was one meeting with a dietician. 
 
P123 
Is IBS life htreatening or can it lead to more serious illnesses 
 
P124 
food intolerance plays a 99% role in my ibs 
 
P125 
Currently looking into having further tests done as pattern and severity has 
increased and to rule out ovarian cancer or hormone problems (monthly probs 
that mirror ibs symptoms but may not be and i always blame ibs for everything) 
 
P126 
Very little support is provided to determine the triggers of IBS to assist in self 
management. Only offered by Docs after several years of complaints and trial of 
various drugs! 
 
P127 
I find in general that GPs and Consultants just shrug their shoulders and you are 
told to "get on with it" 
 
P128 
i do not no a lot about it and it would be nice to lern more about it and what you 
can eat and what not. 
 
P129 
I have suffered an anal fistula and another abcess in the past year. The fistula 
requiring surgery. 
 
P130 
I have found out that certain foods eg bananas brown bread and some cheeses 
effect my condition so I avoid these at all costs. 
 
P131 
Recently my IBS has been extremely bad. I have a possible duodenal ulcer 
which has made me want to eat more which has an effect on my IBS. Also I had 
an exam so my stress levels were higher. I have recently undergone a blood test 
for food intolerance which was positive. I am waiting for the results of an in 
depth blood test to find out which foods I am intolerant to and will eliminate 
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these from my diet to see if that will alleviate my IBS and asthma. My doctor 
hasn't been much help with this. 
 
 
P132 
my ibs ruins my life at times i seem to be free of it and the momment i plan to 
do anything eg go on holiday go out ,along it comes again, sometimes are worse 
than others  
 
P133 
That the most annoying thing is that it seems to be my emotions that control it, 
like excitement or worry. If it was triggered by food I would just avoid the food 
that caused it, but emotions such as worry are hard to control at the best of 
times; even more so when you feel cramps and you are on a bus half way 
towards your destination. 
 
P134 
I would like to understand more about IBS i dont understand why I have the 
illness and I don't understand if it will get better or not. My IBS totally affects 
my life I nerver know how I'm going to feel, somedays I am fine but others I feel 
extremely. i have had 11 weeks off sick in the past year. 
 
P135 
I think the hardest part is when your consultant cannot find any REAL problems 
and sends you away to get on with it! 
 
P136 
I had an operation at 3 weeks of age called pyloryx stenosis (my feeding tube 
was squashed?/) Mu mother also died from pancreatic cancer but was originally 
diagnosed with gall stones 
 
I have never been allergic to anything and am really baffeld as to why this 
condition rears its ugly head randomly and so severely. 
 
P137 
Because the pain can be so intense it is difficult to accept their is not a more 
serious condition underlying. It seems you get tested for everything possible, 
and when their are no positive results for any other condition it is declared you 
have IBS. 
 
P138 
suffered from chronic fungal infections for over 30 years (skin and thrush) 
given penicillin daily for over a year as a child for 'glandular fever' and tonsillitis 
 
P139 
Main feeling when I saw my GP after diagnosis was that as I don't have the 
'more serious' inflammatory bowel diseases I should go away and get on with it. 
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P140 
I have noticed my IBS symtoms are worse in the days before my period starts. I 
suffer badly from fatigue 
 
 
P141 
had a nervous breakdown because of my ibs  
 
P142 
to date I have both received & read conflicting advice & so don't know whether 
I'm doing right for doing wrong! 
 
P143 
Tried all 3 prescribed medicines for IBS and none of them worked, tried several 
free-from diets and herbal remedies and none seem to have worked so far. 
 
P144 
I feel a bit annoyed about the information available. For example some 
alternative treatments and IgG tests promise a cure. I can possibly believe one 
would offer a cure or some understanding, but not all of them. Hence there 
should be some control over claims people can make. 
 
P145 
There is nothing that triggers IBS for me 
 
P146 
Felt fobbed off by first doctor, only seeing another doctor i was referred for tests 
to rule out other things that could cause symptoms. 
 
P147 
My IBS starts as soon as I wake up in the morning, so any appointments I may 
have to make, have to be after midday. Some days I feel so weak that I have to 
spend the day in bed. It means that I miss out on a lot of LIFE. 
 
P148 
Have had it since 1974. Have learned to live with it. 
 
P149 
I think peoples perception of IBS is a contributing factor. If IBS comes from 
stress then making people fell nervous and anixous about thier problems 
hieghtens stress levels. (Excuse any poor spelling english was not my best 
subject!) 
 
P150 
most of the woman on my mum's side of the family have IBS 
 
P151 
I have felt more comfortable about my IBS since joining THe Gut Trust the 
national Charity for Irritable Bowel Syndrome in the UK. www.theguttrust.org  
 
 436 
P152 
significantly worse in the last 2 years 
 
P153 
I dont think GPs understand the level and intensity of the pain suffered on a 
daily basis by many IBS suffers like myself - they never believe how bad the 
pain is or the level of bloating that occurs - i was told it was my imagination  
 
P154 
Tendency to faint due to pain 
 
P155 
It would be really helpful if IBS sufferers were allowed to use disabled toilets! 
 
P156 
The best way I have found to control all the symptoms is regular ibruprophen 
 
P157 
I often feel very specific lower left pain (which has been investigated), which 
feels as if I've pulled a muscle on the inside.  
 
P158 
I feel that IBS in a misunderstood illness that people do not understand unless 
they live with it. It is not just the bowel problem it causes various other 
problems such as depression etc. It is about time that it is recognised for what it 
is. It is a disability. Thank you. 
 
P159 
IBS attacks are totally unpredictable and cause me a great deal of depression as 
I've suffered from it for 33 years. 
 
P160 
Do people with IBS have a increased chance/risk of developing bowel cancer? 
 
P161 
We need stronger pain killers and to be taken seriously 
 
P162 
antibiotics!!!!!!!!!!!! 
 
P163 
diet controlled 
 
P164 
do you feel ibs is related to candida ? 
 
P165 
When I was diagnosed as having IBS I was not convinced. However as IBS is 
such a vague description I have had to accept this. I have not had a normal 
bowel movement since having surgery two and a half years ago for a bladder 
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condition and removal of ovaries. I have never felt constipated but do suffer 
from severe bloating, unpleasant wind and chronic diarrhoea. Bowel movements 
are always extremely loose and can occur any time during the day or night. I do 
not like to leave the house or where I have eaten, eg. restaurant etc. for at least 
an hour after. Prior to surgery I did not have a bowel problem. I was as "regular 
as clockwork" every morning after breakfast. Occasionally if I was going on 
holiday or some other important event was imminent I could dash to the loo on 
the morning of the holiday/event but that was it for the day. Normal service was 
quickly resumed! Various treatments were suggested but these did not make any 
difference. Nor does what I eat, I have used processes of elimination without 
effect. One day a certain food may cause a great upset when it has not done so 
before. The specialist I saw said the IBS could be due to various factors, i.e. 
stress after the operation, physical and psychological. However, I have had 
operations in the past and this problem did not occur then. I have always been 
pleased that operations have been successful so I could get on with my life. This 
is all a complete mystery to me as well as being a great inconvenience. I hope 
your survey will assist in the search for treatments for IBS. 
 
P166 
I found taking pre-bio 7 tablets very useful, and I have been able to manage my 
IBS allot better since taking them. 
 
P167 
my psychologist first pointed out the link between my starting on 
antidepressants and the first major flare up of my IBS, i found colpermin really 
helped with the pain, but not much helps with the diarrhoea 
 
P168 
IBS affects my life a great deal. I can no longer happily or confidently go to 
restaurants as I always need to urgently need toilet soon afterwards and 
sometimes even mid-courses. 
 
P169 
I elimated foods to help with my symptoms and now eat them in moderation 
 
P170 
the symptoms seem to follow a cycle, and it always gets into a vicious circle of 
anxiety that triggers it then it gets worse from the symptoms, and it always of 
course happen at the most inconvenient time. Staying at home with regular diet 
exercise and no stress would cure it, but for the boredom it would not be worth 
it. Imodium has made the single biggest improvement, taking it as a preventative 
measure when needed has restored a lot of my confidence and made the 
condition manageable to a certain extent. P 
 
P171 
Hi, i just wanted to clarify that i dont think my GP is rubbish or anything, Ive 
heard them say there isn't a lot out there for IBS except the couple of anti 
spasmodic drugs that i have tried. By far, the most successful IBS remedy i have 
tried has been natual Aloe Vera juice by a company called Forever Living. The 
stuff tastes awful but it really helped eliminate the bloating and that "urgent" 
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feeling. Im still trying to find something to control the really sharp cramps i get 
in the mornings.  
 
P172 
I had bowel cancer about 10 years ago. 
 
P173 
Had IBS since childhood 
P174 
Good luck with your research 
 
P175 
It is an extremely painful existance on a day to day basis yet no specialist can 
tell you much about it, there's no known cause and no known cure, basically you 
are sent away and told to live with it, basically live in missery!!! I am so ill and 
exhausted with it and have no live!! 
 
 
 
